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ABSTRACT 
 Human Immunodeficiency Virus 1 (HIV-1) remains a significant public health 
concern due to the lack of a cure. In spite of anti-retroviral therapies, HIV-1 persists 
within infected cells as integrated transcriptionally silent proviruses. Re-activation after 
therapy interruption results in new HIV-1 replication. Attempts to clear this reservoir 
through the use of latency reversing agents by targeting cellular mechanisms that 
maintain HIV-1 in a latent state have been unsuccessful. In addition, subsets of latently 
infected cells exist within the reservoir that display differential capacities for provirus 
induction. In order to understand the nature of the reservoir and manipulate it 
therapeutically, more knowledge is needed regarding factors that bias a virus towards 
latency or replication at the time of infection.   
 Because multiple mechanisms that regulate HIV-1 transcription, including 
chromatin remodeling, transcription factor activation and polymerase pausing, are 
regulated by the T cell receptor (TCR), I hypothesized that signaling at the time of 
infection determines proviral fate. I transduced Jurkat cell lines and primary CD4+ T 
	 xi 
cells with chimeric antigen receptors (CARs) that mimicked signaling from the TCR. 
These CARs spanned a 3-log range of binding affinities for their ligand, providing a 
tunable model. High levels of TCR stimulation during infection biased cells towards 
productive replication and the formation of an inducible latent reservoir. Examination of 
the mechanisms downstream from TCR signaling revealed that robust cellular activation 
led to a release of the repressor Negative Elongation Factor from the paused RNA 
Polymerase II, facilitating transcriptional elongation. 
 Because signaling determined the presence of repressive factors, I sought to 
manipulate the balance between latency and expression through recruitment of repressors 
to the HIV-1 provirus using a nuclease-deficient CRISPR Associated Protein 9 fused to a 
Krüppel Associated Box Domain. I screened a pool of guide RNAs that mediated 
transcriptional repression of HIV-1. Our lab discovered that guides bound to the HIV-1 
Long Terminal Repeat prevented viral re-activation in an integrated cell model of HIV-1 
latency.  
 The research presented here confirms my hypothesis that signals during infection 
have prolonged effects on latency reversal. I provide evidence that manipulation of these 
mechanisms represent therapeutic targets for cure efforts. 
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CHAPTER ONE: INTRODUCTION 
 
The Emergence and Pathology of Human Immunodeficiency Virus-1 
  
 Human Immunodeficiency Virus-1 (HIV-1) was first reported in a notice from the 
Centers of Disease Control on June 5, 1981 (CDC, 1981). This medical newsletter, which 
identified an outbreak of Pneumocystis pneumonia among homosexual men in Los 
Angeles, quickly brought attention to the spread of a contagious immunodeficiency. The 
underlying immune dysfunction, Acquired Immunodeficiency Syndrome, would later be 
discovered to be caused by the virus now known as HIV-1 (Gallo and Montagnier, 2003). 
 HIV-1 evolved from SIV or Simian Immunodeficiency Virus (Ringler et al., 
1987; Smith et al., 1988). SIV consists of several species-specific strains that circulate 
among non-human primates, usually resulting in minimal symptoms and long-term 
tolerance (Bostik et al., 2001). Cross-species jumps of these various strains from non-
human primates into human hosts have led to the emergence of both HIV-1 and the 
related virus HIV-2. HIV-1 shares significant homology with the chimpanzee variant of 
SIV, known as SIVcpz, and most likely originated in central Africa in the first half of the 
20th century (Gao et al., 1999). The HIV-1 major groups M, N, O, and P arose from 
separate evolutionary cross-over events from SIVcpz or SIVgor (gorilla) and required the 
acquisition of the ability to inhibit key human restriction factors, so named for the ability 
to restrict viral replication (Sauter and Kirchhoff, 2019). In particular, HIV-1 Group M, 
which evolved from SIVcpz, can robustly inhibit a key restriction factor, tetherin, and 
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thus constitutes the majority of viruses responsible for the current human pandemic 
(Sauter et al., 2009)  
 HIV-1 spread to North America due to increased travel and globalized commerce 
in the mid-1900’s. Once in the United States, the virus spread quickly among Haitian 
immigrants, men who have sex with men (MSM), and hemophiliacs, who were 
susceptible to infection due to their need for frequent blood transfusions (De Cock, Jaffe 
and Curran, 2012). Mass hysteria over both the source of AIDS as well as the mode of 
transmission led to a concerted effort by the National Institutes of Health, the Centers for 
Disease Control, and the Institut Pasteur in Paris to fund AIDS-related research. These 
experiments culminated in the landmark discovery of HIV-1 in 1983 as the causative 
agent of AIDS in North America and Europe by Luc Montagnier and Françoise Barré-
Sinoussi (Barré-Sinoussi et al., 1983). 
 We now know that HIV-1 results in a depletion of the lymphocytic CD4+ T cell 
population. This weakens the adaptive immune response, rendering the host vulnerable to 
a wide variety of opportunistic infections (Frazer et al., 1986; Shearer et al., 1986). Early 
AIDS-identifying diseases included Pneumocystis pneumonia, Kaposi’s sarcoma, and 
toxoplasmosis from Toxoplasma gondii (Pitchenik et al., 1983). With the advent of 
antiretroviral therapies or ART in 1986, remarkable progress has been achieved in 
preventing the onset of AIDS (Mitsuya et al., 1985). This progress was particularly 
enhanced with the design of combination therapy involving cocktails of inhibitors 
(Tisdale et al., 1993). However, in spite of cART, lifelong infection with HIV-1 still 
results in greater risk of cardiovascular disease, kidney failure, and neurocognitive 
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impairments (Freiberg et al., 2013; Guaraldi et al., 2011; Simioni et al., 2010). Patients 
experience permanent immune dysfunction, even after full viral suppression. Persistent 
exposure to viral antigens results in both immune exhaustion and constant inflammation 
(Hunt et al., 2003; French et al., 2009; Hatano et al., 2013). Antiretroviral therapies, 
while essential to prevent progression to AIDS, also cause a number of serious side 
effects including loss of bone density, gastrointestinal discomfort, and hypersensitivity 
(Güerri-Fernández et al., 2017; Santos et al., 2017; Wu et al., 2017). 
 The use of Truvada as pre-exposure prophylaxis (PrEP) beginning in 2012 has 
dramatically changed the trajectory of the HIV public health epidemic. Prescribing 
Truvada to high-risk populations has substantially reduced the spread of the virus (Grant 
et al., 2010). However, neither cART nor PrEP has resulted in a cure for HIV-1 or the 
end of its transmission. In fact, although new infections of HIV-1 within the United 
States have plateaued, infection with HIV-1 is still a matter of much stigma and remains 
prevalent both in poorer regions of the southeastern United States (CDC, 2018) as well as 
Southeast Asia, Eastern Europe, and sub-Saharan Africa (Stuart et al., 2018). Seventy 
percent of all HIV cases occur in sub-Saharan Africa where access to PrEP is extremely 
limited (Kharsany and Karim, 2016). Other groups that are still particularly susceptible to 
infection include MSM, sex-workers, IV-drug users, and minority women (CDC, 2018; 
UNAIDS, Guidance Note on HIV and Sex Work, 2019). Even with proper education and 
increased societal awareness, adherence to medication remains a major barrier to viral 
suppression. Thus, eradication of HIV-1 remains a significant challenge. The United 
Nations has prioritized a strategy, referred to as 90-90-90, in which the global medical 
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community aims to achieve 90% diagnosis of HIV, 90% ART-treatment among those 
diagnoses, and 90% viral suppression among those taking ART (Stover et al., 2016). In 
tandem with this approach, there have been significant efforts to create a broad spectrum 
HIV-1 vaccine, but none of these strategies have so far completely prevented the spread 
of HIV-1 or led to a cure (Rerks-Ngarm et al., 2009; Gray et al., 2011). These factors all 
indicate that continued efforts must be made to eradicate HIV-1 and end both the terrible 
medical burden and social stigma caused by this virus. At the time of this publication, 
more than 35 million people have died from AIDS-related illnesses, including 1 million 
people in 2017 alone (UNAIDS, Global HIV & AIDS Statistics, 2019). 
 
The Life Cycle of HIV-1 
  
 When HIV-1 enters the human body, it is presumably trafficked through the 
mucosa by antigen-presenting cells or APCs (Hladik et al., 2007). These APCs, including 
dendritic cells, Langerhans cells, and macrophages, play an important role in bridging the 
innate and adaptive immune responses. They endocytose pathogens before trafficking 
them to the cell surface in conjunction with an MHC Class II complex (Roche and 
Furuta, 2015). This presentation along with secondary stimulation by cytokines or cell 
surface receptors can trigger a specific response in lymphocytes for which the epitope of 
interest acts as the cognate antigen. 
 Eventually, HIV-1 is delivered by APCs to the lymph nodes, where it spreads to 
various target cells including macrophages, dendritic cells, and the primary reservoir of 
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CD4+ T cells (Barré-Sinoussi et al., 1983; Armstrong and Horne, 1984; Koenig et al., 
1986). The fact that HIV-1 can infect the APCs that present it to its various target cells 
highlight the dual role that can occur within dendritic cells and macrophages. Both direct 
infection and trans-infection through antigen presentation provide two routes through 
which HIV-1 can spread and highlight the importance of cell interactions to viral 
transmission (Cameron et al., 1992; McDonald et al., 2003). For dendritic cells, the 
differentiation state determines which of these routes can occur; for instance, trans-
infection via CD169, a cell surface lectin, is associated with mature DCs (Puryear et al., 
2013). 
 HIV-1 target cells contain the necessary receptors for viral entry: CD4 and a 
coreceptor of CCR5 or CXCR4 (Feng et al., 1996; Deng et al., 1996; Dragic et al., 1996). 
Founder viruses use CCR5 for viral entry and are referred to as R5-tropic. The 
progression to dual-tropic or X4-tropic viruses, which exclusively use CXCR4 for entry, 
is associated with both onset of AIDS and a depletion of R5-expressing cells (Connor et 
al., 1997). This coreceptor switch does not occur in all HIV-infected patients. 
 The HIV-1 virion is spherical and marked by a limited number of glycoprotein 
envelope spikes (Zhu et al., 2006). It consists of a lipid membrane derived from its 
previous host cell (Nguyen et al., 2000) and contains an internal capsid harboring two 
copies of its genome as viral RNA (Chen et al., 2009). In addition, it packages essential 
proteins for its replication, including reverse transcriptase, integrase, and its transcription 
factor Tat (Huang et al., 1994; Bosso et al., 2015; Kessl et al., 2016). In addition, the 
viral accessory protein Vpr or Viral Protein R is also packaged and is required for robust 
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transcription in dendritic cells (Miller et al., 2017). When the HIV-1 envelope binds to its 
appropriate receptors, it triggers fusion with the cell membrane (Maddon et al., 1988). 
Fusion is thought to occur through a suggested series of intermediate steps, in which the 
outer glycoprotein trimer, referred to as gp120, engages with CD4. This allows the 
coreceptor binding site to become accessible; the HIV-1 fusion peptide then can interact 
with the target cell, forming a hairpin which pulls apart the cell membrane and 
facilitating the delivery of the virion (Chan and Kim, 1998; Wang H et al., 2016). 
 Upon entry, HIV-1 unloads its capsid into the cell cytoplasm. Within the capsid, 
the RNA genome is reverse-transcribed into complementary DNA. Although the exact 
timing of reverse transcription has not yet been elucidated, it is believed that reverse 
transcription is completed by the time of nuclear entry (Rankovic et al., 2017). Reverse 
transcription and capsid disruption is tightly correlated as revealed by a recent study by 
the Rousso lab at Ben-Gurion University using time-lapse atomic force microscopy to 
reveal that pressure inside the capsid increases due to the presence of newly formed 
DNA, eventually leading to capsid dissociation. After interaction with the nuclear pore 
complex, the capsid dissociates and the new cDNA is integrated into the host genome by 
the viral protein IN or integrase. HIV-1 is preferentially integrated into introns of actively 
transcribed genes (Han et al., 2004), most of which would be located in euchromatic 
regions near the nuclear pore (Marini et al., 2015; Acuthan et al., 2018). The integration 
site is one of several key factors that determine whether HIV-1 is transcribed. At this 
point, HIV-1 expression is regulated not only by its transactivator Tat but also by the 
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general cellular factors that control gene transcription. This dependency on the host cell 
will be critical to the experiments I outline in this dissertation. 
 Once integrated, the viral genome is referred to as a provirus. This provirus is 
transcribed by the host RNA Polymerase II (RNAPII) for the purpose of making new 
viral RNA or transcribed and translated for the purpose of making new viral proteins. 
HIV-1 transcription is regulated by the binding of specific host factors to the 5’ Long 
Terminal Repeat (LTR). The provirus is flanked on either end by an identical LTR that 
acts as the HIV-1 promoter (Patarca et al., 1987). The presence of both LTRs is directly 
responsible for the capacity of reverse transcriptase to copy the entire genome including 
both the 5’ and 3’ untranslated regions. A number of transcription factors are known to 
bind to the HIV-1 LTR (and downstream sites) including NF-κB, AP-1, SP1, and NFAT 
(Calman et al., 1988; Franza et al., 1988; Garcia et al., 1987; Lu et al., 1991). The 
binding sites of these transcription factors, as well as the structure of the entire provirus, 
are shown in Figure 1.1. During the early stages of transcription, the HIV-1 transactivator 
Tat binds to a specific stem-loop structure in the nascent RNA referred to as the TAR 
region (Hauber and Cullen, 1988). During this process, Tat recruits the host factor P-
TEFb or Positive Transcription Elongation Factor, which hyperphosphorylates the C-
terminal domain of RNAPII. Phosphorylation results in transcriptional elongation and 
successful polymerase processivity (Napolitano et al., 2000; Barboric et al., 2001). P-
TEFb cycles between an active state that is free to phosphorylate RNAPII and an inactive 
state in which it is sequestered by the 7SK RNA complex (Yang et al., 2001). While the 
cellular signals that permit disassembly of the 7SK RNA – P-TEFb complex are not fully 
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elucidated, it has been shown that UV damage or MAPK signaling as a result of TCR 
engagement can activate P-TEFb (Yang et al., 2001; Kim et al., 2011). Therefore, 
successful HIV-1 transcription is regulated by both Tat fluctuations and P-TEFb activity 
(Weinberger et al., 2005). In addition, the use of dual-fluorescence viruses that contain 
both inducible and constitutive reporters has indicated a more general role for cellular 
activation on productive infection (Duverger et al., 2009; Chavez, Calvanese and Verdin, 
2015). Cells with high basal levels of NF-κB are biased towards viral replication and 
away from transcriptional repression (Dahabieh et al., 2014). 
 
Figure 1.1: Binding sites of a select number of key transcription factors to the HIV-1 LTR. (A) HIV-1 
proviral genome including both the 5’ and 3’ LTR’s. (B) Detailed diagram of 5’ LTR including binding 
sites of a select number of key transcription factors, transcriptional start site (referred to as TSS), and 
locations of U3, R, and U5 regions. This figure adapted from (Colin and Van Lint, 2009). 
 
 An additional block to HIV-1 replication occurs at the level of splicing. Because 
HIV-1 encodes its genome as a polycistronic RNA, efficient splicing is required for full 
expression of all viral products (Purcell and Martin, 1993; Emery et al., 2017). The first 
5’ LTR gag
pol
vif
vpr tat
rev
vpu env nef
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nt 1 nt 455 nt 552 nt 638
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RNAs to emerge from the nucleus are fully spliced and contain the transcripts for HIV-1 
Rev and HIV-1 Tat. This is followed by partially spliced transcripts that encode for the 
accessory proteins and the viral envelope. Finally, unspliced RNA enters the cytoplasm, 
resulting in both new copies of the viral genome along with the HIV-1 Gag and Pol 
polyproteins (Stoltzfus, 2009). Because only fully spliced transcripts are exported 
through normal cellular mechanisms, both the partially spliced and unspliced RNAs 
require the HIV-specific Rev-dependent export pathway (Fischer et al., 1995). 
 While a subset of the unspliced RNA remains untranslated as viral RNA, the 
remaining transcripts must be translated by the cellular ribosome. Together, the viral 
capsid, various accessory factors, and the newly synthesized genomic RNA converge at 
the cellular membrane, where they bud to form a new virion (Sundquist and Kräusslich, 
2012). The assembly at the lipid surface requires binding between PtdIns(4,5)P2 and the 
matrix peptide of the Gag polyprotein (Saad et al., 2006). The virion then co-opts the 
cellular ESCRT pathway due to indirect interactions between ESCRT factors and the 
HIV-1 p6 region of Gag to mediate scission from the cellular membrane (Sette et al., 
2016). In doing so, the virus acquires its outer lipid leaflet from the host cell. Further 
maturation by HIV-1 protease results in production of various Gag and Pol proteins, 
including, but not limited to, matrix (MA), capsid (CA), nucleocapsid (NC), reverse 
transcriptase (RT), integrase (IN), and protease (PR) (Swanstrom and Wills, 1997). 
Further rearrangements due to binding between these various proteins and movements of 
capsid into a conical structure results in the formation of a newly infectious particle, 
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capable of undergoing additional rounds of infection (Frank et al., 2015). A depiction of 
the life cycle of HIV-1 is shown (Figure 1.2). 
 
Figure 1.2: Life cycle of HIV-1. Major steps of the HIV-1 life cycle are shown, with emphasis placed on 
the stages where the virus is under the control of host cell machinery, including transcription / translation. 
 
HIV-1 Latency 
Biology and Model Systems 	 		 When the development of cART resulted in the suppression of viremia below the 
limit of detection, it was thought that a complete absence of viral replication would allow 
the host immune system to eradicate HIV-1 since infected cells will eventually undergo 
apoptosis due to either the cytopathic effects of the virus or clearance by NK cells and 
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CD8+ T cells (Koup et al., 1994; Petravic et al., 2014). If these infected cells were 
simultaneously blocked from producing new infectious particles, then a short course of 
ART would theoretically be sufficient to eliminate HIV-1 infection. However, in the 
years following the widespread use of ART, not one patient has achieved a cure through 
this mechanism (Chun et al., 1997). In fact, after decades of antiretroviral treatments, 
even a short interruption of medication results in a predictable rebound of viremia as 
depicted in Figure 1.3 (Van Lint, Bouchat and Marcello, 2013). This is due primarily to 
the persistence of silent proviruses in long-lived memory CD4+ T cells. 
Figure 1.3: HIV-1 rebounds after cART interruption. Depiction of patient viral RNA levels as 
measured by RT-PCR both before and after antiretroviral therapy. Figure based on (Van lint, Bouchat and 
Marcello, 2013). 
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 As a component of the adaptive immune system, CD4+ T cells and their progeny 
clones survive long-term and form the basis of immunological memory (Rogers, Dubey 
and Swain, 2000; Boyman et al., 2009). If HIV-1 is integrated into these cells and if these 
cells do not produce any viral products that could be recognized by the immune system, 
the virus can evade detection. This phenomenon, known as HIV latency, forms the 
primary barrier to a cure for HIV-1. Like any normal cellular gene, HIV-1 can be either 
expressed or repressed. This repression thus prevents viral spread but also shields 
infected cells from antiviral immunity (Finzi et al., 1997). The HIV-1 latent reservoir is 
also maintained by clonal proliferation of latently infected cells, which has been shown to 
allow for cellular duplication without viral re-expression (Wang et al., 2018). 
 Our understanding of the mechanisms which maintain HIV-1 in a latent state 
derive from a number of in vitro models of HIV-1 latency as well as analysis of cells 
removed ex vivo from patients on ART. Among patients with full viral suppression, latent 
provirus has been discovered primarily in resting memory CD4+ T cells. These include 
both transitional memory and central memory subsets (Chomont et al., 2009). PCR 
analysis has confirmed that roughly 1 in 1000 target resting cells are latently infected, but 
it is estimated that only 1 in 1,000,000 target cells contain an inducible latent provirus 
that can easily be re-activated as measured by the viral outgrowth assay or VOA (Ho et 
al., 2013). To perform the VOA, researchers remove peripheral blood mononuclear cells 
(PBMCs) and culture them in limiting dilution along with target cells for HIV-1. The 
PBMCs are then reactivated with phytohaemagglutinin or PHA, which although highly 
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toxic, is a gold standard for latency reactivation in vitro. HIV-1 expression is then 
measured by p24 ELISA (Siliciano and Siliciano, 2005). 
 Although latent HIV-1 has been isolated primarily in CD4+ T cells and is most 
widely studied within this population, it is important to note that this is not the only 
cellular reservoir for latent provirus. Gammadelta or γδ T cells have been described as a 
target for HIV-1 infection and a source of rebounding virus following treatment 
interruption. γδ T cells have an important role in modulating the immune system and 
assisting other cell types, especially at barrier sites including the skin and mucosa (Paul et 
al., 2014). Although less than 10% of γδ T cells are CD4+ in vivo, HIV-1 still requires 
the expression of CD4 in order to bind (Imlach et al., 2003). HIV-1 can be isolated from 
γδ T cells in patients infected with HIV-1 on ART (Soriano-Sarabia et al., 2015). 
Therefore, more information is needed regarding the potential contribution of γδ T cells 
to HIV-1 persistence. 
 Macrophages can also be infected by HIV-1 (Koenig et al., 1986) and form a viral 
reservoir during prolonged ART. This has been identified both in humanized mouse 
models and in SIV-infected primates (Honeycutt et al., 2017; Avalos et al., 2017). 
Microglia, in particular, may contribute to HIV-1 persistence (Llewellyn et al., 2018). 
However, when humanized myeloid only mice (containing human myeloid cells and 
human B cells) were infected with HIV-1 and given ART 5 weeks later, just 1/3 of all 
mice harbored latent virus (Honeycutt et al., 2017). The fact that the majority of mice 
were not latently infected is supportive of the fact that CD4+ T cells, and not 
macrophages, are the primary reservoir for latency. 
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 Because CD4+ T cells are the primary source for rebounding virus, most model 
systems that reproduce HIV-1 latency in a laboratory environment use primary CD4+ T 
cells or CD4+ T cell lines (Table 1.1). The first attempts to model HIV-1 latency were 
performed in A3.01 (Folks et al., 1989) and Jurkat cells (Jordan, Bisgrove and Verdin, 
2003) by the Fauci and Verdin laboratories. Cells with integrated virus but no clear RNA 
or protein production were isolated after multiple rounds of flow cytometry or reverse 
transcriptase activity assays. While these cells are useful for comparisons of various 
latency reversing agents (LRAs), they fail to adequately incorporate all of the 
mechanisms that contribute to HIV-1 latency in vivo. For instance, the A3.01 cell model, 
which resulted in creation of the ACH-2 line, has a defective TAR element that accounts 
for its propensity for latency (Emiliani et al., 1996). 
 Other models use primary cells and attempt to either artificially prolong cell 
survival or infect specific types of cells known to harbor latent proviruses. The Siliciano 
model, for instance, uses the cell survival factor Bcl-2 to prevent cellular apoptosis (Kim 
et al., 2014), while the O’Doherty / Greene model uses the slight perturbation caused by 
spinoculation to enhance viral integration into resting cells (Swiggard et al., 2005; Lassen 
et al., 2012). The Lewin model requires chemokine signaling (Saleh et al., 2007), while 
the Planelles model directly infects certain subsets of memory cells (Bosque and 
Planelles, 2009). 
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Commonly Used Models of HIV-1 Latency  
Model Parental Cell Mechanism to Enrich for Latency References 
ACH-2 (Fauci) A3.01 Defective TAR Element  Folks et al., 1989 
Emiliani et al., 1996 
J-Lat (Verdin) Jurkat Multiple Rounds of Cell Sorting to Isolate  
TNFα – Sensitive Silent Proviruses 
Jordan, Bisgrove and  
Verdin, 2003 
O’Doherty / 
Greene 
Primary CD4+  Spinoculation Swiggard et al., 2005 
Lassen et al., 2012 
Lewin Primary CD4+  Chemokine Signaling (CCL19 and CCL21) Saleh et al., 2007 
Planelles Primary CD4+  Enrichment of Central Memory Cells / 
Polarization Towards Th1 and Th2 
Bosque and Planelles, 
2009 
Siliciano Primary CD4+  Transduction of Bcl-2 Kim et al., 2014 
Table 1.1: Commonly used models of HIV-1 latency. Models are listed along with methods for enrichment of 
latently infected cells. 
 
 Using these models to gain insights into the transcriptional regulation of HIV-1, a 
model has emerged in which multiple mechanisms regulate viral expression including 
epigenetic regulation, recruitment of key transcription factors, and RNAPII pausing. A 
primary determinant of viral reactivation in latently infected cells is a positioned 
nucleosome just downstream from the HIV-1 transcriptional start site, known as nuc-1 
(Verdin, Paras and Van Lint, 1993). This nucleosome appears to be remodeled during 
transcriptional elongation (Van Lint et al., 1996). The chromatin structure is opened 
through the addition of acetyl groups by HATs or histone acetyltransferases, many of 
which are recruited by transcription factors that are induced upon T cell signaling and 
bind the HIV-1 LTR, including NF-κB and AP-1 (Thierry et al., 2004). In contrast, the 
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association of histone deacetylases or HDACs with HIV-1 inhibits transcription 
(Williams et al., 2006). In addition, the chromatin remodeling complex SWI/SNF can 
directly remodel nuc-1, creating a transcriptional block or allowing for polymerase 
processivity (Mahmoudi et al., 2006; Rafati et al., 2011). These alternative roles are still 
being explored, but evidence exists that the binding to nuc-1 of specific variants of 
SWI/SNF, referred to as BAF and PBAF, are responsible. 
 Latency is associated with a lack of histone acetylation (He and Margolis, 2002) 
and premature polymerase pausing. This pausing has been identified in both the 
Henderson and Karn laboratories to be associated with the presence of the host repressive 
factors Negative Elongation Factor (NELF) and DRB Sensitivity Inducing Factor (DSIF) 
with RNAPII (Zhang, Klatt, Gilmour and Henderson, 2007; Jadlowsky et al., 2014). 
These proteins prohibit RNAPII from proceeding downstream and ultimately recruit a 
third factor, Pcf11, which is known to cleave the nascent RNA, repressing HIV-1 
transcription (Zhang, Klatt, Henderson and Gilmour, 2007). NELF and DSIF are both 
regulated by P-TEFb, which modulates their interactions with RNAPII through 
phosphorylation (Ping and Rana, 2001; Fujinaga et al., 2004). Phosphorylated NELF can 
no longer bind the polymerase, while phosphorylated DSIF transitions into an activating 
factor that proceeds downstream with RNAPII. The HIV-1 protein Tat plays a key role in 
this process due to its ability to recruit P-TEFb to RNAPII once it is bound to the HIV-1 
TAR region (Ping and Rana, 2001). 
 Each cell model system of latent HIV-1 has its advantage, although they often 
recapitulate only specific features of the entire latent reservoir. They exaggerate different 
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mechanisms that contribute to latency in order to create a large population of latently 
infected cells. These models are not optimal for understanding how latency is established 
at the time of HIV-1 infection. In particular, we do not know what signals are required for 
productive infection or the establishment of the reservoir. However, these cell models 
have been useful tools for identifying and exploring possible LRAs. 
 
“Shock and Kill” 
 
 Based on the limited knowledge of the mechanisms that maintain latent HIV-1, 
several researchers proposed the use of LRAs to eradicate the viral reservoir. These 
LRAs were designed to prevent deacetylation of nuc-1 or to enhance release of P-TEFb, 
promoting HIV-1 expression; this would allow infected cells to be recognized and cleared 
by the immune system. Even if full reactivation of every integrated provirus was not 
achieved, a functional cure was originally thought to be possible through this process, 
known as “shock and kill” (Hamer, 2004). 
 Initial LRAs were histone deacetylase inhibitors or HDACi’s, including valproic 
acid, which prevent the removal of acetyl groups from open and accessible nucleosomes. 
Valproic acid was already in use as an epilepsy therapeutic and was fast-tracked for HIV-
1 clinical trials (Ylisastigui et al., 2004). One clinical trial indicated that valproic acid 
was capable of inducing a 75% reduction in the amount of inducible latent proviruses by 
the VOA (Lehrman et al., 2005). In spite of promising early results using valproic acid, 
there is now contradictory evidence regarding whether valproic acid can actually reduce 
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the number of inducible latent proviruses, and no clinical trial has shown an effect on the 
size of the entire DNA viral load (Archin et al., 2008; Sagot-Lerolle et al., 2008; Archin 
et al., 2010; Routy et al., 2012).  
 Other HDACi’s under consideration include SAHA or its analog SBHA. While 
SAHA can reactivate latent HIV-1 in HIV-infected cell lines such as J-LATs (based on 
Jurkat cells) and even has been shown to induce HIV-1 RNA expression in ex vivo 
PBMCs (Contreras et al., 2009; Reuse et al., 2009; Archin et al., 2009; Barton et al., 
2016), it has failed to reduce the amount of total HIV-1 DNA in clinical trials (Elliott et 
al., 2014; Barton et al., 2016). Other studies have failed to detect any significant 
increases in the amount of HIV-1 RNA expression within ex vivo patient samples after 
stimulation with either valproic acid or SAHA (Blazkova et al., 2012). As a result of 
these conflicting studies, the use of HDAC inhibitors as single latency reversing agents is 
no longer central to the “shock and kill” strategy of HIV-1 eradication.  
 Other LRAs being explored are known to target different mechanisms that 
maintain latent HIV-1. These include histone methyltransferase inhibitors (Bernhard et 
al., 2011; Bouchat et al., 2012; Friedman et al., 2011; Boehm et al., 2017), DNA 
methyltransferase inhibitors (Kauder et al., 2009; Blazkova et al., 2009; Friedman et al., 
2011), and protein kinase C activators. PKC agonists, in particular, have shown synergy 
with other LRAs, indicating that multiple pathways may have to be engaged in order to 
achieve a clinically relevant level of latency reversal (Bartholomeeusen et al., 2013; Dar 
et al., 2014).  
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 In addition, JQ1 is being explored as a potential LRA (Banerjee et al., 2012; 
Bartholomeeusen et al., 2012; Zhu et al., 2012). It is hypothesized that JQ1, a BET 
bromodomain inhibitor, functions by targeting BRD4, which is known to bind P-TEFb 
(Bisgrove et al., 2007; Bartholomeeusen et al., 2012; Li et al., 2013). Bartholomeeusen et 
al. showed that addition of JQ1 resulted in a release of P-TEFb from the 7SK complex, 
resulting in HIV-1 transcriptional elongation. Melanie Ott’s lab has indicated that a 
BRD4 variant, BRD4S, may directly inhibit HIV-1 expression by associating with the 
nucleosome remodeling complex SWI/SNF (Conrad et al., 2017), providing further 
evidence that JQ1’s regulation of HIV-1 transcription is due to its ability to bind BRD4. 
However, it should be noted that the effects of JQ1 have so far been limited to in vitro 
analysis, and there are serious concerns regarding toxicity of several of the compounds 
listed here, particularly PKC agonists. In spite of promising data using cell lines, no LRA 
has successfully led to substantial clearance of the latent reservoir in a patient as 
measured by PCR.  
 
Establishment of Latent HIV-1 and the Role of T Cell Signaling 
  
 While the concentration of Tat (Donahue et al., 2012; Razooky et al., 2015) and 
the chromatin accessibility within an infected cell are understood as critical to productive 
transcription and infection (Miller-Jensen et al., 2012), the availability of host factors, 
proteins that regulate RNAPII, and transcriptional mechanisms are not fully appreciated. 
It is known that T cell activation is needed for both the activation of host factors 
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necessary for HIV-1 transcription (Acuto and Michel, 2003; Huang and Wange, 2004) as 
well as efficient viral integration. Therefore, T cell activation appears to be required for 
productive infection (Stevenson et al., 1990; Oswald-Richter et al., 2004). Indeed, signals 
from the TCR/CD3 complex and coreceptor CD28 substantially upregulate HIV-1 
expression (Gruters et al., 1991; Natarajan, August and Henderson, 2010). The HIV-1 
protein Nef may co-opt this mechanism by amplifying TCR signaling (Fenard et al., 
2005; Neri et al., 2011).  
 TCR signaling occurs through engagement of a T cell with its cognate antigen 
presented in the context of MHC Class I or II from the same genetic background (Dembić 
et al., 1986; von Boehmer and Kisielow, 1990). CD4+ T cells require presentation from a 
Class II molecule, which are found on professional APCs (Wang and Reinherz, 2002). 
This engagement results in clustering of the TCR/CD3 complexes and CD28 proteins 
(Ohnishi et al., 1995; Lillemeier et al., 2010). When brought into proximity with one 
another, associated Src kinases, including Lck, phosphorylate both the critical 
Immunoreceptor Tyrosine-Based Activation Motifs or ITAMs contained within the CD3 
protein as well as tyrosine residues within the cytoplasmic tail of CD28 (Gibson et al., 
1996; Rossy et al., 2013). These phosphorylated residues then act as binding sites for the 
Syk-kinase, Zap70. In turn, Zap70 is phosphorylated and becomes a key component 
within a newly assembled network of proteins, such as LAT and the SH2-domain 
containing kinases (Neumeister et al., 1995; Lo et al., 2018). A proximal signaling 
complex is orchestrated around LAT (Figure 1.4), resulting in downstream actin 
rearrangements (Bunnell et al., 2001). In addition, the SH2-containing enzyme PLCγ1 is 
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recruited to the plasma membrane, where it cleaves PtdIns(4,5)P2 (Rhee, 2001). As a 
result, multiple arms of the T cell receptor pathway are engaged, resulting in calcium 
release (Bilal et al., 2015), MAP Kinase signaling (Frearson and Alexander, 1998), and 
NF-κB activation downstream of Protein Kinase C (PKC) (Zhao et al., 2014). Activation 
of these multiple cascades increases transcription for a number of host genes and 
differentiation-determining factors (Smith-Garvin, Koretzky and Jordan, 2009; Adair et 
al., 2016). 
 
  
Figure 1.4: T cell receptor signaling results in activation of multiple pathways. TCR signaling leads to 
phosphorylation of critical tyrosine residues within ITAMs that enable the formation of a proximal 
signaling complex. Creation of this complex results in actin reorganization and stimulation of transcription 
factors downstream of PtdIns(4,5)P2. Recreated here with permission, in its entirety from (Brownlie and 
Zamoyska, 2013). Figure caption is the original work of the author of this dissertation. 
  
 In addition to roles upstream of gene transcription, T cell signaling impacts cell 
maturation (Brocker, 1997; Pepper and Jenkins, 2011). Naïve T cells which become 
activated by stimulation through their cognate antigen transition into either effector 
populations or memory cells. Latently infected cells isolated from patients on ART 
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predominately express memory phenotypes (Brenchley et al., 2004; Chomont et al., 
2009). The Planelles model of HIV-1 latency attempts to recapitulate this by 
differentiating CD4+ T cells into central memory cells (Bosque and Planelles, 2009).  
 Several papers, including those from the Henderson lab, have implicated T cell 
signaling in the regulation of productive HIV-1 replication (Natarajan, August and 
Henderson, 2010; Schiralli Lester et al., 2013). For example, studies have suggested that 
different antigen-presenting cell subsets alter HIV-1 replication by differentially 
activating T cells (Kumar et al., 2015). Furthermore, it has been shown that cells with 
low levels of activated NF- κB and decreased expression of activation markers may be 
biased towards harboring latent infections (Duverger et al., 2009; Dahabieh et al., 2014; 
Chavez, Calvanese and Verdin, 2015). Signals that predispose cells towards an anergic 
phenotype have also been linked to repression of HIV-1 (Seu et al., 2015). However, 
these experiments fail to describe the actual signaling cascades that account for this 
correlation, and direct evidence is still needed that minimal TCR signaling during 
infection predisposes HIV-1 towards latency.  
 Understanding the establishment of latent HIV-1 is also essential since it has been 
shown that there are wide differences between the capacities to reactivate latent 
reservoirs from different patients. It was originally assumed that the majority of non-
inducible proviruses were defective, most likely due to errors with reverse transcription. 
However, the Siliciano lab demonstrated that a portion of the non-inducible DNA 
reservoir is fully competent based on sequencing analysis, which is shown in Figure 1.5 
(Ho et al., 2013; Hosmane et al., 2017). Our lack of knowledge regarding the exact 
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mechanisms which account for these various sub-populations of latently infected cells, 
some of which are refractory to the strongest LRAs identified so far, highlights the 
importance of understanding the role of the cellular environment at the time of infection 
on viral fate. A primary goal of my work was to understand the signaling requirements 
for HIV-1 infection and whether the input of signals at the time of infection shaped the 
size of the inducible latent reservoir. 
 
 
Figure 1.5: A significant portion of the latent reservoir consists of non-inducible fully competent 
proviruses. Depiction of the DNA reservoir from various patients on antiretroviral therapy. The size of the 
eggshell is an indication of the number of proviruses. The yellow sphere represents the size of the latent 
reservoir as measured by the viral outgrowth assay. The magenta sphere represents the size of the latent 
reservoir as measured by sequencing. The blue sphere represents the total DNA load. Recreated here with 
permission, in its entirety from (Ho et al., 2013). Figure caption is the original work of the author of this 
dissertation. 
 
“Block and Lock” 
  
 With the future of “shock and kill” approaches to eradication of latent HIV-1 in 
doubt, increasing interest has focused on the formation of the latent reservoir. If we can 
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determine why some cells enable productive infections while others harbor latent 
proviruses, perhaps we can manipulate the balance between these two populations. In 
fact, a growing body of research has focused on a converse strategy to “shock and kill,” 
referred to as “block and lock.” This repressive approach imagines a permanent 
suppressive environment for the integrated provirus, allowing a patient to cease therapy 
indefinitely with only periodic clinical sampling to ensure a lack of viral replication 
(Méndez et al., 2018; Debyser et al., 2018). For example, the Valente lab has focused on 
Tat inhibition through the preferential binding of didehydro-Cortistatin A. This prevents 
engagement between the TAR region and the HIV-1 transactivator (Mousseau et al., 
2012; Mousseau et al., 2015). 
 The global cellular environment not only affects levels of host transcription 
factors but also directly alters the local chromatin landscape where the virus has 
integrated. If we are to achieve a “block and lock” method to repress HIV-1, we will most 
likely have to modify the epigenome along the provirus. This level of precise gene 
editing can be achieved through the use of Clustered Regularly Interspaced Short 
Palindromic Repeats (CRISPR). 
 CRISPR associated protein 9 or Cas9 can be isolated from multiple bacterial 
species including Streptococcus pyogenes and Staphylococcus aureus (Cho et al., 2013; 
Ran et al., 2015). It forms an essential part of the CRISPR defense system in bacterial 
cells. Briefly, CRISPR works by extracting various segments of foreign DNA and 
inserting it into a CRISPR locus. In nature, this would often be phage DNA. When a 
bacterial cell is re-infected with DNA belonging to a pathogen that it has encountered 
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before, the complementary stored sequence will bind to the incoming DNA. This will 
target Cas9 to the pathogenic DNA, which will then perform its exonuclease activity to 
destroy the invader (Barrangou et al., 2007; Mali, Esvelt and Church, 2013). 
 The ease which with this system works has led scientists to substitute 
complementary sequences to phage DNA with a guide RNA directed against a target 
gene of choice. In combination with the bacterial exonuclease, gene editing can then be 
achieved with minimal off-target effects (Kim et al., 2015). A number of labs have 
shown promising results using CRISPR to excise HIV-1 DNA; however, it is expected 
that use of CRISPR in vivo will result in viral escape (Wang G et al., 2016; Wang Z et 
al., 2016). In addition, although CRISPR has relatively few off-target effects, any non-
specific gene editing is a serious concern for therapeutic applications (Fu et al., 2013). To 
prevent this occurrence, I propose using a disabled or nuclease-deficient Cas9 system 
(dCas9) to target chromatin repressors to HIV-1 DNA instead of an exonuclease.  
 Nuclease-deficient Cas9 was developed in an attempt to isolate the residues 
responsible for the exonuclease activity inherent to CRISPR. In order to cut both strands 
of DNA, Cas9 uses two separate domains, referred to as HNH and RuvC. Mutations in 
both domains render the Cas9 defective (Jinek et al., 2012). However, dCas9 retains the 
targeting capabilities of CRISPR and can be used to bring transcription factors directly to 
a gene of interest (Zhang et al., 2015). There are also attempts to modify dCas9 as an 
inducible system under the control of a stimulus such as rapamycin (Zetche, Volz and 
Zhang, 2015; Brocken, Tark-Dame and Dame, 2018).  
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 Other labs have shown the potential for the CRISPR system to induce HIV-1 
expression by fusing a nuclease-deficient Cas9 to various transcriptional activators 
(Zhang et al., 2015; Saayman et al., 2016). I propose the fusing of Cas9 to a Krüppel 
Associated Box (KRAB) Domain. KRAB domains are known to engage with cellular 
KRAB-Associated Protein-1 or Kap1 (also known as Trim28), which recruits various 
transcriptional repressors, resulting in gene silencing and spreading repressive chromatin 
marks (Friedman et al., 1996; Groner et al., 2010). These repressors are believed to 
include histone methyltransferases, histone deacetylases, and heterochromatin protein 1 
(Groner et al., 2010). KRAB-Kap1 has been identified as a key regulator of endogenous 
retroviral elements (Rowe et al., 2010) and thus is a good candidate for both repressing 
HIV-1 and potentially mediating long-term epigenetic silencing of the provirus. 
  
 
Illustration 1.1: dCas9-targeted repression of HIV-1. Nuclease-deficient Cas9 fused to a KRAB domain 
can be used to recruit cellular factors such as Kap1 to the integrated HIV-1 provirus in order to induce 
latency and remodel the local chromatin organization into a heterochromative state. 
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Specific Aims and Hypothesis 
  
 Significant progress has been achieved in the treatment of Human 
Immunodeficiency Virus. Antiretroviral therapies limit progression to AIDS through a 
combination of inhibitors. However, ART does not cure HIV-1 infection. If therapy is 
interrupted, patients experience a viral rebound due to the persistence of an inducible 
reservoir primarily consisting of latently infected CD4+ T cells. This forces patients to 
remain on ART indefinitely, but these medications have substantial side effects and do 
not prevent all pathologies associated with HIV-1. For these reasons, the scientific 
community has prioritized the search for a cure that will eliminate latent HIV-1, but more 
insights are needed regarding the establishment of the latent reservoir. In this dissertation, 
I both investigate the global cellular signals that lead to formation of latent infections and 
bias an infection towards latency by manipulating the local chromatin environment of the 
provirus.  
 Analysis of latently infected cells revealed that the HIV-1 long terminal repeat is 
associated with repressive transcription factors (Bernhard et al., 2013). These repressors 
recruit histone deacetylases that modify the first nucleosome downstream of the 
transcriptional start site into a closed conformation (Williams et al., 2006). As a result, 
RNAPII pauses prematurely and complete viral transcripts are not produced (Feinberg, 
Baltimore and Frankel, 1991; Zhang, Klatt, Gilmour and Henderson, 2007; Natarajan et 
al., 2013). The host immune system then fails to recognize this latent reservoir. While 
data indicates a role for both integration site (Miller-Jensen et al., 2012; Lelak et al., 
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2015) and abundance of the HIV-1 transcriptional transactivator Tat in the establishment 
and maintenance of latency (Donahue et al., 2012; Razooky et al., 2015), recent work 
suggests that the level of cellular activation at the time of infection is also a key 
determinant (Duverger et al., 2009; Dahabieh et al., 2014; Chavez, Calvanese and 
Verdin, 2015). However, these studies have been correlative and direct evidence is still 
needed. To identify signaling cascades that participate in the establishment of HIV-1 
latency, I have designed a tunable and regulated cell model that allows me to modulate T 
cell receptor signaling at the time of infection. Based on the evidence that increased 
cellular stimulation results in enhanced HIV-1 replication (Duverger et al., 2009; 
Dahabieh et al., 2014), I hypothesized that the global cellular environment at the time of 
HIV-1 infection determines the potential for inducible latent infection and that this axis 
can by bypassed by modification of the local chromatin environment. Accordingly, I 
addressed the following aims:  
 Specific Aim 1: Determine the effect of distinct T cell receptor signal 
strengths at the time of HIV-1 infection on viral expression within primary cells and 
reactivation of latent proviruses. I used a novel primary cell system to manipulate TCR 
signaling at the time of infection and examine the signaling requirements for efficient 
HIV-1 expression. To mimic TCR signaling, I transduced CD4+ T cells with chimeric 
antigen receptors that contain both the intracellular signaling domains of CD3ζ and CD28 
along with one of several extracellular Her2 binding domains with different affinities for 
Her2. I used flow cytometry to confirm CAR expression, Alu-PCR to determine HIV-1 
integration, and both RT-PCR and luciferase analysis to measure HIV-1 transcription. 
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With this system, I verified my hypothesis that increased T cell signaling enhances HIV-1 
transcription. I also infected primary T cells and stimulated them through either the low 
or high affinity CAR. I then restimulated sorted non-HIV expressing cells with latency-
reversing agents to measure reactivation. These experiments revealed that differential 
signaling at the time of infection resulted in the formation of subsets of latently infected 
cells with varying capacities for proviral induction. 
 Specific Aim 2: Analyze transcriptional landscape of the provirus among 
cells receiving differential stimulation at the time of HIV-1 infection. I hypothesized 
that cells with minimal stimulation at the time of infection display a bias for the presence 
of host repressors and a lack of polymerase processivity. To test this, I used chromatin 
immunoprecipitation to examine RNAPII processivity and the recruitment of host 
regulators to the transcriptional start site. I also analyzed markers of chromatin 
accessibility such as histone acetylation. These studies identified downstream targets of 
TCR-associated signals that repress HIV-1 during acute infection.  
 Specific Aim 3: Use a nuclease-deficient Cas9 construct to recruit host 
repressors to the provirus and suppress HIV-1 expression. To determine if an 
infection can be biased towards latency after HIV-1 integration I used a nuclease-
deficient Cas9 fused to a Krüppel associated box domain in order to recruit the repressor 
Kap1 to the provirus. HEK293T cells were infected with single-round HIV-Luciferase 
and transfected with a dCas9-KRAB construct. One day later, infected cells were 
transfected with HIV-1 specific guide RNAs to repress viral transcription. HIV-1 
expression was measured by luciferase analysis. I also electroporated latently infected 
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Jurkat cells with the nuclease-deficient Cas9 and HIV-specific guide RNAs to block 
latency reactivation as measured by RT-PCR. I verified my hypothesis that transfection 
with dCas9-KRAB represses HIV-1 RNA and protein expression.  
 My findings elucidated how TCR signaling regulates HIV-1 transcription and 
latency. These experiments may inform both why such a large portion of the latent 
reservoir is non-reactivatable as well as the efficacy of block and lock strategies, whether 
there are new druggable targets that can bias an infection towards or away from latency.  
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CHAPTER TWO: MATERIALS AND METHODS 
 Parts of this chapter were originally published in: Gagne M, Michaels D, Schiralli 
Lester G, Wong W, Gummuluru S, Henderson AJ. Strength of T Cell Signaling 
Regulates HIV-1 Replication and Establishment of Latency. bioRxiv. 
https://doi.org/10.1101/432401. 
 
Cells 	
 Jurkat CD4+ T cells (E6-1) and human embryonic kidney 293T (HEK293T) cells 
were obtained from American Type Culture Collection (ATCC). Jurkat cells were 
cultured in RPMI 1640, 5% FBS (Corning, Inc.), 100 units/mL penicillin (Invitrogen), 100 
µg/mL streptomycin (Invitrogen), and 2mM L-glutamine (Invitrogen). HEK293T cells 
were cultured in Dulbecco’s Modified Eagle Medium, 10% FBS, 100 units/mL penicillin, 
100 µg/mL streptomycin, and 2mM L-glutamine. Cells were grown at 37° C with 5% CO2. 
 Primary CD4+ T cells were derived from de-identified healthy blood 
leukapheresis packs purchased from NY Biologic. Mononuclear cells were enriched from 
leukopacks by centrifugation through Histopaque gradient (Sigma-Aldrich). CD4+ T 
cells were isolated by negative selection using EasySep Human CD4+ T Cell Enrichment 
Kits from StemCell Technologies. CD4+ cells were maintained in RPMI 1640, 10% FBS, 
100 units/mL penicillin, 100 µg/mL streptomycin, and 2mM L-glutamine at 37° C with 5% 
CO2. Prior to transduction with CARs, primary cells were supplemented with 10 units/mL 
IL-2 and 10 ng/mL IL-7. Following transduction, IL-2 was removed from most culture 
conditions.  
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 J-Lat cells (6.3) were obtained from NIH AIDS Reagent Program and were 
cultured in RPMI 1640, 10% FBS, 100 units/mL penicillin, 100 µg/mL streptomycin, and 
2mM L-glutamine. Cells were grown at 37° C with 5% CO2. Following transduction with 
dCas9, J-Lat cells were cultured with 10 µg/mL Blasticidin as a selection marker. 
Blasticidin was removed from media 2 days prior to electroporation. All cells and cell 
lines were split every 2-3 days. 
 
sgRNA Screen 
 
 dsaCas9 sgRNAs were designed using the online program Benchling (Benchling, 
2019) by searching the NL4-3 sequence for 23-base pair long binding sites that contained 
the required PAM sequence of 5’-(N)NGRRT-3’. All chosen sites (see Table 2.1) had an 
efficiency score of > 50% and a specificity score of > 75%. dsaCas9 sgRNAs were 
expressed under the control of a SFFV promoter and were fused to the required tracrRNA 
sequence within the lentiviral vector pHR. In addition, blank dsaCas9 sgRNAs were 
obtained that contained only the tracrRNA component. All dsaCas9 sgRNA plasmids 
were constructed in the Wilson Wong laboratory at the BU School of Biomedical 
Engineering. 
 dspCas9 sgRNAs were chosen based on a literature search (see Table 2.1), with 
sg361 modified from “sg362F T” (in Saayman et al., 2016) in order to not exceed the 
required 20 base pairs for dspCas9. sg397 was obtained from “Protospacer D” in Hu et 
al., 2014. Both sequences were purchased from IDT as Alt-R CRISPR-Cas9 crRNAs and 
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fused to the required sequence (GUUUUAGAGCUAUGCU) necessary to bind to the 
Alt-R CRISPR-Cas9 tracrRNA. Annealing of the two strands of RNA occurred as 
follows: 1 µL of 100 µM crRNA and 1 µL of 100 µM tracrRNA were mixed in 98 µL 
Nuclease-Free Duplex Buffer (IDT) at 95°C for 5 m. Annealed solutions were stored at   
-20°C. In addition, Scramble sgRNAs were obtained from IDT that bound to no known 
region of the human genome (Alt-R CRISPR-Cas9 Negative Control crRNA #1, 
1072544). 
 
crRNA Sequences 
sgRNA sgRNA format Sequence 
dsa397 Plasmid DNA 5’- GGTGTGGCCTGGGCGGGACTG - 3′  
dsa518 Plasmid DNA 5’- AGCTTTATTGAGGCTTAAGCA - 3′  
dsa705 Plasmid DNA 5’- TGCCGTGCGCGCTTCAGCAAG - 3′  
dsa818 Plasmid DNA 5’- GAGCGTCAGTATTAAGCGGGG - 3′  
dsa2285 Plasmid DNA 5’- CCCCCTATCTTTACTTTGACG - 3′  
dsa2839 Plasmid DNA 5’- AATTAGGAATACCACATCCCG - 3′  
dsa5876 Plasmid DNA 5’- AAGCAGTTTTAGGCTGACTTC - 3′  
dsp361 RNA 5’- CUACAAGGGACUUUCCGCUG - 3′  
dsp397 RNA 5’- GUGUGGCCUGGGCGGGACUG - 3′  
Table 2.1: Sequences used for crRNA screen. dsaCas9 sgRNAs and dspCas9 sgRNA sequences are listed. 
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Viruses, Transfections, and Transductions 
 
 CARs were driven by a SFFV promoter in the lentiviral vector pHR (Schier et al., 
1996; Chmielewski et al., 2004). pNL4-3.Luc.R-E- was obtained from NIH AIDS 
Reagent Program. BRU-ΔEnv-GFP was a gift from Dr. Gregory Viglianti (Boston 
University). CAR lentiviruses were made by transfection of lentiviral expression vectors, 
VSV-G env, Rev, Tat, and Gag-Pol constructs into HEK293T cells with 45µL 
polyethylenimine (1 mg/mL) per 6x106 cells. Transfections of HIV-1 included only viral 
plasmids and envelope plasmids. Supernatants of lentiviruses were collected, filtered with 
0.45µm syringe filter (Corning), concentrated by centrifuging through a 20% sucrose 
gradient, and titered on CEM cells (Janas and Wu, 2009). I used a range of multiplicity of 
infections, but most viruses and lentiviruses within this paper were concentrated to 
approximately 1x106 IU/mL.  
 Transfections of dCas9-KRAB in Chapter Four for the purposes of making 
lentiviral vectors were performed similarly. Cotransfections of pNL4-3.Luc.R-E-, dCas9-
KRAB, and sgRNAs into HEK293T cells were also performed similarly but without any 
additional accessory or structural gene plasmids.  
 For transductions with CAR vectors, primary cells were stimulated for 5-6 h with 
10 µg/mL PHA, washed in PBS, and spinoculated by spinning cells with lentivirus and 5 
µg/mL polybrene (Millipore) at 1200g for 90 min. Cells were then supplemented with fresh 
RPMI and IL-7, cultured overnight, and washed in PBS 18 h later. Cells were rested for 
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one week to return to a resting state as confirmed by low CD69 expression prior to HIV-1 
infection.   
 Transductions of Jurkat cells with CAR vectors and J-Lat cells with dCas9 vectors 
were performed similarly. However, no PHA stimulation or cytokine treatment was 
required. CAR-expressing Jurkat cells were sorted based on mCherry expression and 
cultured as pure populations. For sorting details, see Flow Cytometry Methods below. 
 
CAR Stimulation and Infections 		 Non-tissue culture treated plates were coated overnight at 37°C with 1 µg/mL Her2 
(Recombinant Human ErbB2/Her2 Fc Chimera Protein from R&D Systems, 1129-ER). 
Her2 solution was removed from wells, plates were washed 3 times in PBS, and wells 
were blocked for 1 h with a 5% FBS-PBS solution. 
 CAR+ Jurkat or primary CD4+ T cells were infected with HIV-1 and 
simultaneously plated in Her2-treated wells. For experiments in which latently infected 
cells were generated, cells were spinoculated in the Her2-treated wells at 1200xg for 90 
min and then supplemented with fresh RPMI and IL-7.  Following overnight infection, 
cells were washed and either lysed or maintained in fresh media in the absence of Her2. 
 For some experiments, CAR-expressing cells were treated with 10 µM PP2 or 
PP3 (Calbiochem - Millipore Sigma), Src kinase inhibitor and pharmacologically inactive 
analog respectively, at the time of HIV-1 infection. 
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 Infections of HEK293T cells with HIV-1 were performed 24 h prior to dCas9-
KRAB and sgRNA transfection. 
 
Electroporations  
 
 For electroporations, 1x106 J-Lat cells were centrifuged for 10 min at 90xg. Cells 
were then resuspended in 90 µL 1SM buffer. 1SM buffer (5mM KCl, 15mM MgCl2, 
120mM Na2HPO4 pH 7.2, 25mM sodium succinate, 25mM manitol) was prepared as 
described in (Chicaybam et al., 2013). Cells were incubated with 10 µL sgRNA (1000 
nM) in cuvettes. Electroporation was performed in Amaxa Biosystems Nucleofactor I 
with program setting X-005. After electroporation, cells were cultured in RPMI 1640, 
20% FBS (Corning, Inc.), 100 units/mL penicillin (Invitrogen), 100 µg/mL streptomycin 
(Invitrogen), and 2mM L-glutamine (Invitrogen) at 37° C with 5% CO2. 24 h later, cells 
were washed in PBS and replated in normal culture media as described above. 
 
Latency Reversal 		 For reactivation of latent CAR-expressing primary cells, mCherry (CAR) positive 
and GFP (HIV-1) negative cells were sorted at 6 or 7 days post HIV-1 infection. Cells 
were cultured with the following concentrations of LRAs: 5 ng/mL PMA and either 10 or 
100uM ionomycin for 2.5 h, Dynabeads human T-activator CD3/CD28 beads at a ratio to 
cells of 1:1 for 24 h, 50 µM SBHA for 24 h, and 25nM Bryostatin for 24 h. Cells 
		
37 
reactivated with PMA were washed in PBS and re-plated in media. All reactivated cells 
were incubated with 10 ng/mL IL-7. Cells were cultured overnight prior to fixation for flow 
analysis.  
  J-Lat cells were treated with 10 ng/mL TNF-α in order to induce latency reversal. 
Stimulation took place five days following electroporation. RNA was isolated for qRT-
PCR 24 h post latency reversal.	 
 
Luciferase Analysis 	
 Jurkat cells were washed and lysed for luciferase analysis 24 h post infection, 
while primary T cells were measured at 4 days post infection. HEK293T cells were 
washed and lysed for luciferase analysis 48 h post sgRNA and dCas9-KRAB 
transfection. Luciferin (Promega) was added and luciferase activity was measured via 
BioTek Synergy HT Microplate Reader. 
 
Flow Cytometry 	
 Flow data were collected on an LSRII from BD Biosciences. Zombie UV Fixable 
Viability Kit (BioLegend) was used as live/dead stain for reactivation experiments. All 
cells were washed and fixed in a final concentration of 2% paraformaldehyde prior to 
analysis. Cell sorting was performed on a MoFlo Astrios from Beckman Coulter. All 
flow experiments performed at Boston University School of Medicine Flow Cytometry 
Core Facility. 
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 CAR stimulation was determined by CD69 expression (Brilliant Violet 421 anti-
human CD69 antibody; Clone FN50, BioLegend). 
 Memory cell phenotypes were characterized based upon CCR7 and CD45RA 
expression (Pe/Cy7 anti-human CCR7 antibody; Clone G043H7, BioLegend and 
PerCP/Cy5.5 anti-human CD45RA antibody; Clone HI100, BioLegend). 
 
Microarray Analysis and Heatmap Formulation 		 Primary CD4+ T cells were transduced with chimeric antigen receptors and 
allowed to return to a resting state for 1 week. Cells were then stimulated overnight with 
plate-bound Her2 as described above. Untransduced CD4+ T cells were left unstimulated 
or were plated in a solution of 1 µg/mL CD28 (Mouse Anti-Human CD28, #555725, BD 
Biosciences) on previously coated wells of 1 µg/mL CD3 (Mouse Anti-Human CD3, 
#555329, BD Biosciences). Cells were then washed in PBS and lysed for RNA extraction 
using Qiagen miRNeasy Mini Kit (#217004). RNA was stored at -80°C until delivery to 
the BU Microarray and Sequence Resource Core Facility. At the Microarray core, cDNA 
was made and samples were run on a Human Clariom S Array. The Microarray core also 
provide the statistical support described here.  
 Human Clariom S CEL files were normalized to unstimulated cells to produce 
gene-level expression values using the implementation of the Robust Multiarray Average 
(RMA) (Irizarry et al., 2003) in the affy package (version 1.36.1) (Gautier et al., 2004) 
including in the Bioconductor software suite (version 2.11) (Gentleman et al., 2004) and 
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an Entrez Gene – specific probeset mapping (21.0.0) from the Molecular and Behavioral 
Neuroscience Institute (Brainarray) at the University of Michigan (Dai et al., 2005, 
University of Michigan, 2019). Array quality was assessed by computing Relative Log 
Expression (RLE) and Normalized Unscaled Error (NUSE) using the affyPLM package 
(version 1.34.0). Analyses of variance were performed using the f.pvalue function in the 
sva package (version 3.4.0). Differential expression was assessed by performing Student's 
t test on the coefficients of linear models created using the lmFit function in the limma 
package (version 3.14.4). In this way, a one-way ANOVA p value was obtained using a 
linear mixed effects modeling approach to account for differences between donors. 
 Correction for multiple hypothesis testing was accomplished using the Benjamini-
Hochberg false discovery rate (FDR) (Benjamini and Hochberg, 1995). All microarray 
analyses were performed using the R environment for statistical computing (version 
2.15.1). All genes with FDR q values below 0.01 were plotted on a heatmap and 
arbitrarily separated into 5 clusters based on expression profiles.  
 Principal Component Analysis (PCA) was performed using the prcomp R 
function with expression values that had been normalized across all samples to a mean of 
zero and a standard deviation of one. The separation of samples by treatment group along 
the PC1 axis explains 29% of all variance in the experiment. 
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Measurement of HIV-1 Provirus Using Nested Alu-PCR 		 For	measuring	integrated	HIV-1	provirus,	a	nested PCR strategy was adapted 
from (Agosto et al., 2007). Briefly, integrated HIV-1 DNA was amplified using forward 
primers for the luciferase sequence and reverse primers for human Alu (see Table 2.2). 
The first reaction was performed on a TProfessional Thermocycler from Biometra 
according to the following conditions: 4 m at 95° followed by 20 cycles of 15 s at 93°, 15 
s at 50°, and 2.5 m at 70°. A second round of amplification was then performed using a 
forward primer, a reverse primer, and a probe for real time PCR within the HIV-1 3’ R / 
U5 region (see Table 2.2). The amount of amplified copies of HIV-1 was determined 
based on an NL4-3 plasmid copy standard. The second reaction was performed on an 
Applied Biosystems QuantStudio 3 Real-Time PCR system with heating for 4 m at 95° 
and real-time PCR conditions of denaturation for 15 s at 95°, annealing for 30 s at 60°, 
and extension for 1 m at 72°.  
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Oligos Used for Alu-PCR  
Reaction Gene / 
Target 
Primer 
Direction 
Primer Sequence 
1st Step 
Alu Forward 5’-CGTCGCCAGTCAAGTAAC-3′  
luc Reverse 5’-CTGTAATCCCAGCAGTTTGGGAGGC-3′  
2nd Step 3’ R/U5 
Forward 5′-GCCTCAATAAAGCTTGCCTTGA-3′  
Reverse 5′-TCCACACTGACTAAAAGGGTCTGA-3′  
Probe 5′-FAM-CCAGAGTCACACAACAGACG-
TAMRA-3′ 
Table 2.2: Oligos used for Alu-PCR. Oligos are listed for each reaction step. 
 
Measurement of HIV-1 mRNA by RT-PCR 
RT-PCR for Chapter Three 		 RT-PCR for HIV-1 mRNA spliced variants was performed using forward primers 
and reverse primers for spliced HIV-1 env and tat sequences. RT-PCR for HIV-1 mRNA 
after latency reversal was performed using forward primers and reverse primers for 
unspliced HIV-1 tat sequence. All values for both assays were normalized against beta-
actin as a housekeeping gene (see Table 2.3). The reaction was performed on an Applied 
Biosystems QuantStudio 3 Real-Time PCR system with heating for 15 m at 94° and real-
time PCR conditions of denaturation for 15 s at 94°, annealing for 30 s at 60°, and 
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extension for 30 s at 72°. Relative levels of HIV-1 mRNA were determined by delta-delta 
CT. 
 
Oligos Used for RT-PCR in Chapter Three 
Gene / Target Primer Direction Primer Sequence 
env (spliced) 
Forward 5’-TCCCTCAGACCCTTTTAGTCAG-3’ 
Reverse 5’-GATTACTATGGACCACACAACTATTG-3’ 
tat (spliced) 
Forward 5’-TCCCTCAGACCCTTTTAGTCAG-3’ 
Reverse 5’-CATCTGTCCTCTGTCAGTTTC-3’ 
tat (unspliced) 
Forward 5’-GGAGCCAGTAGATCCTAGAC-3′  
Reverse 5’-CTTGGCAATGAAAGCAACAC-3′  
ACTB 
Forward 5’-TGGGACGACATGGAGAA-3′  
Reverse 5′-GGGTGTTGAAGGTCTCAAA-3’  
Table 2.3: Oligos used for RT-PCR in Chapter Three. Oligos are listed for each gene of interest or spliced 
transcript. 
 
RT-PCR for Chapter Four 
 
 RT-PCR for HIV-1 mRNA after latency reversal was performed using forward 
primers and reverse primers for unspliced HIV-1 gag sequence, and all values were 
normalized against beta-globin as a housekeeping gene (see Table 2.4). The reaction was 
performed on an Applied Biosystems QuantStudio 3 Real-Time PCR system with heating 
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for 15 m at 94° and real-time PCR conditions of denaturation for 15 s at 94°, annealing 
for 30 s at 60°, and extension for 30 s at 72°. Primers for HIV-1 were based on Malnati et 
al., 2008. Relative levels of HIV-1 mRNA were determined by delta-delta CT. 
 
Oligos Used for RT-PCR in Chapter Four 
Gene / Target Primer Direction Primer Sequence 
gag  
Forward 5’-TACTGACGCTCTCGCACC-3′  
Probe 5’-FAM-CTCTCTCCTTCTAGCCTC- 
NFQMGB-3’ 
Reverse 5’-TCTCGACGCAGGACTCG-3′  
β-globin  
Forward 5’-CCCTTGGACCCAGAGGTTCT-3’ 
Probe 5’-FAM-GCGAGCATCTGTCCACTCCTG 
ATGCTGTTATGGGCGCTCGC-NFQMGB-3’ 
Reverse 5’-CGAGCACTTTCTTGCCATGA-3’ 
Table 2.4: Oligos used for RT-PCR in Chapter Four. Oligos are listed for each gene of interest. HIV-1 primers span 
an unspliced region. 
 
Chromatin Immunoprecipitation (ChIP) 		 ChIP was performed according to Natarajan et al., 2013 with the addition of a 
nuclei isolation step using Farnham Lysis Buffer prior to sonication with a BioRupter 
Pico. Briefly, cells were washed in PBS and fixed in a final concentration of 1% 
formaldehyde in methanol. Crosslinking was quenched by addition of glycine to a final 
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concentration of 240mM. Cells were then washed, centrifuged, and flash frozen in liquid 
nitrogen. Pellet was lysed in Farnham Lysis Buffer (5mM PIPES pH 8.0, 85mM KCl, 
0.5% NP-40) with addition of Halt Protease and Phosphatase Inhibitor Single-Use 
Cocktail from ThermoFisher before centrifugation to obtain nuclei fraction. Nuclei were 
lysed in RIPA buffer prior to sonication in BioRupter Pico for 15 m with alternating 30 s 
cycles. Samples were centrifuged to remove debris and pre-cleared with addition of 50% 
protein A sepharose bead for 30 m at 4°C. Beads were then pelleted and supernatants 
were split into 100µL portions as input DNA and multiple 300µL portions for sample 
analysis. Samples were incubated with antibodies overnight at 4°C. Antibody-bound 
proteins and cross-linked DNA were isolated by addition of 50% protein A sepharose 
beads for 2 h at 4°C prior to centrifugation. Immunoprecipitates were washed with low 
salt (0.1% SDS, 1% Triton X-100, 2mM EDTA, 20mM Tris-HCl pH 8.0, 150mM NaCl), 
high salt (0.1% SDS, 1% Triton X-100, 2mM EDTA, 20mM Tris-HCl pH 8.0, 500mM 
NaCl), lithium wash (0.25M LiCl, 1% NP-40, 1% sodium deoxycholate, 1mM EDTA, 
10mM Tris-HCl), and Tris-EDTA buffers (10mM Tris, 1mM EDTA) before use of 
elution buffer (1% SDS, 0.1M NaHCO3). Cross-linking was reversed with addition of 5M 
NaCl overnight at 65°C to both samples and input DNA before addition of proteinase K 
to isolate DNA. Sample DNA was purified using ChIP DNA Clean & Concentrator Kit 
(Zymo Research). 
 Antibodies used included anti-NELF-d (Antibody TH1L from Proteintech 
Group), anti-RNAPII antibody (Clone N20 from Santa Cruz Biotechnology), anti-histone 
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H3 antibody (Product 06-599 from Millipore Sigma), and Normal Rabbit IgG (Product 
12-370 from Millipore Sigma). 
 Primers used for the transcriptional start site include the forward primer at +30 
and the reverse primer at +239. Primers used for transcriptional elongation include the 
forward and reverse primers within the tat gene (see Table 2.5).  
 
Oligos Used for Chromatin Immunoprecipitation Assays  
Gene / Target Primer Direction Primer Sequence 
TSS* (+30) Forward 5’-CTGGGAGCTCTCTGGCTAACTA-3′  
TSS* (+239) Reverse 5’-AGATCTCCTCTGGCTTTAC-3′  
tat (+5379) Forward 5’-GGAGCCAGTAGATCCTAGAC-3′  
tat (+5482) Reverse 5’-CTTGGCAATGAAAGCAACAC-3′  
Table 2.5: Oligos used for chromatin immunoprecipitation. Oligos are listed for each gene region of interest. 
Asterisk (*) refers to HIV-1 transcriptional start site. 
 
Statistical Analysis 		 All statistical analysis performed using unpaired student’s t test except for 
Microarray Analysis as detailed above. 
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CHAPTER THREE: STRENGTH OF T CELL SIGNALING REGULATES HIV-1 
REPLICATION AND ESTABLISHMENT OF LATENCY 
 Parts of this chapter were originally published in: Gagne M, Michaels D, Schiralli 
Lester G, Wong W, Gummuluru S, Henderson AJ. Strength of T Cell Signaling 
Regulates HIV-1 Replication and Establishment of Latency. bioRxiv. 
https://doi.org/10.1101/432401. 
 
INTRODUCTION 
Experimental Rationale 	
 HIV-1 persists in a transcriptionally silent latent state in long-lived memory T 
cells. Although antiretroviral therapies suppress HIV-1 replication, interruption of 
treatment results in rapid viral rebound. Therefore, HIV-1 patients must remain on ART 
indefinitely, despite long term side effects, development of treatment resistance, and 
viral-induced inflammation (Wong et al., 1997; Chun et al., 1997; Harrigan, Whaley and 
Montaner, 1999). For this reason, one strategy currently being explored for cure efforts is 
“shock and kill,” in which latent HIV-1 is reactivated in conjunction with ART using 
latency-reversing agents. Following reactivation, infected cells are predicted to be 
eliminated by HIV-specific immunity or virally induced apoptosis. However, clinical 
trials using LRAs have only minimally perturbed the size of the viral reservoir (Sagot-
Lerolle et al., 2008; Archin et al., 2010; Archin et al., 2012).  
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 A cure for latent HIV-1 will require a better understanding of the biochemical 
factors involved. Latency in chronically infected primary cells and cell lines is regulated 
by multiple transcriptional mechanisms including NF-κB activation, chromatin 
accessibility, provirus transcription initiation, Tat availability, P-TEFb sequestration, and 
transcriptional elongation (Quivy, De Walque and Van Lint, 2007; Ruelas and Greene, 
2013; Agosto, Gagne and Henderson, 2015; Cary, Fujinaga and Peterlin, 2016; Agosto 
and Henderson, 2018). However, what is not understood is how latency is initially 
established within a cell and if events at the time of HIV-1 infection influence the 
transcriptional status of the provirus. These questions are relevant since the latent 
reservoir is established within the first two weeks of infection (Chun et al., 1998; 
Whitney et al., 2014). New cure strategies will need to limit the size of the reservoir at 
early time points. 
 One mechanism that could predispose HIV-1 towards active replication or 
transcriptional repression and latency is signaling through the T cell receptor. 
Engagement of the TCR and costimulatory CD28 molecule result in a multitude of 
cellular outcomes that influence HIV-1 replication including cytoskeleton reorganization, 
the activation of transcription factors, enhanced RNAPII processivity, and chromatin 
remodeling (Huang and Wange, 2004; Kim et al., 2011; Allison et al., 2016). I 
hypothesized that the magnitude of T cell signaling during HIV-1 infection will dictate 
the course of the infection. In order to manipulate signal strength received by a T cell at 
the time of HIV-1 infection, I utilized chimeric antigen receptors (CARs) that recapitulate 
T cell receptor and CD28 signaling.  
		
48 
Chimeric Antigen Receptors 	
 Chimeric antigen receptors or CARs are engineered ligand binding domains fused 
to signaling domains of interest. In this way, researchers can approximate endogenous 
receptor signaling but via a mechanism that they can control (Gross and Eshhar, 1992). 
CARs are widely used as cancer therapeutics where they can repurpose either NK cells or 
T cells to specifically recognize an oncogenic marker (Sommermeyer et al., 2016; 
Romanski et al., 2016). One potential target is human epidermal growth factor receptor 2. 
Her2 is a receptor tyrosine kinase involved in cellular activation (Lee et al., 1989); its 
overexpression correlates with several pathologies including breast cancer (Berns et al., 
1992), pancreatic cancer (Yamanaka et al., 1993), and glioblastomas (Ahmed et al., 
2010). Therefore, multiple labs have attempted to use chimeric antigen receptors specific 
for Her2 in order to drive CD8+ T cells towards elimination of Her2+ cells. For instance, 
in a Phase I clinical trial for patients with Her2-specific pancreatic cancer, at least one 
patient achieved a 50% reduction in the number of his lesions (Feng et al., 2018). 
 The recognition component of the Her2 chimeric antigen receptor used in my 
system consists of a single-chain variable fragment (scFv). Single-chain variable 
fragments engineered to bind Her2 were originally developed in the 1990’s. Schier et al. 
screened a scFv library and discovered the C6.5 fragment, which was later mutated to 
produce a number of other scFvs with differing affinities for the Her2 ligand (Schier et 
al., 1996). This panel of Her2 receptors span 3 logs of affinity for their cognate antigen. 
The Wong laboratory at Boston University cloned these ligand-binding domains onto a 
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receptor with the intracellular signaling domains of CD3ζ and CD28, the two main 
components of the T cell receptor signaling complex. CD3ζ contains the six critical 
ITAMs (immunoreceptor tyrosine-based activation motifs) that are responsible for signal 
transduction due to their capacity to become phosphorylated (Bettini et al., 2017). CD28 
also contains multiple tyrosine residues that become phosphorylated, although they do 
not form a classic ITAM motif (Natarajan, August and Henderson, 2010; Ogawa et al., 
2013). By providing Her2 to this system, I aimed to induce similar signaling cascades to 
those activated by T cell receptor recognition of a MHC-peptide complex. Through these 
chimeric antigen receptors, which are identical apart from their Her2-binding domain, I 
was able to modulate the strength of signal that a cell receives. Differences in Her2 
binding correlated with differential induction of T cell responses, providing our lab with a 
tool to manipulate cellular stimulation at the time of viral infection. A similar approach, 
in which various CD3ζ ITAMs were mutated to prevent phosphorylation, resulted in 
phenotypic and functional differences in CAR-expressing CD8+ T cells (Feucht et al., 
2018). This study provided supporting evidence for my hypothesis that signaling 
differences downstream from a TCR-based CAR could be used to interrogate the role of 
the TCR on HIV-1 expression. 
 Using these CARs, I demonstrate that induction of stronger T cell receptor 
signaling at the time of HIV-1 infection increases subsequent HIV-1 transcription and 
replication. Robust signals also facilitated the formation of latently infected cells that 
were readily inducible upon secondary stimulation with phorbol esters, as well as PKC 
agonists. Minimal signaling through CARs, although sufficient for HIV-1 integration, 
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failed to support robust viral expression and interestingly, generated a deep-seated latent 
infection. Transcriptional elongation of HIV-1 provirus was limited by RNAPII pausing 
in the absence of CAR signaling; however, strong CAR signaling correlated with 
decreased Negative Elongation Factor binding and enhanced RNAPII processivity. My 
results suggest a model in which signaling strength influences HIV-1 transcription and 
establishment of latency at the time of initial infection of CD4+ T cells. 
 
RESULTS 	
CARs Induce T Cell Signaling 	
 To examine how signaling cascades downstream from the T cell receptor regulate 
HIV-1 transcription, I utilized CARs as can be seen in Figure 3.1A. Intracellular 
signaling domains for the CARs include CD3ζ with its ITAMs and the CD28 
costimulatory domain with its four critical tyrosine residues (Chmielewski, Hombach and 
Abken, 2014). Furthermore, a mCherry tag provides a marker for positive selection of 
CAR+ cells. The extracellular ligand-binding domains of the CARs consist of a single 
chain variable fragment that recognizes receptor tyrosine-protein kinase erbB-2 (Her2) 
(Schier et al., 1996; Chmielewski, et al., 2004). By using different scFvs, a library of 
CARs with variable binding affinities for Her2 ligand spanning three logs was generated 
(Figure 3.1B). CARs were transduced into Jurkat T cells and primary CD4+ T cells. By 
enriching for mCherry, I obtained CAR+ populations that were >90% pure (Figure 3.1C).  
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Figure 3.1: Chimeric antigen receptors used for tunable T cell signaling. (A) The design of CARs 
including CD3ζ and CD28 signaling domains. (B) CAR single chain variable fragments with their 
corresponding dissociation constants for the Her2 ligand. I refer to these CARs by their relative ligand 
affinity. (C) Enrichment of primary CD4+ T cells based on mCherry expression following CAR 
transduction. See also Figures 3.2 and 3.3. 
 
  
A
B
C
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 I examined whether stimulation through the CARs lead to global transcriptional 
changes consistent with T cell receptor engagement. These changes would include both 
upregulation of activation markers and key cytokines as well as corresponding 
downregulation of other gene networks in order to dampen the level of immune 
activation. To analyze the effect of Her2 stimulation on CAR-expressing cells, I cultured 
low affinity and high affinity CAR-expressing primary CD4+ T cells with plate-bound 
Her2 ligand for 24 h as well as untransduced CD4+ T cells with or without CD3 and 
CD28 antibodies. I then extracted the RNA and performed microarray analysis using a 
Human Clariom S array. All gene expression levels were compared to the baseline of 
unstimulated cells, and those genes whose one-way Anova FDR-corrected q values were 
less than 0.01 were selected. This allowed for the creation of a heatmap of 4,966 
significantly modified genes clustered based on their expression profiles. Clusters 4 and 5 
represent genes that are downregulated upon cell activation, while Clusters 1 and 3 
represent genes that are clearly upregulated upon cellular stimulation. As can be seen in 
Figure 3.2, stimulation through the low or high affinity CARs represents intermediate 
phenotypes between that of the unstimulated or TCR-engaged populations. The log2 
expression of a selection of well-known genes from Clusters 1 and 3 are listed in Table 
3.1. Our lab is interested in further exploring how suboptimal cellular activation leads to 
unique phenotypes. However, for the purposes of this paper, the pathways and genes 
expected to be activated downstream from the T cell receptor pathway are indeed being 
engaged, confirming that binding of the receptors provide me with a way to activate a 
range of signaling inputs at the time of infection. 
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Table 3.1: Log2 expression of differentially regulated genes upon cell activation. A selection of commonly 
described genes located in Clusters 1 and 3 from the heatmap shown in Figure 3.2 are presented along with their log2 
expression values. This list is in no way comprehensive and is shown as an example of the types of genes upregulated 
upon CAR stimulation. 
 
 Principal component analysis was also performed on the genes identified as 
significantly different from the unstimulated CD4+ T cell condition. This analysis, along 
with the full list of genes used for the creation of the heatmap in Figure 3.2 is provided in 
the Appendix. 
 Cells were also examined for the expression of phenotypic markers following 
stimulation. I monitored CD69, a transmembrane lectin and a marker for CD4+ T cell 
activation, by flow cytometry before and after receptor activation with Her 2 (Figure 3.3).  
Primary CD4+ T cells transduced with either the low affinity or the high affinity 
receptors were stimulated with plate-bound Her2 ligand for 24 h.  In the absence of 
ligand, less than 7% of the cells were positive for CD69, verifying that there is no ectopic 
CD69 
PDCD1 
CTLA4 
IL2 
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TNF 
KLF10 
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IL21R 
TRAF1 
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 3 
Donor  
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Donor 
 1 
Donor 
 3 
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6.6 6.7 7.2 7.9 7.9 8.0 8.3 8.3 8.2 8.3 8.2 7.8 
5.6 5.9 5.6 6.0 6.2 6.5 6.7 6.4 6.9 6.6 7.0 7.3 
4.5 4.6 5.4 5.8 6.1 6.0 6.3 6.5 6.4 6.9 6.9 6.8 
1.7 1.5 1.3 3.5 4.3 3.7 4.8 4.9 4.9 6.9 7.8 7.3 
3.4 3.3 3.6 4.5 4.5 4.1 4.7 4.6 4.3 5.1 4.7 4.7 
7.8 7.7 7.3 8.7 9.5 9.3 9.0 9.3 9.3 9.1 9.1 9.3 
2.3 4.7 6.4 3.4 5.2 6.7 4.3 6.7 7.5 8.3 9.2 10.8 
6.5 6.5 7.2 6.7 6.5 7.1 7.1 7.3 7.6 8.3 8.5 8.8 
7.5 7.6 7.8 8.3 8.0 8.1 8.5 8.0 8.3 8.2 8.1 8.4 
6.0 7.0 6.4 7.8 7.9 7.9 8.1 8.1 8.3 8.1 8.4 8.6 
4.2 4.8 5.2 5.5 5.3 6.0 5.7 5.9 6.1 5.5 6.0 6.2 
6.9 6.4 6.9 6.6 6.6 6.7 6.6 6.5 6.4 7.7 7.0 7.3 
7.0 7.8 7.7 7.7 8.4 7.5 8.0 8.6 7.6 9.2 9.1 8.8 
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CAR signaling. Activating cells with Her2 induced CD69 expression in the low affinity 
and high affinity receptors relative to their affinity for ligand. 
 I also looked at markers associated with T cell maturation. One week post 
stimulation, primary cells stimulated through either the low or high affinity receptor were 
analyzed for expression of memory markers CCR7 and CD45RA. CCR7 is a lymph node 
homing receptor, and CD45RA is downregulated upon memory cell differentiation. 
Activation through the endogenous T cell receptor using antibodies to CD3 and CD28 
resulted in the expansion of the CCR7+ CD45RA- central memory population and to a 
lesser extent a CCR7- CD45RA- pool of effector memory cells (Figure 3.4). CAR 
engagement regardless of receptor affinity polarized cells towards similar memory cell 
phenotypes. Taken together, these data demonstrate that CARs can be used to activate a 
spectrum of T cell responses and provide a tool to modulate T cell signaling. Importantly, 
the CARs do not drive cells towards an aberrant phenotype. 
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Figure 3.2: Signaling through chimeric antigen receptors alters the expression of genes downstream 
from the T cell receptor. CD4+ T cells isolated from healthy human donors were transduced with low 
affinity or high affinity CARs and then allowed to return to a resting state. Cells were either then stimulated 
through the receptor or left unstimulated. RNA was isolated 24 h later and converted to cDNA before being 
run on a Human Clariom S array. Gene expression levels for both cell types and TCR-stimulated CD4+ T 
cells were compared to unstimulated cells. All genes with a one-way Anova FDR-corrected q value of < 
0.01 were plotted in a heatmap and clustered according to expression profiles. Data is presented as a 
heatmap based on RNA expression and represents three independent donors. 
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Figure 3.3: Differential signaling through chimeric antigen receptors. CD4+ T cells isolated from 
healthy human donors were transduced with low affinity or high affinity CARs and then allowed to return 
to a resting state. Cells were either then stimulated through the receptor or left unstimulated. CD69 
expression was compared to a negative control of untransduced cells one day after Her2 stimulation. Data 
is presented as dot plots based on flow cytometry analysis and is from a representative experiment that has 
been performed four times with different donors.  
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Figure 3.4: Signaling through chimeric antigen receptors polarizes cells towards a central memory 
phenotype. CD4+ T cells isolated from healthy human donors were transduced with low affinity or high 
affinity CARs and then allowed to return to a resting state. Cells were then stimulated through the receptor 
for two days and compared to untransduced cells treated with or without antibodies to CD3 and CD28 at a 
ratio of 1:1. Analysis was performed 7 days post stimulation, and cells were cultured in IL-7 and IL-2 
during the intervening period. The use of CCR7 and CD45RA can be used to classify cells into three 
distinct populations: CCR7+ CD45RA+ naïve-like cells, CCR7+ CD45RA- central memory cells, and 
CCR7- CD45RA- effector memory cells. Data is presented as dot plots based on flow cytometry analysis 
and is from a representative experiment that has been performed three times with different donors.  
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T Cell Signaling at the Time of HIV-1 Infection Regulates Provirus Expression 	
 To determine whether T cell signaling influences viral infection, Jurkat T cells 
expressing low affinity or high affinity CARs were plated on Her2-coated wells and 
simultaneously infected with VSV-G pseudotyped NL4-3.Luc, a single-cycle HIV-1 
clone which contains a luciferase reporter gene in place of nef. VSV-G or Vesicular 
Stomatitis Virus Envelope Glycoprotein G allowed me to bypass potentially confounding 
effects from receptor/chemokine receptor signaling due to gp120 binding (Davis et al., 
1997) and focus specifically on CAR-associated signaling cascades. To assess whether 
signaling influenced the establishment of infection, I measured levels of HIV-1 proviral 
DNA using a previously described nested Alu-PCR approach (Agosto et al., 2007). I 
modified the assay by designing primers to the luciferase open reading frame to estimate 
the relative frequency of HIV-1 integration without confounding signals from the 
lentiviral vectors used to express the CARs (see Chapter 2). CAR-associated signaling 
did not affect the infection of Jurkat cells since I detected comparable numbers of 
proviruses regardless of the presence or absence of CAR ligand (Figure 3.5A). When 
HIV-1 expression was measured by luciferase activity, Jurkat cells infected in the context 
of strong CAR signaling expressed greater than 10-fold more HIV-1 compared to 
untreated controls (Figure 3.5B). In contrast, engagement of the low affinity CAR led to a 
modest 3-fold expression compared to unstimulated cells despite a similar proviral load 
as the high affinity CAR-expressing cells. These data indicate that strong T cell signaling 
at the time of infection facilitates HIV-1 expression without enhancing provirus 
integration. 
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Figure 3.5: T cell signaling at the time of HIV-1 infection regulates provirus expression.                     
(A and B) Jurkat T cells were transduced with the high or low affinity CAR. Cells were stimulated through 
the CAR at the time of HIV-1 infection with VSV-G pseudotyped NL4-3.Luc. (A) Relative levels of 
integrated provirus 24 h post infection of high or low affinity Jurkat T cells using nested Alu-PCR. 
Uninfected CAR-expressing Jurkat T cells were a negative control. (B) Luciferase activity measured 24 h 
post-infection presented as fold difference in relative light units (RLUs) over unstimulated cells for each 
CAR+ cell line. **p<0.005,***p≤0.0005. A and B were performed in triplicate and are representative of 
four independent experiments. Data are presented as mean ± standard deviation. (C and D) Primary CD4+ T 
cells isolated from healthy human donors were transduced with CARs and given one week to return to a 
resting state. Cells were stimulated through the CAR at the time of HIV-1 infection with single-round 
VSV-G pseudotyped NL4-3.Luc. (C) Relative levels of integrated provirus 24 h after infection of high or 
low affinity CAR-expressing primary T cells (from the same donor) using nested Alu-PCR. Uninfected 
CAR-expressing primary T cells were a negative control. Results are from a single experiment performed 
in triplicate and are representative of two independent experiments. Data are presented as mean ± standard 
deviation. (D) Luciferase activity measured 4 days post infection presented as fold difference in RLUs over 
unstimulated cells for each CAR+ cell line. Experiments from two separate donors are shown and are 
representative of three independent experiments. See also Figure 3.6 and 3.7. 
 
 I confirmed that these differences were due to downstream signaling cascades 
emanating from the CARs by using the Src kinase inhibitor, PP2. Src kinases are the first 
downstream targets of T cell receptor activation and are recruited to the phosphorylated 
ITAMs (Gibson et al., 1996; Rossy et al., 2013). In the presence of PP2, the increase in 
HIV-1 expression upon CAR stimulation was attenuated, consistent with T cell signaling 
as a regulator of HIV-1 expression (Figure 3.6). The pharmacologically inactive version 
of this inhibitor, PP3, had no effect on the ability of CARs to influence HIV-1 expression. 
 To confirm that differences in luciferase activity were a result of transcriptional 
upregulation and not post-transcriptional events, I examined production of spliced viral 
mRNAs in HIV-1 infected CAR-expressing Jurkat T cells. A major impediment to 
successful HIV-1 replication occurs at the level of splicing (Yukl et al., 2018). I analyzed 
infected Jurkat cells to measure whether increased cellular activation resulted in 
increased expression of fully-spliced and partially-spliced viral transcripts. RT-PCR 
confirmed that increased cellular activation resulted in not only greater levels of fully-
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spliced RNA transcripts but also partially-spliced transcripts (Figure 3.7). Although 
differences were detected between the amount of partially-spliced and fully-spliced 
mRNAs, this effect was most likely due to primer binding efficiencies or splicing kinetics 
(Klotman et al., 1991; Puray-Chavez et al., 2017). In addition, not all products are spliced 
in equal ratios, with env transcripts being relatively highly expressed (Ocwieja et al., 
2012). Regardless, the fact that all measured spliced products increased upon greater T 
cell stimulation indicated that transcription was the limiting step of HIV-1 expression in 
response to TCR signaling.  
 I validated the observation that signal strength influenced HIV-1 replication and 
transcription using primary CD4+ T cells that were transduced with either the low 
affinity or high affinity CAR. Following transduction, cells were allowed to return to a 
resting state as monitored by low CD69 expression before infection with HIV-1 in the 
absence or presence of the ligand Her2. Consistent with the data from Jurkat cells, similar 
levels of proviral DNA were detected in primary CD4+ T cells regardless of the strength 
of CAR signaling (Figure 3.5C). Cells that received robust stimulation at the time of 
infection expressed 1.5- to 4-fold more HIV-1 than cells stimulated through the low 
affinity receptor (Figure 3.5D). 
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Figure 3.6: Src kinase inhibitor PP2 inhibits CAR-mediated HIV-1 transcription. CAR+ Jurkat T cells 
were stimulated with or without Her2 in the absence or presence of 10µM PP2 or PP3 at the time of HIV-1 
infection with single-round VSV-G pseudotyped NL4-3.Luc. 24 h post infection, cells were lysed to 
measure luciferase. Data are presented as fold difference in RLUs over unstimulated cells for each CAR+ 
population. **p<0.005, ***p≤0.0005. Figure 3.6 was performed in triplicate and is representative of five 
independent experiments. Data are presented as mean ± standard deviation. 
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Figure 3.7: T cell signaling at the time of HIV-1 infection regulates provirus expression by inducing 
transcription. (A and B) CAR+ Jurkat T cells were stimulated with or without Her2 at the time of HIV-1 
infection with VSV-G pseudotyped NL4-3.Luc. 24 h post infection, cells were lysed in order to measure 
HIV-1 transcripts by qRT-PCR. (A) Fold difference in HIV-1 env transcripts over corresponding 
unstimulated conditions as an indication of production of partially spliced RNAs. Although env gene is 
heavily deleted in provirus, the 5’ end of the gene remains intact. (B) Fold difference in HIV-1 tat 
transcripts over corresponding unstimulated conditions as an indication of production of fully spliced 
RNAs. **p<0.005,***p<0.0005. A and B were performed in quadruplicate. Data are presented as mean ± 
standard deviation.  
 
 To gain insight into whether there is a threshold or minimal T cell signal required 
for HIV-1 infection and replication, I transduced Jurkat T cells with CAR receptors that 
spanned a range of binding affinities (Figure 3.1B). These cells were infected with NL4-
3.Luc as described above in the absence or presence of Her2. Although the high affinity 
condition supported HIV-1 infection and transcription, the intermediate and low affinity 
receptors did not support HIV-1 expression (Figure 3.8A). This was despite similar levels 
of infection as determined by measuring proviral DNA (Figure 3.8B). These data suggest 
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that T cell signaling controls HIV-1 expression by a digital on/off mechanism since viral 
expression does not linearly correlate with signal strength. 
 
 
Figure 3.8: Robust T cell signaling is required for HIV-1 transcription. (A) Jurkat T cells were 
transduced and positively selected for indicated CARs and then infected with NL4-3.Luc. 24 h post 
infection, cells were lysed for luciferase analysis. Data are presented as fold difference in RLUs over 
unstimulated cells for each CAR+ population. **p<0.005, ***p<0.0001. (B) Relative levels of integrated 
provirus after infection of CAR-expressing Jurkats using nested Alu-PCR. A and B were performed in 
triplicate and are representative of four independent experiments. Data are presented as mean ± standard 
deviation. 
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Robust Signals During HIV-1 Infection Establishes an Inducible Latent Reservoir 	
 I hypothesized that differential T cell signaling during infection alters the size of 
the inducible latent reservoir. To examine this, I infected CAR-expressing primary CD4+ 
T cells with VSV-G pseudotyped Bru-dENV-GFP (GFP-expressing single cycle HIV-1) 
in the presence of Her2 ligand. One week post infection, cells were sorted for both 
mCherry expression as a marker for CAR transduction and lack of GFP expression in 
order to enrich for latently infected cells. CAR+/GFPneg cells were reactivated with PMA 
plus ionomycin or left unstimulated to control for spontaneous HIV-1 reactivation 
(Figure 3.9A). PMA, a phorbol ester, and ionomycin, a calcium ionophore, engage two 
separate arms of the T cell activation pathway. PMA and ionomycin significantly 
reactivated HIV-1 expression within cells that had been initially infected in the context of 
strong signaling, resulting in a 3- to 9-fold increase in the percentage of GFP positive 
cells and a 1000-fold induction of HIV-1 mRNA measured by qRT-PCR (Figure 3.9B 
and 3.9C). However, the observed reactivation of HIV-1 was modest in cells infected at 
the time of stimulation through the low affinity CAR. A 200-fold induction of HIV-1 
RNA was detected in reactivated latently infected cells expressing low affinity CARs, 
and less than a 2-fold change was observed in the percentage of GFP+ cells. Therefore, 
despite both minimal and robust signaling resulting in comparable amounts of integrated 
HIV-1 provirus, robust signaling was not only necessary for active transcription but also 
supported the generation of a population of latently infected cells that could be readily 
induced to express HIV-1. The population of latent cells generated in response to weaker 
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CAR signaling was more resistant to reversal suggesting that HIV-1 in these cells was 
strongly repressed.  
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Figure 3.9: Robust signals during HIV-1 infection establish an inducible latent reservoir. (A) Outline 
of experimental plan to enrich for latently infected cells following infection. Primary CD4+ T cells are 
infected with BRU-dEnv-GFP and GFP-negative cells are sorted to enrich for latently infected cells.        
(B) Percent GFP+ HIV-expressing cells after stimulation of latent cells with various latency-reversing 
agents: PMA plus ionomycin, antibodies to endogenous CD3 and CD28, SBHA, and Bryostatin.  Data are 
from seven separate donors, and each form of LRA stimulation was performed on cells from 2-3 donors. 
(C) Latently-infected cells were restimulated with PMA and ionomycin. HIV-1 expression was monitored 
by measuring Tat RNA by qRT-PCR. Values are shown as fold difference in HIV-1 transcripts over 
corresponding non-reactivated controls. All data in C are derived from 4-6 replicates and are representative 
of three independent experiments with different donors. Data are presented as mean ± standard deviation. 
*p<0.05, **p<0.005, ***p<0.0001. 
 
 I also used other common latency-reversing agents in order to determine if 
targeting alternative activation pathways could reverse the refractory nature of the low 
stimulation cells. Antibodies to CD3 and CD28, which would engage the endogenous T 
cell receptors and fully re-activate these cells, failed to reverse the repressed virus in cells 
that expressed the low affinity CAR. SBHA (an HDACi) and bryostatin (a PKC agonist) 
failed to significantly reactivate cells that had received either high or low levels of 
stimulation at the initial time of infection. (Figure 3.9B). 
 
RNAPII Processivity Limits HIV-1 Transcription in the Absence of Robust Signaling 	
 I was interested in mechanisms that governed HIV-1 repression following 
integration in the absence of sufficient T cell signaling; therefore, I examined the binding 
of transcriptional regulators on the HIV-1 LTR by chromatin immunoprecipitation 
(ChIP). Jurkat T cells expressing low or high affinity CARs were infected with NL4-
3.Luc in the absence or presence of Her2 ligand. One day post-infection, cells were fixed 
and chromatin was prepared for ChIP.  
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 Since HIV-1 proviral latency correlates with a positioned nucleosome that is 
downstream of the transcriptional start site, I explored whether the LTR was associated 
with post-translationally modified histones as an indicator of chromatin organization. 
ChIPs for acetylated histone H3 showed no significant difference in binding of the HIV-1 
LTR between cells infected in the absence or presence of T cell signaling (Figure 3.10A). 
Taken together with the lack of effect of histone deacetylase inhibitors on latency 
reversal (Figure 3.9B), it would seem that chromatin accessibility does not appear to be 
limiting HIV-1 proviral transcription during the early stages of infection. 
 I then examined RNAPII processivity by measuring RNAPII occupancy at 
multiple points in the HIV-1 proviral genome, including the transcriptional start site and 
downstream in the HIV-1 tat gene. RNAPII was detected at the HIV-1 transcriptional 
start site whether cells were activated through a CAR or were unstimulated (Figure 
3.10B). However, signaling through the high affinity receptor resulted in an increase in 
downstream RNAPII by greater than 4-fold, whereas only modest levels of RNAPII were 
found downstream in the absence of signals or following weak signaling (Figure 3.10C).  
 Since these data indicated a role for transcriptional pausing, I examined if CAR 
signaling altered the presence of the pausing factor NELF at the HIV-1 transcriptional 
start site. Using ChIPs, I determined that signaling through the high affinity receptor 
diminished binding of NELF at the HIV-1 LTR by greater than 85% (Figure 3.10D). 
These data support a model in which a lack of robust T cell signaling limits HIV-1 
transcription by establishing a paused polymerase complex.  
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Figure 3.10: RNAPII processivity limits HIV-1 transcription in the absence of robust signaling.      
CAR-expressing Jurkat T cells were infected with single-round VSV-G NL4-3.Luc and simultaneously 
plated with or without Her2 ligand. 24 h later, cells were fixed for chromatin immunoprecipitation.          
(A) ChIP for presence of acetylated H3 near the transcriptional start site  (nuc-1). (B) ChIP for RNAPII at 
the HIV-1 transcriptional start site. (C) ChIP for RNAPII associated with the HIV-1 tat gene to measure 
polymerase processivity. Data from A-C are normalized to corresponding IgG controls for each stimulation 
condition. (D) ChIP for NELF-d at the HIV-1 transcriptional start site. Data is normalized to corresponding 
unstimulated condition for each CAR+ cell line. A-D were performed in triplicate and are representative of 
at least three independent experiments in Jurkat T cells. Data are presented as mean ± standard deviation. 
Primers used for HIV-1 transcriptional start site are +30 and +239. Primers used for tat gene are +5379 and 
+5482. *p<0.05, **p<0.005, ***p≤0.0005 
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DISCUSSION 	
 Previous studies suggest that cell signaling may be a key regulator of HIV-1 
expression and latency. The latent reservoir is enriched for antigen specific T cells, 
including those that respond to CMV, HSV, tuberculosis, and HIV (Douek et al., 2002; 
Demoustier et al., 2002; Casazza et al., 2009; Geldmacher et al., 2010; Hu et al., 2016). 
Furthermore, the use of superantigens during viral entry increases HIV-1 replication 
(Laurence, Hodtsev and Posnett, 1992). Partial activation, cellular polarization, cell-to-
cell contact, and/or infection of resting quiescent cells through perturbation have also 
been suggested to bias infections towards latency (Agosto and Henderson, 2018; Saleh et 
al., 2007; Bosque and Planelles, 2009; Pace et al., 2011; Agosto et al., 2018; Kumar et 
al., 2018). Therefore, the extent of cell activation is a key determinant in regulating the 
course of HIV-1 infection including the formation of the reservoir.  
 I have shown that differential signaling through CARs, which mimic TCR 
signaling, influences HIV-1 transcription and latency. In the lymph node, the primary site 
for both HIV-1 replication and the persistent latent reservoir (Biberfeld et al., 1986; Shen 
et al., 2003; Aid et al., 2018), T cells sample lymph node resident antigen presenting cells 
in search for antigen. Some of these interactions, facilitated by the presentation of the T 
cell cognate antigen, will result in robust T cell activation, clonal expansion, and changes 
in gene expression. However, most MHC complexes will lack cognate antigen and 
initiate weak signaling (Zehn, Lee and Bevan, 2009; Martinez et al., 2016). Using 
multiple CARs whose affinities for the Her2 ligand span several logs, I delivered a range 
of signaling inputs to model the spectrum of T cell receptor signaling events. My data 
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indicates that stronger T cell activation at the time of infection, which would be akin to 
antigen-specific responses, correlates with robust HIV-1 expression as well as the 
establishment of inducible latently infected cells. I do not address here the possibility that 
additional factors may compensate for suboptimal T cell receptor signaling. Interactions 
with antigen presenting cells would engage a number of costimulatory molecules and 
inhibitory receptors. In addition, the presence of inflammatory cytokines, such as would 
be expected during the acute stages of HIV-1 infection, may alter the level of cellular 
activation. Whether the ability of T cell stimulation to regulate HIV-1 is a matter of 
quality or simply quantity of signal should be examined further.  
 Having a library of CARs with a range of binding affinities allowed me to 
determine if HIV-1 responds to signaling in an analog fashion correlating with signal 
input or digitally regulated by specific thresholds resulting in all-or-none responses 
(Zikherman and Au-Yeung, 2015). Signaling through the CARs with affinities that were 
intermediate did not support active transcription despite a greater than 10-fold increase in 
binding affinity compared to the low affinity receptor. These results would suggest that 
TCR signaling provides more of an on/off switch and that there exist signaling thresholds 
that must be overcome to assure efficient transcription and replication. 
 Signal transduction and gene expression are inherently noisy processes, and 
stochastic events are hypothesized to drive HIV-1 latency. That latency and HIV-1 
replication are driven by episodic bursts of proviral transcription and Tat levels has been 
supported by mathematical modeling and experiments using engineered virus models 
(Burnett et al., 2009; Donahue et al., 2012; Razooky et al., 2015). Even if latency is 
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driven by random fluctuations of provirus transcription, T cell associated signals are 
strong modulators of noise, and targeting these pathways could enhance treatments 
directed at HIV-1 reactivation (Dar et al., 2014). However, it is important to appreciate 
that although signaling and transcription are subject to stochastic variation, these are 
coordinated and combinatorial processes that lead to defined patterns of gene expression 
and phenotypic outcomes (Banos, Agelopoulos and Thanos, 2013). 
 Regulated aspects of transcription include assembly of multi-subunit complexes 
such as RNAPII and associated cofactors, chromatin, and transcription factors at the 
LTR. Figure 3.10 suggests that the association of NELF with RNAPII is regulated by 
TCR signaling. Multiple positive and negative signals are known to converge on NELF-
driven transcriptional pausing. P-TEFb relieves NELF repression through 
phosphorylation (Fujinaga, et al., 2004) and is itself regulated by cellular stress and 
signals (Garriga et al., 1998; Zhou and Yik, 2006; Fujinaga et al., 2015).  
 My data regarding the lack of histone acetylation as a block to transcriptional 
elongation at the time of viral integration is in marked contrast to its acknowledged role 
in the maintenance of HIV-1 latency in chronically infected cell lines and patient samples 
ex vivo (He and Margolis, 2002; Archin et al., 2009). However, our lab has shown that 
NELF interacts with co-repressors including NCoR1-GPS2-HDAC3 at the HIV-1 
promoter (Natarajan et al., 2013) which may reinforce HIV-1 latency, especially during 
chronic infection, by facilitating post-translational modifications of histones and 
chromatin organization. 
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 I propose that strength of signal at the time of infection acts as a bifurcating event 
leading to either robust transcription and the establishment of an inducible latent 
reservoir or minimal transcription and deep-seated latency (Illustration 3.1). My 
observations are consistent with the previous characterization of patient reservoirs that 
identified three subsets of latently infected cells: a small population of cells carrying 
inducible provirus, larger populations of cells with intact proviruses that are difficult to 
reactivate, and many defective proviruses (Ho et al., 2013). Successful purging of the 
latent reservoir may require the use of a cocktail of latency reversing agents or the 
development of novel strategies to block reactivation (Xing and Siliciano, 2013; Darcis et 
al., 2015; Darcis et al., 2017). 
  
Illustration 3.1: T cell signaling during HIV-1 infection drives viral fate. Amplitude of TCR signaling 
cascade polarizes cells towards a favorable environment for productive HIV-1 infection and the formation 
of a readily inducible latent reservoir or an unfavorable environment for viral replication marked by 
uninducible latency.
T Cell
HIV Virion
Strength of Signal
Minimal HIV 
Expression & 
Uninducible Latency
Inducible HIV 
Latency
HIV Expression
HIV Expression
Reactivation
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CHAPTER FOUR: NUCLEASE-DEFICIENT CAS9-KRAB CAN BE USED TO 
SILENCE HIV-1 EXPRESSION THROUGH REDUCTION IN RNAPII 
INITIATION 	
INTRODUCTION 	
Discovery of CRISPR-Cas9 and Use as an HIV-1 Therapeutic 	
 CRISPR-Cas9 offers significant advantages over other strategies for gene editing. 
TALENs (transcription activator-like effector nucleases) and zinc finger nucleases were 
widely considered the most accurate molecular tools to target specific sections of the 
genome (Miller et al., 2007; Mussolino et al., 2011), but the application of a CRISPR-
based approach heralded a new era in gene editing. In 2013, the laboratories of Feng 
Zhang and George Church simultaneously demonstrated that a Cas9 system adapted from 
Streptococcus pyogenes could be used for genome editing in both cell lines and induced 
pluripotent stem cells (Cong et al., 2013; Mali et al., 2013). Both approaches were based 
on the capacity of the bacterial CRISPR system to excise foreign DNA and insert it 
between the palindromic repeats in a region known as the protospacer. This protospacer 
is then cleaved, along with an adjoining portion of the palindrome, inserted into CRISPR 
Associated Protein 9, and recruited to its complementary sequence located within an 
invading pathogen (Mali, Esvelt and Church, 2013). It should also be pointed out that any 
corresponding DNA sequence must be immediately upstream from a Protospacer 
Adjacent Motif (PAM) site. The PAM specific sequence for Cas9 isolated from 
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Staphylococcus aureus, the bacterial species used for some of the experiments outlined in 
this chapter, is 5’-(N)NGRRT-3’. N refers to any nucleotide, while R denotes a purine 
base (Xie et al., 2018). 
 By operating under these particular requirements, the exonuclease is directly 
targeted to a specific gene with minimal off-target effects (Kim et al., 2015). By 
providing their own protospacer sequence in the form a small guide RNA (sgRNA), the 
Church and Zhang labs were able to redirect the CRISPR system to bind to and excise a 
human gene of interest. 
 An immediate application of CRISPR-based gene editing was its potential as an 
HIV-1 therapeutic. Since HIV-1 persists as transcriptionally silent latent proviruses, 
CRISPR provides a possible mechanism that could be used to excise integrated HIV-1. 
The Khalili lab first demonstrated the capacity of CRISPR to remove integrated 
proviruses through the use of guide RNAs directed towards the U3 region of the HIV-1 
LTR (Hu et al., 2014).  However, significant questions still remain regarding method of 
delivery in vivo, off-target effects (which, although minimal, could still pose significant 
health concerns), complete removal of all latent proviruses, and viral escape (Fu et al., 
2013; Wang G et al., 2016; Wang Z et al., 2016; Mout et al., 2017). The Khalili lab 
performed in vivo experiments using humanized mice infected with HIV-1, but failed to 
completely excise all HIV-1 DNA. In addition, significant targeting differences were 
seen between various tissue sites, with reduced efficacy in the central nervous system 
(Kaminski et al., 2016). 	
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 For these reasons, I propose the use of a nuclease-deficient Cas9 to recruit 
chromatin-modifying factors to the HIV-1 provirus instead of degrading the genome. 
This approach provides the additional benefit of removing any immune pressure resulting 
in viral escape as in theory no transcription and thus no replication would occur at all. 
New efforts at the use of adeno-associated vectors as a delivery system could bypass the 
current issues with cellular penetrance and might allow the system I describe here to be 
brought into the clinic (Platt et al., 2014).  	
Cas9-KRAB Construct for Targeted Gene Repression 	
 The first attempts to fuse a nuclease-deficient Cas9 to a Krüppel Associated Box 
Domain was first described by the Wang and Gersbach labs in the mid-2010’s (Lawhorn, 
Ferreira and Wang, 2014; Thakore et al., 2015). KRAB domains are known to bind to the 
endogenous host factor, Kap1 or KRAB-Associated Protein-1, which together target 
various repressors to the region of the genome to which the KRAB domain is bound. 
These repressors include histone deacetylases, histone lysine-methyltransferases, and 
DNA methyltransferases. As a result, the surrounding genes become silenced, and we can 
detect both the spreading of marks associated with heterochromatin and a lack of 
transcription (Friedman et al., 1996; Groner et al., 2010; Oleksiewicz et al., 2017). It is 
hypothesized that KRAB-Kap1 may mediate this transcriptional effect through directly 
dislodging the RNAPII complex (Moosmann et al., 1997; Groner et al., 2010). 
 Most KRAB-containing proteins have been described in mouse embryonic cells, 
such as the zinc-finger protein ZFP809 that can repress murine leukemia virus and 
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murine endogenous retroviruses (Wolf and Goff, 2009; Wolf et al., 2015). The human 
KRAB-containing zinc-finger protein ZNF93 has recently been discovered as a 
restriction factor for the long interspersed nuclear element 1 or L1 in human embryonic 
stem cells (Jacobs et al., 2014). KRAB-Kap 1 has consistently been shown to play an 
important role in cellular gene regulation and its adaptation to the CRISPR-Cas9 system 
offers a novel approach to targeted epigenetic editing. 
 My goal was to introduce a nuclease-deficient Cas9-KRAB domain construct into 
cells at the time of infection with HIV-1. Together with sgRNAs directed against regions 
of the HIV-1 genome immediately upstream of the appropriate PAM site, our lab was 
able to successfully repress HIV-1 expression. We further illustrated the potential of this 
nuclease-deficient Cas9 system by electroporating it into latently infected T cells. The 
exonuclease was capable of preventing viral reactivation, highlighting its prospective role 
as an HIV-1 therapeutic. In this way, I aimed to bias an infection towards long-term 
transcriptional repression or inactivation. 
 
RESULTS 	
Nuclease-Deficient Cas9-KRAB Suppresses HIV-1 Expression 	
 I obtained nuclease-deficient Cas9-KRAB plasmids from the Wilson Wong 
laboratory at Boston University. They created two separate fusion constructs, one based 
on Staphylococcus aureus and a second on Streptococcus pyogenes. Although the 
dsaCas9 is more specific due to its more stringent PAM sequence, dspCas9 is more 
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widely used and was the first variant isolated by the Church and Zhang labs. One sgRNA 
(dsp361) was modified from a sgRNA described in a paper using a dCas9 fused to an 
activating domain and overlaps the NF-κB sites in the HIV-1 LTR (Saayman et al., 
2016). A separate sgRNA (dsp397) binds to the SP1 site in the LTR (Hu et al., 2014). 
Alex Olson, a technician in the Henderson lab who performed several of the experiments 
described in this chapter, identified a panel of dsaCas9 guide RNAs that would bind to 
the NL4-3 HIV-1 sequence using the online tool Benchling (Illustration 4.1) (Benchling, 
2019). These sgRNAs span the proviral genome. 
  
 
Illustration 4.1: Selection of HIV-1 binding sgRNAs for CRISPR-mediated epigenetic silencing. 
Binding sites were selected using the online tool Benchling that spanned the HIV-1 genome, including sites 
in the LTR, gag-pol, and tat. Schematic based off of a figure modified from (Colin and Van Lint, 2009).  
  
 We first cotransfected the DNA sequences encoding for the dsaCas9 sgRNAs 
with NL4-3.Luc, a singe-cycle luciferase construct, into HEK293T cells and measured 
luciferase at 48 hours post transfection. Both dsa397 and dsa518, located within the HIV-
1 LTR, showed the greatest effect on luciferase repression and we focused primarily on 
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these guides (Figure 4.1A). We further illustrated the potential of this system to block 
HIV-1 expression by infecting HEK293T cells with VSV-G pseudotyped NL4-3.Luc 
while transfecting with dsaCas9. Twenty-four hours later, we transfected cells with 
plasmids encoding for the sgRNAs and measured luciferase units three days post-
infection.  We were able to block at least 50% of viral transcription resulting from HIV-1 
infection (Figure 4.1B). 
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Figure 4.1: KRAB binding to the HIV-1 LTR inhibits viral expression. (A) HEK293T cells were co-
transfected with VSV-G NL4-3.Luc, dsaCas9-KRAB, and the indicated sgRNA. 48 h later, cells were lysed 
for luciferase analysis. Data are presented as fold difference in RLUs over tracrRNA only control. (B) 
HEK293T cells were infected with VSV-G NL4-3.Luc and simultaneously transfected with dsaCas9-
KRAB. 24 h later, cells were transfected with the indicated sgRNA. 48 h post infection, cells were lysed for 
luciferase analysis. Data are presented as fold difference in RLUs over “tracrRNA only” control and 
represent mean ± standard deviation. Data in B was performed in triplicate. “tracrRNA only” refers to the 
addition of the sequence corresponding to the tracrRNA without the crRNA sequence necessary to bind 
HIV-1. “No Cas9” refers to HIV-1 transfection only. 
 
Nuclease-Deficient Cas9-KRAB Prevents Latent HIV-1 Reactivation 	
 J-Lat cells harbor an integrated latent copy of HIV-1 that is responsive to various 
Tat inducers including TNF-α and phorbol esters (Jordan, Bisgrove and Verdin, 2003; 
Williams et al., 2007). We thus sought to determine if we could block HIV-1 reactivation 
in these cells through the use of our nuclease-deficient Cas9 construct. Because J-Lat 
cells are not easily transfected with plasmids, we used our dspCas9 system, for which we 
had RNA transcripts of our sgRNAs. Following transduction of the J-Lats with dspCas9 
expressed in a lentiviral vector, cells with the exonuclease were enriched through the use 
of an antibiotic selection marker. We then electroporated the J-Lats with either of the 
sgRNAs for the Streptococcus pyogenes construct. Five days post electroporation, cells 
were restimulated using TNF-α. Although treatment with the LRA resulted in a baseline 
9-fold increase in HIV-1 RNA as measured by qRT-PCR, this was reduced by more than 
50% in the samples treated with the sgRNAs (Figure 4.2).  
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Figure 4.2: KRAB-Kap1 blocks HIV-1 latency reversal in J-Lat cells. J-Lat cells were transduced with 
a dCas9-KRAB plasmid within a selection vector. Cells were electroporated with sgRNAs indicated above 
and reactivated with 10 ng/mL TNFα five days post-electroporation. HIV-1 transcription was measured by 
qRT-PCR using gag-specific primers 24 h after stimulation. Values are shown as fold difference in HIV-1 
RNA transcripts over corresponding non-reactivated controls. “sgScramble” refers to the selection of a 
sgRNA not known to bind to any predicted sequence in the human genome.  
 
DISCUSSION 
 
 The use of latency-reversing agents to reactivate transcriptionally silent HIV-1 
has so far been unable to eradicate the DNA reservoir in any clinical trial. In fact, most 
HDACi’s have failed to result in any detectable reduction in proviral load (Sagot-Lerolle 
et al., 2008; Archin et al., 2010; Archin et al., 2012). Efforts to permanently suppress 
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HIV-1 or to bias an infection during the early stages towards latency must be considered 
as potential therapeutics. 
 The most challenging aspect to permanent HIV-1 suppression is our ability to 
specifically target transcriptional host repressors to the provirus. CRISPR-based gene 
editing provides a substantial improvement over previous strategies, due to the specificity 
of its binding and the lack of off-target effects. However, the possibility of viral escape 
poses a major barrier to its successful use as a nuclease. I propose its adaptation, 
however, to a delivery system in which it can be used to bring binding partners, such as a 
KRAB domain, to the proviral genome. Other labs have used a nuclease-deficient Cas9 to 
deliver an activating domain to the HIV-1 LTR (Zhang et al., 2015; Saayman et al., 
2016). While this approach seems feasible, the data presented in Chapter 3 illustrates the 
challenges at reversing latency once established. Host repressors recruit other 
transcription factors, which in turn target larger complexes such as HDACs, histone 
methyltransferases, and polymerase-binding factors such as NELF. In concert with one 
another, large transcriptional networks and scaffolds are formed, resulting in entrenched 
heterochromatin (Ivanov et al., 2007; Natarajan et al., 2013; Meier and Brehm, 2014). 
For instance, evidence exists that Kap1 may operate in conjunction with the newly 
discovered HUSH complex to silence endogenous retroviral elements in mouse 
embryonic stem cells (Robbez-Masson et al., 2018). HUSH, or the human silencing hub, 
has been identified as a restriction factor for HIV-1 and HIV-2 expression and is targeted 
for ubiquitination by the HIV-2 protein Vpx or Viral Protein X (Chougui et al., 2018; 
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Yurkovetskiy et al., 2018). Future work will need to be performed to determine if HUSH 
and Kap1 interact directly or indirectly. 
 The existence of multiple layers of repressive factors that cooperate to silence 
HIV-1 expression suggests that the reverse strategy of “block and lock” may be viable 
(Darcis, Van Driessche and Van Lint, 2017). If we can bias latency towards a specific 
fate, we may be able to achieve a functional cure through intrinsic entrenchment of this 
repression. My data indicated that guide RNAs directed specifically against the HIV-1 
LTR inhibit viral expression. These guides enabled us to suppress HIV-1 transcription 
shortly after infection and achieve a more than 50% block to latency reversal in 
chronically infected cells. The differences in efficacy of different guide RNAs indicate 
that a cocktail of multiple guides may be necessary to repress viral transcription beyond a 
point where a patient can interrupt therapy. It is not surprising that the most effective 
guides overlap with specific binding sites in the HIV-1 LTR, perhaps indicating a dual 
role of KRAB-Kap1 recruitment and a direct steric hindrance to transcription factor 
binding. 
 A major challenge to bringing this approach into clinical trials is the method of 
cellular delivery. However, multiple labs have seen success with adenovirus-based 
vectors, and I believe that an approach like this may be reasonable (Platt et al., 2014; 
Kaminski et al., 2016). Because the system described here does not result in gene 
deletion, I hypothesize that any of the already rare off-target effects will be minimal and 
that this strategy poses no risk of hereditary gene editing. 
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CHAPTER FIVE: DISCUSSION AND FUTURE IMPLICATIONS 	
Summary of Results 	
 The results described within this dissertation highlight the importance of the 
cellular and local chromatin environments at the time of HIV-1 infection on the fate of 
the virus. They also enabled me to verify the hypotheses detailed within the Specific 
Aims that were listed in the first chapter. For Specific Aim 1, I determined the effect of 
distinct T cell receptor signal strengths at the time of HIV-1 infection on viral expression 
within primary cells and reactivation of latent proviruses. To study this, I manipulated the 
cellular activation state through the use of chimeric antigen receptors that mimicked the 
endogenous T cell receptor. Through the substitution of single chain variable fragments 
differing in antigen binding affinity, I modulated the strength of signal that a cell received 
at the time of viral infection. These CARs intersected the native T cell receptor signaling 
pathways, as demonstrated by similar global transcriptional changes (Figure 3.2) and 
increased CD69 expression (Figure 3.3). Further evidence of their effects can be seen via 
the differences observed in acute HIV-1 expression. 
 Stimulation of CAR-expressing cells with their cognate Her2 antigen resulted in 
an increase in viral expression, and this response correlated with the strength of cellular 
activation (Figure 3.5). However, I detected no similar increase in viral integration, 
implying that the observed effects were due to post-integration events. I further 
confirmed these results by direct measurement of RNA transcripts and saw a similar 
pattern as observed with the luciferase analysis (Figure 3.7).  
		
86 
 It was reasonable to assume that cells which expressed higher levels of HIV-1 at 
early time points would be less likely to also harbor inducible latent proviruses since the 
total number of integrated proviruses was held constant. However, cells that received the 
greatest amount of stimulation during viral infection were also the most responsive to 
latency-reversing agents predicted to activate HIV-1 transcription through different 
biochemical pathways (Figure 3.9). 
 To address Specific Aim 2, for which I analyzed the transcriptional landscape of 
the provirus among cell receiving differential stimulation at the time of HIV-1 infection, I 
performed chromatin immunoprecipitation. I discovered that the local chromatin 
environment was open and accessible as measured by histone acetylation regardless of 
cellular activation. This is in agreement with multiple other studies that revealed a bias 
towards open chromatin that can be attenuated if host factors involved in nuclear import 
are knocked out or their interactions with HIV-1 capsid are blocked (Wang et al., 2007; 
Koh et al., 2013; Sowd et al., 2016). The data in Figure 3.10 indicated that successful 
polymerase processivity only occurred under high activation conditions in concert with 
release of the pausing factor NELF from the HIV-1 LTR. Based on this evidence, I 
concluded that although HIV-1 preferentially integrates into regions of open chromatin, 
the level of global cellular activation regulates whether host repressors are recruited to 
the provirus. The lack of responsiveness of the virus within minimally activated cells to 
secondary stimulation suggests that early association with host repressors results in 
entrenched transcriptional repression and deep-seated latency. 
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 These results led me to hypothesize that I could bias an infection towards deep-
seated latency, which was the basis for Specific Aim 3. I hypothesized that I could use a 
nuclease-deficient Cas9 construct to recruit host repressors to the provirus and suppress 
HIV-1 expression. By fusing dCas9 to a KRAB domain, we were able to substantially 
block HIV-1 expression upon transfection with an HIV-1 plasmid and achieved a greater 
than 50% reduction in viral protein production after infection (Figure 4.1B). In order to 
determine whether KRAB-Kap1 could induce permanent repression, we electroporated a 
J-Lat line bearing both a silent copy of HIV-1 along with a nuclease-deficient Cas9 
construct with LTR-specific sgRNAs. Treatment of these cells with TNF-α was not 
sufficient to achieve substantial viral reactivation as it did in the control condition, in 
which there was a 9-fold increase in viral protein production (Figure 4.2). This 
experiments listed here confirm my central hypothesis that the global cellular 
environment at the time of HIV-1 infection determines the potential for inducible latent 
infection and that this axis can by bypassed by modification of the local chromatin 
environment. 
  	
Latency: A Goal or an Obstacle? 	
 Based on the data detailed in this defense as well as the failure of multiple clinical 
trials to clear the entire viral reservoir, I propose that a functional cure of HIV-1 cannot 
be achieved through latency reversal. There is growing evidence that the latent reservoir 
is not homogenous, but rather a collection of multiple subsets in which latency is both 
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regulated by different mechanisms and has differing capacities to be re-activated. I have 
illustrated here that the level of cellular activation at the time of infection may determine 
whether latently infected cells are inducible or non-inducible. It has been known for some 
time that significant portions of the viral reservoir are refractory to standard LRAs in 
spite of their intact genomic content (Ho et al., 2013; Hosmane et al., 2017). I have 
argued in this dissertation that the cellular conditions at the time of viral entry determine 
the long-term fate of the virus and their susceptibility to LRAs. Minimal levels of 
stimulation, which may be sufficient for viral entry and integration, are inadequate to 
recruit an activating transcriptional network at the time of infection or to remove a 
repressive network during secondary stimulation.  
 The existence of these multiple subsets also calls into question the accepted 
paradigm of chromatin in establishment of latency. Exactly why I did not detect any 
changes in histone acetylation are not clear, but my data suggests that initial proviral 
repression may recruit other host factors, resulting in an entrenched network of 
chromatin-modifying factors and other repressive complexes. Histone acetylation, then, 
may be a marker for specific subsets of latently infected cells and not the entire reservoir. 
 This may explain the discrepancy between the importance of histone acetylation 
in cell line models and the complete absence of any evidence that histone deacetylase 
inhibitors can perturb the viral reservoir in vivo. However, evidence exists that a cocktail 
of LRAs including HDACi’s result in greater viral reactivation than a single drug, 
perhaps through interruption of multiple arms of whatever repressive transcriptional 
network eventually maintains a silent provirus in its latent state. 
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 Regardless, no clinical drug may be capable of clearing the entire viral reservoir. 
Instead, based on my data indicating that multiple forms of latency exist, I propose that a 
functional cure may be achieved through treatments that bias infected cells towards deep-
seated latency. Virus integrated into cells with the low-affinity chimeric antigen receptors 
was not easily responsive to PMA or antibodies against the endogenous CD3 and CD28 
receptors, which are significantly stronger than any cocktail which may be brought into 
clinic. It is reasonable to assume then that no biological effect may achieve a greater level 
of stimulation either. Antigen presentation in the context of an antigen-presenting cell 
may provide multiple signals but it is unlikely that this interaction would persist for a full 
day, as in an in vitro anti-CD3/CD28 condition. These infected cells then might pose no 
direct harm to the host, although they may re-seed the latent reservoir through clonal 
proliferation.  
 
Remaining Mechanistic Questions 	
 My work does not address all suggested mechanisms that contribute to latency 
such as host integration site, proviral genomic integrity, and transcriptional interference 
from neighboring genes. Regarding polymerase interference, evidence from our lab has 
shown that RNAPII read-through from the host promoter contributes little to HIV-1 
transcriptional regulation. Through analysis of multiple cell lines with integrated 
proviruses in differing orientation to the host gene, no differences could be detected in 
latency reversal (Kaczmarek Michaels et al., 2015). However, binding of NELF appeared 
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to be the primary regulatory factor in all conditions, in agreement with the evidence 
presented in Chapter Three. Future work on this project should consist of genomic 
sequencing to determine if I am polarizing integration sites towards or away from 
heterochromatic regions under low activation conditions and further PCR analysis to 
verify the integration of the viral genome, similar to that outlined by the Siliciano group 
(Bruner et al., 2016).  
 
The Impact of TCR Signaling on T Cell Function and Differentiation 
 
 In an effort to verify that signaling through the chimeric antigen receptors 
recapitulated endogenous TCR signaling cascades, I analyzed the phenotypes of 
differentially stimulated CD4+ T cells in multiple experiments including a microarray 
and flow analysis of surface markers. In addition to validating the CAR system, these 
assays raise a number of intriguing questions regarding the impact of signal strength on T 
cell function. As can be seen in the microarray analysis in Figure 3.2, multiple genes are 
immediately induced or repressed upon the slightest level of cellular stimulation. These 
genes, including the transcription factor KLF10, appear to require a low signaling 
threshold in order to become expressed. Other genes, including IL2, are transcribed in a 
gradient fashion and directly correlated to the level of upstream activation. Finally, a 
subset of genes exists, including FOXP3, a differentiation marker for Tregs (Allan et al., 
2005), that is induced by robust signaling, only achieved through engagement of the 
endogenous receptor (Table 3.1). 
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 Instead of the creation of distinct T cell subsets in which all cells that express the 
same surface antigens have similar gene profiles, our data suggest that there may be a 
functional spectrum regardless of T cell phenotype. A range of transcriptional activity 
can exist within the same cell subsets due to varying signaling thresholds that may or 
may not have been reached. TCR stimulation uniformly results in an expansion of the 
CCR7+ CD45RA- population (Figure 3.4), often indicative of central memory cells 
(Okada et al., 2008). However, the expression of most gene transcripts in Figure 3.2 are 
distinctly different between cells stimulated through the low affinity CAR and those 
activated by antibodies to CD3 and CD28. The impact of signaling on T cell cytokine 
production, further differentiation, and other functional outcomes within these memory 
populations may be considerable. 
 Some of the genes most differentially regulated upon TCR stimulation in Figure 
3.2 and Table A.1 (see Appendix) are those involved in either DNA replication, such as 
the nuclease RNASEH1 and the replication protein RPA3, or metabolism, including the 
glycolysis enzymes ENO1 and PGK1. The metabolic profiles of T cell subsets and their 
role within the immune response are of significant interest. For instance, a recent study 
identified glycolysis-related gene networks as critical to the capacity of Th17 cells to 
differentiate into Th1 cells (Karmaus et al., 2019). Further, it has been shown that the 
capacity of the host cell to conduct glycolysis is a key regulator of HIV-1 replication 
(Hegedus, Kavanagh Williamson and Huthoff, 2014) and may itself be increased upon 
viral infection (Hollenbaugh, Munger and Kim, 2011). My experiments highlight the 
importance of T cell signaling on both HIV-1 replication and cellular differentiation.  
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Study Limitations 
 
 While the research contained within this dissertation highlights several key 
mechanisms which regulate latent HIV-1, the findings presented here are in no way 
intended to be a complete summary of all factors which bias the balance between 
inducible and non-inducible latent reservoirs. I have thoroughly discussed the impact of 
signal amplitude on HIV-1 expression, but I have not analyzed signal quality. Future 
experiments within the Henderson lab will include the mutations of key residues within 
the CD28 and CD3ζ signaling domains of the chimeric antigen receptors in order to 
determine which residues and more importantly which signaling cascades are critical for 
the increase in HIV-1 expression that is observed upon TCR engagement.  
 In addition, work done by a fellow graduate student, Kyle Pedro, has indicated 
that HIV-1 infections in the context of an immunological synapse between a CD4+ T cell 
and a dendritic cell can compensate for suboptimal signaling within the target cell. The 
exact nature of these compensatory signals, and if inhibitory signals from receptors such 
as CTLA-4, PD-1, and Tim-3 also modulate the TCR-HIV axis, is not explored here.  
 I have also not described the nature of timing on HIV-1 infection. It is known that 
T cell activation prior to viral entry facilitates robust HIV-1 replication; however, the role 
of weak T cell signaling at this time point has not been fully examined. Minimal cellular 
activation prior to HIV-1 fusion with the cell membrane may allow for the expression of 
necessary entry receptors without providing an optimal environment for reverse 
transcription of the viral RNA genome or transcription of the integrated provirus. For 
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instance, the Lewin model of HIV-1 latency manipulates cells via treatment with CCL19 
and CCL21, which renders them susceptible to HIV-1 integration but is not sufficient for 
subsequent transcription (Saleh et al., 2007). The fact that the CCL19 receptor CCR7 
regulates HIV-1 integration via NF-κB induction (Saleh et al., 2016), but that this is 
inadequate for NF-κB - mediated transcription, provides more evidence for our 
conclusions regarding the existence of signaling thresholds that control HIV-1 
expression. In contrast to the effects of CCR7 ligands, culturing CD4+ T cells with IL-7 
prior to infection has been shown to provide the necessary stimulation for efficient HIV-1 
replication (Steffens et al., 2002), while IL-27 restricts HIV-1 expression in PBMCs 
(Fakruddin et al., 2007). The level of cellular activation prior to viral entry, and the exact 
quantity and quality of signaling cascades involved, should be explored in further studies. 
 My experiments focused on the impact of T cell receptor signaling at the time of 
infection on HIV-1 expression and latency reversal and revealed that this effect persisted 
for at least one week. However, latency in the context of a HIV+ individual may persist 
for the entire lifespan of an infected cell. With further optimization of our tunable model 
to extend the time of survival of CAR+ primary CD4+ T cells after HIV-1 infection, the 
Henderson lab will be able to address questions about the dynamics of latency reversal. 
 In addition, I have not discussed the mechanisms that contribute to HIV-1 latency 
in other cellular reservoirs. In Chapter One, I discussed the contributions of γδ T cells and 
macrophages to HIV-1 persistence. Although evidence exists that establishment and 
maintenance of HIV-1 latency may require cell-specific factors, I do not address that 
here. For instance, HIV-1 inhibits apoptosis within infected macrophages by upregulating 
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the cell survival receptor TREM-1 or Triggering receptor expressed on myeloid cells-1 
(Yuan et al., 2017). This is a cell-specific mechanism, which relies upon signals 
downstream from TREM-1 to establish latency. The Cannon lab also identified the 
CoREST complex (Corepressor to RE1 silencing transcription factor) as a microglia-
specific inhibitor of HIV-1 transcription in humanized mice. Because this is a unique 
mechanism for silencing of HIV-1 expression, microglia cells are especially responsive to 
LRAs that disrupt the CoREST complex (Llewellyn et al., 2018). However, my 
experiments highlight the establishment of HIV-1 latency in CD4+ T cells and the LRAs 
that may disrupt viral repression in those cells. Future cure efforts will require both the 
manipulation of the balance between inducible and non-inducible latent CD4+ T cell 
subsets as well as strategies to target HIV-1 persistence in other cell types. 
 In regards to the use of nuclease-deficient Cas9-KRAB, I have only presented 
preliminary data here. I have not described a method of delivery or analyzed any off-
target effects. Our lab is currently conducting experiments using multiple forms of 
latency reversing agents, and our eventual goal is to examine KRAB-Kap1 repression of 
HIV-1 in primary CD4+ T cells. KRAB-Kap1 is a promising complex for manipulating 
HIV-1 proviral expression. If we can better understand the function of other cellular host 
factors, additional key transcription factors might be utilized in a cell-specific manner. 
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Clinical Implications 	
 A functional cure of HIV-1 would have profound benefits to those living with 
HIV/AIDS. In spite of all of the progress obtained since the height of the epidemic in the 
1980’s, a significant portion of the population remains at risk of contracting HIV-1 and 
living with lifelong immune dysfunction. Challenges at producing a broad-spectrum 
vaccine or at achieving a clinically viable cure using gene excision remain daunting. 
Instead, a functional cure, in which a patient can cease antiretroviral therapy for years or 
decades with only occasional follow-up, represents the gold standard of HIV-1 therapy 
going forward. 
 The existence of at least two latent reservoirs, one which is readily inducible to 
the strongest LRAs ex vivo and one which remains refractory to stimulation after multiple 
challenges (Hosmane et al., 2017), suggests that a complete reversal of all potentially 
inducible latent proviruses may not be feasible. Instead, I present here the possibility of 
achieving permanent epigenetic silencing of all integrated HIV-1. Since cellular 
mechanisms that are recruited at the time of infection have long-term consequences on 
viral fate, there may be a therapeutic window in which to bias the balance between these 
two latent populations. My work also suggests that a two-step approach may be required: 
a cocktail of LRAs taken shortly after infection to remove the most easily reversible 
proviruses and then a gene editing based technique to further suppress all remaining 
infections into a deep-seated latency. 
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 The viral reservoir after years of suppressive therapy will not resemble the 
original population of infected cells. Differences in clonal proliferation and changes to 
epigenetic marks may alter the chromatin environment so that it no longer mimics the 
layers of repression observed in the original infected ancestor cells (Zerihun et al., 2015; 
Wang et al., 2018). However, the ability of KRAB-Kap1 mediated repression to persist 
despite cellular division (Ayyanathan et al., 2003) suggests that some of the epigenetic 
changes which occur during a new round of viral infection today may dictate the nature 
and dynamics of the latent reservoir for the remaining decades of a patient’s life. While 
this poses serious challenges, the research conducted for this dissertation suggests that we 
may also be able to shape the future latent reservoir in a beneficial manner for the patient. 
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APPENDIX: MICROARRAY ANALYIS OF DIFFERENTIALLY STIMULATED 
CD4+ T CELLS IN CHAPTER THREE 	
Principal Component Analysis 	
 Principal component analysis was performed on the genes listed as significantly 
different from the baseline unstimulated CD4+ T cell condition in the microarray shown 
for Figure 3.2. The separation of samples by treatment along the PC1 axis explains 29% 
of all variance, while PC2 explains 16% of all variance (Figure A.1). Clear clustering can 
be seen between all experimental conditions, with the low and high affinity CAR-
expressing cells appearing intermediate between the unstimulated and TCR-stimulated 
groups.  
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Figure A.1: Magnitude of T cell signaling differentially regulates genes in a gradient fashion. 
Signaling from the low affinity and high affinity CAR display an intermediate phenotype between that of 
the unstimulated and TCR-stimulated conditions. Principal component analysis was performed on all genes 
listed as significantly differentially expressed between conditions. The percentage of variance across all 
conditions explained by each principal component axis is listed as a percentage. See also Figure 3.2.  	
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Microarray Analysis 	
 All genes shown in the microarray in Figure 3.2, each of which has a one-way 
Anova FDR-corrected q value of less than 0.01. Each gene is listed along with its Human 
Entrez Gene ID, accepted description, and cluster number.  
Table A.1: List of genes whose expression is significantly altered upon TCR stimulation. All genes from the 
microarray listed in Figure 3.2 are described in the following pages. Genes were arbitrarily assigned to clusters based 
on gene expression patterns.  
10952 SEC61B Sec61	translocon	beta	subunit 1
51114 ZDHHC9 zinc	finger	DHHC-type	containing	9 1
115098 CCDC124 coiled-coil	domain	containing	124 1
64118 DUS1L dihydrouridine	synthase	1	like 1
79644 SRD5A3 steroid	5	alpha-reductase	3 1
9643 MORF4L2 mortality	factor	4	like	2 1
1802 DPH2 DPH2	homolog 1
150223 YDJC YdjC	homolog	(bacterial) 1
54998 AURKAIP1 aurora	kinase	A	interacting	protein	1 1
7277 TUBA4A tubulin	alpha	4a 1
55004 LAMTOR1 late	endosomal/lysosomal	adaptor,	MAPK	and	MTOR	activator	1 1
8321 FZD1 frizzled	class	receptor	1 1
4074 M6PR mannose-6-phosphate	receptor,	cation	dependent 1
2720 GLB1 galactosidase	beta	1 1
7469 NELFA negative	elongation	factor	complex	member	A 1
60496 AASDHPPT aminoadipate-semialdehyde	dehydrogenase-phosphopantetheinyl	transferase 1
5479 PPIB peptidylprolyl	isomerase	B 1
84337 ELOF1 elongation	factor	1	homolog 1
27314 RAB30 RAB30,	member	RAS	oncogene	family 1
27247 NFU1 NFU1	iron-sulfur	cluster	scaffold 1
157922 CAMSAP1 calmodulin	regulated	spectrin	associated	protein	1 1
51629 SLC25A39 solute	carrier	family	25	member	39 1
64769 MEAF6 MYST/Esa1	associated	factor	6 1
29081 METTL5 methyltransferase	like	5 1
58527 ABRACL ABRA	C-terminal	like 1
11315 PARK7 Parkinsonism	associated	deglycase 1
1233 CCR4 C-C	motif	chemokine	receptor	4 1
4726 NDUFS6 NADH:ubiquinone	oxidoreductase	subunit	S6 1
6346 CCL1 C-C	motif	chemokine	ligand	1 1
28974 C19orf53 chromosome	19	open	reading	frame	53 1
10286 BCAS2 breast	carcinoma	amplified	sequence	2 1
5133 PDCD1 programmed	cell	death	1 1
6846 XCL2 X-C	motif	chemokine	ligand	2 1
6375 XCL1 X-C	motif	chemokine	ligand	1 1
11043 MID2 midline	2 1
83443 SF3B5 splicing	factor	3b	subunit	5 1
9764 KIAA0513 KIAA0513 1
4697 NDUFA4 NDUFA4,	mitochondrial	complex	associated 1
55852 TEX2 testis	expressed	2 1
5777 PTPN6 protein	tyrosine	phosphatase,	non-receptor	type	6 1
5325 PLAGL1 PLAG1	like	zinc	finger	1 1
928 CD9 CD9	molecule 1
10897 YIF1A Yip1	interacting	factor	homolog	A,	membrane	trafficking	protein 1
Human	Entrez	
Gene	ID(s) Symbol Description Cluster
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26090 ABHD12 abhydrolase	domain	containing	12 1
89927 C16orf45 chromosome	16	open	reading	frame	45 1
8600 TNFSF11 tumor	necrosis	factor	superfamily	member	11 1
3394 IRF8 interferon	regulatory	factor	8 1
5606 MAP2K3 mitogen-activated	protein	kinase	kinase	3 1
2539 G6PD glucose-6-phosphate	dehydrogenase 1
7074 TIAM1 T-cell	lymphoma	invasion	and	metastasis	1 1
518 ATP5G3 ATP	synthase,	H+	transporting,	mitochondrial	Fo	complex	subunit	C3	(subunit	9) 1
3732 CD82 CD82	molecule 1
619279 ZNF704 zinc	finger	protein	704 1
51406 NOL7 nucleolar	protein	7 1
6500 SKP1 S-phase	kinase	associated	protein	1 1
1020 CDK5 cyclin	dependent	kinase	5 1
2787 GNG5 G	protein	subunit	gamma	5 1
91582 RPS19BP1 ribosomal	protein	S19	binding	protein	1 1
200894 ARL13B ADP	ribosylation	factor	like	GTPase	13B 1
6367 CCL22 C-C	motif	chemokine	ligand	22 1
55630 SLC39A4 solute	carrier	family	39	member	4 1
3682 ITGAE integrin	subunit	alpha	E 1
2589 GALNT1 polypeptide	N-acetylgalactosaminyltransferase	1 1
22906 TRAK1 trafficking	kinesin	protein	1 1
9562 MINPP1 multiple	inositol-polyphosphate	phosphatase	1 1
5875 RABGGTA Rab	geranylgeranyltransferase	alpha	subunit 1
2182 ACSL4 acyl-CoA	synthetase	long-chain	family	member	4 1
5997 RGS2 regulator	of	G-protein	signaling	2 1
5066 PAM peptidylglycine	alpha-amidating	monooxygenase 1
51096 UTP18 UTP18,	small	subunit	processome	component 1
51726 DNAJB11 DnaJ	heat	shock	protein	family	(Hsp40)	member	B11 1
3320 HSP90AA1 heat	shock	protein	90	alpha	family	class	A	member	1 1
54438 GFOD1 glucose-fructose	oxidoreductase	domain	containing	1 1
5569 PKIA protein	kinase	(cAMP-dependent,	catalytic)	inhibitor	alpha 1
90441 ZNF622 zinc	finger	protein	622 1
7133 TNFRSF1B TNF	receptor	superfamily	member	1B 1
27333 GOLIM4 golgi	integral	membrane	protein	4 1
134637 ADAT2 adenosine	deaminase,	tRNA	specific	2 1
7150 TOP1 topoisomerase	(DNA)	I 1
10915 TCERG1 transcription	elongation	regulator	1 1
811 CALR calreticulin 1
8425 LTBP4 latent	transforming	growth	factor	beta	binding	protein	4 1
5450 POU2AF1 POU	class	2	associating	factor	1 1
56253 CRTAM cytotoxic	and	regulatory	T-cell	molecule 1
23305 ACSL6 acyl-CoA	synthetase	long-chain	family	member	6 1
57472 CNOT6 CCR4-NOT	transcription	complex	subunit	6 1
58526 MID1IP1 MID1	interacting	protein	1 1
11057 ABHD2 abhydrolase	domain	containing	2 1
25822 DNAJB5 DnaJ	heat	shock	protein	family	(Hsp40)	member	B5 1
9882 TBC1D4 TBC1	domain	family	member	4 1
58493 INIP INTS3	and	NABP	interacting	protein 1
4023 LPL lipoprotein	lipase 1
79929 MAP6D1 MAP6	domain	containing	1 1
3904 LAIR2 leukocyte	associated	immunoglobulin	like	receptor	2 1
11098 PRSS23 protease,	serine	23 1
23012 STK38L serine/threonine	kinase	38	like 1
11022 TDRKH tudor	and	KH	domain	containing 1
4151 MB myoglobin 1
26090 ABHD12 abhydrolase	domain	containing	13 1
89927 C16orf45 chromosome	16	open	reading	frame	46 1
8600 TNFSF11 tumor	necrosis	factor	superfamily	member	12 1
3394 IRF8 interferon	regulatory	factor	9 1
5606 MAP2K3 mitogen-activated	protein	kinase	kinase	4 1
2539 G6PD glucose-6-phosphate	dehydrogenase 1
7074 TIAM1 T-cell	lymphoma	invasion	and	metastasis	2 1
518 ATP5G3 ATP	synthase,	H+	transporting,	mitochondrial	Fo	complex	subunit	C3	(subunit	9) 1
3732 CD82 CD82	molecule 1
619279 ZNF704 zinc	finger	protein	705 1
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5683 PSMA2 proteasome	subunit	alpha	2 1
5689 PSMB1 proteasome	subunit	beta	1 1
10808 HSPH1 heat	shock	protein	family	H	(Hsp110)	member	1 1
3274 HRH2 histamine	receptor	H2 1
10128 LRPPRC leucine	rich	pentatricopeptide	repeat	containing 1
1718 DHCR24 24-dehydrocholesterol	reductase 1
84679 SLC9A7 solute	carrier	family	9	member	A7 1
80185 TTI2 TELO2	interacting	protein	2 1
84890 ADO 2-aminoethanethiol	dioxygenase 1
388753 COA6 cytochrome	c	oxidase	assembly	factor	6 1
8140 SLC7A5 solute	carrier	family	7	member	5 1
55486 PARL presenilin	associated	rhomboid	like 1
7415 VCP valosin	containing	protein 1
2180 ACSL1 acyl-CoA	synthetase	long-chain	family	member	1 1
7803 PTP4A1 protein	tyrosine	phosphatase	type	IVA,	member	1 1
29107 NXT1 nuclear	transport	factor	2	like	export	factor	1 1
53615 MBD3 methyl-CpG	binding	domain	protein	3 1
84328 LZIC leucine	zipper	and	CTNNBIP1	domain	containing 1
51428 DDX41 DEAD-box	helicase	41 1
150678 COPS9 COP9	signalosome	subunit	9 1
54915 YTHDF1 YTH	N6-methyladenosine	RNA	binding	protein	1 1
1368 CPM carboxypeptidase	M 1
7128 TNFAIP3 TNF	alpha	induced	protein	3 1
81570 CLPB ClpB	homolog,	mitochondrial	AAA	ATPase	chaperonin 1
7071 KLF10 Kruppel	like	factor	10 1
3725 JUN Jun	proto-oncogene,	AP-1	transcription	factor	subunit 1
22827 PUF60 poly(U)	binding	splicing	factor	60 1
54733 SLC35F2 solute	carrier	family	35	member	F2 1
2153 F5 coagulation	factor	V 1
3516 RBPJ recombination	signal	binding	protein	for	immunoglobulin	kappa	J	region 1
7203 CCT3 chaperonin	containing	TCP1	subunit	3 1
4869 NPM1 nucleophosmin 1
22948 CCT5 chaperonin	containing	TCP1	subunit	5 1
54888 NSUN2 NOP2/Sun	RNA	methyltransferase	family	member	2 1
11001 SLC27A2 solute	carrier	family	27	member	2 1
11169 WDHD1 WD	repeat	and	HMG-box	DNA	binding	protein	1 1
2107 ETF1 eukaryotic	translation	termination	factor	1 1
8568 RRP1 ribosomal	RNA	processing	1 1
2023 ENO1 enolase	1 1
50628 GEMIN4 gem	nuclear	organelle	associated	protein	4 1
9322 TRIP10 thyroid	hormone	receptor	interactor	10 1
84295 PHF6 PHD	finger	protein	6 1
9939 RBM8A RNA	binding	motif	protein	8A 1
55605 KIF21A kinesin	family	member	21A 1
1173 AP2M1 adaptor	related	protein	complex	2	mu	1	subunit 1
9618 TRAF4 TNF	receptor	associated	factor	4 1
10098 TSPAN5 tetraspanin	5 1
23246 BOP1 block	of	proliferation	1 1
6385 SDC4 syndecan	4 1
908 CCT6A chaperonin	containing	TCP1	subunit	6A 1
54206 ERRFI1 ERBB	receptor	feedback	inhibitor	1 1
28984 RGCC regulator	of	cell	cycle 1
5315 PKM pyruvate	kinase,	muscle 1
402055 SRRD SRR1	domain	containing 1
3028 HSD17B10 hydroxysteroid	17-beta	dehydrogenase	10 1
10783 NEK6 NIMA	related	kinase	6 1
26521 TIMM8B translocase	of	inner	mitochondrial	membrane	8	homolog	B 1
10067 SCAMP3 secretory	carrier	membrane	protein	3 1
4706 NDUFAB1 NADH:ubiquinone	oxidoreductase	subunit	AB1 1
10514 MYBBP1A MYB	binding	protein	1a 1
10541 ANP32B acidic	nuclear	phosphoprotein	32	family	member	B 1
27044 SND1 staphylococcal	nuclease	and	tudor	domain	containing	1 1
4121 MAN1A1 mannosidase	alpha	class	1A	member	1 1
3945 LDHB lactate	dehydrogenase	B 1
84946 LTV1 LTV1	ribosome	biogenesis	factor 1
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9456 HOMER1 homer	scaffolding	protein	1 1
80896 NPL N-acetylneuraminate	pyruvate	lyase 1
1026 CDKN1A cyclin	dependent	kinase	inhibitor	1A 1
50615 IL21R interleukin	21	receptor 1
83858 ATAD3B ATPase	family,	AAA	domain	containing	3B 1
3326 HSP90AB1 heat	shock	protein	90	alpha	family	class	B	member	1 1
1493 CTLA4 cytotoxic	T-lymphocyte	associated	protein	4 1
8444 DYRK3 dual	specificity	tyrosine	phosphorylation	regulated	kinase	3 1
23135 KDM6B lysine	demethylase	6B 1
23223 RRP12 ribosomal	RNA	processing	12	homolog 1
25902 MTHFD1L methylenetetrahydrofolate	dehydrogenase	(NADP+	dependent)	1-like 1
22856 CHSY1 chondroitin	sulfate	synthase	1 1
85458 DIXDC1 DIX	domain	containing	1 1
817 CAMK2D calcium/calmodulin	dependent	protein	kinase	II	delta 1
10252 SPRY1 sprouty	RTK	signaling	antagonist	1 1
25911 DPCD deleted	in	primary	ciliary	dyskinesia	homolog	(mouse) 1
219 ALDH1B1 aldehyde	dehydrogenase	1	family	member	B1 1
57213 SPRYD7 SPRY	domain	containing	7 1
10171 RCL1 RNA	terminal	phosphate	cyclase	like	1 1
5516 PPP2CB protein	phosphatase	2	catalytic	subunit	beta 1
25929 GEMIN5 gem	nuclear	organelle	associated	protein	5 1
55161 TMEM33 transmembrane	protein	33 1
25778 DSTYK dual	serine/threonine	and	tyrosine	protein	kinase 1
11338 U2AF2 U2	small	nuclear	RNA	auxiliary	factor	2 1
283871 PGP phosphoglycolate	phosphatase 1
8884 SLC5A6 solute	carrier	family	5	member	6 1
79586 CHPF chondroitin	polymerizing	factor 1
283373 ANKRD52 ankyrin	repeat	domain	52 1
55319 TMA16 translation	machinery	associated	16	homolog 1
55269 PSPC1 paraspeckle	component	1 1
7511 XPNPEP1 X-prolyl	aminopeptidase	1 1
1836 SLC26A2 solute	carrier	family	26	member	2 1
113251 LARP4 La	ribonucleoprotein	domain	family	member	4 1
9656 MDC1 mediator	of	DNA	damage	checkpoint	1 1
254428 SLC41A1 solute	carrier	family	41	member	1 1
8161 COIL coilin 1
65059 RAPH1 Ras	association	(RalGDS/AF-6)	and	pleckstrin	homology	domains	1 1
8807 IL18RAP interleukin	18	receptor	accessory	protein 1
10018 BCL2L11 BCL2	like	11 1
2597 GAPDH glyceraldehyde-3-phosphate	dehydrogenase 1
6907 TBL1X transducin	beta	like	1X-linked 1
9047 SH2D2A SH2	domain	containing	2A 1
64759 TNS3 tensin	3 1
200734 SPRED2 sprouty	related	EVH1	domain	containing	2 1
6050 RNH1 ribonuclease/angiogenin	inhibitor	1 1
1390 CREM cAMP	responsive	element	modulator 1
4810 NHS NHS	actin	remodeling	regulator 1
969 CD69 CD69	molecule 1
597 BCL2A1 BCL2	related	protein	A1 1
1293 COL6A3 collagen	type	VI	alpha	3	chain 1
64218 SEMA4A semaphorin	4A 1
8464 SUPT3H SPT3	homolog,	SAGA	and	STAGA	complex	component 1
3557 IL1RN interleukin	1	receptor	antagonist 1
6319 SCD stearoyl-CoA	desaturase 1
10849 CD3EAP CD3e	molecule	associated	protein 1
50 ACO2 aconitase	2 1
160760 PPTC7 PTC7	protein	phosphatase	homolog 1
51255 RNF181 ring	finger	protein	181 1
90378 SAMD1 sterile	alpha	motif	domain	containing	1 1
191 AHCY adenosylhomocysteinase 1
9446 GSTO1 glutathione	S-transferase	omega	1 1
6780 STAU1 staufen	double-stranded	RNA	binding	protein	1 1
9112 MTA1 metastasis	associated	1 1
2885 GRB2 growth	factor	receptor	bound	protein	2 1
4642 MYO1D myosin	ID 1
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10273 STUB1 STIP1	homology	and	U-box	containing	protein	1 1
64651 CSRNP1 cysteine	and	serine	rich	nuclear	protein	1 1
22822 PHLDA1 pleckstrin	homology	like	domain	family	A	member	1 1
8566 PDXK pyridoxal	(pyridoxine,	vitamin	B6)	kinase 1
8482 SEMA7A semaphorin	7A	(John	Milton	Hagen	blood	group) 1
7421 VDR vitamin	D	(1,25-	dihydroxyvitamin	D3)	receptor 1
59269 HIVEP3 human	immunodeficiency	virus	type	I	enhancer	binding	protein	3 1
54602 NDFIP2 Nedd4	family	interacting	protein	2 1
1958 EGR1 early	growth	response	1 1
1846 DUSP4 dual	specificity	phosphatase	4 1
1959 EGR2 early	growth	response	2 1
135228 CD109 CD109	molecule 1
8013 NR4A3 nuclear	receptor	subfamily	4	group	A	member	3 1
4345 CD200 CD200	molecule 1
3604 TNFRSF9 TNF	receptor	superfamily	member	9 1
51320 MEX3C mex-3	RNA	binding	family	member	C 1
9645 MICAL2 microtubule	associated	monooxygenase,	calponin	and	LIM	domain	containing	2 1
5738 PTGFRN prostaglandin	F2	receptor	inhibitor 1
6004 RGS16 regulator	of	G-protein	signaling	16 1
9669 EIF5B eukaryotic	translation	initiation	factor	5B 1
3662 IRF4 interferon	regulatory	factor	4 1
57109 REXO4 REX4	homolog,	3'-5'	exonuclease 1
79814 AGMAT agmatinase 1
55544 RBM38 RNA	binding	motif	protein	38 1
9904 RBM19 RNA	binding	motif	protein	19 1
10488 CREB3 cAMP	responsive	element	binding	protein	3 1
4791 NFKB2 nuclear	factor	kappa	B	subunit	2 1
54874 FNBP1L formin	binding	protein	1	like 1
55640 FLVCR2 feline	leukemia	virus	subgroup	C	cellular	receptor	family	member	2 1
9513 FXR2 FMR1	autosomal	homolog	2 1
29979 UBQLN1 ubiquilin	1 1
55341 LSG1 large	60S	subunit	nuclear	export	GTPase	1 1
9987 HNRNPDL heterogeneous	nuclear	ribonucleoprotein	D	like 1
3783 KCNN4 potassium	calcium-activated	channel	subfamily	N	member	4 1
6520 SLC3A2 solute	carrier	family	3	member	2 1
26574 AATF apoptosis	antagonizing	transcription	factor 1
56957 OTUD7B OTU	deubiquitinase	7B 1
65094 JMJD4 jumonji	domain	containing	4 1
56270 WDR45B WD	repeat	domain	45B 1
5688 PSMA7 proteasome	subunit	alpha	7 1
51042 ZNF593 zinc	finger	protein	593 1
3727 JUND JunD	proto-oncogene,	AP-1	transcription	factor	subunit 1
85437 ZCRB1 zinc	finger	CCHC-type	and	RNA	binding	motif	containing	1 1
55813 UTP6 UTP6,	small	subunit	processome	component 1
90480 GADD45GIP1 GADD45G	interacting	protein	1 1
5831 PYCR1 pyrroline-5-carboxylate	reductase	1 1
4643 MYO1E myosin	IE 1
1407 CRY1 cryptochrome	circadian	clock	1 1
1329 COX5B cytochrome	c	oxidase	subunit	5B 1
7915 ALDH5A1 aldehyde	dehydrogenase	5	family	member	A1 1
51529 ANAPC11 anaphase	promoting	complex	subunit	11 1
31 ACACA acetyl-CoA	carboxylase	alpha 1
57568 SIPA1L2 signal	induced	proliferation	associated	1	like	2 1
6599 SMARCC1
SWI/SNF	related,	matrix	associated,	actin	dependent	regulator	of	chromatin	subfamily	
c	member	1 1
9486 CHST10 carbohydrate	sulfotransferase	10 1
56938 ARNTL2 aryl	hydrocarbon	receptor	nuclear	translocator	like	2 1
3192 HNRNPU heterogeneous	nuclear	ribonucleoprotein	U 1
23507 LRRC8B leucine	rich	repeat	containing	8	family	member	B 1
26031 OSBPL3 oxysterol	binding	protein	like	3 1
7528 YY1 YY1	transcription	factor 1
23429 RYBP RING1	and	YY1	binding	protein 1
5591 PRKDC protein	kinase,	DNA-activated,	catalytic	polypeptide 1
7525 YES1 YES	proto-oncogene	1,	Src	family	tyrosine	kinase 1
8932 MBD2 methyl-CpG	binding	domain	protein	2 1
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4779 NFE2L1 nuclear	factor,	erythroid	2	like	1 1
3054 HCFC1 host	cell	factor	C1 1
2194 FASN fatty	acid	synthase 1
28964 GIT1 GIT	ArfGAP	1 1
29886 SNX8 sorting	nexin	8 1
10153 CEBPZ CCAAT/enhancer	binding	protein	zeta 1
79050 NOC4L nucleolar	complex	associated	4	homolog 1
10400 PEMT phosphatidylethanolamine	N-methyltransferase 1
115353 LRRC42 leucine	rich	repeat	containing	42 1
57478 USP31 ubiquitin	specific	peptidase	31 1
1459 CSNK2A2 casein	kinase	2	alpha	2 1
282969 FUOM fucose	mutarotase 1
84320 ACBD6 acyl-CoA	binding	domain	containing	6 1
56259 CTNNBL1 catenin	beta	like	1 1
254394 MCM9 minichromosome	maintenance	9	homologous	recombination	repair	factor 1
4884 NPTX1 neuronal	pentraxin	1 1
10804 GJB6 gap	junction	protein	beta	6 1
6617 SNAPC1 small	nuclear	RNA	activating	complex	polypeptide	1 1
57584 ARHGAP21 Rho	GTPase	activating	protein	21 1
4763 NF1 neurofibromin	1 1
7486 WRN Werner	syndrome	RecQ	like	helicase 1
11325 DDX42 DEAD-box	helicase	42 1
10975 UQCR11 ubiquinol-cytochrome	c	reductase,	complex	III	subunit	XI 1
5424 POLD1 DNA	polymerase	delta	1,	catalytic	subunit 1
9986 RCE1 Ras	converting	CAAX	endopeptidase	1 1
90525 SHF Src	homology	2	domain	containing	F 1
55760 DHX32 DEAH-box	helicase	32	(putative) 1
1263 PLK3 polo	like	kinase	3 1
8651 SOCS1 suppressor	of	cytokine	signaling	1 1
54936 ADPRHL2 ADP-ribosylhydrolase	like	2 1
5531 PPP4C protein	phosphatase	4	catalytic	subunit 1
23640 HSPBP1 HSPA	(Hsp70)	binding	protein	1 1
113000 RPUSD1 RNA	pseudouridylate	synthase	domain	containing	1 1
55527 FEM1A fem-1	homolog	A 1
1175 AP2S1 adaptor	related	protein	complex	2	sigma	1	subunit 1
148022 TICAM1 toll	like	receptor	adaptor	molecule	1 1
55684 RABL6 RAB,	member	RAS	oncogene	family-like	6 1
8175 SF3A2 splicing	factor	3a	subunit	2 1
284106 CISD3 CDGSH	iron	sulfur	domain	3 1
125988 C19orf70 chromosome	19	open	reading	frame	70 1
84134 TOMM40L translocase	of	outer	mitochondrial	membrane	40	like 1
5094 PCBP2 poly(rC)	binding	protein	2 1
11140 CDC37 cell	division	cycle	37 1
2354 FOSB FosB	proto-oncogene,	AP-1	transcription	factor	subunit 1
84216 TMEM117 transmembrane	protein	117 1
677 ZFP36L1 ZFP36	ring	finger	protein	like	1 1
7040 TGFB1 transforming	growth	factor	beta	1 1
9265 CYTH3 cytohesin	3 1
80700 UBXN6 UBX	domain	protein	6 1
10048 RANBP9 RAN	binding	protein	9 1
3560 IL2RB interleukin	2	receptor	subunit	beta 1
7763 ZFAND5 zinc	finger	AN1-type	containing	5 1
9249 DHRS3 dehydrogenase/reductase	3 1
51564 HDAC7 histone	deacetylase	7 1
92558 BICDL1 BICD	family	like	cargo	adaptor	1 1
26262 TSPAN17 tetraspanin	17 1
54985 HCFC1R1 host	cell	factor	C1	regulator	1 1
923 CD6 CD6	molecule 1
10625 IVNS1ABP influenza	virus	NS1A	binding	protein 1
57062 DDX24 DEAD-box	helicase	24 1
22859 ADGRL1 adhesion	G	protein-coupled	receptor	L1 1
79169 C1orf35 chromosome	1	open	reading	frame	35 1
7057 THBS1 thrombospondin	1 1
1105 CHD1 chromodomain	helicase	DNA	binding	protein	1 1
113246 C12orf57 chromosome	12	open	reading	frame	57 1
6193 RPS5 ribosomal	protein	S5 1
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353322 ANKRD37 ankyrin	repeat	domain	37 1
140823 ROMO1 reactive	oxygen	species	modulator	1 1
401052 LOC401052 uncharacterized	LOC401052 1
10948 STARD3 StAR	related	lipid	transfer	domain	containing	3 1
80198 MUS81 MUS81	structure-specific	endonuclease	subunit 1
1855 DVL1 dishevelled	segment	polarity	protein	1 1
3556 IL1RAP interleukin	1	receptor	accessory	protein 1
4602 MYB MYB	proto-oncogene,	transcription	factor 1
8496 PPFIBP1 PPFIA	binding	protein	1 1
1960 EGR3 early	growth	response	3 1
3164 NR4A1 nuclear	receptor	subfamily	4	group	A	member	1 1
4862 NPAS2 neuronal	PAS	domain	protein	2 1
2672 GFI1 growth	factor	independent	1	transcriptional	repressor 1
5270 SERPINE2 serpin	family	E	member	2 1
57190 SELENON selenoprotein	N 1
54815 GATAD2A GATA	zinc	finger	domain	containing	2A 1
8270 LAGE3 L	antigen	family	member	3 1
5524 PTPA protein	phosphatase	2	phosphatase	activator 1
57688 ZSWIM6 zinc	finger	SWIM-type	containing	6 1
51079 NDUFA13 NADH:ubiquinone	oxidoreductase	subunit	A13 1
3720 JARID2 jumonji	and	AT-rich	interaction	domain	containing	2 1
4851 NOTCH1 notch	1 1
23326 USP22 ubiquitin	specific	peptidase	22 1
6938 TCF12 transcription	factor	12 1
9704 DHX34 DEAH-box	helicase	34 1
26155 NOC2L NOC2	like	nucleolar	associated	transcriptional	repressor 1
165 AEBP1 AE	binding	protein	1 1
115024 NT5C3B 5'-nucleotidase,	cytosolic	IIIB 1
10865 ARID5A AT-rich	interaction	domain	5A 1
26051 PPP1R16B protein	phosphatase	1	regulatory	subunit	16B 1
728489 DNLZ DNL-type	zinc	finger 1
8761 PABPC4 poly(A)	binding	protein	cytoplasmic	4 1
2768 GNA12 G	protein	subunit	alpha	12 1
6633 SNRPD2 small	nuclear	ribonucleoprotein	D2	polypeptide 1
7265 TTC1 tetratricopeptide	repeat	domain	1 1
2879 GPX4 glutathione	peroxidase	4 1
59286 UBL5 ubiquitin	like	5 1
5971 RELB RELB	proto-oncogene,	NF-kB	subunit 1
9092 SART1 squamous	cell	carcinoma	antigen	recognized	by	T-cells	1 1
23020 SNRNP200 small	nuclear	ribonucleoprotein	U5	subunit	200 1
123169 LEO1 LEO1	homolog,	Paf1/RNA	polymerase	II	complex	component 1
3995 FADS3 fatty	acid	desaturase	3 1
4298 MLLT1 MLLT1,	super	elongation	complex	subunit 1
54926 UBE2R2 ubiquitin	conjugating	enzyme	E2	R2 1
3984 LIMK1 LIM	domain	kinase	1 1
5966 REL REL	proto-oncogene,	NF-kB	subunit 1
10451 VAV3 vav	guanine	nucleotide	exchange	factor	3 1
6713 SQLE squalene	epoxidase 1
3309 HSPA5 heat	shock	protein	family	A	(Hsp70)	member	5 1
79876 UBA5 ubiquitin	like	modifier	activating	enzyme	5 1
2534 FYN FYN	proto-oncogene,	Src	family	tyrosine	kinase 1
84524 ZC3H8 zinc	finger	CCCH-type	containing	8 1
56937 PMEPA1 prostate	transmembrane	protein,	androgen	induced	1 1
7016 TESK1 testis-specific	kinase	1 1
7185 TRAF1 TNF	receptor	associated	factor	1 1
10746 MAP3K2 mitogen-activated	protein	kinase	kinase	kinase	2 1
51429 SNX9 sorting	nexin	9 1
55342 STRBP spermatid	perinuclear	RNA	binding	protein 1
56172 ANKH ANKH	inorganic	pyrophosphate	transport	regulator 1
54880 BCOR BCL6	corepressor 1
9766 SUSD6 sushi	domain	containing	6 1
6722 SRF serum	response	factor 1
9603 NFE2L3 nuclear	factor,	erythroid	2	like	3 1
27161 AGO2 argonaute	2,	RISC	catalytic	component 1
29954 POMT2 protein	O-mannosyltransferase	2 1
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8428 STK24 serine/threonine	kinase	24 1
10072 DPP3 dipeptidyl	peptidase	3 1
4282 MIF macrophage	migration	inhibitory	factor	(glycosylation-inhibiting	factor) 1
22876 INPP5F inositol	polyphosphate-5-phosphatase	F 1
3399 ID3 inhibitor	of	DNA	binding	3,	HLH	protein 1
26018 LRIG1 leucine	rich	repeats	and	immunoglobulin	like	domains	1 1
2275 FHL3 four	and	a	half	LIM	domains	3 1
153020 RASGEF1B RasGEF	domain	family	member	1B 1
55589 BMP2K BMP2	inducible	kinase 1
23683 PRKD3 protein	kinase	D3 1
25797 QPCT glutaminyl-peptide	cyclotransferase 1
23541 SEC14L2 SEC14	like	lipid	binding	2 1
4929 NR4A2 nuclear	receptor	subfamily	4	group	A	member	2 1
55573 CDV3 CDV3	homolog 1
55353 LAPTM4B lysosomal	protein	transmembrane	4	beta 1
5367 PMCH pro-melanin	concentrating	hormone 1
9076 CLDN1 claudin	1 1
3267 AGFG1 ArfGAP	with	FG	repeats	1 1
27076 LYPD3 LY6/PLAUR	domain	containing	3 1
521 ATP5I ATP	synthase,	H+	transporting,	mitochondrial	Fo	complex	subunit	E 1
1340 COX6B1 cytochrome	c	oxidase	subunit	6B1 1
51700 CYB5R2 cytochrome	b5	reductase	2 1
2118 ETV4 ETS	variant	4 1
54935 DUSP23 dual	specificity	phosphatase	23 1
6168 RPL37A ribosomal	protein	L37a 1
79763 ISOC2 isochorismatase	domain	containing	2 1
55621 TRMT1 tRNA	methyltransferase	1 1
11267 SNF8 SNF8,	ESCRT-II	complex	subunit 1
1347 COX7A2 cytochrome	c	oxidase	subunit	7A2 1
79724 ZNF768 zinc	finger	protein	768 1
28955 DEXI Dexi	homolog 1
10555 AGPAT2 1-acylglycerol-3-phosphate	O-acyltransferase	2 1
143903 LAYN layilin 1
283209 PGM2L1 phosphoglucomutase	2	like	1 1
8507 ENC1 ectodermal-neural	cortex	1 1
9749 PHACTR2 phosphatase	and	actin	regulator	2 1
7390 UROS uroporphyrinogen	III	synthase 1
84293 FAM213A family	with	sequence	similarity	213	member	A 1
169792 GLIS3 GLIS	family	zinc	finger	3 1
11019 LIAS lipoic	acid	synthetase 1
9537 TP53I11 tumor	protein	p53	inducible	protein	11 1
64092 SAMSN1 SAM	domain,	SH3	domain	and	nuclear	localization	signals	1 1
9398 CD101 CD101	molecule 1
128866 CHMP4B charged	multivesicular	body	protein	4B 1
914 CD2 CD2	molecule 1
56941 HMCES 5-hydroxymethylcytosine	(hmC)	binding,	ES	cell-specific 1
2744 GLS glutaminase 1
481 ATP1B1 ATPase	Na+/K+	transporting	subunit	beta	1 1
7832 BTG2 BTG	anti-proliferation	factor	2 1
121260 SLC15A4 solute	carrier	family	15	member	4 1
91647 ATPAF2 ATP	synthase	mitochondrial	F1	complex	assembly	factor	2 1
11319 ECD ecdysoneless	cell	cycle	regulator 1
473 RERE arginine-glutamic	acid	dipeptide	repeats 1
6830 SUPT6H SPT6	homolog,	histone	chaperone 1
10428 CFDP1 craniofacial	development	protein	1 1
2969 GTF2I general	transcription	factor	IIi 1
23396 PIP5K1C phosphatidylinositol-4-phosphate	5-kinase	type	1	gamma 1
220213 OTUD1 OTU	deubiquitinase	1 1
5937 RBMS1 RNA	binding	motif	single	stranded	interacting	protein	1 1
60436 TGIF2 TGFB	induced	factor	homeobox	2 1
4772 NFATC1 nuclear	factor	of	activated	T-cells	1 1
2026 ENO2 enolase	2 1
6774 STAT3 signal	transducer	and	activator	of	transcription	3 1
80233 FAAP100 Fanconi	anemia	core	complex	associated	protein	100 1
9859 CEP170 centrosomal	protein	170 1
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3091 HIF1A hypoxia	inducible	factor	1	alpha	subunit 1
26278 SACS sacsin	molecular	chaperone 1
8202 NCOA3 nuclear	receptor	coactivator	3 1
4928 NUP98 nucleoporin	98 1
3446 IFNA10 interferon	alpha	10 1
4637 MYL6 myosin	light	chain	6 1
51192 CKLF chemokine	like	factor 1
11006 LILRB4 leukocyte	immunoglobulin	like	receptor	B4 1
29085 PHPT1 phosphohistidine	phosphatase	1 1
10591 DNPH1 2'-deoxynucleoside	5'-phosphate	N-hydrolase	1 1
8871 SYNJ2 synaptojanin	2 1
27151 CPAMD8 C3	and	PZP	like,	alpha-2-macroglobulin	domain	containing	8 1
4122 MAN2A2 mannosidase	alpha	class	2A	member	2 1
85450 ITPRIP inositol	1,4,5-trisphosphate	receptor	interacting	protein 1
115708 TRMT61A tRNA	methyltransferase	61A 1
119 ADD2 adducin	2 1
100506581 C16orf95 chromosome	16	open	reading	frame	95 1
25814 ATXN10 ataxin	10 1
2004 ELK3 ELK3,	ETS	transcription	factor 1
23670 TMEM2 transmembrane	protein	2 1
1119 CHKA choline	kinase	alpha 1
51530 ZC3HC1 zinc	finger	C3HC-type	containing	1 1
84865 CCDC142 coiled-coil	domain	containing	142 1
94104 PAXBP1 PAX3	and	PAX7	binding	protein	1 1
23138 N4BP3 NEDD4	binding	protein	3 1
55128 TRIM68 tripartite	motif	containing	68 1
8505 PARG poly(ADP-ribose)	glycohydrolase 1
7343 UBTF upstream	binding	transcription	factor,	RNA	polymerase	I 1
56970 ATXN7L3 ataxin	7	like	3 1
2314 FLII FLII,	actin	remodeling	protein 1
2622 GAS8 growth	arrest	specific	8 1
7090 TLE3 transducin	like	enhancer	of	split	3 1
64718 UNKL unkempt	family	like	zinc	finger 1
284654 RSPO1 R-spondin	1 1
79171 RBM42 RNA	binding	motif	protein	42 1
7874 USP7 ubiquitin	specific	peptidase	7 1
9757 KMT2B lysine	methyltransferase	2B 1
37 ACADVL acyl-CoA	dehydrogenase,	very	long	chain 1
26279 PLA2G2D phospholipase	A2	group	IID 1
4296 MAP3K11 mitogen-activated	protein	kinase	kinase	kinase	11 1
5739 PTGIR prostaglandin	I2	(prostacyclin)	receptor	(IP) 1
9058 SLC13A2 solute	carrier	family	13	member	2 1
79064 TMEM223 transmembrane	protein	223 1
55206 SBNO1 strawberry	notch	homolog	1 1
24148 PRPF6 pre-mRNA	processing	factor	6 1
2535 FZD2 frizzled	class	receptor	2 1
7259 TSPYL1 TSPY	like	1 1
8439 NSMAF neutral	sphingomyelinase	activation	associated	factor 1
150946 GAREM2 GRB2	associated	regulator	of	MAPK1	subtype	2 1
5213 PFKM phosphofructokinase,	muscle 2
6429 SRSF4 serine	and	arginine	rich	splicing	factor	4 2
60481 ELOVL5 ELOVL	fatty	acid	elongase	5 2
966 CD59 CD59	molecule 2
9276 COPB2 coatomer	protein	complex	subunit	beta	2 2
51386 EIF3L eukaryotic	translation	initiation	factor	3	subunit	L 2
2072 ERCC4 ERCC	excision	repair	4,	endonuclease	catalytic	subunit 2
4358 MPV17 MPV17,	mitochondrial	inner	membrane	protein 2
8655 DYNLL1 dynein	light	chain	LC8-type	1 2
80219 COQ10B coenzyme	Q10B 2
8992 ATP6V0E1 ATPase	H+	transporting	V0	subunit	e1 2
148203 ZNF738 zinc	finger	protein	738 2
93380 MMGT1 membrane	magnesium	transporter	1 2
51060 TXNDC12 thioredoxin	domain	containing	12 2
6539 SLC6A12 solute	carrier	family	6	member	12 2
388591 RNF207 ring	finger	protein	207 2
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6727 SRP14 signal	recognition	particle	14 2
729852 UMAD1 UBAP1-MVB12-associated	(UMA)	domain	containing	1 2
80381 CD276 CD276	molecule 2
84258 SYT3 synaptotagmin	3 2
23251 KIAA1024 KIAA1024 2
114836 SLAMF6 SLAM	family	member	6 2
6207 RPS13 ribosomal	protein	S13 2
728798 FRMPD2B FERM	and	PDZ	domain	containing	2B,	pseudogene 2
51759 C9orf78 chromosome	9	open	reading	frame	78 2
8837 CFLAR CASP8	and	FADD	like	apoptosis	regulator 2
55012 PPP2R3C protein	phosphatase	2	regulatory	subunit	B''gamma 2
118426 BORCS5 BLOC-1	related	complex	subunit	5 2
8804 CREG1 cellular	repressor	of	E1A	stimulated	genes	1 2
51008 ASCC1 activating	signal	cointegrator	1	complex	subunit	1 2
142 PARP1 poly(ADP-ribose)	polymerase	1 2
90355 C5orf30 chromosome	5	open	reading	frame	30 2
4802 NFYC nuclear	transcription	factor	Y	subunit	gamma 2
51188 SS18L2 SS18	like	2 2
84318 CCDC77 coiled-coil	domain	containing	77 2
133015 PACRGL PARK2	coregulated	like 2
79691 QTRT2 queuine	tRNA-ribosyltransferase	accessory	subunit	2 2
10055 SAE1 SUMO1	activating	enzyme	subunit	1 2
8030 CCDC6 coiled-coil	domain	containing	6 2
3383 ICAM1 intercellular	adhesion	molecule	1 2
81691 LOC81691 exonuclease	NEF-sp 2
90417 KNSTRN kinetochore	localized	astrin/SPAG5	binding	protein 2
7453 WARS tryptophanyl-tRNA	synthetase 2
9232 PTTG1 pituitary	tumor-transforming	1 2
51155 HN1 hematological	and	neurological	expressed	1 2
11244 ZHX1 zinc	fingers	and	homeoboxes	1 2
6790 AURKA aurora	kinase	A 2
7049 TGFBR3 transforming	growth	factor	beta	receptor	3 2
55165 CEP55 centrosomal	protein	55 2
57405 SPC25 SPC25,	NDC80	kinetochore	complex	component 2
221150 SKA3 spindle	and	kinetochore	associated	complex	subunit	3 2
157570 ESCO2 establishment	of	sister	chromatid	cohesion	N-acetyltransferase	2 2
9055 PRC1 protein	regulator	of	cytokinesis	1 2
157313 CDCA2 cell	division	cycle	associated	2 2
51433 ANAPC5 anaphase	promoting	complex	subunit	5 2
83540 NUF2 NUF2,	NDC80	kinetochore	complex	component 2
9738 CCP110 centriolar	coiled-coil	protein	110 2
11183 MAP4K5 mitogen-activated	protein	kinase	kinase	kinase	kinase	5 2
22974 TPX2 TPX2,	microtubule	nucleation	factor 2
10112 KIF20A kinesin	family	member	20A 2
3161 HMMR hyaluronan	mediated	motility	receptor 2
79840 NHEJ1 non-homologous	end	joining	factor	1 2
3148 HMGB2 high	mobility	group	box	2 2
9787 DLGAP5 DLG	associated	protein	5 2
9212 AURKB aurora	kinase	B 2
699 BUB1 BUB1	mitotic	checkpoint	serine/threonine	kinase 2
11113 CIT citron	rho-interacting	serine/threonine	kinase 2
51203 NUSAP1 nucleolar	and	spindle	associated	protein	1 2
644 BLVRA biliverdin	reductase	A 2
9928 KIF14 kinesin	family	member	14 2
7153 TOP2A topoisomerase	(DNA)	II	alpha 2
84548 TMEM185A transmembrane	protein	185A 2
54842 MFSD6 major	facilitator	superfamily	domain	containing	6 2
860 RUNX2 runt	related	transcription	factor	2 2
8501 SLC43A1 solute	carrier	family	43	member	1 2
255231 MCOLN2 mucolipin	2 2
1326 MAP3K8 mitogen-activated	protein	kinase	kinase	kinase	8 2
4818 NKG7 natural	killer	cell	granule	protein	7 2
347734 SLC35B2 solute	carrier	family	35	member	B2 2
2786 GNG4 G	protein	subunit	gamma	4 2
6574 SLC20A1 solute	carrier	family	20	member	1 2
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1889 ECE1 endothelin	converting	enzyme	1 2
54977 SLC25A38 solute	carrier	family	25	member	38 2
55362 TMEM63B transmembrane	protein	63B 2
81562 LMAN2L lectin,	mannose	binding	2	like 2
55974 SLC50A1 solute	carrier	family	50	member	1 2
55432 YOD1 YOD1	deubiquitinase 2
64776 C11orf1 chromosome	11	open	reading	frame	1 2
92335 STRADA STE20-related	kinase	adaptor	alpha 2
5603 MAPK13 mitogen-activated	protein	kinase	13 2
85235 HIST1H2AH histone	cluster	1	H2A	family	member	h 2
8360 HIST1H4D histone	cluster	1	H4	family	member	d 2
3017 HIST1H2BD histone	cluster	1	H2B	family	member	d 2
8334 HIST1H2AC histone	cluster	1	H2A	family	member	c 2
3007 HIST1H1D histone	cluster	1	H1	family	member	d 2
9447 AIM2 absent	in	melanoma	2 2
51510 CHMP5 charged	multivesicular	body	protein	5 2
8969 HIST1H2AG histone	cluster	1	H2A	family	member	g 2
8336 HIST1H2AM histone	cluster	1	H2A	family	member	m 2
8339 HIST1H2BG histone	cluster	1	H2B	family	member	g 2
8329 HIST1H2AI histone	cluster	1	H2A	family	member	i 2
3012 HIST1H2AE histone	cluster	1	H2A	family	member	e 2
55145 THAP1 THAP	domain	containing	1 2
55143 CDCA8 cell	division	cycle	associated	8 2
1870 E2F2 E2F	transcription	factor	2 2
8365 HIST1H4H histone	cluster	1	H4	family	member	h 2
10682 EBP emopamil	binding	protein	(sterol	isomerase) 2
51512 GTSE1 G2	and	S-phase	expressed	1 2
8331 HIST1H2AJ histone	cluster	1	H2A	family	member	j 2
64792 IFT22 intraflagellar	transport	22 2
8342 HIST1H2BM histone	cluster	1	H2B	family	member	m 2
94120 SYTL3 synaptotagmin	like	3 2
64782 AEN apoptosis	enhancing	nuclease 2
64793 CEP85 centrosomal	protein	85 2
4717 NDUFC1 NADH:ubiquinone	oxidoreductase	subunit	C1 2
92815 HIST3H2A histone	cluster	3	H2A 2
291 SLC25A4 solute	carrier	family	25	member	4 2
10459 MAD2L2 MAD2	mitotic	arrest	deficient-like	2	(yeast) 2
9242 MSC musculin 2
332 BIRC5 baculoviral	IAP	repeat	containing	5 2
3835 KIF22 kinesin	family	member	22 2
1398 CRK CRK	proto-oncogene,	adaptor	protein 2
8367 HIST1H4E histone	cluster	1	H4	family	member	e 2
10945 KDELR1 KDEL	endoplasmic	reticulum	protein	retention	receptor	1 2
79738 BBS10 Bardet-Biedl	syndrome	10 2
63931 MRPS14 mitochondrial	ribosomal	protein	S14 2
54987 C1orf123 chromosome	1	open	reading	frame	123 2
4090 SMAD5 SMAD	family	member	5 2
55831 EMC3 ER	membrane	protein	complex	subunit	3 2
255520 ELMOD2 ELMO	domain	containing	2 2
51128 SAR1B secretion	associated	Ras	related	GTPase	1B 2
55140 ELP3 elongator	acetyltransferase	complex	subunit	3 2
302 ANXA2 annexin	A2 2
149420 PDIK1L PDLIM1	interacting	kinase	1	like 2
26586 CKAP2 cytoskeleton	associated	protein	2 2
135114 HINT3 histidine	triad	nucleotide	binding	protein	3 2
57102 C12orf4 chromosome	12	open	reading	frame	4 2
219790 RTKN2 rhotekin	2 2
80067 DCAF17 DDB1	and	CUL4	associated	factor	17 2
1654 DDX3X DEAD-box	helicase	3,	X-linked 2
151188 ARL6IP6 ADP	ribosylation	factor	like	GTPase	6	interacting	protein	6 2
10313 RTN3 reticulon	3 2
150468 CKAP2L cytoskeleton	associated	protein	2	like 2
55182 RNF220 ring	finger	protein	220 2
9887 SMG7 SMG7,	nonsense	mediated	mRNA	decay	factor 2
5579 PRKCB protein	kinase	C	beta 2
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55435 AP1AR adaptor	related	protein	complex	1	associated	regulatory	protein 2
253635 GPATCH11 G-patch	domain	containing	11 2
55033 FKBP14 FK506	binding	protein	14 2
5355 PLP2 proteolipid	protein	2 2
51227 PIGP phosphatidylinositol	glycan	anchor	biosynthesis	class	P 2
11321 GPN1 GPN-loop	GTPase	1 2
51573 GDE1 glycerophosphodiester	phosphodiesterase	1 2
23786 BCL2L13 BCL2	like	13 2
6103 RPGR retinitis	pigmentosa	GTPase	regulator 2
26263 FBXO22 F-box	protein	22 2
7163 TPD52 tumor	protein	D52 2
51068 NMD3 NMD3	ribosome	export	adaptor 2
51026 GOLT1B golgi	transport	1B 2
122809 SOCS4 suppressor	of	cytokine	signaling	4 2
83695 RHNO1 RAD9-HUS1-RAD1	interacting	nuclear	orphan	1 2
26040 SETBP1 SET	binding	protein	1 2
5378 PMS1 PMS1	homolog	1,	mismatch	repair	system	component 2
10641 NPRL2 NPR2-like,	GATOR1	complex	subunit 2
84967 LSM10 LSM10,	U7	small	nuclear	RNA	associated 2
9702 CEP57 centrosomal	protein	57 2
23062 GGA2 golgi	associated,	gamma	adaptin	ear	containing,	ARF	binding	protein	2 2
54780 NSMCE4A NSE4	homolog	A,	SMC5-SMC6	complex	component 2
199857 ALG14 ALG14,	UDP-N-acetylglucosaminyltransferase	subunit 2
28977 MRPL42 mitochondrial	ribosomal	protein	L42 2
25996 REXO2 RNA	exonuclease	2 2
3364 HUS1 HUS1	checkpoint	clamp	component 2
134359 POC5 POC5	centriolar	protein 2
64778 FNDC3B fibronectin	type	III	domain	containing	3B 2
256356 GK5 glycerol	kinase	5	(putative) 2
9194 SLC16A7 solute	carrier	family	16	member	7 2
55037 PTCD3 pentatricopeptide	repeat	domain	3 2
8148 TAF15 TATA-box	binding	protein	associated	factor	15 2
285282 RABL3 RAB,	member	of	RAS	oncogene	family	like	3 2
51095 TRNT1 tRNA	nucleotidyl	transferase	1 2
8563 THOC5 THO	complex	5 2
9317 PTER phosphotriesterase	related 2
1605 DAG1 dystroglycan	1 2
83939 EIF2A eukaryotic	translation	initiation	factor	2A 2
5877 RABIF RAB	interacting	factor 2
10923 SUB1 SUB1	homolog,	transcriptional	regulator 2
387263 C6orf120 chromosome	6	open	reading	frame	120 2
28972 SPCS1 signal	peptidase	complex	subunit	1 2
10463 SLC30A9 solute	carrier	family	30	member	9 2
1974 EIF4A2 eukaryotic	translation	initiation	factor	4A2 2
6993 DYNLT1 dynein	light	chain	Tctex-type	1 2
285331 CCDC66 coiled-coil	domain	containing	66 2
51691 LSM8 LSM8	homolog,	U6	small	nuclear	RNA	associated 2
84274 COQ5 coenzyme	Q5,	methyltransferase 2
9046 DOK2 docking	protein	2 2
80824 DUSP16 dual	specificity	phosphatase	16 2
11186 RASSF1 Ras	association	domain	family	member	1 2
9524 TECR trans-2,3-enoyl-CoA	reductase 2
55909 BIN3 bridging	integrator	3 2
953 ENTPD1 ectonucleoside	triphosphate	diphosphohydrolase	1 2
8530 CST7 cystatin	F 2
11269 DDX19B DEAD-box	helicase	19B 2
8766 RAB11A RAB11A,	member	RAS	oncogene	family 2
25977 NECAP1 NECAP	endocytosis	associated	1 2
2000 ELF4 E74	like	ETS	transcription	factor	4 2
11040 PIM2 Pim-2	proto-oncogene,	serine/threonine	kinase 2
2585 GALK2 galactokinase	2 2
144402 CPNE8 copine	8 2
79139 DERL1 derlin	1 2
80196 RNF34 ring	finger	protein	34 2
11262 SP140 SP140	nuclear	body	protein 2
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55312 RFK riboflavin	kinase 2
64854 USP46 ubiquitin	specific	peptidase	46 2
387882 C12orf75 chromosome	12	open	reading	frame	75 2
11270 NRM nurim	(nuclear	envelope	membrane	protein) 2
896 CCND3 cyclin	D3 2
143888 KDELC2 KDEL	motif	containing	2 2
5008 OSM oncostatin	M 2
10602 CDC42EP3 CDC42	effector	protein	3 2
54918 CMTM6 CKLF	like	MARVEL	transmembrane	domain	containing	6 2
1063 CENPF centromere	protein	F 2
84243 ZDHHC18 zinc	finger	DHHC-type	containing	18 2
382 ARF6 ADP	ribosylation	factor	6 2
134266 GRPEL2 GrpE	like	2,	mitochondrial 2
3001 GZMA granzyme	A 2
6352 CCL5 C-C	motif	chemokine	ligand	5 2
55028 C17orf80 chromosome	17	open	reading	frame	80 2
23258 DENND5A DENN	domain	containing	5A 2
56954 NIT2 nitrilase	family	member	2 2
93621 MRFAP1 Morf4	family	associated	protein	1 2
5347 PLK1 polo	like	kinase	1 2
58190 CTDSP1 CTD	small	phosphatase	1 2
2014 EMP3 epithelial	membrane	protein	3 2
5269 SERPINB6 serpin	family	B	member	6 2
113802 HENMT1 HEN1	methyltransferase	homolog	1 2
10578 GNLY granulysin 2
5551 PRF1 perforin	1 2
26610 ELP4 elongator	acetyltransferase	complex	subunit	4 2
9477 MED20 mediator	complex	subunit	20 2
8634 RTCA RNA	3'-terminal	phosphate	cyclase 2
3428 IFI16 interferon	gamma	inducible	protein	16 2
63901 FAM111A family	with	sequence	similarity	111	member	A 2
55796 MBNL3 muscleblind	like	splicing	regulator	3 2
2177 FANCD2 Fanconi	anemia	complementation	group	D2 3
86 ACTL6A actin	like	6A 3
57696 DDX55 DEAD-box	helicase	55 3
54920 DUS2 dihydrouridine	synthase	2 3
22809 ATF5 activating	transcription	factor	5 3
56052 ALG1 ALG1,	chitobiosyldiphosphodolichol	beta-mannosyltransferase 3
51099 ABHD5 abhydrolase	domain	containing	5 3
142940 TRUB1 TruB	pseudouridine	synthase	family	member	1 3
23729 SHPK sedoheptulokinase 3
9016 SLC25A14 solute	carrier	family	25	member	14 3
10352 WARS2 tryptophanyl	tRNA	synthetase	2,	mitochondrial 3
24140 FTSJ1 FtsJ	RNA	methyltransferase	homolog	1	(E.	coli) 3
23463 ICMT isoprenylcysteine	carboxyl	methyltransferase 3
54974 THG1L tRNA-histidine	guanylyltransferase	1	like 3
124808 CCDC43 coiled-coil	domain	containing	43 3
5306 PITPNA phosphatidylinositol	transfer	protein	alpha 3
643155 SMIM15 small	integral	membrane	protein	15 3
51260 PBDC1 polysaccharide	biosynthesis	domain	containing	1 3
10200 MPHOSPH6 M-phase	phosphoprotein	6 3
283578 TMED8 transmembrane	p24	trafficking	protein	family	member	8 3
79154 DHRS11 dehydrogenase/reductase	11 3
1743 DLST dihydrolipoamide	S-succinyltransferase 3
5277 PIGA phosphatidylinositol	glycan	anchor	biosynthesis	class	A 3
995 CDC25C cell	division	cycle	25C 3
3833 KIFC1 kinesin	family	member	C1 3
1967 EIF2B1 eukaryotic	translation	initiation	factor	2B	subunit	alpha 3
119392 SFR1 SWI5	dependent	homologous	recombination	repair	protein	1 3
55795 PCID2 PCI	domain	containing	2 3
81542 TMX1 thioredoxin	related	transmembrane	protein	1 3
55215 FANCI Fanconi	anemia	complementation	group	I 3
23172 FAM175B family	with	sequence	similarity	175	member	B 3
5711 PSMD5 proteasome	26S	subunit,	non-ATPase	5 3
153339 TMEM167A transmembrane	protein	167A 3
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3842 TNPO1 transportin	1 3
84928 TMEM209 transmembrane	protein	209 3
51263 MRPL30 mitochondrial	ribosomal	protein	L30 3
7327 UBE2G2 ubiquitin	conjugating	enzyme	E2	G2 3
23169 SLC35D1 solute	carrier	family	35	member	D1 3
10617 STAMBP STAM	binding	protein 3
8697 CDC23 cell	division	cycle	23 3
83930 STARD3NL STARD3	N-terminal	like 3
54556 ING3 inhibitor	of	growth	family	member	3 3
6185 RPN2 ribophorin	II 3
253558 LCLAT1 lysocardiolipin	acyltransferase	1 3
64710 NUCKS1 nuclear	casein	kinase	and	cyclin	dependent	kinase	substrate	1 3
1635 DCTD dCMP	deaminase 3
91687 CENPL centromere	protein	L 3
55308 DDX19A DEAD-box	helicase	19A 3
411 ARSB arylsulfatase	B 3
5889 RAD51C RAD51	paralog	C 3
7531 YWHAE tyrosine	3-monooxygenase/tryptophan	5-monooxygenase	activation	protein	epsilon 3
79607 FAM118B family	with	sequence	similarity	118	member	B 3
8883 NAE1 NEDD8	activating	enzyme	E1	subunit	1 3
2990 GUSB glucuronidase	beta 3
4076 CAPRIN1 cell	cycle	associated	protein	1 3
4841 NONO non-POU	domain	containing,	octamer-binding 3
23511 NUP188 nucleoporin	188 3
54811 ZNF562 zinc	finger	protein	562 3
23279 NUP160 nucleoporin	160 3
10146 G3BP1 G3BP	stress	granule	assembly	factor	1 3
27085 MTBP MDM2	binding	protein 3
23310 NCAPD3 non-SMC	condensin	II	complex	subunit	D3 3
6634 SNRPD3 small	nuclear	ribonucleoprotein	D3	polypeptide 3
10920 COPS8 COP9	signalosome	subunit	8 3
1678 TIMM8A translocase	of	inner	mitochondrial	membrane	8	homolog	A	(yeast) 3
1798 DPAGT1 dolichyl-phosphate	N-acetylglucosaminephosphotransferase	1 3
79135 APOO apolipoprotein	O 3
3187 HNRNPH1 heterogeneous	nuclear	ribonucleoprotein	H1	(H) 3
89944 GLB1L2 galactosidase	beta	1	like	2 3
5096 PCCB propionyl-CoA	carboxylase	beta	subunit 3
55254 TMEM39A transmembrane	protein	39A 3
6341 SCO1 SCO1,	cytochrome	c	oxidase	assembly	protein 3
59067 IL21 interleukin	21 3
166968 MIER3 MIER	family	member	3 3
51524 TMEM138 transmembrane	protein	138 3
7555 CNBP CCHC-type	zinc	finger	nucleic	acid	binding	protein 3
57645 POGK pogo	transposable	element	with	KRAB	domain 3
1622 DBI diazepam	binding	inhibitor,	acyl-CoA	binding	protein 3
23741 EID1 EP300	interacting	inhibitor	of	differentiation	1 3
84881 RPUSD4 RNA	pseudouridylate	synthase	domain	containing	4 3
79868 ALG13 ALG13,	UDP-N-acetylglucosaminyltransferase	subunit 3
10910 SUGT1 SGT1	homolog,	MIS12	kinetochore	complex	assembly	cochaperone 3
6902 TBCA tubulin	folding	cofactor	A 3
51094 ADIPOR1 adiponectin	receptor	1 3
54534 MRPL50 mitochondrial	ribosomal	protein	L50 3
5271 SERPINB8 serpin	family	B	member	8 3
51318 MRPL35 mitochondrial	ribosomal	protein	L35 3
9978 RBX1 ring-box	1 3
5885 RAD21 RAD21	cohesin	complex	component 3
9184 BUB3 BUB3,	mitotic	checkpoint	protein 3
25847 ANAPC13 anaphase	promoting	complex	subunit	13 3
25912 C1orf43 chromosome	1	open	reading	frame	43 3
9025 RNF8 ring	finger	protein	8 3
10959 TMED2 transmembrane	p24	trafficking	protein	2 3
1070 CETN3 centrin	3 3
7419 VDAC3 voltage	dependent	anion	channel	3 3
5356 PLRG1 pleiotropic	regulator	1 3
54529 ASNSD1 asparagine	synthetase	domain	containing	1 3
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51441 YTHDF2 YTH	N6-methyladenosine	RNA	binding	protein	2 3
5481 PPID peptidylprolyl	isomerase	D 3
23098 SARM1 sterile	alpha	and	TIR	motif	containing	1 3
22907 DHX30 DEAH-box	helicase	30 3
65220 NADK NAD	kinase 3
201725 C4orf46 chromosome	4	open	reading	frame	46 3
2241 FER FER	tyrosine	kinase 3
79598 CEP97 centrosomal	protein	97 3
23760 PITPNB phosphatidylinositol	transfer	protein	beta 3
2965 GTF2H1 general	transcription	factor	IIH	subunit	1 3
6392 SDHD succinate	dehydrogenase	complex	subunit	D 3
10001 MED6 mediator	complex	subunit	6 3
24145 PANX1 pannexin	1 3
26985 AP3M1 adaptor	related	protein	complex	3	mu	1	subunit 3
54853 WDR55 WD	repeat	domain	55 3
9839 ZEB2 zinc	finger	E-box	binding	homeobox	2 3
5710 PSMD4 proteasome	26S	subunit,	non-ATPase	4 3
284695 ZNF326 zinc	finger	protein	326 3
598 BCL2L1 BCL2	like	1 3
29927 SEC61A1 Sec61	translocon	alpha	1	subunit 3
91368 CDKN2AIPNL CDKN2A	interacting	protein	N-terminal	like 3
51639 SF3B6 splicing	factor	3b	subunit	6 3
10483 SEC23B Sec23	homolog	B,	coat	complex	II	component 3
6732 SRPK1 SRSF	protein	kinase	1 3
9412 MED21 mediator	complex	subunit	21 3
80777 CYB5B cytochrome	b5	type	B 3
5861 RAB1A RAB1A,	member	RAS	oncogene	family 3
84191 FAM96A family	with	sequence	similarity	96	member	A 3
4710 NDUFB4 NADH:ubiquinone	oxidoreductase	subunit	B4 3
51538 ZCCHC17 zinc	finger	CCHC-type	containing	17 3
7385 UQCRC2 ubiquinol-cytochrome	c	reductase	core	protein	II 3
221443 OARD1 O-acyl-ADP-ribose	deacylase	1 3
55101 ATP5SL ATP5S	like 3
51300 TIMMDC1 translocase	of	inner	mitochondrial	membrane	domain	containing	1 3
375 ARF1 ADP	ribosylation	factor	1 3
7979 SHFM1 split	hand/foot	malformation	(ectrodactyly)	type	1 3
5706 PSMC6 proteasome	26S	subunit,	ATPase	6 3
5092 PCBD1 pterin-4	alpha-carbinolamine	dehydratase	1 3
58517 RBM25 RNA	binding	motif	protein	25 3
10298 PAK4 p21	(RAC1)	activated	kinase	4 3
91942 NDUFAF2 NADH:ubiquinone	oxidoreductase	complex	assembly	factor	2 3
195827 AAED1 AhpC/TSA	antioxidant	enzyme	domain	containing	1 3
2960 GTF2E1 general	transcription	factor	IIE	subunit	1 3
509 ATP5C1 ATP	synthase,	H+	transporting,	mitochondrial	F1	complex,	gamma	polypeptide	1 3
84268 RPAIN RPA	interacting	protein 3
8089 YEATS4 YEATS	domain	containing	4 3
9416 DDX23 DEAD-box	helicase	23 3
466 ATF1 activating	transcription	factor	1 3
55151 TMEM38B transmembrane	protein	38B 3
84964 ALKBH6 alkB	homolog	6 3
84950 PRPF38A pre-mRNA	processing	factor	38A 3
64981 MRPL34 mitochondrial	ribosomal	protein	L34 3
1827 RCAN1 regulator	of	calcineurin	1 3
51569 UFM1 ubiquitin	fold	modifier	1 3
57117 INTS12 integrator	complex	subunit	12 3
9588 PRDX6 peroxiredoxin	6 3
28978 TMEM14A transmembrane	protein	14A 3
7332 UBE2L3 ubiquitin	conjugating	enzyme	E2	L3 3
378 ARF4 ADP	ribosylation	factor	4 3
51495 HACD3 3-hydroxyacyl-CoA	dehydratase	3 3
9555 H2AFY H2A	histone	family	member	Y 3
10635 RAD51AP1 RAD51	associated	protein	1 3
11198 SUPT16H SPT16	homolog,	facilitates	chromatin	remodeling	subunit 3
23595 ORC3 origin	recognition	complex	subunit	3 3
30009 TBX21 T-box	21 3
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5167 ENPP1 ectonucleotide	pyrophosphatase/phosphodiesterase	1 3
28987 NOB1 NIN1/PSMD8	binding	protein	1	homolog 3
7329 UBE2I ubiquitin	conjugating	enzyme	E2	I 3
246184 CDC26 cell	division	cycle	26 3
4712 NDUFB6 NADH:ubiquinone	oxidoreductase	subunit	B6 3
253782 CERS6 ceramide	synthase	6 3
11014 KDELR2 KDEL	endoplasmic	reticulum	protein	retention	receptor	2 3
56943 ENY2 ENY2,	transcription	and	export	complex	2	subunit 3
440145 MZT1 mitotic	spindle	organizing	protein	1 3
84128 WDR75 WD	repeat	domain	75 3
55660 PRPF40A pre-mRNA	processing	factor	40	homolog	A 3
23322 RPGRIP1L RPGRIP1	like 3
3178 HNRNPA1 heterogeneous	nuclear	ribonucleoprotein	A1 3
9275 BCL7B BCL	tumor	suppressor	7B 3
65991 FUNDC2 FUN14	domain	containing	2 3
64794 DDX31 DEAD-box	helicase	31 3
8798 DYRK4 dual	specificity	tyrosine	phosphorylation	regulated	kinase	4 3
55315 SLC29A3 solute	carrier	family	29	member	3 3
219541 MED19 mediator	complex	subunit	19 3
729993 SHISA9 shisa	family	member	9 3
8394 PIP5K1A phosphatidylinositol-4-phosphate	5-kinase	type	1	alpha 3
93487 MAPK1IP1L mitogen-activated	protein	kinase	1	interacting	protein	1	like 3
25994 HIGD1A HIG1	hypoxia	inducible	domain	family	member	1A 3
87178 PNPT1 polyribonucleotide	nucleotidyltransferase	1 3
6629 SNRPB2 small	nuclear	ribonucleoprotein	polypeptide	B2 3
25879 DCAF13 DDB1	and	CUL4	associated	factor	13 3
134430 WDR36 WD	repeat	domain	36 3
23658 LSM5 LSM5	homolog,	U6	small	nuclear	RNA	and	mRNA	degradation	associated 3
9128 PRPF4 pre-mRNA	processing	factor	4 3
8891 EIF2B3 eukaryotic	translation	initiation	factor	2B	subunit	gamma 3
10269 ZMPSTE24 zinc	metallopeptidase	STE24 3
498 ATP5A1
ATP	synthase,	H+	transporting,	mitochondrial	F1	complex,	alpha	subunit	1,	cardiac	
muscle 3
1738 DLD dihydrolipoamide	dehydrogenase 3
54332 GDAP1 ganglioside	induced	differentiation	associated	protein	1 3
85465 SELENOI selenoprotein	I 3
5701 PSMC2 proteasome	26S	subunit,	ATPase	2 3
3035 HARS histidyl-tRNA	synthetase 3
55361 PI4K2A phosphatidylinositol	4-kinase	type	2	alpha 3
5687 PSMA6 proteasome	subunit	alpha	6 3
23016 EXOSC7 exosome	component	7 3
214 ALCAM activated	leukocyte	cell	adhesion	molecule 3
2108 ETFA electron	transfer	flavoprotein	alpha	subunit 3
29960 MRM2 mitochondrial	rRNA	methyltransferase	2 3
5690 PSMB2 proteasome	subunit	beta	2 3
3735 KARS lysyl-tRNA	synthetase 3
10666 CD226 CD226	molecule 3
10237 SLC35B1 solute	carrier	family	35	member	B1 3
80218 NAA50 N(alpha)-acetyltransferase	50,	NatE	catalytic	subunit 3
57476 GRAMD1B GRAM	domain	containing	1B 3
10376 TUBA1B tubulin	alpha	1b 3
11102 RPP14 ribonuclease	P/MRP	subunit	p14 3
11340 EXOSC8 exosome	component	8 3
6717 SRI sorcin 3
2395 FXN frataxin 3
8872 CDC123 cell	division	cycle	123 3
8533 COPS3 COP9	signalosome	subunit	3 3
79869 CPSF7 cleavage	and	polyadenylation	specific	factor	7 3
493856 CISD2 CDGSH	iron	sulfur	domain	2 3
9319 TRIP13 thyroid	hormone	receptor	interactor	13 3
54927 CHCHD3 coiled-coil-helix-coiled-coil-helix	domain	containing	3 3
10042 HMGXB4 HMG-box	containing	4 3
55787 TXLNG taxilin	gamma 3
4522 MTHFD1
methylenetetrahydrofolate	dehydrogenase,	cyclohydrolase	and	
formyltetrahydrofolate	synthetase	1 3
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10007 GNPDA1 glucosamine-6-phosphate	deaminase	1 3
10229 COQ7 coenzyme	Q7,	hydroxylase 3
2079 ERH enhancer	of	rudimentary	homolog	(Drosophila) 3
29796 UQCR10 ubiquinol-cytochrome	c	reductase,	complex	III	subunit	X 3
5705 PSMC5 proteasome	26S	subunit,	ATPase	5 3
128061 C1orf131 chromosome	1	open	reading	frame	131 3
10284 SAP18 Sin3A	associated	protein	18 3
3015 H2AFZ H2A	histone	family	member	Z 3
54957 TXNL4B thioredoxin	like	4B 3
10944 C11orf58 chromosome	11	open	reading	frame	58 3
23788 MTCH2 mitochondrial	carrier	2 3
6118 RPA2 replication	protein	A2 3
65260 COA7 cytochrome	c	oxidase	assembly	factor	7	(putative) 3
3419 IDH3A isocitrate	dehydrogenase	3	(NAD(+))	alpha 3
285381 DPH3 diphthamide	biosynthesis	3 3
11103 KRR1 KRR1,	small	subunit	processome	component	homolog 3
56942 CMC2 C-X9-C	motif	containing	2 3
5440 POLR2K RNA	polymerase	II	subunit	K 3
326625 MMAB methylmalonic	aciduria	(cobalamin	deficiency)	cblB	type 3
23587 ELP5 elongator	acetyltransferase	complex	subunit	5 3
57129 MRPL47 mitochondrial	ribosomal	protein	L47 3
51202 DDX47 DEAD-box	helicase	47 3
80273 GRPEL1 GrpE	like	1,	mitochondrial 3
79017 GGCT gamma-glutamylcyclotransferase 3
401505 TOMM5 translocase	of	outer	mitochondrial	membrane	5 3
7353 UFD1L ubiquitin	fusion	degradation	1	like	(yeast) 3
54205 CYCS cytochrome	c,	somatic 3
10289 EIF1B eukaryotic	translation	initiation	factor	1B 3
124637 CYB5D1 cytochrome	b5	domain	containing	1 3
27429 HTRA2 HtrA	serine	peptidase	2 3
5691 PSMB3 proteasome	subunit	beta	3 3
8683 SRSF9 serine	and	arginine	rich	splicing	factor	9 3
78996 C7orf49 chromosome	7	open	reading	frame	49 3
81892 SLIRP SRA	stem-loop	interacting	RNA	binding	protein 3
30968 STOML2 stomatin	like	2 3
55052 MRPL20 mitochondrial	ribosomal	protein	L20 3
441531 PGAM4 phosphoglycerate	mutase	family	member	4 3
7019 TFAM transcription	factor	A,	mitochondrial 3
55239 OGFOD1 2-oxoglutarate	and	iron	dependent	oxygenase	domain	containing	1 3
5515 PPP2CA protein	phosphatase	2	catalytic	subunit	alpha 3
4361 MRE11A MRE11	homolog	A,	double	strand	break	repair	nuclease 3
5718 PSMD12 proteasome	26S	subunit,	non-ATPase	12 3
4528 MTIF2 mitochondrial	translational	initiation	factor	2 3
10576 CCT2 chaperonin	containing	TCP1	subunit	2 3
529 ATP6V1E1 ATPase	H+	transporting	V1	subunit	E1 3
150274 HSCB HscB	mitochondrial	iron-sulfur	cluster	cochaperone 3
140609 NEK7 NIMA	related	kinase	7 3
113444 SMIM12 small	integral	membrane	protein	12 3
10197 PSME3 proteasome	activator	subunit	3 3
152519 NIPAL1 NIPA	like	domain	containing	1 3
506 ATP5B ATP	synthase,	H+	transporting,	mitochondrial	F1	complex,	beta	polypeptide 3
5692 PSMB4 proteasome	subunit	beta	4 3
92400 RBM18 RNA	binding	motif	protein	18 3
5110 PCMT1 protein-L-isoaspartate	(D-aspartate)	O-methyltransferase 3
10480 EIF3M eukaryotic	translation	initiation	factor	3	subunit	M 3
4520 MTF1 metal	regulatory	transcription	factor	1 3
526 ATP6V1B2 ATPase	H+	transporting	V1	subunit	B2 3
7319 UBE2A ubiquitin	conjugating	enzyme	E2	A 3
4836 NMT1 N-myristoyltransferase	1 3
54470 ARMCX6 armadillo	repeat	containing,	X-linked	6 3
56852 RAD18 RAD18,	E3	ubiquitin	protein	ligase 3
10436 EMG1 EMG1,	N1-specific	pseudouridine	methyltransferase 3
4704 NDUFA9 NADH:ubiquinone	oxidoreductase	subunit	A9 3
27257 LSM1 LSM1	homolog,	mRNA	degradation	associated 3
79719 AAGAB alpha-	and	gamma-adaptin	binding	protein 3
25904 CNOT10 CCR4-NOT	transcription	complex	subunit	10 3
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8892 EIF2B2 eukaryotic	translation	initiation	factor	2B	subunit	beta 3
892 CCNC cyclin	C 3
169200 TMEM64 transmembrane	protein	64 3
56984 PSMG2 proteasome	assembly	chaperone	2 3
223 ALDH9A1 aldehyde	dehydrogenase	9	family	member	A1 3
9330 GTF3C3 general	transcription	factor	IIIC	subunit	3 3
6184 RPN1 ribophorin	I 3
116228 COX20 COX20,	cytochrome	c	oxidase	assembly	factor 3
9967 THRAP3 thyroid	hormone	receptor	associated	protein	3 3
4725 NDUFS5 NADH:ubiquinone	oxidoreductase	subunit	S5 3
80135 RPF1 ribosome	production	factor	1	homolog 3
5501 PPP1CC protein	phosphatase	1	catalytic	subunit	gamma 3
28511 NKIRAS2 NFKB	inhibitor	interacting	Ras	like	2 3
51234 EMC4 ER	membrane	protein	complex	subunit	4 3
10671 DCTN6 dynactin	subunit	6 3
2631 GBAS glioblastoma	amplified	sequence 3
23306 NEMP1 nuclear	envelope	integral	membrane	protein	1 3
10799 RPP40 ribonuclease	P/MRP	subunit	p40 3
57563 KLHL8 kelch	like	family	member	8 3
328 APEX1 apurinic/apyrimidinic	endodeoxyribonuclease	1 3
90701 SEC11C SEC11	homolog	C,	signal	peptidase	complex	subunit 3
23480 SEC61G Sec61	translocon	gamma	subunit 3
8819 SAP30 Sin3A	associated	protein	30 3
52 ACP1 acid	phosphatase	1,	soluble 3
1349 COX7B cytochrome	c	oxidase	subunit	7B 3
7386 UQCRFS1 ubiquinol-cytochrome	c	reductase,	Rieske	iron-sulfur	polypeptide	1 3
26355 FAM162A family	with	sequence	similarity	162	member	A 3
29074 MRPL18 mitochondrial	ribosomal	protein	L18 3
79036 KXD1 KxDL	motif	containing	1 3
26156 RSL1D1 ribosomal	L1	domain	containing	1 3
55505 NOP10 NOP10	ribonucleoprotein 3
522 ATP5J ATP	synthase,	H+	transporting,	mitochondrial	Fo	complex	subunit	F6 3
387521 TMEM189 transmembrane	protein	189 3
5547 PRCP prolylcarboxypeptidase 3
26995 TRUB2 TruB	pseudouridine	synthase	family	member	2 3
153527 ZMAT2 zinc	finger	matrin-type	2 3
84126 ATRIP ATR	interacting	protein 3
201931 TMEM192 transmembrane	protein	192 3
4719 NDUFS1 NADH:ubiquinone	oxidoreductase	core	subunit	S1 3
27095 TRAPPC3 trafficking	protein	particle	complex	3 3
9217 VAPB VAMP	associated	protein	B	and	C 3
10548 TM9SF1 transmembrane	9	superfamily	member	1 3
55110 MAGOHB mago	homolog	B,	exon	junction	complex	core	component 3
9512 PMPCB peptidase,	mitochondrial	processing	beta	subunit 3
58505 OSTC oligosaccharyltransferase	complex	non-catalytic	subunit 3
55071 C9orf40 chromosome	9	open	reading	frame	40 3
29086 BABAM1 BRISC	and	BRCA1	A	complex	member	1 3
327 APEH acylaminoacyl-peptide	hydrolase 3
221120 ALKBH3 alkB	homolog	3,	alpha-ketoglutaratedependent	dioxygenase 3
79109 MAPKAP1 mitogen-activated	protein	kinase	associated	protein	1 3
375444 C5orf34 chromosome	5	open	reading	frame	34 3
113829 SLC35A4 solute	carrier	family	35	member	A4 3
8350 HIST1H3A histone	cluster	1	H3	family	member	a 3
79760 GEMIN7 gem	nuclear	organelle	associated	protein	7 3
79002 C19orf43 chromosome	19	open	reading	frame	43 3
8407 TAGLN2 transgelin	2 3
5805 PTS 6-pyruvoyltetrahydropterin	synthase 3
8226 PUDP pseudouridine	5'-phosphatase 3
8330 HIST1H2AK histone	cluster	1	H2A	family	member	k 3
6944 VPS72 vacuolar	protein	sorting	72	homolog 3
22913 RALY RALY	heterogeneous	nuclear	ribonucleoprotein 3
9793 CKAP5 cytoskeleton	associated	protein	5 3
11065 UBE2C ubiquitin	conjugating	enzyme	E2	C 3
81605 URM1 ubiquitin	related	modifier	1 3
6388 SDF2 stromal	cell	derived	factor	2 3
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8970 HIST1H2BJ histone	cluster	1	H2B	family	member	j 3
8345 HIST1H2BH histone	cluster	1	H2B	family	member	h 3
2491 CENPI centromere	protein	I 3
5090 PBX3 PBX	homeobox	3 3
24137 KIF4A kinesin	family	member	4A 3
50943 FOXP3 forkhead	box	P3 3
8346 HIST1H2BI histone	cluster	1	H2B	family	member	i 3
8357 HIST1H3H histone	cluster	1	H3	family	member	h 3
8368 HIST1H4L histone	cluster	1	H4	family	member	l 3
8355 HIST1H3G histone	cluster	1	H3	family	member	g 3
8348 HIST1H2BO histone	cluster	1	H2B	family	member	o 3
734 OSGIN2 oxidative	stress	induced	growth	inhibitor	family	member	2 3
968 CD68 CD68	molecule 3
11004 KIF2C kinesin	family	member	2C 3
80222 TARS2 threonyl-tRNA	synthetase	2,	mitochondrial	(putative) 3
81603 TRIM8 tripartite	motif	containing	8 3
123606 NIPA1 non	imprinted	in	Prader-Willi/Angelman	syndrome	1 3
6046 BRD2 bromodomain	containing	2 3
3006 HIST1H1C histone	cluster	1	H1	family	member	c 3
29916 SNX11 sorting	nexin	11 3
9817 KEAP1 kelch	like	ECH	associated	protein	1 3
3996 LLGL1 LLGL1,	scribble	cell	polarity	complex	component 3
5827 PXMP2 peroxisomal	membrane	protein	2 3
318 NUDT2 nudix	hydrolase	2 3
117177 RAB3IP RAB3A	interacting	protein 3
80227 PAAF1 proteasomal	ATPase	associated	factor	1 3
116064 LRRC58 leucine	rich	repeat	containing	58 3
56890 MDM1 Mdm1	nuclear	protein 3
84058 WDR54 WD	repeat	domain	54 3
4087 SMAD2 SMAD	family	member	2 3
899 CCNF cyclin	F 3
8349 HIST2H2BE histone	cluster	2	H2B	family	member	e 3
84193 SETD3 SET	domain	containing	3 3
140901 STK35 serine/threonine	kinase	35 3
55704 CCDC88A coiled-coil	domain	containing	88A 3
23132 RAD54L2 RAD54-like	2	(S.	cerevisiae) 3
56672 AKIP1 A-kinase	interacting	protein	1 3
11218 DDX20 DEAD-box	helicase	20 3
27291 R3HCC1L R3H	domain	and	coiled-coil	containing	1	like 3
874 CBR3 carbonyl	reductase	3 3
84959 UBASH3B ubiquitin	associated	and	SH3	domain	containing	B 3
10134 BCAP31 B-cell	receptor-associated	protein	31 3
4968 OGG1 8-oxoguanine	DNA	glycosylase 3
415116 PIM3 Pim-3	proto-oncogene,	serine/threonine	kinase 3
80199 FUZ fuzzy	planar	cell	polarity	protein 3
967 CD63 CD63	molecule 3
84232 MAF1 MAF1	homolog,	negative	regulator	of	RNA	polymerase	III 3
572 BAD BCL2	associated	agonist	of	cell	death 3
26608 TBL2 transducin	beta	like	2 3
5538 PPT1 palmitoyl-protein	thioesterase	1 3
3008 HIST1H1E histone	cluster	1	H1	family	member	e 3
65062 TMEM237 transmembrane	protein	237 3
8294 HIST1H4I histone	cluster	1	H4	family	member	i 3
8335 HIST1H2AB histone	cluster	1	H2A	family	member	b 3
3024 HIST1H1A histone	cluster	1	H1	family	member	a 3
439 ASNA1 arsA	arsenite	transporter,	ATP-binding,	homolog	1	(bacterial) 3
2805 GOT1 glutamic-oxaloacetic	transaminase	1 3
57539 WDR35 WD	repeat	domain	35 3
163786 SASS6 SAS-6	centriolar	assembly	protein 3
3189 HNRNPH3 heterogeneous	nuclear	ribonucleoprotein	H3 3
85236 HIST1H2BK histone	cluster	1	H2B	family	member	k 3
5881 RAC3 ras-related	C3	botulinum	toxin	substrate	3	(rho	family,	small	GTP	binding	protein	Rac3) 3
10614 HEXIM1 hexamethylene	bisacetamide	inducible	1 3
283464 GXYLT1 glucoside	xylosyltransferase	1 3
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3014 H2AFX H2A	histone	family	member	X 3
25853 DCAF12 DDB1	and	CUL4	associated	factor	12 3
56994 CHPT1 choline	phosphotransferase	1 3
9551 ATP5J2 ATP	synthase,	H+	transporting,	mitochondrial	Fo	complex	subunit	F2 3
27304 MOCS3 molybdenum	cofactor	synthesis	3 3
113130 CDCA5 cell	division	cycle	associated	5 3
81887 LAS1L LAS1	like,	ribosome	biogenesis	factor 3
5201 PFDN1 prefoldin	subunit	1 3
91057 CCDC34 coiled-coil	domain	containing	34 3
468 ATF4 activating	transcription	factor	4 3
161823 ADAL adenosine	deaminase	like 3
55723 ASF1B anti-silencing	function	1B	histone	chaperone 3
91442 FAAP24 Fanconi	anemia	core	complex	associated	protein	24 3
220002 CYB561A3 cytochrome	b561	family	member	A3 3
84759 PCGF1 polycomb	group	ring	finger	1 3
112950 MED8 mediator	complex	subunit	8 3
587 BCAT2 branched	chain	amino	acid	transaminase	2 3
643 CXCR5 C-X-C	motif	chemokine	receptor	5 3
55794 DDX28 DEAD-box	helicase	28 3
6470 SHMT1 serine	hydroxymethyltransferase	1 3
10651 MTX2 metaxin	2 3
54921 CHTF8 chromosome	transmission	fidelity	factor	8 3
51283 BFAR bifunctional	apoptosis	regulator 3
57456 KIAA1143 KIAA1143 3
54995 OXSM 3-oxoacyl-ACP	synthase,	mitochondrial 3
79102 RNF26 ring	finger	protein	26 3
79000 AUNIP aurora	kinase	A	and	ninein	interacting	protein 3
4947 OAZ2 ornithine	decarboxylase	antizyme	2 3
25979 DHRS7B dehydrogenase/reductase	7B 3
23052 ENDOD1 endonuclease	domain	containing	1 3
728568 C12orf73 chromosome	12	open	reading	frame	73 3
54890 ALKBH5 alkB	homolog	5,	RNA	demethylase 3
348793 WDR53 WD	repeat	domain	53 3
57045 TWSG1 twisted	gastrulation	BMP	signaling	modulator	1 3
84844 PHF5A PHD	finger	protein	5A 3
79228 THOC6 THO	complex	6 3
27235 COQ2 coenzyme	Q2,	polyprenyltransferase 3
170371 C10orf128 chromosome	10	open	reading	frame	128 3
1861 TOR1A torsin	family	1	member	A 3
150771 ITPRIPL1 inositol	1,4,5-trisphosphate	receptor	interacting	protein-like	1 3
56180 MOSPD1 motile	sperm	domain	containing	1 3
4702 NDUFA8 NADH:ubiquinone	oxidoreductase	subunit	A8 3
55246 CCDC25 coiled-coil	domain	containing	25 3
5684 PSMA3 proteasome	subunit	alpha	3 3
54942 FAM206A family	with	sequence	similarity	206	member	A 3
9836 LCMT2 leucine	carboxyl	methyltransferase	2 3
55344 PLCXD1 phosphatidylinositol	specific	phospholipase	C	X	domain	containing	1 3
49854 ZBTB21 zinc	finger	and	BTB	domain	containing	21 3
25926 NOL11 nucleolar	protein	11 3
1854 DUT deoxyuridine	triphosphatase 3
662 BNIP1 BCL2	interacting	protein	1 3
29928 TIMM22 translocase	of	inner	mitochondrial	membrane	22	homolog 3
78988 MRPL57 mitochondrial	ribosomal	protein	L57 3
121642 ALKBH2 alkB	homolog	2,	alpha-ketoglutarate	dependent	dioxygenase 3
10535 RNASEH2A ribonuclease	H2	subunit	A 3
339230 CCDC137 coiled-coil	domain	containing	137 3
51399 TRAPPC4 trafficking	protein	particle	complex	4 3
23239 PHLPP1 PH	domain	and	leucine	rich	repeat	protein	phosphatase	1 3
23212 RRS1 ribosome	biogenesis	regulator	homolog 3
26520 TIMM9 translocase	of	inner	mitochondrial	membrane	9 3
84879 MFSD2A major	facilitator	superfamily	domain	containing	2A 3
28973 MRPS18B mitochondrial	ribosomal	protein	S18B 3
118472 ZNF511 zinc	finger	protein	511 3
8531 YBX3 Y-box	binding	protein	3 3
746 TMEM258 transmembrane	protein	258 3
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147007 TMEM199 transmembrane	protein	199 3
55829 SELENOS selenoprotein	S 3
23478 SEC11A SEC11	homolog	A,	signal	peptidase	complex	subunit 3
5713 PSMD7 proteasome	26S	subunit,	non-ATPase	7 3
65005 MRPL9 mitochondrial	ribosomal	protein	L9 3
27301 APEX2 apurinic/apyrimidinic	endodeoxyribonuclease	2 3
27315 PGAP2 post-GPI	attachment	to	proteins	2 3
27075 TSPAN13 tetraspanin	13 3
6396 SEC13 SEC13	homolog,	nuclear	pore	and	COPII	coat	complex	component 3
29101 SSU72 SSU72	homolog,	RNA	polymerase	II	CTD	phosphatase 3
79035 NABP2 nucleic	acid	binding	protein	2 3
5160 PDHA1 pyruvate	dehydrogenase	(lipoamide)	alpha	1 3
115416 MALSU1 mitochondrial	assembly	of	ribosomal	large	subunit	1 3
9218 VAPA VAMP	associated	protein	A 3
3396 MRPL58 mitochondrial	ribosomal	protein	L58 3
64976 MRPL40 mitochondrial	ribosomal	protein	L40 3
1123 CHN1 chimerin	1 3
149603 RNF187 ring	finger	protein	187 3
84246 MED10 mediator	complex	subunit	10 3
7260 TSSC1 tumor	suppressing	subtransferable	candidate	1 3
10084 PQBP1 polyglutamine	binding	protein	1 3
661 POLR3D RNA	polymerase	III	subunit	D 3
56257 MEPCE methylphosphate	capping	enzyme 3
9371 KIF3B kinesin	family	member	3B 3
92002 FAM58A family	with	sequence	similarity	58	member	A 3
114049 WBSCR22 Williams-Beuren	syndrome	chromosome	region	22 3
55038 CDCA4 cell	division	cycle	associated	4 3
339263 C17orf51 chromosome	17	open	reading	frame	51 3
11137 PWP1 PWP1	homolog,	endonuclein 3
55278 QRSL1 glutaminyl-tRNA	synthase	(glutamine-hydrolyzing)-like	1 3
8811 GALR2 galanin	receptor	2 3
118424 UBE2J2 ubiquitin	conjugating	enzyme	E2	J2 3
3596 IL13 interleukin	13 3
7918 GPANK1 G-patch	domain	and	ankyrin	repeats	1 3
376267 RAB15 RAB15,	member	RAS	oncogene	family 3
8754 ADAM9 ADAM	metallopeptidase	domain	9 3
22916 NCBP2 nuclear	cap	binding	protein	subunit	2 3
79172 CENPO centromere	protein	O 3
84547 PGBD1 piggyBac	transposable	element	derived	1 3
28960 DCPS decapping	enzyme,	scavenger 3
10741 RBBP9 RB	binding	protein	9,	serine	hydrolase 3
283106 CSNK2A3 casein	kinase	2	alpha	3 3
84065 TMEM222 transmembrane	protein	222 3
5686 PSMA5 proteasome	subunit	alpha	5 3
6573 SLC19A1 solute	carrier	family	19	member	1 3
51634 RBMX2 RNA	binding	motif	protein,	X-linked	2 3
54802 TRIT1 tRNA	isopentenyltransferase	1 3
10280 SIGMAR1 sigma	non-opioid	intracellular	receptor	1 3
5496 PPM1G protein	phosphatase,	Mg2+/Mn2+	dependent	1G 3
970 CD70 CD70	molecule 3
9289 ADGRG1 adhesion	G	protein-coupled	receptor	G1 3
115939 TSR3 TSR3,	acp	transferase	ribosome	maturation	factor 3
550 AUP1 ancient	ubiquitous	protein	1 3
9560 CCL4L2 C-C	motif	chemokine	ligand	4	like	2 3
3567 IL5 interleukin	5 3
91319 DERL3 derlin	3 3
5743 PTGS2 prostaglandin-endoperoxide	synthase	2 3
3703 STT3A STT3A,	catalytic	subunit	of	the	oligosaccharyltransferase	complex 3
118980 SFXN2 sideroflexin	2 3
3578 IL9 interleukin	9 3
10276 NET1 neuroepithelial	cell	transforming	1 3
6348 CCL3 C-C	motif	chemokine	ligand	3 3
10201 NME6 NME/NM23	nucleoside	diphosphate	kinase	6 3
84296 GINS4 GINS	complex	subunit	4 3
200933 FBXO45 F-box	protein	45 3
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9050 PSTPIP2 proline-serine-threonine	phosphatase	interacting	protein	2 3
8356 HIST1H3J histone	cluster	1	H3	family	member	j 3
64745 METTL17 methyltransferase	like	17 3
53838 C11orf24 chromosome	11	open	reading	frame	24 3
10293 TRAIP TRAF	interacting	protein 3
51023 MRPS18C mitochondrial	ribosomal	protein	S18C 3
26150 RIBC2 RIB43A	domain	with	coiled-coils	2 3
4049 LTA lymphotoxin	alpha 3
25828 TXN2 thioredoxin	2 3
5886 RAD23A RAD23	homolog	A,	nucleotide	excision	repair	protein 3
84522 JAGN1 jagunal	homolog	1 3
128178 EDARADD EDAR	associated	death	domain 3
51163 DBR1 debranching	RNA	lariats	1 3
84545 MRPL43 mitochondrial	ribosomal	protein	L43 3
84311 MRPL45 mitochondrial	ribosomal	protein	L45 3
132720 C4orf32 chromosome	4	open	reading	frame	32 3
3775 KCNK1 potassium	two	pore	domain	channel	subfamily	K	member	1 3
54069 MIS18A MIS18	kinetochore	protein	A 3
55255 WDR41 WD	repeat	domain	41 3
9334 B4GALT5 beta-1,4-galactosyltransferase	5 3
80262 C16orf70 chromosome	16	open	reading	frame	70 3
55122 AKIRIN2 akirin	2 3
81610 FAM83D family	with	sequence	similarity	83	member	D 3
55116 TMEM39B transmembrane	protein	39B 3
7976 FZD3 frizzled	class	receptor	3 3
83693 HSDL1 hydroxysteroid	dehydrogenase	like	1 3
5571 PRKAG1 protein	kinase	AMP-activated	non-catalytic	subunit	gamma	1 3
6839 SUV39H1 suppressor	of	variegation	3-9	homolog	1 3
3052 HCCS holocytochrome	c	synthase 3
1435 CSF1 colony	stimulating	factor	1 3
4682 NUBP1 nucleotide	binding	protein	1 3
873 CBR1 carbonyl	reductase	1 3
4605 MYBL2 MYB	proto-oncogene	like	2 3
84057 MND1 meiotic	nuclear	divisions	1 3
2617 GARS glycyl-tRNA	synthetase 3
55148 UBR7 ubiquitin	protein	ligase	E3	component	n-recognin	7	(putative) 3
6241 RRM2 ribonucleotide	reductase	regulatory	subunit	M2 3
91801 ALKBH8 alkB	homolog	8,	tRNA	methyltransferase 3
195828 ZNF367 zinc	finger	protein	367 3
54541 DDIT4 DNA	damage	inducible	transcript	4 3
4292 MLH1 mutL	homolog	1 3
9837 GINS1 GINS	complex	subunit	1 3
27000 DNAJC2 DnaJ	heat	shock	protein	family	(Hsp40)	member	C2 3
55005 RMND1 required	for	meiotic	nuclear	division	1	homolog 3
5715 PSMD9 proteasome	26S	subunit,	non-ATPase	9 3
220134 SKA1 spindle	and	kinetochore	associated	complex	subunit	1 3
55322 C5orf22 chromosome	5	open	reading	frame	22 3
890 CCNA2 cyclin	A2 3
9833 MELK maternal	embryonic	leucine	zipper	kinase 3
64151 NCAPG non-SMC	condensin	I	complex	subunit	G 3
4860 PNP purine	nucleoside	phosphorylase 3
8846 ALKBH1 alkB	homolog	1,	histone	H2A	dioxygenase 3
23397 NCAPH non-SMC	condensin	I	complex	subunit	H 3
79733 E2F8 E2F	transcription	factor	8 3
55872 PBK PDZ	binding	kinase 3
11079 RER1 retention	in	endoplasmic	reticulum	sorting	receptor	1 3
51290 ERGIC2 ERGIC	and	golgi	2 3
6729 SRP54 signal	recognition	particle	54 3
121441 NEDD1 neural	precursor	cell	expressed,	developmentally	down-regulated	1 3
983 CDK1 cyclin	dependent	kinase	1 3
6734 SRPRA SRP	receptor	alpha	subunit 3
10438 C1D C1D	nuclear	receptor	corepressor 3
11212 PROSC proline	synthetase	cotranscribed	homolog	(bacterial) 3
79023 NUP37 nucleoporin	37 3
54433 GAR1 GAR1	ribonucleoprotein 3
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6504 SLAMF1 signaling	lymphocytic	activation	molecule	family	member	1 3
23107 MRPS27 mitochondrial	ribosomal	protein	S27 3
9585 KIF20B kinesin	family	member	20B 3
959 CD40LG CD40	ligand 3
4218 RAB8A RAB8A,	member	RAS	oncogene	family 3
23549 DNPEP aspartyl	aminopeptidase 3
7272 TTK TTK	protein	kinase 3
84920 ALG10 ALG10,	alpha-1,2-glucosyltransferase 3
2218 FKTN fukutin 3
1786 DNMT1 DNA	methyltransferase	1 3
29078 NDUFAF4 NADH:ubiquinone	oxidoreductase	complex	assembly	factor	4 3
144455 E2F7 E2F	transcription	factor	7 3
25983 NGDN neuroguidin 3
11051 NUDT21 nudix	hydrolase	21 3
6426 SRSF1 serine	and	arginine	rich	splicing	factor	1 3
348995 NUP43 nucleoporin	43 3
81556 VWA9 von	Willebrand	factor	A	domain	containing	9 3
286826 LIN9 lin-9	DREAM	MuvB	core	complex	component 3
10615 SPAG5 sperm	associated	antigen	5 3
10721 POLQ DNA	polymerase	theta 3
25800 SLC39A6 solute	carrier	family	39	member	6 3
26958 COPG2 coatomer	protein	complex	subunit	gamma	2 3
5894 RAF1 Raf-1	proto-oncogene,	serine/threonine	kinase 3
8669 EIF3J eukaryotic	translation	initiation	factor	3	subunit	J 3
9131 AIFM1 apoptosis	inducing	factor,	mitochondria	associated	1 3
28969 BZW2 basic	leucine	zipper	and	W2	domains	2 3
9136 RRP9
ribosomal	RNA	processing	9,	small	subunit	(SSU)	processome	component,	homolog	
(yeast) 3
11033 ADAP1 ArfGAP	with	dual	PH	domains	1 3
9377 COX5A cytochrome	c	oxidase	subunit	5A 3
51103 NDUFAF1 NADH:ubiquinone	oxidoreductase	complex	assembly	factor	1 3
196264 MPZL3 myelin	protein	zero	like	3 3
83732 RIOK1 RIO	kinase	1 3
116092 DNTTIP1 deoxynucleotidyltransferase	terminal	interacting	protein	1 3
8480 RAE1 ribonucleic	acid	export	1 3
9556 C14orf2 chromosome	14	open	reading	frame	2 3
403 ARL3 ADP	ribosylation	factor	like	GTPase	3 3
10542 LAMTOR5 late	endosomal/lysosomal	adaptor,	MAPK	and	MTOR	activator	5 3
23365 ARHGEF12 Rho	guanine	nucleotide	exchange	factor	12 3
56947 MFF mitochondrial	fission	factor 3
84233 TMEM126A transmembrane	protein	126A 3
3422 IDI1 isopentenyl-diphosphate	delta	isomerase	1 3
81502 HM13 histocompatibility	minor	13 3
27339 PRPF19 pre-mRNA	processing	factor	19 3
9875 URB1 URB1	ribosome	biogenesis	1	homolog	(S.	cerevisiae) 3
8454 CUL1 cullin	1 3
51232 CRIM1 cysteine	rich	transmembrane	BMP	regulator	1 3
9675 TTI1 TELO2	interacting	protein	1 3
9373 PLAA phospholipase	A2	activating	protein 3
4849 CNOT3 CCR4-NOT	transcription	complex	subunit	3 3
9261 MAPKAPK2 mitogen-activated	protein	kinase-activated	protein	kinase	2 3
2926 GRSF1 G-rich	RNA	sequence	binding	factor	1 3
54931 TRMT10C tRNA	methyltransferase	10C,	mitochondrial	RNase	P	subunit 3
140465 MYL6B myosin	light	chain	6B 3
64374 SIL1 SIL1	nucleotide	exchange	factor 3
51388 NIP7 NIP7,	nucleolar	pre-rRNA	processing	protein 3
2037 EPB41L2 erythrocyte	membrane	protein	band	4.1	like	2 3
2146 EZH2 enhancer	of	zeste	2	polycomb	repressive	complex	2	subunit 3
1503 CTPS1 CTP	synthase	1 3
51056 LAP3 leucine	aminopeptidase	3 3
64422 ATG3 autophagy	related	3 3
64425 POLR1E RNA	polymerase	I	subunit	E 3
5876 RABGGTB Rab	geranylgeranyltransferase	beta	subunit 3
27340 UTP20 UTP20,	small	subunit	processome	component 3
79954 NOL10 nucleolar	protein	10 3
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10885 WDR3 WD	repeat	domain	3 3
467 ATF3 activating	transcription	factor	3 3
10775 POP4 POP4	homolog,	ribonuclease	P/MRP	subunit 3
27166 PRELID1 PRELI	domain	containing	1 3
56945 MRPS22 mitochondrial	ribosomal	protein	S22 3
821 CANX calnexin 3
10525 HYOU1 hypoxia	up-regulated	1 3
7037 TFRC transferrin	receptor 3
56005 MYDGF myeloid	derived	growth	factor 3
9879 DDX46 DEAD-box	helicase	46 3
55131 RBM28 RNA	binding	motif	protein	28 3
55920 RCC2 regulator	of	chromosome	condensation	2 3
3954 LETM1 leucine	zipper	and	EF-hand	containing	transmembrane	protein	1 3
23603 CORO1C coronin	1C 3
54948 MRPL16 mitochondrial	ribosomal	protein	L16 3
22894 DIS3 DIS3	homolog,	exosome	endoribonuclease	and	3'-5'	exoribonuclease 3
51249 TMEM69 transmembrane	protein	69 3
7873 MANF mesencephalic	astrocyte	derived	neurotrophic	factor 3
5393 EXOSC9 exosome	component	9 3
23197 FAF2 Fas	associated	factor	family	member	2 3
5888 RAD51 RAD51	recombinase 3
23761 PISD phosphatidylserine	decarboxylase 3
125061 AFMID arylformamidase 3
5019 OXCT1 3-oxoacid	CoA-transferase	1 3
53371 NUP54 nucleoporin	54 3
23404 EXOSC2 exosome	component	2 3
8208 CHAF1B chromatin	assembly	factor	1	subunit	B 3
6240 RRM1 ribonucleotide	reductase	catalytic	subunit	M1 3
78995 C17orf53 chromosome	17	open	reading	frame	53 3
84930 MASTL microtubule	associated	serine/threonine	kinase	like 3
51514 DTL denticleless	E3	ubiquitin	protein	ligase	homolog 3
3837 KPNB1 karyopherin	subunit	beta	1 3
9156 EXO1 exonuclease	1 3
51194 IPO11 importin	11 3
10036 CHAF1A chromatin	assembly	factor	1	subunit	A 3
160897 GPR180 G	protein-coupled	receptor	180 3
8243 SMC1A structural	maintenance	of	chromosomes	1A 3
1122 CHML CHM	like,	Rab	escort	protein	2 3
22984 PDCD11 programmed	cell	death	11 3
488 ATP2A2 ATPase	sarcoplasmic/endoplasmic	reticulum	Ca2+	transporting	2 3
1874 E2F4 E2F	transcription	factor	4 3
55746 NUP133 nucleoporin	133 3
55973 BCAP29 B-cell	receptor	associated	protein	29 3
84271 POLDIP3 DNA	polymerase	delta	interacting	protein	3 3
55127 HEATR1 HEAT	repeat	containing	1 3
128869 PIGU phosphatidylinositol	glycan	anchor	biosynthesis	class	U 3
79053 ALG8 ALG8,	alpha-1,3-glucosyltransferase 3
2956 MSH6 mutS	homolog	6 3
57678 GPAM glycerol-3-phosphate	acyltransferase,	mitochondrial 3
9401 RECQL4 RecQ	like	helicase	4 3
79796 ALG9 ALG9,	alpha-1,2-mannosyltransferase 3
993 CDC25A cell	division	cycle	25A 3
56926 NCLN nicalin 3
9816 URB2 URB2	ribosome	biogenesis	2	homolog	(S.	cerevisiae) 3
10560 SLC19A2 solute	carrier	family	19	member	2 3
80223 RAB11FIP1 RAB11	family	interacting	protein	1 3
9733 SART3 squamous	cell	carcinoma	antigen	recognized	by	T-cells	3 3
22934 RPIA ribose	5-phosphate	isomerase	A 3
10531 PITRM1 pitrilysin	metallopeptidase	1 3
3251 HPRT1 hypoxanthine	phosphoribosyltransferase	1 3
8833 GMPS guanine	monophosphate	synthase 3
2175 FANCA Fanconi	anemia	complementation	group	A 3
25788 RAD54B RAD54	homolog	B	(S.	cerevisiae) 3
80155 NAA15 N(alpha)-acetyltransferase	15,	NatA	auxiliary	subunit 3
79723 SUV39H2 suppressor	of	variegation	3-9	homolog	2 3
132789 GNPDA2 glucosamine-6-phosphate	deaminase	2 3
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23234 DNAJC9 DnaJ	heat	shock	protein	family	(Hsp40)	member	C9 3
57510 XPO5 exportin	5 3
6119 RPA3 replication	protein	A3 3
39 ACAT2 acetyl-CoA	acetyltransferase	2 3
7993 UBXN8 UBX	domain	protein	8 3
10105 PPIF peptidylprolyl	isomerase	F 3
57003 CCDC47 coiled-coil	domain	containing	47 3
57415 C3orf14 chromosome	3	open	reading	frame	14 3
10652 YKT6 YKT6	v-SNARE	homolog	(S.	cerevisiae) 3
7374 UNG uracil	DNA	glycosylase 3
51602 NOP58 NOP58	ribonucleoprotein 3
6566 SLC16A1 solute	carrier	family	16	member	1 3
4173 MCM4 minichromosome	maintenance	complex	component	4 3
894 CCND2 cyclin	D2 3
9790 BMS1 BMS1,	ribosome	biogenesis	factor 3
51118 UTP11 UTP11,	small	subunit	processome	component	homolog	(S.	cerevisiae) 3
51126 NAA20 N(alpha)-acetyltransferase	20,	NatB	catalytic	subunit 3
10950 BTG3 BTG	anti-proliferation	factor	3 3
10574 CCT7 chaperonin	containing	TCP1	subunit	7 3
55646 LYAR Ly1	antibody	reactive 3
84319 CMSS1 cms1	ribosomal	small	subunit	homolog	(yeast) 3
120425 JAML junction	adhesion	molecule	like 3
10471 PFDN6 prefoldin	subunit	6 3
51497 NELFCD negative	elongation	factor	complex	member	C/D 3
131076 CCDC58 coiled-coil	domain	containing	58 3
2067 ERCC1 ERCC	excision	repair	1,	endonuclease	non-catalytic	subunit 3
55299 BRIX1 BRX1,	biogenesis	of	ribosomes 3
8520 HAT1 histone	acetyltransferase	1 3
1845 DUSP3 dual	specificity	phosphatase	3 3
2321 FLT1 fms	related	tyrosine	kinase	1 3
5422 POLA1 DNA	polymerase	alpha	1,	catalytic	subunit 3
55759 WDR12 WD	repeat	domain	12 3
26010 SPATS2L spermatogenesis	associated	serine	rich	2	like 3
5887 RAD23B RAD23	homolog	B,	nucleotide	excision	repair	protein 3
23516 SLC39A14 solute	carrier	family	39	member	14 3
83743 GRWD1 glutamate	rich	WD	repeat	containing	1 3
5702 PSMC3 proteasome	26S	subunit,	ATPase	3 3
54487 DGCR8 DGCR8,	microprocessor	complex	subunit 3
55720 TSR1 TSR1,	ribosome	maturation	factor 3
2547 XRCC6 X-ray	repair	cross	complementing	6 3
5982 RFC2 replication	factor	C	subunit	2 3
27346 TMEM97 transmembrane	protein	97 3
80179 MYO19 myosin	XIX 3
9343 EFTUD2 elongation	factor	Tu	GTP	binding	domain	containing	2 3
220042 DDIAS DNA	damage	induced	apoptosis	suppressor 3
8318 CDC45 cell	division	cycle	45 3
5471 PPAT phosphoribosyl	pyrophosphate	amidotransferase 3
990 CDC6 cell	division	cycle	6 3
90861 HN1L hematological	and	neurological	expressed	1	like 3
29128 UHRF1 ubiquitin	like	with	PHD	and	ring	finger	domains	1 3
1111 CHEK1 checkpoint	kinase	1 3
55854 ZC3H15 zinc	finger	CCCH-type	containing	15 3
4998 ORC1 origin	recognition	complex	subunit	1 3
5111 PCNA proliferating	cell	nuclear	antigen 3
54962 TIPIN TIMELESS	interacting	protein 3
51377 UCHL5 ubiquitin	C-terminal	hydrolase	L5 3
9125 CNOT9 CCR4-NOT	transcription	complex	subunit	9 3
11222 MRPL3 mitochondrial	ribosomal	protein	L3 3
1965 EIF2S1 eukaryotic	translation	initiation	factor	2	subunit	alpha 3
6427 SRSF2 serine	and	arginine	rich	splicing	factor	2 3
10623 POLR3C RNA	polymerase	III	subunit	C 3
7884 SLBP stem-loop	binding	protein 3
79622 SNRNP25 small	nuclear	ribonucleoprotein	U11/U12	subunit	25 3
4172 MCM3 minichromosome	maintenance	complex	component	3 3
2237 FEN1 flap	structure-specific	endonuclease	1 3
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171568 POLR3H RNA	polymerase	III	subunit	H 3
8704 B4GALT2 beta-1,4-galactosyltransferase	2 3
55388 MCM10 minichromosome	maintenance	10	replication	initiation	factor 3
26509 MYOF myoferlin 3
94097 SFXN5 sideroflexin	5 3
55379 LRRC59 leucine	rich	repeat	containing	59 3
2271 FH fumarate	hydratase 3
26284 ERAL1 Era	like	12S	mitochondrial	rRNA	chaperone	1 3
2958 GTF2A2 general	transcription	factor	IIA	subunit	2 3
1869 E2F1 E2F	transcription	factor	1 3
11332 ACOT7 acyl-CoA	thioesterase	7 3
898 CCNE1 cyclin	E1 3
5983 RFC3 replication	factor	C	subunit	3 3
3021 H3F3B H3	histone	family	member	3B 3
10419 PRMT5 protein	arginine	methyltransferase	5 3
64858 DCLRE1B DNA	cross-link	repair	1B 3
10054 UBA2 ubiquitin	like	modifier	activating	enzyme	2 3
2176 FANCC Fanconi	anemia	complementation	group	C 3
51124 IER3IP1 immediate	early	response	3	interacting	protein	1 3
126526 C19orf47 chromosome	19	open	reading	frame	47 3
60386 SLC25A19 solute	carrier	family	25	member	19 3
56910 STARD7 StAR	related	lipid	transfer	domain	containing	7 3
3976 LIF leukemia	inhibitory	factor 3
1841 DTYMK deoxythymidylate	kinase 3
10556 RPP30 ribonuclease	P/MRP	subunit	p30 3
10360 NPM3 nucleophosmin/nucleoplasmin	3 3
114034 TOE1 target	of	EGR1,	member	1	(nuclear) 3
79693 YRDC yrdC	N6-threonylcarbamoyltransferase	domain	containing 3
5631 PRPS1 phosphoribosyl	pyrophosphate	synthetase	1 3
56851 EMC7 ER	membrane	protein	complex	subunit	7 3
10949 HNRNPA0 heterogeneous	nuclear	ribonucleoprotein	A0 3
51559 NT5DC3 5'-nucleotidase	domain	containing	3 3
79682 CENPU centromere	protein	U 3
9410 SNRNP40 small	nuclear	ribonucleoprotein	U5	subunit	40 3
8624 PSMG1 proteasome	assembly	chaperone	1 3
5557 PRIM1 primase	(DNA)	subunit	1 3
55159 RFWD3 ring	finger	and	WD	repeat	domain	3 3
29089 UBE2T ubiquitin	conjugating	enzyme	E2	T 3
84515 MCM8 minichromosome	maintenance	8	homologous	recombination	repair	factor 3
11164 NUDT5 nudix	hydrolase	5 3
203068 TUBB tubulin	beta	class	I 3
6472 SHMT2 serine	hydroxymethyltransferase	2 3
132 ADK adenosine	kinase 3
401541 CENPP centromere	protein	P 3
805 CALM2 calmodulin	2 3
4616 GADD45B growth	arrest	and	DNA	damage	inducible	beta 3
10328 EMC8 ER	membrane	protein	complex	subunit	8 3
5546 PRCC papillary	renal	cell	carcinoma	(translocation-associated) 3
1164 CKS2 CDC28	protein	kinase	regulatory	subunit	2 3
27242 TNFRSF21 TNF	receptor	superfamily	member	21 3
9318 COPS2 COP9	signalosome	subunit	2 3
56993 TOMM22 translocase	of	outer	mitochondrial	membrane	22 3
84549 MAK16 MAK16	homolog 3
5437 POLR2H RNA	polymerase	II	subunit	H 3
388272 C16orf87 chromosome	16	open	reading	frame	87 3
113115 MTFR2 mitochondrial	fission	regulator	2 3
4043 LRPAP1 LDL	receptor	related	protein	associated	protein	1 3
55347 ABHD10 abhydrolase	domain	containing	10 3
79968 WDR76 WD	repeat	domain	76 3
262 AMD1 adenosylmethionine	decarboxylase	1 3
27131 SNX5 sorting	nexin	5 3
93081 TEX30 testis	expressed	30 3
200081 TXLNA taxilin	alpha 3
84334 APOPT1 apoptogenic	1,	mitochondrial 3
8836 GGH gamma-glutamyl	hydrolase 3
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1528 CYB5A cytochrome	b5	type	A 3
122769 LRR1 leucine	rich	repeat	protein	1 3
8896 BUD31 BUD31	homolog 3
7922 SLC39A7 solute	carrier	family	39	member	7 3
83903 GSG2 germ	cell	associated	2,	haspin 3
79019 CENPM centromere	protein	M 3
10038 PARP2 poly(ADP-ribose)	polymerase	2 3
11130 ZWINT ZW10	interacting	kinetochore	protein 3
91 ACVR1B activin	A	receptor	type	1B 3
6742 SSBP1 single	stranded	DNA	binding	protein	1 3
7398 USP1 ubiquitin	specific	peptidase	1 3
79980 DSN1 DSN1	homolog,	MIS12	kinetochore	complex	component 3
9134 CCNE2 cyclin	E2 3
387103 CENPW centromere	protein	W 3
9984 THOC1 THO	complex	1 3
23421 ITGB3BP integrin	subunit	beta	3	binding	protein 3
54108 CHRAC1 chromatin	accessibility	complex	1 3
79801 SHCBP1 SHC	binding	and	spindle	associated	1 3
3185 HNRNPF heterogeneous	nuclear	ribonucleoprotein	F 3
813 CALU calumenin 3
10733 PLK4 polo	like	kinase	4 3
211 ALAS1 5'-aminolevulinate	synthase	1 3
81831 NETO2 neuropilin	and	tolloid	like	2 3
79001 VKORC1 vitamin	K	epoxide	reductase	complex	subunit	1 3
26123 TCTN3 tectonic	family	member	3 3
25896 INTS7 integrator	complex	subunit	7 3
64834 ELOVL1 ELOVL	fatty	acid	elongase	1 3
80304 WDCP WD	repeat	and	coiled	coil	containing 3
51550 CINP cyclin	dependent	kinase	2	interacting	protein 3
38 ACAT1 acetyl-CoA	acetyltransferase	1 3
79084 WDR77 WD	repeat	domain	77 3
219988 PATL1 PAT1	homolog	1,	processing	body	mRNA	decay	factor 3
63979 FIGNL1 fidgetin	like	1 3
10772 SRSF10 serine	and	arginine	rich	splicing	factor	10 3
6788 STK3 serine/threonine	kinase	3 3
85459 CEP295 centrosomal	protein	295 3
2746 GLUD1 glutamate	dehydrogenase	1 3
58490 RPRD1B regulation	of	nuclear	pre-mRNA	domain	containing	1B 3
3005 H1F0 H1	histone	family	member	0 3
55163 PNPO pyridoxamine	5'-phosphate	oxidase 3
114134 SLC2A13 solute	carrier	family	2	member	13 3
7384 UQCRC1 ubiquinol-cytochrome	c	reductase	core	protein	I 3
23509 POFUT1 protein	O-fucosyltransferase	1 3
975 CD81 CD81	molecule 3
7408 VASP vasodilator-stimulated	phosphoprotein 3
93323 HAUS8 HAUS	augmin	like	complex	subunit	8 3
124535 HSF5 heat	shock	transcription	factor	5 3
85444 LRRCC1 leucine	rich	repeat	and	coiled-coil	centrosomal	protein	1 3
51150 SDF4 stromal	cell	derived	factor	4 3
56919 DHX33 DEAH-box	helicase	33 3
23035 PHLPP2 PH	domain	and	leucine	rich	repeat	protein	phosphatase	2 3
8879 SGPL1 sphingosine-1-phosphate	lyase	1 3
51593 SRRT serrate,	RNA	effector	molecule 3
790 CAD carbamoyl-phosphate	synthetase	2,	aspartate	transcarbamylase,	and	dihydroorotase 3
6541 SLC7A1 solute	carrier	family	7	member	1 3
6835 SURF2 surfeit	2 3
84306 PDCD2L programmed	cell	death	2	like 3
51693 TRAPPC2L trafficking	protein	particle	complex	2	like 3
7001 PRDX2 peroxiredoxin	2 3
22976 PAXIP1 PAX	interacting	protein	1 3
51692 CPSF3 cleavage	and	polyadenylation	specific	factor	3 3
11193 WBP4 WW	domain	binding	protein	4 3
6827 SUPT4H1 SPT4	homolog,	DSIF	elongation	factor	subunit 3
116224 FAM122A family	with	sequence	similarity	122A 3
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51110 LACTB2 lactamase	beta	2 3
29063 ZCCHC4 zinc	finger	CCHC-type	containing	4 3
57552 NCEH1 neutral	cholesterol	ester	hydrolase	1 3
60528 ELAC2 elaC	ribonuclease	Z	2 3
79174 CRELD2 cysteine	rich	with	EGF	like	domains	2 3
83940 TATDN1 TatD	DNase	domain	containing	1 3
117246 FTSJ3 FtsJ	homolog	3 3
390916 NUDT19 nudix	hydrolase	19 3
1478 CSTF2 cleavage	stimulation	factor	subunit	2 3
1017 CDK2 cyclin	dependent	kinase	2 3
221830 TWISTNB TWIST	neighbor 3
10383 TUBB4B tubulin	beta	4B	class	IVb 3
65003 MRPL11 mitochondrial	ribosomal	protein	L11 3
5366 PMAIP1 phorbol-12-myristate-13-acetate-induced	protein	1 3
54939 COMMD4 COMM	domain	containing	4 3
56912 IFT46 intraflagellar	transport	46 3
51258 MRPL51 mitochondrial	ribosomal	protein	L51 3
6478 SIAH2 siah	E3	ubiquitin	protein	ligase	2 3
29093 MRPL22 mitochondrial	ribosomal	protein	L22 3
79073 TMEM109 transmembrane	protein	109 3
92745 SLC38A5 solute	carrier	family	38	member	5 3
9183 ZW10 zw10	kinetochore	protein 3
6390 SDHB succinate	dehydrogenase	complex	iron	sulfur	subunit	B 3
64223 MLST8 MTOR	associated	protein,	LST8	homolog 3
55915 LANCL2 LanC	like	2 3
57095 PITHD1 PITH	domain	containing	1 3
7917 BAG6 BCL2	associated	athanogene	6 3
1603 DAD1 defender	against	cell	death	1 3
533 ATP6V0B ATPase	H+	transporting	V0	subunit	b 3
130355 C2orf76 chromosome	2	open	reading	frame	76 3
9040 UBE2M ubiquitin	conjugating	enzyme	E2	M 3
5708 PSMD2 proteasome	26S	subunit,	non-ATPase	2 3
253714 MMS22L MMS22	like,	DNA	repair	protein 3
5685 PSMA4 proteasome	subunit	alpha	4 3
5203 PFDN4 prefoldin	subunit	4 3
1376 CPT2 carnitine	palmitoyltransferase	2 3
27229 TUBGCP4 tubulin	gamma	complex	associated	protein	4 3
83746 L3MBTL2 L3MBTL2	polycomb	repressive	complex	1	subunit 3
334 APLP2 amyloid	beta	precursor	like	protein	2 3
1737 DLAT dihydrolipoamide	S-acetyltransferase 3
5034 P4HB prolyl	4-hydroxylase	subunit	beta 3
51053 GMNN geminin,	DNA	replication	inhibitor 3
51728 POLR3K RNA	polymerase	III	subunit	K 3
116138 KLHDC3 kelch	domain	containing	3 3
27249 MMADHC methylmalonic	aciduria	and	homocystinuria,	cblD	type 3
57019 CIAPIN1 cytokine	induced	apoptosis	inhibitor	1 3
81037 CLPTM1L CLPTM1	like 3
9862 MED24 mediator	complex	subunit	24 3
580 BARD1 BRCA1	associated	RING	domain	1 3
9703 KIAA0100 KIAA0100 3
9538 EI24 EI24,	autophagy	associated	transmembrane	protein 3
28957 MRPS28 mitochondrial	ribosomal	protein	S28 3
23534 TNPO3 transportin	3 3
54471 MIEF1 mitochondrial	elongation	factor	1 3
51264 MRPL27 mitochondrial	ribosomal	protein	L27 3
689 BTF3 basic	transcription	factor	3 3
7982 ST7 suppression	of	tumorigenicity	7 3
5984 RFC4 replication	factor	C	subunit	4 3
81875 ISG20L2 interferon	stimulated	exonuclease	gene	20	like	2 3
80010 RMI1 RecQ	mediated	genome	instability	1 3
127253 TYW3 tRNA-yW	synthesizing	protein	3	homolog 3
8607 RUVBL1 RuvB	like	AAA	ATPase	1 3
10971 YWHAQ tyrosine	3-monooxygenase/tryptophan	5-monooxygenase	activation	protein	theta 3
51253 MRPL37 mitochondrial	ribosomal	protein	L37 3
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740 MRPL49 mitochondrial	ribosomal	protein	L49 3
92399 MRRF mitochondrial	ribosome	recycling	factor 3
6941 TCF19 transcription	factor	19 3
4176 MCM7 minichromosome	maintenance	complex	component	7 3
79751 SLC25A22 solute	carrier	family	25	member	22 3
129401 NUP35 nucleoporin	35 3
4085 MAD2L1 MAD2	mitotic	arrest	deficient-like	1	(yeast) 3
79892 MCMBP minichromosome	maintenance	complex	binding	protein 3
7705 ZNF146 zinc	finger	protein	146 3
10857 PGRMC1 progesterone	receptor	membrane	component	1 3
140707 BRI3BP BRI3	binding	protein 3
84798 C19orf48 chromosome	19	open	reading	frame	48 3
4733 DRG1 developmentally	regulated	GTP	binding	protein	1 3
3458 IFNG interferon	gamma 3
7124 TNF tumor	necrosis	factor 3
60678 EEFSEC eukaryotic	elongation	factor,	selenocysteine-tRNA	specific 3
55706 NDC1 NDC1	transmembrane	nucleoporin 3
56006 SMG9 SMG9,	nonsense	mediated	mRNA	decay	factor 3
1437 CSF2 colony	stimulating	factor	2 3
9093 DNAJA3 DnaJ	heat	shock	protein	family	(Hsp40)	member	A3 3
55536 CDCA7L cell	division	cycle	associated	7	like 3
23594 ORC6 origin	recognition	complex	subunit	6 3
81611 ANP32E acidic	nuclear	phosphoprotein	32	family	member	E 3
55166 CENPQ centromere	protein	Q 3
90121 TSR2 TSR2,	ribosome	maturation	factor 3
64795 RMND5A required	for	meiotic	nuclear	division	5	homolog	A 3
2187 FANCB Fanconi	anemia	complementation	group	B 3
3595 IL12RB2 interleukin	12	receptor	subunit	beta	2 3
2747 GLUD2 glutamate	dehydrogenase	2 3
57001 SDHAF3 succinate	dehydrogenase	complex	assembly	factor	3 3
10714 POLD3 DNA	polymerase	delta	3,	accessory	subunit 3
51522 TMEM14C transmembrane	protein	14C 3
8841 HDAC3 histone	deacetylase	3 3
134145 FAM173B family	with	sequence	similarity	173	member	B 3
10527 IPO7 importin	7 3
10768 AHCYL1 adenosylhomocysteinase	like	1 3
29851 ICOS inducible	T-cell	costimulator 3
5433 POLR2D RNA	polymerase	II	subunit	D 3
9533 POLR1C RNA	polymerase	I	subunit	C 3
54675 CRLS1 cardiolipin	synthase	1 3
145173 B3GLCT beta	3-glucosyltransferase 3
57602 USP36 ubiquitin	specific	peptidase	36 3
9801 MRPL19 mitochondrial	ribosomal	protein	L19 3
10539 GLRX3 glutaredoxin	3 3
10921 RNPS1 RNA	binding	protein	with	serine	rich	domain	1 3
92856 IMP4 IMP4	homolog,	U3	small	nucleolar	ribonucleoprotein 3
5810 RAD1 RAD1	checkpoint	DNA	exonuclease 3
10797 MTHFD2
methylenetetrahydrofolate	dehydrogenase	(NADP+	dependent)	2,	
methenyltetrahydrofolate	cyclohydrolase 3
55735 DNAJC11 DnaJ	heat	shock	protein	family	(Hsp40)	member	C11 3
10713 USP39 ubiquitin	specific	peptidase	39 3
81929 SEH1L SEH1	like	nucleoporin 3
5717 PSMD11 proteasome	26S	subunit,	non-ATPase	11 3
5917 RARS arginyl-tRNA	synthetase 3
27258 LSM3 LSM3	homolog,	U6	small	nuclear	RNA	and	mRNA	degradation	associated 3
51182 HSPA14 heat	shock	protein	family	A	(Hsp70)	member	14 3
6950 TCP1 t-complex	1 3
5860 QDPR quinoid	dihydropteridine	reductase 3
8079 MLF2 myeloid	leukemia	factor	2 3
51645 PPIL1 peptidylprolyl	isomerase	like	1 3
5985 RFC5 replication	factor	C	subunit	5 3
3843 IPO5 importin	5 3
22936 ELL2 elongation	factor	for	RNA	polymerase	II	2 3
10166 SLC25A15 solute	carrier	family	25	member	15 3
55622 TTC27 tetratricopeptide	repeat	domain	27 3
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51002 TPRKB TP53RK	binding	protein 3
23392 KIAA0368 KIAA0368 3
53407 STX18 syntaxin	18 3
10059 DNM1L dynamin	1	like 3
9774 BCLAF1 BCL2	associated	transcription	factor	1 3
84641 MFSD14B major	facilitator	superfamily	domain	containing	14B 3
8677 STX10 syntaxin	10 3
81873 ARPC5L actin	related	protein	2/3	complex	subunit	5	like 3
51575 ESF1 ESF1	nucleolar	pre-rRNA	processing	protein	homolog 3
988 CDC5L cell	division	cycle	5	like 3
2957 GTF2A1 general	transcription	factor	IIA	subunit	1 3
23597 ACOT9 acyl-CoA	thioesterase	9 3
81554 RCC1L RCC1	like 3
3654 IRAK1 interleukin	1	receptor	associated	kinase	1 3
55149 MTPAP mitochondrial	poly(A)	polymerase 3
80775 TMEM177 transmembrane	protein	177 3
64216 TFB2M transcription	factor	B2,	mitochondrial 3
10592 SMC2 structural	maintenance	of	chromosomes	2 3
140735 DYNLL2 dynein	light	chain	LC8-type	2 3
47 ACLY ATP	citrate	lyase 3
5832 ALDH18A1 aldehyde	dehydrogenase	18	family	member	A1 3
1138 CHRNA5 cholinergic	receptor	nicotinic	alpha	5	subunit 3
125228 FAM210A family	with	sequence	similarity	210	member	A 3
23649 POLA2 DNA	polymerase	alpha	2,	accessory	subunit 3
55627 SMPD4 sphingomyelin	phosphodiesterase	4 3
6510 SLC1A5 solute	carrier	family	1	member	5 3
58478 ENOPH1 enolase-phosphatase	1 3
2806 GOT2 glutamic-oxaloacetic	transaminase	2 3
5534 PPP3R1 protein	phosphatase	3	regulatory	subunit	B,	alpha 3
88745 RRP36 ribosomal	RNA	processing	36 3
79863 RBFA ribosome	binding	factor	A	(putative) 3
10884 MRPS30 mitochondrial	ribosomal	protein	S30 3
9015 TAF1A TATA-box	binding	protein	associated	factor,	RNA	polymerase	I	subunit	A 3
79029 SPATA5L1 spermatogenesis	associated	5	like	1 3
80311 KLHL15 kelch	like	family	member	15 3
64946 CENPH centromere	protein	H 3
8438 RAD54L RAD54-like	(S.	cerevisiae) 3
7298 TYMS thymidylate	synthetase 3
9768 KIAA0101 KIAA0101 3
6502 SKP2 S-phase	kinase	associated	protein	2 3
5427 POLE2 DNA	polymerase	epsilon	2,	accessory	subunit 3
79902 NUP85 nucleoporin	85 3
8723 SNX4 sorting	nexin	4 3
5932 RBBP8 RB	binding	protein	8,	endonuclease 3
3070 HELLS helicase,	lymphoid-specific 3
672 BRCA1 BRCA1,	DNA	repair	associated 3
79075 DSCC1 DNA	replication	and	sister	chromatid	cohesion	1 3
7083 TK1 thymidine	kinase	1 3
91768 CABLES1 Cdk5	and	Abl	enzyme	substrate	1 3
10099 TSPAN3 tetraspanin	3 3
130074 FAM168B family	with	sequence	similarity	168	member	B 3
79807 GSTCD glutathione	S-transferase	C-terminal	domain	containing 3
83480 PUS3 pseudouridylate	synthase	3 3
54442 KCTD5 potassium	channel	tetramerization	domain	containing	5 3
55559 HAUS7 HAUS	augmin	like	complex	subunit	7 3
79003 MIS12 MIS12,	kinetochore	complex	component 3
1763 DNA2 DNA	replication	helicase/nuclease	2 3
9328 GTF3C5 general	transcription	factor	IIIC	subunit	5 3
10552 ARPC1A actin	related	protein	2/3	complex	subunit	1A 3
29925 GMPPB GDP-mannose	pyrophosphorylase	B 3
134353 LSM11 LSM11,	U7	small	nuclear	RNA	associated 3
25914 RTTN rotatin 3
207 AKT1 AKT	serine/threonine	kinase	1 3
64837 KLC2 kinesin	light	chain	2 3
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8131 NPRL3 NPR3	like,	GATOR1	complex	subunit 3
116113 FOXP4 forkhead	box	P4 3
55677 IWS1 IWS1,	SUPT6H	interacting	protein 3
10749 KIF1C kinesin	family	member	1C 3
9019 MPZL1 myelin	protein	zero	like	1 3
84885 ZDHHC12 zinc	finger	DHHC-type	containing	12 3
55509 BATF3 basic	leucine	zipper	ATF-like	transcription	factor	3 3
54976 C20orf27 chromosome	20	open	reading	frame	27 3
56616 DIABLO diablo	IAP-binding	mitochondrial	protein 3
10856 RUVBL2 RuvB	like	AAA	ATPase	2 3
55969 C20orf24 chromosome	20	open	reading	frame	24 3
100506012 PPP5D1 PPP5	tetratricopeptide	repeat	domain	containing	1 3
57418 WDR18 WD	repeat	domain	18 3
10572 SIVA1 SIVA1	apoptosis	inducing	factor 3
9653 HS2ST1 heparan	sulfate	2-O-sulfotransferase	1 3
9031 BAZ1B bromodomain	adjacent	to	zinc	finger	domain	1B 3
55922 NKRF NFKB	repressing	factor 3
10594 PRPF8 pre-mRNA	processing	factor	8 3
2235 FECH ferrochelatase 3
54934 KANSL2 KAT8	regulatory	NSL	complex	subunit	2 3
339231 ARL16 ADP	ribosylation	factor	like	GTPase	16 3
5514 PPP1R10 protein	phosphatase	1	regulatory	subunit	10 3
4193 MDM2 MDM2	proto-oncogene 3
126731 CCSAP centriole,	cilia	and	spindle	associated	protein 3
387338 NSUN4 NOP2/Sun	RNA	methyltransferase	family	member	4 3
64318 NOC3L NOC3	like	DNA	replication	regulator 3
64083 GOLPH3 golgi	phosphoprotein	3 3
10478 SLC25A17 solute	carrier	family	25	member	17 3
11157 LSM6 LSM6	homolog,	U6	small	nuclear	RNA	and	mRNA	degradation	associated 3
79989 TTC26 tetratricopeptide	repeat	domain	26 3
56894 AGPAT3 1-acylglycerol-3-phosphate	O-acyltransferase	3 3
1983 EIF5 eukaryotic	translation	initiation	factor	5 3
56652 C10orf2 chromosome	10	open	reading	frame	2 3
22891 ZNF365 zinc	finger	protein	365 3
221035 REEP3 receptor	accessory	protein	3 3
54707 GPN2 GPN-loop	GTPase	2 3
51022 GLRX2 glutaredoxin	2 3
79066 METTL16 methyltransferase	like	16 3
57862 ZNF410 zinc	finger	protein	410 3
9240 PNMA1 paraneoplastic	Ma	antigen	1 3
51204 TACO1 translational	activator	of	cytochrome	c	oxidase	I 3
7292 TNFSF4 tumor	necrosis	factor	superfamily	member	4 3
79568 C2orf47 chromosome	2	open	reading	frame	47 3
7584 ZNF35 zinc	finger	protein	35 3
4709 NDUFB3 NADH:ubiquinone	oxidoreductase	subunit	B3 3
55572 FOXRED1 FAD	dependent	oxidoreductase	domain	containing	1 3
56683 C21orf59 chromosome	21	open	reading	frame	59 3
23423 TMED3 transmembrane	p24	trafficking	protein	3 3
5134 PDCD2 programmed	cell	death	2 3
84289 ING5 inhibitor	of	growth	family	member	5 3
527 ATP6V0C ATPase	H+	transporting	V0	subunit	c 3
1978 EIF4EBP1 eukaryotic	translation	initiation	factor	4E	binding	protein	1 3
6628 SNRPB small	nuclear	ribonucleoprotein	polypeptides	B	and	B1 3
1981 EIF4G1 eukaryotic	translation	initiation	factor	4	gamma	1 3
10221 TRIB1 tribbles	pseudokinase	1 3
157506 RDH10 retinol	dehydrogenase	10	(all-trans) 3
79413 ZBED2 zinc	finger	BED-type	containing	2 3
6182 MRPL12 mitochondrial	ribosomal	protein	L12 3
201514 ZNF584 zinc	finger	protein	584 3
7023 TFAP4 transcription	factor	AP-4 3
8228 PNPLA4 patatin	like	phospholipase	domain	containing	4 3
2593 GAMT guanidinoacetate	N-methyltransferase 3
9144 SYNGR2 synaptogyrin	2 3
2876 GPX1 glutathione	peroxidase	1 3
29914 UBIAD1 UbiA	prenyltransferase	domain	containing	1 3
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5050 PAFAH1B3 platelet	activating	factor	acetylhydrolase	1b	catalytic	subunit	3 3
23276 KLHL18 kelch	like	family	member	18 3
51647 FAM96B family	with	sequence	similarity	96	member	B 3
23381 SMG5 SMG5,	nonsense	mediated	mRNA	decay	factor 3
5714 PSMD8 proteasome	26S	subunit,	non-ATPase	8 3
4946 OAZ1 ornithine	decarboxylase	antizyme	1 3
6647 SOD1 superoxide	dismutase	1,	soluble 3
4234 METTL1 methyltransferase	like	1 3
116238 TLCD1 TLC	domain	containing	1 3
7167 TPI1 triosephosphate	isomerase	1 3
10953 TOMM34 translocase	of	outer	mitochondrial	membrane	34 3
27341 RRP7A ribosomal	RNA	processing	7	homolog	A 3
65057 ACD adrenocortical	dysplasia	homolog 3
64943 NT5DC2 5'-nucleotidase	domain	containing	2 3
5425 POLD2 DNA	polymerase	delta	2,	accessory	subunit 3
79143 MBOAT7 membrane	bound	O-acyltransferase	domain	containing	7 3
9361 LONP1 lon	peptidase	1,	mitochondrial 3
6150 MRPL23 mitochondrial	ribosomal	protein	L23 3
1337 COX6A1 cytochrome	c	oxidase	subunit	6A1 3
10726 NUDC nuclear	distribution	C,	dynein	complex	regulator 3
51690 LSM7 LSM7	homolog,	U6	small	nuclear	RNA	and	mRNA	degradation	associated 3
5441 POLR2L RNA	polymerase	II	subunit	L 3
55272 IMP3 IMP3,	U3	small	nucleolar	ribonucleoprotein 3
11047 ADRM1 adhesion	regulating	molecule	1 3
23170 TTLL12 tubulin	tyrosine	ligase	like	12 3
53354 PANK1 pantothenate	kinase	1 3
3692 EIF6 eukaryotic	translation	initiation	factor	6 3
5709 PSMD3 proteasome	26S	subunit,	non-ATPase	3 3
23543 RBFOX2 RNA	binding	protein,	fox-1	homolog	2 3
56834 GPR137 G	protein-coupled	receptor	137 3
8402 SLC25A11 solute	carrier	family	25	member	11 3
5694 PSMB6 proteasome	subunit	beta	6 3
10113 PREB prolactin	regulatory	element	binding 3
26073 POLDIP2 DNA	polymerase	delta	interacting	protein	2 3
28989 NTMT1 N-terminal	Xaa-Pro-Lys	N-methyltransferase	1 3
55856 ACOT13 acyl-CoA	thioesterase	13 3
29934 SNX12 sorting	nexin	12 3
23645 PPP1R15A protein	phosphatase	1	regulatory	subunit	15A 3
51278 IER5 immediate	early	response	5 3
10063 COX17 COX17,	cytochrome	c	oxidase	copper	chaperone 3
83706 FERMT3 fermitin	family	member	3 3
54973 CPSF3L cleavage	and	polyadenylation	specific	factor	3-like 3
401466 C8orf59 chromosome	8	open	reading	frame	59 3
84287 ZDHHC16 zinc	finger	DHHC-type	containing	16 3
10257 ABCC4 ATP	binding	cassette	subfamily	C	member	4 3
23466 CBX6 chromobox	6 3
64965 MRPS9 mitochondrial	ribosomal	protein	S9 3
51097 SCCPDH saccharopine	dehydrogenase	(putative) 3
51659 GINS2 GINS	complex	subunit	2 3
6434 TRA2B transformer	2	beta	homolog	(Drosophila) 3
471 ATIC
5-aminoimidazole-4-carboxamide	ribonucleotide	formyltransferase/IMP	
cyclohydrolase 3
23074 UHRF1BP1L UHRF1	binding	protein	1	like 3
10598 AHSA1 activator	of	Hsp90	ATPase	activity	1 3
1653 DDX1 DEAD/H-box	helicase	1 3
57695 USP37 ubiquitin	specific	peptidase	37 3
3840 KPNA4 karyopherin	subunit	alpha	4 3
54517 PUS7 pseudouridylate	synthase	7	(putative) 3
8870 IER3 immediate	early	response	3 3
9761 MLEC malectin 3
116225 ZMYND19 zinc	finger	MYND-type	containing	19 3
6183 MRPS12 mitochondrial	ribosomal	protein	S12 3
9308 CD83 CD83	molecule 3
10061 ABCF2 ATP	binding	cassette	subfamily	F	member	2 3
6484 ST3GAL4 ST3	beta-galactoside	alpha-2,3-sialyltransferase	4 3
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283742 FAM98B family	with	sequence	similarity	98	member	B 3
27158 NDOR1 NADPH	dependent	diflavin	oxidoreductase	1 3
126792 B3GALT6 beta-1,3-galactosyltransferase	6 3
51400 PPME1 protein	phosphatase	methylesterase	1 3
10694 CCT8 chaperonin	containing	TCP1	subunit	8 3
29090 TIMM21 translocase	of	inner	mitochondrial	membrane	21 3
4670 HNRNPM heterogeneous	nuclear	ribonucleoprotein	M 3
10988 METAP2 methionyl	aminopeptidase	2 3
9868 TOMM70 translocase	of	outer	mitochondrial	membrane	70 3
1431 CS citrate	synthase 3
3157 HMGCS1 3-hydroxy-3-methylglutaryl-CoA	synthase	1 3
11112 HIBADH 3-hydroxyisobutyrate	dehydrogenase 3
10213 PSMD14 proteasome	26S	subunit,	non-ATPase	14 3
1434 CSE1L chromosome	segregation	1	like 3
51081 MRPS7 mitochondrial	ribosomal	protein	S7 3
23590 PDSS1 prenyl	(decaprenyl)	diphosphate	synthase,	subunit	1 3
6749 SSRP1 structure	specific	recognition	protein	1 3
3562 IL3 interleukin	3 3
10189 ALYREF Aly/REF	export	factor 3
6431 SRSF6 serine	and	arginine	rich	splicing	factor	6 3
292 SLC25A5 solute	carrier	family	25	member	5 3
23160 WDR43 WD	repeat	domain	43 3
2030 SLC29A1 solute	carrier	family	29	member	1	(Augustine	blood	group) 3
5536 PPP5C protein	phosphatase	5	catalytic	subunit 3
9188 DDX21 DEAD-box	helicase	21 3
8726 EED embryonic	ectoderm	development 3
29889 GNL2 G	protein	nucleolar	2 3
4436 MSH2 mutS	homolog	2 3
4175 MCM6 minichromosome	maintenance	complex	component	6 3
10939 AFG3L2 AFG3	like	matrix	AAA	peptidase	subunit	2 3
1994 ELAVL1 ELAV	like	RNA	binding	protein	1 3
23450 SF3B3 splicing	factor	3b	subunit	3 3
29781 NCAPH2 non-SMC	condensin	II	complex	subunit	H2 3
5707 PSMD1 proteasome	26S	subunit,	non-ATPase	1 3
10657 KHDRBS1 KH	RNA	binding	domain	containing,	signal	transduction	associated	1 3
10432 RBM14 RNA	binding	motif	protein	14 3
7518 XRCC4 X-ray	repair	cross	complementing	4 3
3301 DNAJA1 DnaJ	heat	shock	protein	family	(Hsp40)	member	A1 3
2935 GSPT1 G1	to	S	phase	transition	1 3
1982 EIF4G2 eukaryotic	translation	initiation	factor	4	gamma	2 3
3184 HNRNPD heterogeneous	nuclear	ribonucleoprotein	D 3
23082 PPRC1 peroxisome	proliferator-activated	receptor	gamma,	coactivator-related	1 3
27089 UQCRQ ubiquinol-cytochrome	c	reductase	complex	III	subunit	VII 3
7165 TPD52L2 tumor	protein	D52	like	2 3
29098 RANGRF RAN	guanine	nucleotide	release	factor 3
8260 NAA10 N(alpha)-acetyltransferase	10,	NatA	catalytic	subunit 3
51373 MRPS17 mitochondrial	ribosomal	protein	S17 3
1892 ECHS1 enoyl-CoA	hydratase,	short	chain	1 3
22868 FASTKD2 FAST	kinase	domains	2 3
5931 RBBP7 RB	binding	protein	7,	chromatin	remodeling	factor 3
84135 UTP15 UTP15,	small	subunit	processome	component 3
23165 NUP205 nucleoporin	205 3
5202 PFDN2 prefoldin	subunit	2 3
84331 MCRIP2 MAPK	regulated	corepressor	interacting	protein	2 3
705 BYSL bystin	like 3
3622 ING2 inhibitor	of	growth	family	member	2 3
9631 NUP155 nucleoporin	155 3
79711 IPO4 importin	4 3
1660 DHX9 DEAH-box	helicase	9 3
7372 UMPS uridine	monophosphate	synthetase 3
199953 TMEM201 transmembrane	protein	201 3
3068 HDGF hepatoma-derived	growth	factor 3
10295 BCKDK branched	chain	ketoacid	dehydrogenase	kinase 3
144097 C11orf84 chromosome	11	open	reading	frame	84 3
4628 MYH10 myosin	heavy	chain	10 3
84649 DGAT2 diacylglycerol	O-acyltransferase	2 3
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516 ATP5G1 ATP	synthase,	H+	transporting,	mitochondrial	Fo	complex	subunit	C1	(subunit	9) 3
5719 PSMD13 proteasome	26S	subunit,	non-ATPase	13 3
1212 CLTB clathrin	light	chain	B 3
8882 ZPR1 ZPR1	zinc	finger 3
10430 TMEM147 transmembrane	protein	147 3
10534 SSSCA1 Sjogren	syndrome/scleroderma	autoantigen	1 3
8664 EIF3D eukaryotic	translation	initiation	factor	3	subunit	D 3
79572 ATP13A3 ATPase	13A3 3
10452 TOMM40 translocase	of	outer	mitochondrial	membrane	40 3
3615 IMPDH2 inosine	monophosphate	dehydrogenase	2 3
85476 GFM1 G	elongation	factor	mitochondrial	1 3
10575 CCT4 chaperonin	containing	TCP1	subunit	4 3
2184 FAH fumarylacetoacetate	hydrolase 3
201161 CENPV centromere	protein	V 3
121053 C12orf45 chromosome	12	open	reading	frame	45 3
5198 PFAS phosphoribosylformylglycinamidine	synthase 3
113419 TEX261 testis	expressed	261 3
3308 HSPA4 heat	shock	protein	family	A	(Hsp70)	member	4 3
9654 TTLL4 tubulin	tyrosine	ligase	like	4 3
23 ABCF1 ATP	binding	cassette	subfamily	F	member	1 3
4171 MCM2 minichromosome	maintenance	complex	component	2 3
9929 JOSD1 Josephin	domain	containing	1 3
949 SCARB1 scavenger	receptor	class	B	member	1 3
192111 PGAM5 PGAM	family	member	5,	mitochondrial	serine/threonine	protein	phosphatase 3
23277 CLUH clustered	mitochondria	homolog 3
27042 DIEXF digestive	organ	expansion	factor	homolog	(zebrafish) 3
10155 TRIM28 tripartite	motif	containing	28 3
54919 DNAAF5 dynein	axonemal	assembly	factor	5 3
7517 XRCC3 X-ray	repair	cross	complementing	3 3
4174 MCM5 minichromosome	maintenance	complex	component	5 3
84817 TXNDC17 thioredoxin	domain	containing	17 3
5434 POLR2E RNA	polymerase	II	subunit	E 3
9146 HGS hepatocyte	growth	factor-regulated	tyrosine	kinase	substrate 3
79709 COLGALT1 collagen	beta(1-O)galactosyltransferase	1 3
2802 GOLGA3 golgin	A3 3
2706 GJB2 gap	junction	protein	beta	2 3
55120 FANCL Fanconi	anemia	complementation	group	L 3
25885 POLR1A RNA	polymerase	I	subunit	A 3
54107 POLE3 DNA	polymerase	epsilon	3,	accessory	subunit 3
57464 STRIP2 striatin	interacting	protein	2 3
1848 DUSP6 dual	specificity	phosphatase	6 3
154807 VKORC1L1 vitamin	K	epoxide	reductase	complex	subunit	1	like	1 3
127396 ZNF684 zinc	finger	protein	684 3
222229 LRWD1 leucine	rich	repeats	and	WD	repeat	domain	containing	1 3
351 APP amyloid	beta	precursor	protein 3
63932 CXorf56 chromosome	X	open	reading	frame	56 3
65108 MARCKSL1 MARCKS	like	1 3
23413 NCS1 neuronal	calcium	sensor	1 3
2963 GTF2F2 general	transcription	factor	IIF	subunit	2 3
548645 DNAJC25 DnaJ	heat	shock	protein	family	(Hsp40)	member	C25 3
56655 POLE4 DNA	polymerase	epsilon	4,	accessory	subunit 3
7532 YWHAG tyrosine	3-monooxygenase/tryptophan	5-monooxygenase	activation	protein	gamma 3
84326 METTL26 methyltransferase	like	26 3
51259 TMEM216 transmembrane	protein	216 3
8662 EIF3B eukaryotic	translation	initiation	factor	3	subunit	B 3
14 AAMP angio	associated	migratory	cell	protein 3
29893 PSMC3IP PSMC3	interacting	protein 3
55142 HAUS2 HAUS	augmin	like	complex	subunit	2 3
10204 NUTF2 nuclear	transport	factor	2 3
81620 CDT1 chromatin	licensing	and	DNA	replication	factor	1 3
11072 DUSP14 dual	specificity	phosphatase	14 3
10538 BATF basic	leucine	zipper	ATF-like	transcription	factor 3
1022 CDK7 cyclin	dependent	kinase	7 3
79080 CCDC86 coiled-coil	domain	containing	86 3
64979 MRPL36 mitochondrial	ribosomal	protein	L36 3
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112812 FDX1L ferredoxin	1	like 3
1642 DDB1 damage	specific	DNA	binding	protein	1 3
84262 PSMG3 proteasome	assembly	chaperone	3 3
55862 ECHDC1 ethylmalonyl-CoA	decarboxylase	1 3
64785 GINS3 GINS	complex	subunit	3 3
5438 POLR2I RNA	polymerase	II	subunit	I 3
286 ANK1 ankyrin	1 3
51534 VTA1 vesicle	trafficking	1 3
2717 GLA galactosidase	alpha 3
84916 UTP4 UTP4,	small	subunit	processome	component 3
64963 MRPS11 mitochondrial	ribosomal	protein	S11 3
6351 CCL4 C-C	motif	chemokine	ligand	4 3
79022 TMEM106C transmembrane	protein	106C 3
8395 PIP5K1B phosphatidylinositol-4-phosphate	5-kinase	type	1	beta 3
4809 SNU13 SNU13	homolog,	small	nuclear	ribonucleoprotein	(U4/U6.U5) 3
60673 ATG101 autophagy	related	101 3
29105 CFAP20 cilia	and	flagella	associated	protein	20 3
114971 PTPMT1 protein	tyrosine	phosphatase,	mitochondrial	1 3
27020 NPTN neuroplastin 3
10248 POP7 POP7	homolog,	ribonuclease	P/MRP	subunit 3
9775 EIF4A3 eukaryotic	translation	initiation	factor	4A3 3
79155 TNIP2 TNFAIP3	interacting	protein	2 3
1211 CLTA clathrin	light	chain	A 3
5693 PSMB5 proteasome	subunit	beta	5 3
7262 PHLDA2 pleckstrin	homology	like	domain	family	A	member	2 3
131566 DCBLD2 discoidin,	CUB	and	LCCL	domain	containing	2 3
29902 FAM216A family	with	sequence	similarity	216	member	A 3
51013 EXOSC1 exosome	component	1 3
27309 ZNF330 zinc	finger	protein	330 3
64983 MRPL32 mitochondrial	ribosomal	protein	L32 3
5036 PA2G4 proliferation-associated	2G4 3
51010 EXOSC3 exosome	component	3 3
147184 TMEM99 transmembrane	protein	99 3
60314 C12orf10 chromosome	12	open	reading	frame	10 3
79590 MRPL24 mitochondrial	ribosomal	protein	L24 3
154467 CCDC167 coiled-coil	domain	containing	167 3
483 ATP1B3 ATPase	Na+/K+	transporting	subunit	beta	3 3
282991 BLOC1S2 biogenesis	of	lysosomal	organelles	complex	1	subunit	2 3
10322 SMYD5 SMYD	family	member	5 3
4000 LMNA lamin	A/C 3
1497 CTNS cystinosin,	lysosomal	cystine	transporter 3
51073 MRPL4 mitochondrial	ribosomal	protein	L4 3
6449 SGTA small	glutamine	rich	tetratricopeptide	repeat	containing	alpha 3
10186 LHFP lipoma	HMGIC	fusion	partner 3
55847 CISD1 CDGSH	iron	sulfur	domain	1 3
25940 FAM98A family	with	sequence	similarity	98	member	A 3
9861 PSMD6 proteasome	26S	subunit,	non-ATPase	6 3
356 FASLG Fas	ligand 3
79077 DCTPP1 dCTP	pyrophosphatase	1 3
57514 ARHGAP31 Rho	GTPase	activating	protein	31 3
84259 DCUN1D5 defective	in	cullin	neddylation	1	domain	containing	5 3
1104 RCC1 regulator	of	chromosome	condensation	1 3
54555 DDX49 DEAD-box	helicase	49 3
84769 MPV17L2 MPV17	mitochondrial	inner	membrane	protein	like	2 3
119559 SFXN4 sideroflexin	4 3
55968 NSFL1C NSFL1	cofactor 3
3066 HDAC2 histone	deacetylase	2 3
1984 EIF5A eukaryotic	translation	initiation	factor	5A 3
4792 NFKBIA NFKB	inhibitor	alpha 3
7314 UBB ubiquitin	B 3
5704 PSMC4 proteasome	26S	subunit,	ATPase	4 3
125144 LRRC75A-AS1 LRRC75A	antisense	RNA	1 3
50486 G0S2 G0/G1	switch	2 3
54955 C1orf109 chromosome	1	open	reading	frame	109 3
25804 LSM4 LSM4	homolog,	U6	small	nuclear	RNA	and	mRNA	degradation	associated 3
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51021 MRPS16 mitochondrial	ribosomal	protein	S16 3
54475 NLE1 notchless	homolog	1 3
56915 EXOSC5 exosome	component	5 3
92579 G6PC3 glucose-6-phosphatase	catalytic	subunit	3 3
2590 GALNT2 polypeptide	N-acetylgalactosaminyltransferase	2 3
54663 WDR74 WD	repeat	domain	74 3
4201 MEA1 male-enhanced	antigen	1 3
3558 IL2 interleukin	2 3
5250 SLC25A3 solute	carrier	family	25	member	3 3
1844 DUSP2 dual	specificity	phosphatase	2 3
5326 PLAGL2 PLAG1	like	zinc	finger	2 3
83596 BCL2L12 BCL2	like	12 3
84285 EIF1AD eukaryotic	translation	initiation	factor	1A	domain	containing 3
5245 PHB prohibitin 3
27351 DESI1 desumoylating	isopeptidase	1 3
5902 RANBP1 RAN	binding	protein	1 3
54982 CLN6 ceroid-lipofuscinosis,	neuronal	6,	late	infantile,	variant 3
5725 PTBP1 polypyrimidine	tract	binding	protein	1 3
30000 TNPO2 transportin	2 3
51144 HSD17B12 hydroxysteroid	17-beta	dehydrogenase	12 3
5552 SRGN serglycin 3
5251 PHEX phosphate	regulating	endopeptidase	homolog,	X-linked 3
4953 ODC1 ornithine	decarboxylase	1 3
8740 TNFSF14 tumor	necrosis	factor	superfamily	member	14 3
6723 SRM spermidine	synthase 3
55352 COPRS coordinator	of	PRMT5	and	differentiation	stimulator 3
7866 IFRD2 interferon	related	developmental	regulator	2 3
23076 RRP1B ribosomal	RNA	processing	1B 3
112464 PRKCDBP protein	kinase	C	delta	binding	protein 3
66005 CHID1 chitinase	domain	containing	1 3
388962 BOLA3 bolA	family	member	3 3
7293 TNFRSF4 TNF	receptor	superfamily	member	4 3
4927 NUP88 nucleoporin	88 3
3002 GZMB granzyme	B 3
3559 IL2RA interleukin	2	receptor	subunit	alpha 3
79033 ERI3 ERI1	exoribonuclease	family	member	3 3
494143 CHAC2 ChaC	cation	transport	regulator	homolog	2 3
84833 USMG5 up-regulated	during	skeletal	muscle	growth	5	homolog	(mouse) 3
7283 TUBG1 tubulin	gamma	1 3
51371 POMP proteasome	maturation	protein 3
51605 TRMT6 tRNA	methyltransferase	6 3
54865 GPATCH4 G-patch	domain	containing	4 3
219927 MRPL21 mitochondrial	ribosomal	protein	L21 3
2091 FBL fibrillarin 3
5695 PSMB7 proteasome	subunit	beta	7 3
1460 CSNK2B casein	kinase	2	beta 3
7965 AIMP2 aminoacyl	tRNA	synthetase	complex	interacting	multifunctional	protein	2 3
200916 RPL22L1 ribosomal	protein	L22	like	1 3
4700 NDUFA6 NADH:ubiquinone	oxidoreductase	subunit	A6 3
10549 PRDX4 peroxiredoxin	4 3
84807 NFKBID NFKB	inhibitor	delta 3
2288 FKBP4 FK506	binding	protein	4 3
3276 PRMT1 protein	arginine	methyltransferase	1 3
60488 MRPS35 mitochondrial	ribosomal	protein	S35 3
23481 PES1 pescadillo	ribosomal	biogenesis	factor	1 3
196383 RILPL2 Rab	interacting	lysosomal	protein	like	2 3
2224 FDPS farnesyl	diphosphate	synthase 3
55003 PAK1IP1 PAK1	interacting	protein	1 3
126382 NR2C2AP nuclear	receptor	2C2	associated	protein 3
51504 TRMT112 tRNA	methyltransferase	11-2	homolog	(S.	cerevisiae) 3
92609 TIMM50 translocase	of	inner	mitochondrial	membrane	50 3
708 C1QBP complement	C1q	binding	protein 3
10327 AKR1A1 aldo-keto	reductase	family	1	member	A1 3
6921 TCEB1 transcription	elongation	factor	B	subunit	1 3
26517 TIMM13 translocase	of	inner	mitochondrial	membrane	13 3
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84313 VPS25 vacuolar	protein	sorting	25	homolog 3
63875 MRPL17 mitochondrial	ribosomal	protein	L17 3
5435 POLR2F RNA	polymerase	II	subunit	F 3
79833 GEMIN6 gem	nuclear	organelle	associated	protein	6 3
1736 DKC1 dyskerin	pseudouridine	synthase	1 3
23560 GTPBP4 GTP	binding	protein	4 3
7371 UCK2 uridine-cytidine	kinase	2 3
3182 HNRNPAB heterogeneous	nuclear	ribonucleoprotein	A/B 3
4691 NCL nucleolin 3
56902 PNO1 partner	of	NOB1	homolog 3
3313 HSPA9 heat	shock	protein	family	A	(Hsp70)	member	9 3
1019 CDK4 cyclin	dependent	kinase	4 3
5901 RAN RAN,	member	RAS	oncogene	family 3
10528 NOP56 NOP56	ribonucleoprotein 3
29015 SLC43A3 solute	carrier	family	43	member	3 3
25819 NOCT nocturnin 3
26230 TIAM2 T-cell	lymphoma	invasion	and	metastasis	2 3
10969 EBNA1BP2 EBNA1	binding	protein	2 3
10135 NAMPT nicotinamide	phosphoribosyltransferase 3
10196 PRMT3 protein	arginine	methyltransferase	3 3
6626 SNRPA small	nuclear	ribonucleoprotein	polypeptide	A 3
8668 EIF3I eukaryotic	translation	initiation	factor	3	subunit	I 3
113174 SAAL1 serum	amyloid	A	like	1 3
54984 PINX1 PIN2/TERF1	interacting,	telomerase	inhibitor	1 3
6636 SNRPF small	nuclear	ribonucleoprotein	polypeptide	F 3
5052 PRDX1 peroxiredoxin	1 3
51493 RTCB RNA	2',3'-cyclic	phosphate	and	5'-OH	ligase 3
3608 ILF2 interleukin	enhancer	binding	factor	2 3
11091 WDR5 WD	repeat	domain	5 3
10056 FARSB phenylalanyl-tRNA	synthetase	beta	subunit 3
10492 SYNCRIP synaptotagmin	binding	cytoplasmic	RNA	interacting	protein 3
8061 FOSL1 FOS	like	1,	AP-1	transcription	factor	subunit 3
3329 HSPD1 heat	shock	protein	family	D	(Hsp60)	member	1 3
9221 NOLC1 nucleolar	and	coiled-body	phosphoprotein	1 3
6631 SNRPC small	nuclear	ribonucleoprotein	polypeptide	C 3
7416 VDAC1 voltage	dependent	anion	channel	1 3
1647 GADD45A growth	arrest	and	DNA	damage	inducible	alpha 3
3605 IL17A interleukin	17A 3
617 BCS1L BCS1	homolog,	ubiquinol-cytochrome	c	reductase	complex	chaperone 3
93436 ARMC6 armadillo	repeat	containing	6 3
10227 MFSD10 major	facilitator	superfamily	domain	containing	10 3
55624 POMGNT1 protein	O-linked	mannose	N-acetylglucosaminyltransferase	1	(beta	1,2-) 3
64768 IPPK inositol-pentakisphosphate	2-kinase 3
126321 MFSD12 major	facilitator	superfamily	domain	containing	12 3
8192 CLPP caseinolytic	mitochondrial	matrix	peptidase	proteolytic	subunit 3
84300 UQCC2 ubiquinol-cytochrome	c	reductase	complex	assembly	factor	2 3
10244 RABEPK Rab9	effector	protein	with	kelch	motifs 3
57819 LSM2 LSM2	homolog,	U6	small	nuclear	RNA	and	mRNA	degradation	associated 3
28958 COA3 cytochrome	c	oxidase	assembly	factor	3 3
2109 ETFB electron	transfer	flavoprotein	beta	subunit 3
11266 DUSP12 dual	specificity	phosphatase	12 3
51474 LIMA1 LIM	domain	and	actin	binding	1 3
4731 NDUFV3 NADH:ubiquinone	oxidoreductase	subunit	V3 3
4701 NDUFA7 NADH:ubiquinone	oxidoreductase	subunit	A7 3
9238 TBRG4 transforming	growth	factor	beta	regulator	4 3
29080 CCDC59 coiled-coil	domain	containing	59 3
29985 SLC39A3 solute	carrier	family	39	member	3 3
1537 CYC1 cytochrome	c1 3
8784 TNFRSF18 TNF	receptor	superfamily	member	18 3
9526 MPDU1 mannose-P-dolichol	utilization	defect	1 3
26121 PRPF31 pre-mRNA	processing	factor	31 3
977 CD151 CD151	molecule	(Raph	blood	group) 3
83460 EMC6 ER	membrane	protein	complex	subunit	6 3
64960 MRPS15 mitochondrial	ribosomal	protein	S15 3
2950 GSTP1 glutathione	S-transferase	pi	1 3
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112939 NACC1 nucleus	accumbens	associated	1 3
51293 CD320 CD320	molecule 3
5119 CHMP1A charged	multivesicular	body	protein	1A 3
8886 DDX18 DEAD-box	helicase	18 3
8818 DPM2 dolichyl-phosphate	mannosyltransferase	subunit	2,	regulatory 3
26519 TIMM10 translocase	of	inner	mitochondrial	membrane	10	homolog	(yeast) 3
4236 MFAP1 microfibrillar	associated	protein	1 3
5214 PFKP phosphofructokinase,	platelet 3
79894 ZNF672 zinc	finger	protein	672 3
51116 MRPS2 mitochondrial	ribosomal	protein	S2 3
29950 SERTAD1 SERTA	domain	containing	1 3
23399 CTDNEP1 CTD	nuclear	envelope	phosphatase	1 3
54881 TEX10 testis	expressed	10 3
10245 TIMM17B translocase	of	inner	mitochondrial	membrane	17	homolog	B	(yeast) 3
51236 HGH1 HGH1	homolog 3
55697 VAC14 Vac14,	PIKFYVE	complex	component 3
27183 VPS4A vacuolar	protein	sorting	4	homolog	A 3
5394 EXOSC10 exosome	component	10 3
55157 DARS2 aspartyl-tRNA	synthetase	2,	mitochondrial 3
3726 JUNB JunB	proto-oncogene,	AP-1	transcription	factor	subunit 3
3281 HSBP1 heat	shock	factor	binding	protein	1 3
55658 RNF126 ring	finger	protein	126 3
9455 HOMER2 homer	scaffolding	protein	2 3
345630 FBLL1 fibrillarin-like	1 3
29923 HILPDA hypoxia	inducible	lipid	droplet	associated 3
54968 TMEM70 transmembrane	protein	70 3
84002 B3GNT5 UDP-GlcNAc:betaGal	beta-1,3-N-acetylglucosaminyltransferase	5 3
10573 MRPL28 mitochondrial	ribosomal	protein	L28 3
55168 MRPS18A mitochondrial	ribosomal	protein	S18A 3
4817 NIT1 nitrilase	1 3
7247 TSN translin 3
54148 MRPL39 mitochondrial	ribosomal	protein	L39 3
29100 TMEM208 transmembrane	protein	208 3
9326 ZNHIT3 zinc	finger	HIT-type	containing	3 3
5682 PSMA1 proteasome	subunit	alpha	1 3
64708 COPS7B COP9	signalosome	subunit	7B 3
6415 SELENOW selenoprotein	W 3
10069 RWDD2B RWD	domain	containing	2B 3
54840 APTX aprataxin 3
112495 GTF3C6 general	transcription	factor	IIIC	subunit	6 3
10102 TSFM Ts	translation	elongation	factor,	mitochondrial 3
29097 CNIH4 cornichon	family	AMPA	receptor	auxiliary	protein	4 3
9391 CIAO1 cytosolic	iron-sulfur	assembly	component	1 3
221143 EEF1AKMT1 eukaryotic	translation	elongation	factor	1	alpha	lysine	methyltransferase	1 3
4116 MAGOH mago	homolog,	exon	junction	complex	core	component 3
54887 UHRF1BP1 UHRF1	binding	protein	1 3
128553 TSHZ2 teashirt	zinc	finger	homeobox	2 3
9088 PKMYT1 protein	kinase,	membrane	associated	tyrosine/threonine	1 3
51154 MRTO4 MRT4	homolog,	ribosome	maturation	factor 3
10131 TRAP1 TNF	receptor	associated	protein	1 3
63933 MCUR1 mitochondrial	calcium	uniporter	regulator	1 3
10212 DDX39A DEAD-box	helicase	39A 3
51714 SELENOT selenoprotein	T 3
4191 MDH2 malate	dehydrogenase	2 3
10498 CARM1 coactivator	associated	arginine	methyltransferase	1 3
5817 PVR poliovirus	receptor 3
80764 THAP7 THAP	domain	containing	7 3
2193 FARSA phenylalanyl-tRNA	synthetase	alpha	subunit 3
7284 TUFM Tu	translation	elongation	factor,	mitochondrial 3
5426 POLE DNA	polymerase	epsilon,	catalytic	subunit 3
5962 RDX radixin 3
10785 WDR4 WD	repeat	domain	4 3
27101 CACYBP calcyclin	binding	protein 3
23291 FBXW11 F-box	and	WD	repeat	domain	containing	11 3
2632 GBE1 1,4-alpha-glucan	branching	enzyme	1 3
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84172 POLR1B RNA	polymerase	I	subunit	B 3
55324 ABCF3 ATP	binding	cassette	subfamily	F	member	3 3
60625 DHX35 DEAH-box	helicase	35 3
8815 BANF1 barrier	to	autointegration	factor	1 3
9937 DCLRE1A DNA	cross-link	repair	1A 3
10980 COPS6 COP9	signalosome	subunit	6 3
27069 GHITM growth	hormone	inducible	transmembrane	protein 3
2827 GPR3 G	protein-coupled	receptor	3 3
5432 POLR2C RNA	polymerase	II	subunit	C 3
7458 EIF4H eukaryotic	translation	initiation	factor	4H 3
51499 TRIAP1 TP53	regulated	inhibitor	of	apoptosis	1 3
5781 PTPN11 protein	tyrosine	phosphatase,	non-receptor	type	11 3
53 ACP2 acid	phosphatase	2,	lysosomal 3
653122 LSM12P1 LSM12	pseudogene	1 3
94081 SFXN1 sideroflexin	1 3
8125 ANP32A acidic	nuclear	phosphoprotein	32	family	member	A 3
3312 HSPA8 heat	shock	protein	family	A	(Hsp70)	member	8 3
54994 GID8 GID	complex	subunit	8	homolog 3
8898 MTMR2 myotubularin	related	protein	2 3
5905 RANGAP1 Ran	GTPase	activating	protein	1 3
23141 ANKLE2 ankyrin	repeat	and	LEM	domain	containing	2 3
196483 EEF2KMT eukaryotic	elongation	factor	2	lysine	methyltransferase 3
65083 NOL6 nucleolar	protein	6 3
51001 MTERF3 mitochondrial	transcription	termination	factor	3 3
51537 MTFP1 mitochondrial	fission	process	1 3
64065 PERP PERP,	TP53	apoptosis	effector 3
6428 SRSF3 serine	and	arginine	rich	splicing	factor	3 3
60592 SCOC short	coiled-coil	protein 3
58477 SRPRB SRP	receptor	beta	subunit 3
51015 ISOC1 isochorismatase	domain	containing	1 3
3838 KPNA2 karyopherin	subunit	alpha	2 3
2553 GABPB1 GA	binding	protein	transcription	factor	beta	subunit	1 3
57486 NLN neurolysin 3
10130 PDIA6 protein	disulfide	isomerase	family	A	member	6 3
65008 MRPL1 mitochondrial	ribosomal	protein	L1 3
133957 CCDC127 coiled-coil	domain	containing	127 3
131474 CHCHD4 coiled-coil-helix-coiled-coil-helix	domain	containing	4 3
65265 C8orf33 chromosome	8	open	reading	frame	33 3
10440 TIMM17A translocase	of	inner	mitochondrial	membrane	17	homolog	A	(yeast) 3
27292 DIMT1 DIM1	dimethyladenosine	transferase	1	homolog 3
7336 UBE2V2 ubiquitin	conjugating	enzyme	E2	V2 3
80746 TSEN2 tRNA	splicing	endonuclease	subunit	2 3
8914 TIMELESS timeless	circadian	clock 3
2665 GDI2 GDP	dissociation	inhibitor	2 3
83877 TM2D2 TM2	domain	containing	2 3
2618 GART
phosphoribosylglycinamide	formyltransferase,	phosphoribosylglycinamide	synthetase,	
phosphoribosylaminoimidazole	synthetase 3
81034 SLC25A32 solute	carrier	family	25	member	32 3
29088 MRPL15 mitochondrial	ribosomal	protein	L15 3
56647 BCCIP BRCA2	and	CDKN1A	interacting	protein 3
10935 PRDX3 peroxiredoxin	3 3
5464 PPA1 pyrophosphatase	(inorganic)	1 3
55226 NAT10 N-acetyltransferase	10 3
27349 MCAT malonyl-CoA-acyl	carrier	protein	transacylase 3
11335 CBX3 chromobox	3 3
1267 CNP 2',3'-cyclic	nucleotide	3'	phosphodiesterase 3
28998 MRPL13 mitochondrial	ribosomal	protein	L13 3
6945 MLX MLX,	MAX	dimerization	protein 3
23203 PMPCA peptidase,	mitochondrial	processing	alpha	subunit 3
4190 MDH1 malate	dehydrogenase	1 3
84790 TUBA1C tubulin	alpha	1c 3
54997 TESC tescalcin 3
153443 SRFBP1 serum	response	factor	binding	protein	1 3
55164 SHQ1 SHQ1,	H/ACA	ribonucleoprotein	assembly	factor 3
8939 FUBP3 far	upstream	element	binding	protein	3 3
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84991 RBM17 RNA	binding	motif	protein	17 3
26354 GNL3 G	protein	nucleolar	3 3
84154 RPF2 ribosome	production	factor	2	homolog 3
10946 SF3A3 splicing	factor	3a	subunit	3 3
8727 CTNNAL1 catenin	alpha	like	1 3
100287932 TIMM23 translocase	of	inner	mitochondrial	membrane	23 3
7027 TFDP1 transcription	factor	Dp-1 3
55775 TDP1 tyrosyl-DNA	phosphodiesterase	1 3
4723 NDUFV1 NADH:ubiquinone	oxidoreductase	core	subunit	V1 3
9352 TXNL1 thioredoxin	like	1 3
84541 KBTBD8 kelch	repeat	and	BTB	domain	containing	8 3
10563 CXCL13 C-X-C	motif	chemokine	ligand	13 3
5796 PTPRK protein	tyrosine	phosphatase,	receptor	type	K 3
10940 POP1 POP1	homolog,	ribonuclease	P/MRP	subunit 3
9818 NUP58 nucleoporin	58 3
8602 NOP14 NOP14	nucleolar	protein 3
10606 PAICS
phosphoribosylaminoimidazole	carboxylase;	
phosphoribosylaminoimidazolesuccinocarboxamide	synthase 3
10963 STIP1 stress	induced	phosphoprotein	1 3
51018 RRP15 ribosomal	RNA	processing	15	homolog 3
284098 PIGW phosphatidylinositol	glycan	anchor	biosynthesis	class	W 3
8661 EIF3A eukaryotic	translation	initiation	factor	3	subunit	A 3
79731 NARS2 asparaginyl-tRNA	synthetase	2,	mitochondrial	(putative) 3
54806 AHI1 Abelson	helper	integration	site	1 3
55326 AGPAT5 1-acylglycerol-3-phosphate	O-acyltransferase	5 3
9277 WDR46 WD	repeat	domain	46 3
34 ACADM acyl-CoA	dehydrogenase,	C-4	to	C-12	straight	chain 3
9933 PUM3 pumilio	RNA	binding	family	member	3 3
3183 HNRNPC heterogeneous	nuclear	ribonucleoprotein	C	(C1/C2) 3
3609 ILF3 interleukin	enhancer	binding	factor	3 3
8847 DLEU2 deleted	in	lymphocytic	leukemia	2	(non-protein	coding) 3
84444 DOT1L DOT1	like	histone	lysine	methyltransferase 3
79728 PALB2 partner	and	localizer	of	BRCA2 3
7675 ZNF121 zinc	finger	protein	121 3
3190 HNRNPK heterogeneous	nuclear	ribonucleoprotein	K 3
54928 IMPAD1 inositol	monophosphatase	domain	containing	1 3
55055 ZWILCH zwilch	kinetochore	protein 3
51649 MRPS23 mitochondrial	ribosomal	protein	S23 3
6432 SRSF7 serine	and	arginine	rich	splicing	factor	7 3
9689 BZW1 basic	leucine	zipper	and	W2	domains	1 3
57122 NUP107 nucleoporin	107 3
55839 CENPN centromere	protein	N 3
7337 UBE3A ubiquitin	protein	ligase	E3A 3
7520 XRCC5 X-ray	repair	cross	complementing	5 3
29843 SENP1 SUMO1/sentrin	specific	peptidase	1 3
5981 RFC1 replication	factor	C	subunit	1 3
87 ACTN1 actinin	alpha	1 3
92162 TMEM88 transmembrane	protein	88 3
10951 CBX1 chromobox	1 3
2821 GPI glucose-6-phosphate	isomerase 3
79931 TNIP3 TNFAIP3	interacting	protein	3 3
54512 EXOSC4 exosome	component	4 3
8682 PEA15 phosphoprotein	enriched	in	astrocytes	15 3
5033 P4HA1 prolyl	4-hydroxylase	subunit	alpha	1 3
80762 NDFIP1 Nedd4	family	interacting	protein	1 3
10262 SF3B4 splicing	factor	3b	subunit	4 3
5230 PGK1 phosphoglycerate	kinase	1 3
7334 UBE2N ubiquitin	conjugating	enzyme	E2	N 3
143279 HECTD2 HECT	domain	E3	ubiquitin	protein	ligase	2 3
440093 H3F3C H3	histone	family	member	3C 3
760 CA2 carbonic	anhydrase	2 3
6621 SNAPC4 small	nuclear	RNA	activating	complex	polypeptide	4 3
4678 NASP nuclear	autoantigenic	sperm	protein 3
339448 C1orf174 chromosome	1	open	reading	frame	174 3
8099 CDK2AP1 cyclin	dependent	kinase	2	associated	protein	1 3
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2968 GTF2H4 general	transcription	factor	IIH	subunit	4 3
64928 MRPL14 mitochondrial	ribosomal	protein	L14 3
51651 PTRH2 peptidyl-tRNA	hydrolase	2 3
23583 SMUG1 single-strand-selective	monofunctional	uracil-DNA	glycosylase	1 3
7295 TXN thioredoxin 3
2017 CTTN cortactin 3
8493 PPM1D protein	phosphatase,	Mg2+/Mn2+	dependent	1D 3
10813 UTP14A UTP14A	small	subunit	processome	component 3
84267 C9orf64 chromosome	9	open	reading	frame	64 3
55276 PGM2 phosphoglucomutase	2 3
54606 DDX56 DEAD-box	helicase	56 3
130367 SGPP2 sphingosine-1-phosphate	phosphatase	2 3
1317 SLC31A1 solute	carrier	family	31	member	1 3
11333 PDAP1 PDGFA	associated	protein	1 3
51020 HDDC2 HD	domain	containing	2 3
23512 SUZ12 SUZ12	polycomb	repressive	complex	2	subunit 3
9927 MFN2 mitofusin	2 3
84365 NIFK nucleolar	protein	interacting	with	the	FHA	domain	of	MKI67 3
80742 PRR3 proline	rich	3 3
10557 RPP38 ribonuclease	P/MRP	subunit	p38 3
26589 MRPL46 mitochondrial	ribosomal	protein	L46 3
51491 NOP16 NOP16	nucleolar	protein 3
10899 JTB jumping	translocation	breakpoint 3
51218 GLRX5 glutaredoxin	5 3
11331 PHB2 prohibitin	2 3
10195 ALG3 ALG3,	alpha-1,3-	mannosyltransferase 3
6503 SLA Src-like-adaptor 3
65993 MRPS34 mitochondrial	ribosomal	protein	S34 3
6364 CCL20 C-C	motif	chemokine	ligand	20 3
7551 ZNF3 zinc	finger	protein	3 4
53405 CLIC5 chloride	intracellular	channel	5 4
130589 GALM galactose	mutarotase 4
8574 AKR7A2 aldo-keto	reductase	family	7	member	A2 4
29062 WDR91 WD	repeat	domain	91 4
6051 RNPEP arginyl	aminopeptidase 4
688 KLF5 Kruppel	like	factor	5 4
10620 ARID3B AT-rich	interaction	domain	3B 4
144195 SLC2A14 solute	carrier	family	2	member	14 4
10475 TRIM38 tripartite	motif	containing	38 4
90529 STPG1 sperm	tail	PG-rich	repeat	containing	1 4
6195 RPS6KA1 ribosomal	protein	S6	kinase	A1 4
864 RUNX3 runt	related	transcription	factor	3 4
10474 TADA3 transcriptional	adaptor	3 4
90589 ZNF625 zinc	finger	protein	625 4
84941 HSH2D hematopoietic	SH2	domain	containing 4
127943 FCRLB Fc	receptor	like	B 4
54894 RNF43 ring	finger	protein	43 4
64121 RRAGC Ras	related	GTP	binding	C 4
347732 CATSPER3 cation	channel	sperm	associated	3 4
54914 FOCAD focadhesin 4
90488 TMEM263 transmembrane	protein	263 4
339201 ASB16-AS1 ASB16	antisense	RNA	1 4
4641 MYO1C myosin	IC 4
92014 SLC25A51 solute	carrier	family	25	member	51 4
5871 MAP4K2 mitogen-activated	protein	kinase	kinase	kinase	kinase	2 4
27010 TPK1 thiamin	pyrophosphokinase	1 4
2043 EPHA4 EPH	receptor	A4 4
4603 MYBL1 MYB	proto-oncogene	like	1 4
83988 NCALD neurocalcin	delta 4
79158 GNPTAB N-acetylglucosamine-1-phosphate	transferase	alpha	and	beta	subunits 4
57646 USP28 ubiquitin	specific	peptidase	28 4
23403 FBXO46 F-box	protein	46 4
11059 WWP1 WW	domain	containing	E3	ubiquitin	protein	ligase	1 4
7700 ZNF141 zinc	finger	protein	141 4
5311 PKD2 polycystin	2,	transient	receptor	potential	cation	channel 4
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79627 OGFRL1 opioid	growth	factor	receptor	like	1 4
286827 TRIM59 tripartite	motif	containing	59 4
10902 BRD8 bromodomain	containing	8 4
26269 FBXO8 F-box	protein	8 4
11153 FICD FIC	domain	containing 4
9846 GAB2 GRB2	associated	binding	protein	2 4
57580 PREX1 phosphatidylinositol-3,4,5-trisphosphate	dependent	Rac	exchange	factor	1 4
3248 HPGD hydroxyprostaglandin	dehydrogenase	15-(NAD) 4
133308 SLC9B2 solute	carrier	family	9	member	B2 4
55650 PIGV phosphatidylinositol	glycan	anchor	biosynthesis	class	V 4
168374 ZNF92 zinc	finger	protein	92 4
115426 UHRF2 ubiquitin	like	with	PHD	and	ring	finger	domains	2 4
100133211 LOC100133211 related	RAS	viral	(r-ras)	oncogene	homolog	2	pseudogene 4
2800 GOLGA1 golgin	A1 4
22858 ICK intestinal	cell	kinase 4
64005 MYO1G myosin	IG 4
54820 NDE1 nudE	neurodevelopment	protein	1 4
81602 CDADC1 cytidine	and	dCMP	deaminase	domain	containing	1 4
920 CD4 CD4	molecule 4
27013 CNPPD1 cyclin	Pas1/PHO80	domain	containing	1 4
84440 RAB11FIP4 RAB11	family	interacting	protein	4 4
9368 SLC9A3R1 SLC9A3	regulator	1 4
4798 NFRKB nuclear	factor	related	to	kappaB	binding	protein 4
154141 MBOAT1 membrane	bound	O-acyltransferase	domain	containing	1 4
5867 RAB4A RAB4A,	member	RAS	oncogene	family 4
54941 RNF125 ring	finger	protein	125 4
100131827 ZNF717 zinc	finger	protein	717 4
9814 SFI1 SFI1	centrin	binding	protein 4
55758 RCOR3 REST	corepressor	3 4
149840 C20orf196 chromosome	20	open	reading	frame	196 4
222068 TMED4 transmembrane	p24	trafficking	protein	4 4
84993 UBL7 ubiquitin	like	7 4
57493 HEG1 heart	development	protein	with	EGF	like	domains	1 4
652 BMP4 bone	morphogenetic	protein	4 4
6448 SGSH N-sulfoglucosamine	sulfohydrolase 4
5635 PRPSAP1 phosphoribosyl	pyrophosphate	synthetase	associated	protein	1 4
340061 TMEM173 transmembrane	protein	173 4
51164 DCTN4 dynactin	subunit	4 4
83986 FAM234A family	with	sequence	similarity	234	member	A 4
440515 ZNF506 zinc	finger	protein	506 4
2185 PTK2B protein	tyrosine	kinase	2	beta 4
9159 PCSK7 proprotein	convertase	subtilisin/kexin	type	7 4
148137 PROSER3 proline	and	serine	rich	3 4
84196 USP48 ubiquitin	specific	peptidase	48 4
2909 ARHGAP35 Rho	GTPase	activating	protein	35 4
10194 TSHZ1 teashirt	zinc	finger	homeobox	1 4
6482 ST3GAL1 ST3	beta-galactoside	alpha-2,3-sialyltransferase	1 4
165918 RNF168 ring	finger	protein	168 4
1027 CDKN1B cyclin	dependent	kinase	inhibitor	1B 4
162962 ZNF836 zinc	finger	protein	836 4
90233 ZNF551 zinc	finger	protein	551 4
58986 TMEM8A transmembrane	protein	8A 4
80017 C14orf159 chromosome	14	open	reading	frame	159 4
8707 B3GALT2 beta-1,3-galactosyltransferase	2 4
8717 TRADD TNFRSF1A	associated	via	death	domain 4
6293 VPS52 VPS52,	GARP	complex	subunit 4
54843 SYTL2 synaptotagmin	like	2 4
4126 MANBA mannosidase	beta 4
57589 RIC1 RIC1	homolog,	RAB6A	GEF	complex	partner	1 4
23233 EXOC6B exocyst	complex	component	6B 4
22898 DENND3 DENN	domain	containing	3 4
157638 FAM84B family	with	sequence	similarity	84	member	B 4
4644 MYO5A myosin	VA 4
51684 SUFU SUFU	negative	regulator	of	hedgehog	signaling 4
3956 LGALS1 galectin	1 4
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79695 GALNT12 polypeptide	N-acetylgalactosaminyltransferase	12 4
340252 ZNF680 zinc	finger	protein	680 4
8831 SYNGAP1 synaptic	Ras	GTPase	activating	protein	1 4
23625 FAM89B family	with	sequence	similarity	89	member	B 4
92979 MARCH9 membrane	associated	ring-CH-type	finger	9 4
9926 LPGAT1 lysophosphatidylglycerol	acyltransferase	1 4
23218 NBEAL2 neurobeachin	like	2 4
9975 NR1D2 nuclear	receptor	subfamily	1	group	D	member	2 4
11278 KLF12 Kruppel	like	factor	12 4
11184 MAP4K1 mitogen-activated	protein	kinase	kinase	kinase	kinase	1 4
9467 SH3BP5 SH3	domain	binding	protein	5 4
4084 MXD1 MAX	dimerization	protein	1 4
23370 ARHGEF18 Rho/Rac	guanine	nucleotide	exchange	factor	18 4
5295 PIK3R1 phosphoinositide-3-kinase	regulatory	subunit	1 4
90139 TSPAN18 tetraspanin	18 4
11238 CA5B carbonic	anhydrase	5B 4
440068 CARD17 caspase	recruitment	domain	family	member	17 4
994 CDC25B cell	division	cycle	25B 4
114804 RNF157 ring	finger	protein	157 4
84687 PPP1R9B protein	phosphatase	1	regulatory	subunit	9B 4
5732 PTGER2 prostaglandin	E	receptor	2 4
6693 SPN sialophorin 4
137835 TMEM71 transmembrane	protein	71 4
818 CAMK2G calcium/calmodulin	dependent	protein	kinase	II	gamma 4
2081 ERN1 endoplasmic	reticulum	to	nucleus	signaling	1 4
373156 GSTK1 glutathione	S-transferase	kappa	1 4
9938 ARHGAP25 Rho	GTPase	activating	protein	25 4
340547 VSIG1 V-set	and	immunoglobulin	domain	containing	1 4
6920 TCEA3 transcription	elongation	factor	A3 4
8635 RNASET2 ribonuclease	T2 4
114932 MRFAP1L1 Morf4	family	associated	protein	1	like	1 4
4615 MYD88 myeloid	differentiation	primary	response	88 4
5443 POMC proopiomelanocortin 4
10636 RGS14 regulator	of	G-protein	signaling	14 4
6536 SLC6A9 solute	carrier	family	6	member	9 4
10125 RASGRP1 RAS	guanyl	releasing	protein	1 4
441108 C5orf56 chromosome	5	open	reading	frame	56 4
51317 PHF21A PHD	finger	protein	21A 4
11214 AKAP13 A-kinase	anchoring	protein	13 4
2035 EPB41 erythrocyte	membrane	protein	band	4.1 4
10404 CPQ carboxypeptidase	Q 4
203328 SUSD3 sushi	domain	containing	3 4
4542 MYO1F myosin	IF 4
3587 IL10RA interleukin	10	receptor	subunit	alpha 4
80321 CEP70 centrosomal	protein	70 4
51135 IRAK4 interleukin	1	receptor	associated	kinase	4 4
54704 PDP1 pyruvate	dehyrogenase	phosphatase	catalytic	subunit	1 4
7096 TLR1 toll	like	receptor	1 4
57140 RNPEPL1 arginyl	aminopeptidase	like	1 4
79792 GSDMD gasdermin	D 4
2550 GABBR1 gamma-aminobutyric	acid	type	B	receptor	subunit	1 4
8519 IFITM1 interferon	induced	transmembrane	protein	1 4
3631 INPP4A inositol	polyphosphate-4-phosphatase	type	I	A 4
22900 CARD8 caspase	recruitment	domain	family	member	8 4
7799 PRDM2 PR/SET	domain	2 4
79865 TREML2 triggering	receptor	expressed	on	myeloid	cells	like	2 4
6311 ATXN2 ataxin	2 4
338799 LINC01089 long	intergenic	non-protein	coding	RNA	1089 4
1901 S1PR1 sphingosine-1-phosphate	receptor	1 4
4194 MDM4 MDM4,	p53	regulator 4
8737 RIPK1 receptor	interacting	serine/threonine	kinase	1 4
51185 CRBN cereblon 4
64108 RTP4 receptor	transporter	protein	4 4
23351 KHNYN KH	and	NYN	domain	containing 4
5899 RALB RAS	like	proto-oncogene	B 4
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100506334 LINC00649 long	intergenic	non-protein	coding	RNA	649 4
128338 DRAM2 DNA	damage	regulated	autophagy	modulator	2 4
283349 RASSF3 Ras	association	domain	family	member	3 4
222255 ATXN7L1 ataxin	7	like	1 4
409 ARRB2 arrestin	beta	2 4
9674 KIAA0040 KIAA0040 4
7360 UGP2 UDP-glucose	pyrophosphorylase	2 4
51246 SHISA5 shisa	family	member	5 4
9985 REC8 REC8	meiotic	recombination	protein 4
283130 SLC25A45 solute	carrier	family	25	member	45 4
59339 PLEKHA2 pleckstrin	homology	domain	containing	A2 4
10577 NPC2 NPC	intracellular	cholesterol	transporter	2 4
3120 HLA-DQB2 major	histocompatibility	complex,	class	II,	DQ	beta	2 4
54870 QRICH1 glutamine	rich	1 4
78991 PCYOX1L prenylcysteine	oxidase	1	like 4
64863 METTL4 methyltransferase	like	4 4
4240 MFGE8 milk	fat	globule-EGF	factor	8	protein 4
51439 FAM8A1 family	with	sequence	similarity	8	member	A1 4
10140 TOB1 transducer	of	ERBB2,	1 4
23484 LEPROTL1 leptin	receptor	overlapping	transcript-like	1 4
51292 GMPR2 guanosine	monophosphate	reductase	2 4
120224 TMEM45B transmembrane	protein	45B 4
9337 CNOT8 CCR4-NOT	transcription	complex	subunit	8 4
23582 CCNDBP1 cyclin	D1	binding	protein	1 4
284309 ZNF776 zinc	finger	protein	776 4
8440 NCK2 NCK	adaptor	protein	2 4
10581 IFITM2 interferon	induced	transmembrane	protein	2 4
51390 AIG1 androgen	induced	1 4
56477 CCL28 C-C	motif	chemokine	ligand	28 4
201627 DENND6A DENN	domain	containing	6A 4
101 ADAM8 ADAM	metallopeptidase	domain	8 4
10311 DSCR3 DSCR3	arrestin	fold	containing 4
156 GRK2 G	protein-coupled	receptor	kinase	2 4
55339 WDR33 WD	repeat	domain	33 4
90736 FAM104B family	with	sequence	similarity	104	member	B 4
64857 PLEKHG2 pleckstrin	homology	and	RhoGEF	domain	containing	G2 4
54813 KLHL28 kelch	like	family	member	28 4
140461 ASB8 ankyrin	repeat	and	SOCS	box	containing	8 4
81846 SBF2 SET	binding	factor	2 4
25943 C20orf194 chromosome	20	open	reading	frame	194 4
54868 TMEM104 transmembrane	protein	104 4
23171 GPD1L glycerol-3-phosphate	dehydrogenase	1-like 4
2745 GLRX glutaredoxin 4
54970 TTC12 tetratricopeptide	repeat	domain	12 4
84614 ZBTB37 zinc	finger	and	BTB	domain	containing	37 4
828 CAPS calcyphosine 4
1659 DHX8 DEAH-box	helicase	8 4
147694 ZNF548 zinc	finger	protein	548 4
26036 ZNF451 zinc	finger	protein	451 4
285550 FAM200B family	with	sequence	similarity	200	member	B 4
147658 ZNF534 zinc	finger	protein	534 4
147923 ZNF420 zinc	finger	protein	420 4
7536 SF1 splicing	factor	1 4
285596 FAM153A family	with	sequence	similarity	153	member	A 4
57452 GALNT16 polypeptide	N-acetylgalactosaminyltransferase	16 4
56339 METTL3 methyltransferase	like	3 4
100129842 ZNF737 zinc	finger	protein	737 4
124460 SNX20 sorting	nexin	20 4
51696 HECA hdc	homolog,	cell	cycle	regulator 4
6811 STX5 syntaxin	5 4
51643 TMBIM4 transmembrane	BAX	inhibitor	motif	containing	4 4
388650 FAM69A family	with	sequence	similarity	69	member	A 4
8027 STAM signal	transducing	adaptor	molecule 4
4850 CNOT4 CCR4-NOT	transcription	complex	subunit	4 4
4676 NAP1L4 nucleosome	assembly	protein	1	like	4 4
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7690 ZNF131 zinc	finger	protein	131 4
6789 STK4 serine/threonine	kinase	4 4
55634 KRBOX4 KRAB	box	domain	containing	4 4
63897 HEATR6 HEAT	repeat	containing	6 4
1374 CPT1A carnitine	palmitoyltransferase	1A 4
6402 SELL selectin	L 4
7592 ZNF41 zinc	finger	protein	41 4
372 ARCN1 archain	1 4
23451 SF3B1 splicing	factor	3b	subunit	1 4
163081 ZNF567 zinc	finger	protein	567 4
7381 UQCRB ubiquinol-cytochrome	c	reductase	binding	protein 4
6230 RPS25 ribosomal	protein	S25 4
83452 RAB33B RAB33B,	member	RAS	oncogene	family 4
56987 BBX BBX,	HMG-box	containing 4
9541 CIR1 corepressor	interacting	with	RBPJ,	1 4
9534 ZNF254 zinc	finger	protein	254 4
54986 ULK4 unc-51	like	kinase	4 4
64421 DCLRE1C DNA	cross-link	repair	1C 4
51531 TRMO tRNA	methyltransferase	O 4
114781 BTBD9 BTB	domain	containing	9 4
5150 PDE7A phosphodiesterase	7A 4
55729 ATF7IP activating	transcription	factor	7	interacting	protein 4
285343 TCAIM T-cell	activation	inhibitor,	mitochondrial 4
6671 SP4 Sp4	transcription	factor 4
9252 RPS6KA5 ribosomal	protein	S6	kinase	A5 4
64940 STAG3L4 stromal	antigen	3-like	4	(pseudogene) 4
10681 GNB5 G	protein	subunit	beta	5 4
3845 KRAS KRAS	proto-oncogene,	GTPase 4
54542 RC3H2 ring	finger	and	CCCH-type	domains	2 4
961 CD47 CD47	molecule 4
84084 RAB6C RAB6C,	member	RAS	oncogene	family 4
22883 CLSTN1 calsyntenin	1 4
3385 ICAM3 intercellular	adhesion	molecule	3 4
57533 TBC1D14 TBC1	domain	family	member	14 4
375743 PTAR1 protein	prenyltransferase	alpha	subunit	repeat	containing	1 4
3738 KCNA3 potassium	voltage-gated	channel	subfamily	A	member	3 4
9697 TRAM2 translocation	associated	membrane	protein	2 4
55296 TBC1D19 TBC1	domain	family	member	19 4
9873 FCHSD2 FCH	and	double	SH3	domains	2 4
105371242 LOC105371242 peptidyl-prolyl	cis-trans	isomerase	A-like	4C 4
643836 ZFP62 ZFP62	zinc	finger	protein 4
23161 SNX13 sorting	nexin	13 4
9197 SLC33A1 solute	carrier	family	33	member	1 4
1955 MEGF9 multiple	EGF	like	domains	9 4
57198 ATP8B2 ATPase	phospholipid	transporting	8B2 4
105372141 LOC105372141 uncharacterized	LOC105372141 4
9798 IST1 IST1,	ESCRT-III	associated	factor 4
54521 WDR44 WD	repeat	domain	44 4
57534 MIB1 mindbomb	E3	ubiquitin	protein	ligase	1 4
84124 ZNF394 zinc	finger	protein	394 4
25852 ARMC8 armadillo	repeat	containing	8 4
54739 XAF1 XIAP	associated	factor	1 4
8869 ST3GAL5 ST3	beta-galactoside	alpha-2,3-sialyltransferase	5 4
5027 P2RX7 purinergic	receptor	P2X	7 4
51 ACOX1 acyl-CoA	oxidase	1 4
9482 STX8 syntaxin	8 4
84079 ANKRD27 ankyrin	repeat	domain	27 4
10855 HPSE heparanase 4
23097 CDK19 cyclin	dependent	kinase	19 4
54149 C21orf91 chromosome	21	open	reading	frame	91 4
9258 MFHAS1 malignant	fibrous	histiocytoma	amplified	sequence	1 4
5613 PRKX protein	kinase,	X-linked 4
8237 USP11 ubiquitin	specific	peptidase	11 4
134553 C5orf24 chromosome	5	open	reading	frame	24 4
9913 SUPT7L SPT7-like	STAGA	complex	gamma	subunit 4
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64077 LHPP phospholysine	phosphohistidine	inorganic	pyrophosphate	phosphatase 4
28232 SLCO3A1 solute	carrier	organic	anion	transporter	family	member	3A1 4
51606 ATP6V1H ATPase	H+	transporting	V1	subunit	H 4
83541 FAM110A family	with	sequence	similarity	110	member	A 4
146857 SLFN13 schlafen	family	member	13 4
136895 C7orf31 chromosome	7	open	reading	frame	31 4
360023 ZBTB41 zinc	finger	and	BTB	domain	containing	41 4
56985 ADPRM ADP-ribose/CDP-alcohol	diphosphatase,	manganese	dependent 4
92799 SHKBP1 SH3KBP1	binding	protein	1 4
23199 GSE1 Gse1	coiled-coil	protein 4
259197 NCR3 natural	cytotoxicity	triggering	receptor	3 4
10299 MARCH6 membrane	associated	ring-CH-type	finger	6 4
1757 SARDH sarcosine	dehydrogenase 4
27005 USP21 ubiquitin	specific	peptidase	21 4
51244 CCDC174 coiled-coil	domain	containing	174 4
8573 CASK calcium/calmodulin	dependent	serine	protein	kinase 4
8603 FAM193A family	with	sequence	similarity	193	member	A 4
26043 UBXN7 UBX	domain	protein	7 4
57105 CYSLTR2 cysteinyl	leukotriene	receptor	2 4
55180 LINS1 lines	homolog	1 4
153642 ARSK arylsulfatase	family	member	K 4
91663 MYADM myeloid	associated	differentiation	marker 4
23131 GPATCH8 G-patch	domain	containing	8 4
11143 KAT7 lysine	acetyltransferase	7 4
23259 DDHD2 DDHD	domain	containing	2 4
148268 ZNF570 zinc	finger	protein	570 4
50809 HP1BP3 heterochromatin	protein	1	binding	protein	3 4
9991 PTBP3 polypyrimidine	tract	binding	protein	3 4
285513 GPRIN3 GPRIN	family	member	3 4
1859 DYRK1A dual	specificity	tyrosine	phosphorylation	regulated	kinase	1A 4
10513 APPBP2 amyloid	beta	precursor	protein	binding	protein	2 4
27252 KLHL20 kelch	like	family	member	20 4
374354 NHLRC2 NHL	repeat	containing	2 4
7159 TP53BP2 tumor	protein	p53	binding	protein	2 4
27018 BEX3 brain	expressed	X-linked	3 4
7433 VIPR1 vasoactive	intestinal	peptide	receptor	1 4
9946 CRYZL1 crystallin	zeta	like	1 4
23229 ARHGEF9 Cdc42	guanine	nucleotide	exchange	factor	9 4
286336 FAM78A family	with	sequence	similarity	78	member	A 4
6809 STX3 syntaxin	3 4
8776 MTMR1 myotubularin	related	protein	1 4
8545 CGGBP1 CGG	triplet	repeat	binding	protein	1 4
26136 TES testin	LIM	domain	protein 4
93594 TBC1D31 TBC1	domain	family	member	31 4
51281 ANKMY1 ankyrin	repeat	and	MYND	domain	containing	1 4
58486 ZBED5 zinc	finger	BED-type	containing	5 4
4253 MIA2 melanoma	inhibitory	activity	2 4
4170 MCL1 BCL2	family	apoptosis	regulator 4
2272 FHIT fragile	histidine	triad 4
10866 HCP5 HLA	complex	P5	(non-protein	coding) 4
57396 CLK4 CDC	like	kinase	4 4
171425 CLYBL citrate	lyase	beta	like 4
7248 TSC1 tuberous	sclerosis	1 4
129685 TAF8 TATA-box	binding	protein	associated	factor	8 4
22920 KIFAP3 kinesin	associated	protein	3 4
159091 FAM122C family	with	sequence	similarity	122C 4
25957 PNISR PNN	interacting	serine	and	arginine	rich	protein 4
91300 R3HDM4 R3H	domain	containing	4 4
51427 ZNF107 zinc	finger	protein	107 4
168850 ZNF800 zinc	finger	protein	800 4
2273 FHL1 four	and	a	half	LIM	domains	1 4
10392 NOD1 nucleotide	binding	oligomerization	domain	containing	1 4
1656 DDX6 DEAD-box	helicase	6 4
3991 LIPE lipase	E,	hormone	sensitive	type 4
91949 COG7 component	of	oligomeric	golgi	complex	7 4
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57120 GOPC golgi	associated	PDZ	and	coiled-coil	motif	containing 4
84911 ZNF382 zinc	finger	protein	382 4
125488 TTC39C tetratricopeptide	repeat	domain	39C 4
51752 ERAP1 endoplasmic	reticulum	aminopeptidase	1 4
222236 NAPEPLD N-acyl	phosphatidylethanolamine	phospholipase	D 4
54331 GNG2 G	protein	subunit	gamma	2 4
23248 RPRD2 regulation	of	nuclear	pre-mRNA	domain	containing	2 4
4940 OAS3 2'-5'-oligoadenylate	synthetase	3 4
2011 MARK2 microtubule	affinity	regulating	kinase	2 4
56882 CDC42SE1 CDC42	small	effector	1 4
23635 SSBP2 single	stranded	DNA	binding	protein	2 4
4149 MAX MYC	associated	factor	X 4
51199 NIN ninein 4
285195 SLC9A9 solute	carrier	family	9	member	A9 4
8473 OGT O-linked	N-acetylglucosamine	(GlcNAc)	transferase 4
285440 CYP4V2 cytochrome	P450	family	4	subfamily	V	member	2 4
9709 HERPUD1 homocysteine	inducible	ER	protein	with	ubiquitin	like	domain	1 4
54816 ZNF280D zinc	finger	protein	280D 4
26578 OSTF1 osteoclast	stimulating	factor	1 4
6815 STYX serine/threonine/tyrosine	interacting	protein 4
663 BNIP2 BCL2	interacting	protein	2 4
9779 TBC1D5 TBC1	domain	family	member	5 4
55773 TBC1D23 TBC1	domain	family	member	23 4
57185 NIPAL3 NIPA	like	domain	containing	3 4
23204 ARL6IP1 ADP	ribosylation	factor	like	GTPase	6	interacting	protein	1 4
8773 SNAP23 synaptosome	associated	protein	23 4
6303 SAT1 spermidine/spermine	N1-acetyltransferase	1 4
57560 IFT80 intraflagellar	transport	80 4
2948 GSTM4 glutathione	S-transferase	mu	4 4
3115 HLA-DPB1 major	histocompatibility	complex,	class	II,	DP	beta	1 4
79668 PARP8 poly(ADP-ribose)	polymerase	family	member	8 4
4707 NDUFB1 NADH:ubiquinone	oxidoreductase	subunit	B1 4
22901 ARSG arylsulfatase	G 4
84343 HPS3 HPS3,	biogenesis	of	lysosomal	organelles	complex	2	subunit	1 4
54407 SLC38A2 solute	carrier	family	38	member	2 4
50999 TMED5 transmembrane	p24	trafficking	protein	5 4
3958 LGALS3 galectin	3 4
64840 PORCN porcupine	homolog	(Drosophila) 4
5562 PRKAA1 protein	kinase	AMP-activated	catalytic	subunit	alpha	1 4
9039 UBA3 ubiquitin	like	modifier	activating	enzyme	3 4
57649 PHF12 PHD	finger	protein	12 4
90806 ANGEL2 angel	homolog	2 4
7581 ZNF33A zinc	finger	protein	33A 4
375248 ANKRD36 ankyrin	repeat	domain	36 4
8821 INPP4B inositol	polyphosphate-4-phosphatase	type	II	B 4
23613 ZMYND8 zinc	finger	MYND-type	containing	8 4
567 B2M beta-2-microglobulin 4
9666 DZIP3 DAZ	interacting	zinc	finger	protein	3 4
3459 IFNGR1 interferon	gamma	receptor	1 4
55285 RBM41 RNA	binding	motif	protein	41 4
201895 SMIM14 small	integral	membrane	protein	14 4
29058 TMEM230 transmembrane	protein	230 4
9958 USP15 ubiquitin	specific	peptidase	15 4
917 CD3G CD3g	molecule 4
10181 RBM5 RNA	binding	motif	protein	5 4
55788 LMBRD1 LMBR1	domain	containing	1 4
6814 STXBP3 syntaxin	binding	protein	3 4
1666 DECR1 2,4-dienoyl-CoA	reductase	1,	mitochondrial 4
51506 UFC1 ubiquitin-fold	modifier	conjugating	enzyme	1 4
6281 S100A10 S100	calcium	binding	protein	A10 4
28962 OSTM1 osteopetrosis	associated	transmembrane	protein	1 4
54677 CROT carnitine	O-octanoyltransferase 4
8799 PEX11B peroxisomal	biogenesis	factor	11	beta 4
1730 DIAPH2 diaphanous	related	formin	2 4
9694 EMC2 ER	membrane	protein	complex	subunit	2 4
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7181 NR2C1 nuclear	receptor	subfamily	2	group	C	member	1 4
51108 METTL9 methyltransferase	like	9 4
27141 CIDEB cell	death-inducing	DFFA-like	effector	b 4
64376 IKZF5 IKAROS	family	zinc	finger	5 4
7756 ZNF207 zinc	finger	protein	207 4
256471 MFSD8 major	facilitator	superfamily	domain	containing	8 4
3660 IRF2 interferon	regulatory	factor	2 4
64431 ACTR6 ARP6	actin-related	protein	6	homolog 4
79872 CBLL1 Cbl	proto-oncogene	like	1 4
337976 KRTAP20-2 keratin	associated	protein	20-2 4
51347 TAOK3 TAO	kinase	3 4
1998 ELF2 E74	like	ETS	transcription	factor	2 4
84236 RHBDD1 rhomboid	domain	containing	1 4
89978 DPH6 diphthamine	biosynthesis	6 4
8767 RIPK2 receptor	interacting	serine/threonine	kinase	2 4
79096 C11orf49 chromosome	11	open	reading	frame	49 4
5930 RBBP6 RB	binding	protein	6,	ubiquitin	ligase 4
645142 PPIAL4D peptidylprolyl	isomerase	A	like	4D 4
148867 SLC30A7 solute	carrier	family	30	member	7 4
145389 SLC38A6 solute	carrier	family	38	member	6 4
26115 TANC2 tetratricopeptide	repeat,	ankyrin	repeat	and	coiled-coil	containing	2 4
26515 TIMM10B translocase	of	inner	mitochondrial	membrane	10	homolog	B	(yeast) 4
10491 CRTAP cartilage	associated	protein 4
962 CD48 CD48	molecule 4
3128 HLA-DRB6 major	histocompatibility	complex,	class	II,	DR	beta	6	(pseudogene) 4
84333 PCGF5 polycomb	group	ring	finger	5 4
6301 SARS seryl-tRNA	synthetase 4
148362 BROX BRO1	domain	and	CAAX	motif	containing 4
51322 WAC WW	domain	containing	adaptor	with	coiled-coil 4
2060 EPS15 epidermal	growth	factor	receptor	pathway	substrate	15 4
64747 MFSD1 major	facilitator	superfamily	domain	containing	1 4
79745 CLIP4 CAP-Gly	domain	containing	linker	protein	family	member	4 4
84272 YIPF4 Yip1	domain	family	member	4 4
3163 HMOX2 heme	oxygenase	2 4
1521 CTSW cathepsin	W 4
85025 TMEM60 transmembrane	protein	60 4
56674 TMEM9B TMEM9	domain	family	member	B 4
3384 ICAM2 intercellular	adhesion	molecule	2 4
26061 HACL1 2-hydroxyacyl-CoA	lyase	1 4
27065 NSG1 neuron	specific	gene	family	member	1 4
29994 BAZ2B bromodomain	adjacent	to	zinc	finger	domain	2B 4
6643 SNX2 sorting	nexin	2 4
27240 SIT1 signaling	threshold	regulating	transmembrane	adaptor	1 4
3117 HLA-DQA1 major	histocompatibility	complex,	class	II,	DQ	alpha	1 4
27163 NAAA N-acylethanolamine	acid	amidase 4
84795 PYROXD2 pyridine	nucleotide-disulphide	oxidoreductase	domain	2 4
8667 EIF3H eukaryotic	translation	initiation	factor	3	subunit	H 4
254887 ZDHHC23 zinc	finger	DHHC-type	containing	23 4
124961 ZFP3 ZFP3	zinc	finger	protein 4
26071 FAM127B family	with	sequence	similarity	127	member	B 4
23149 FCHO1 FCH	domain	only	1 4
374395 TMEM179B transmembrane	protein	179B 4
3688 ITGB1 integrin	subunit	beta	1 4
4711 NDUFB5 NADH:ubiquinone	oxidoreductase	subunit	B5 4
9871 SEC24D SEC24	homolog	D,	COPII	coat	complex	component 4
56898 BDH2 3-hydroxybutyrate	dehydrogenase,	type	2 4
23585 TMEM50A transmembrane	protein	50A 4
3133 HLA-E major	histocompatibility	complex,	class	I,	E 4
124512 METTL23 methyltransferase	like	23 4
11000 SLC27A3 solute	carrier	family	27	member	3 4
126626 GABPB2 GA	binding	protein	transcription	factor	beta	subunit	2 4
257160 RNF214 ring	finger	protein	214 4
9649 RALGPS1 Ral	GEF	with	PH	domain	and	SH3	binding	motif	1 4
26273 FBXO3 F-box	protein	3 4
54509 RHOF ras	homolog	family	member	F,	filopodia	associated 4
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285093 RTP5 receptor	transporter	protein	5	(putative) 4
25793 FBXO7 F-box	protein	7 4
7770 ZNF227 zinc	finger	protein	227 4
85403 EAF1 ELL	associated	factor	1 4
4582 MUC1 mucin	1,	cell	surface	associated 4
1029 CDKN2A cyclin	dependent	kinase	inhibitor	2A 4
3717 JAK2 Janus	kinase	2 4
1992 SERPINB1 serpin	family	B	member	1 4
25821 MTO1 mitochondrial	tRNA	translation	optimization	1 4
51635 DHRS7 dehydrogenase/reductase	7 4
51747 LUC7L3 LUC7	like	3	pre-mRNA	splicing	factor 4
10628 TXNIP thioredoxin	interacting	protein 4
5533 PPP3CC protein	phosphatase	3	catalytic	subunit	gamma 4
5130 PCYT1A phosphate	cytidylyltransferase	1,	choline,	alpha 4
10219 KLRG1 killer	cell	lectin	like	receptor	G1 4
3127 HLA-DRB5 major	histocompatibility	complex,	class	II,	DR	beta	5 4
253461 ZBTB38 zinc	finger	and	BTB	domain	containing	38 4
80267 EDEM3 ER	degradation	enhancing	alpha-mannosidase	like	protein	3 4
149628 PYHIN1 pyrin	and	HIN	domain	family	member	1 4
55508 SLC35E3 solute	carrier	family	35	member	E3 4
89853 MVB12B multivesicular	body	subunit	12B 4
2313 FLI1 Fli-1	proto-oncogene,	ETS	transcription	factor 4
79591 C10orf76 chromosome	10	open	reading	frame	76 4
9204 ZMYM6 zinc	finger	MYM-type	containing	6 4
25975 EGFL6 EGF	like	domain	multiple	6 4
10039 PARP3 poly(ADP-ribose)	polymerase	family	member	3 4
54855 FAM46C family	with	sequence	similarity	46	member	C 4
171586 ABHD3 abhydrolase	domain	containing	3 4
55809 TRERF1 transcriptional	regulating	factor	1 4
115825 WDFY2 WD	repeat	and	FYVE	domain	containing	2 4
23059 CLUAP1 clusterin	associated	protein	1 4
79877 DCAKD dephospho-CoA	kinase	domain	containing 4
84273 NOA1 nitric	oxide	associated	1 4
4835 NQO2 NAD(P)H	quinone	dehydrogenase	2 4
283237 TTC9C tetratricopeptide	repeat	domain	9C 4
5797 PTPRM protein	tyrosine	phosphatase,	receptor	type	M 4
3820 KLRB1 killer	cell	lectin	like	receptor	B1 4
4217 MAP3K5 mitogen-activated	protein	kinase	kinase	kinase	5 4
64773 PCED1A PC-esterase	domain	containing	1A 4
2054 STX2 syntaxin	2 4
824 CAPN2 calpain	2 4
79577 CDC73 cell	division	cycle	73 4
3108 HLA-DMA major	histocompatibility	complex,	class	II,	DM	alpha 4
154075 SAMD3 sterile	alpha	motif	domain	containing	3 4
7905 REEP5 receptor	accessory	protein	5 4
199704 ZNF585A zinc	finger	protein	585A 4
88455 ANKRD13A ankyrin	repeat	domain	13A 4
6668 SP2 Sp2	transcription	factor 4
1604 CD55 CD55	molecule	(Cromer	blood	group) 4
64420 SUSD1 sushi	domain	containing	1 4
1235 CCR6 C-C	motif	chemokine	receptor	6 4
2838 GPR15 G	protein-coupled	receptor	15 4
440026 TMEM41B transmembrane	protein	41B 4
729230 CCR2 C-C	motif	chemokine	receptor	2 4
94101 ORMDL1 ORMDL	sphingolipid	biosynthesis	regulator	1 4
1075 CTSC cathepsin	C 4
90624 LYRM7 LYR	motif	containing	7 4
801 CALM1 calmodulin	1 4
55967 NDUFA12 NADH:ubiquinone	oxidoreductase	subunit	A12 4
8477 GPR65 G	protein-coupled	receptor	65 4
57544 TXNDC16 thioredoxin	domain	containing	16 4
1512 CTSH cathepsin	H 4
84902 CEP89 centrosomal	protein	89 4
7576 ZNF28 zinc	finger	protein	28 4
29116 MYLIP myosin	regulatory	light	chain	interacting	protein 4
		
148 
	
50808 AK3 adenylate	kinase	3 4
7289 TULP3 tubby	like	protein	3 4
6166 RPL36AL ribosomal	protein	L36a	like 4
54414 SIAE sialic	acid	acetylesterase 4
23673 STX12 syntaxin	12 4
833 CARS cysteinyl-tRNA	synthetase 4
7940 LST1 leukocyte	specific	transcript	1 4
2040 STOM stomatin 4
5720 PSME1 proteasome	activator	subunit	1 4
51101 ZC2HC1A zinc	finger	C2HC-type	containing	1A 4
1102 RCBTB2 RCC1	and	BTB	domain	containing	protein	2 4
2752 GLUL glutamate-ammonia	ligase 4
3123 HLA-DRB1 major	histocompatibility	complex,	class	II,	DR	beta	1 4
23608 MKRN1 makorin	ring	finger	protein	1 4
5429 POLH DNA	polymerase	eta 4
100507463 PSMB8-AS1 PSMB8	antisense	RNA	1	(head	to	head) 4
4261 CIITA class	II	major	histocompatibility	complex	transactivator 4
6916 TBXAS1 thromboxane	A	synthase	1 4
116496 FAM129A family	with	sequence	similarity	129	member	A 4
643911 CRNDE colorectal	neoplasia	differentially	expressed	(non-protein	coding) 4
4094 MAF MAF	bZIP	transcription	factor 4
10788 IQGAP2 IQ	motif	containing	GTPase	activating	protein	2 4
3122 HLA-DRA major	histocompatibility	complex,	class	II,	DR	alpha 4
3113 HLA-DPA1 major	histocompatibility	complex,	class	II,	DP	alpha	1 4
196527 ANO6 anoctamin	6 4
10370 CITED2 Cbp/p300	interacting	transactivator	with	Glu/Asp	rich	carboxy-terminal	domain	2 4
941 CD80 CD80	molecule 4
202 AIM1 absent	in	melanoma	1 4
2664 GDI1 GDP	dissociation	inhibitor	1 4
6609 SMPD1 sphingomyelin	phosphodiesterase	1 4
84138 SLC7A6OS solute	carrier	family	7	member	6	opposite	strand 4
254251 LCORL ligand	dependent	nuclear	receptor	corepressor	like 4
2643 GCH1 GTP	cyclohydrolase	1 4
1633 DCK deoxycytidine	kinase 4
64127 NOD2 nucleotide	binding	oligomerization	domain	containing	2 4
51061 TXNDC11 thioredoxin	domain	containing	11 4
5451 POU2F1 POU	class	2	homeobox	1 4
29968 PSAT1 phosphoserine	aminotransferase	1 4
4939 OAS2 2'-5'-oligoadenylate	synthetase	2 4
669 BPGM bisphosphoglycerate	mutase 4
5165 PDK3 pyruvate	dehydrogenase	kinase	3 4
79823 CAMKMT calmodulin-lysine	N-methyltransferase 4
1979 EIF4EBP2 eukaryotic	translation	initiation	factor	4E	binding	protein	2 4
54495 TMX3 thioredoxin	related	transmembrane	protein	3 4
80350 LPAL2 lipoprotein(a)	like	2,	pseudogene 4
51703 ACSL5 acyl-CoA	synthetase	long-chain	family	member	5 4
4267 CD99 CD99	molecule 4
152007 GLIPR2 GLI	pathogenesis	related	2 4
79071 ELOVL6 ELOVL	fatty	acid	elongase	6 4
26277 TINF2 TERF1	interacting	nuclear	factor	2 4
388323 GLTPD2 glycolipid	transfer	protein	domain	containing	2 5
348262 MCRIP1 MAPK	regulated	corepressor	interacting	protein	1 5
770 CA11 carbonic	anhydrase	11 5
140606 SELENOM selenoprotein	M 5
7643 ZNF90 zinc	finger	protein	90 5
5118 PCOLCE procollagen	C-endopeptidase	enhancer 5
27113 BBC3 BCL2	binding	component	3 5
60 ACTB actin	beta 5
4137 MAPT microtubule	associated	protein	tau 5
2051 EPHB6 EPH	receptor	B6 5
9435 CHST2 carbohydrate	sulfotransferase	2 5
810 CALML3 calmodulin	like	3 5
84513 PLPP5 phospholipid	phosphatase	5 5
1406 CRX cone-rod	homeobox 5
23178 PASK PAS	domain	containing	serine/threonine	kinase 5
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84310 C7orf50 chromosome	7	open	reading	frame	50 5
56125 PCDHB11 protocadherin	beta	11 5
440073 IQSEC3 IQ	motif	and	Sec7	domain	3 5
2889 RAPGEF1 Rap	guanine	nucleotide	exchange	factor	1 5
865 CBFB core-binding	factor	beta	subunit 5
157 GRK3 G	protein-coupled	receptor	kinase	3 5
100462981 MTRNR2L2 MT-RNR2-like	2 5
51764 GNG13 G	protein	subunit	gamma	13 5
353134 LCE1D late	cornified	envelope	1D 5
64743 WDR13 WD	repeat	domain	13 5
80194 TMEM134 transmembrane	protein	134 5
23678 SGK3 serum/glucocorticoid	regulated	kinase	family	member	3 5
115703 ARHGAP33 Rho	GTPase	activating	protein	33 5
100316904 SAP25 Sin3A	associated	protein	25 5
256949 KANK3 KN	motif	and	ankyrin	repeat	domains	3 5
9990 SLC12A6 solute	carrier	family	12	member	6 5
83593 RASSF5 Ras	association	domain	family	member	5 5
126695 KDF1 keratinocyte	differentiation	factor	1 5
100130958 SYCE1L synaptonemal	complex	central	element	protein	1	like 5
286075 ZNF707 zinc	finger	protein	707 5
85407 NKD1 naked	cuticle	homolog	1 5
753 LDLRAD4 low	density	lipoprotein	receptor	class	A	domain	containing	4 5
23417 MLYCD malonyl-CoA	decarboxylase 5
284723 SLC25A34 solute	carrier	family	25	member	34 5
348013 TMEM255B transmembrane	protein	255B 5
85027 SMIM3 small	integral	membrane	protein	3 5
388595 TMEM82 transmembrane	protein	82 5
535 ATP6V0A1 ATPase	H+	transporting	V0	subunit	a1 5
9531 BAG3 BCL2	associated	athanogene	3 5
915 CD3D CD3d	molecule 5
10507 SEMA4D semaphorin	4D 5
56940 DUSP22 dual	specificity	phosphatase	22 5
55030 FBXO34 F-box	protein	34 5
10765 KDM5B lysine	demethylase	5B 5
921 CD5 CD5	molecule 5
6223 RPS19 ribosomal	protein	S19 5
132299 OCIAD2 OCIA	domain	containing	2 5
341567 H1FNT H1	histone	family	member	N,	testis	specific 5
64061 TSPYL2 TSPY	like	2 5
27086 FOXP1 forkhead	box	P1 5
6821 SUOX sulfite	oxidase 5
57092 PCNP PEST	proteolytic	signal	containing	nuclear	protein 5
93145 OLFM2 olfactomedin	2 5
129804 FBLN7 fibulin	7 5
79778 MICALL2 MICAL	like	2 5
1514 CTSL cathepsin	L 5
1543 CYP1A1 cytochrome	P450	family	1	subfamily	A	member	1 5
23275 POFUT2 protein	O-fucosyltransferase	2 5
148223 C19orf25 chromosome	19	open	reading	frame	25 5
268 AMH anti-Mullerian	hormone 5
10362 HMG20B high	mobility	group	20B 5
116983 ACAP3 ArfGAP	with	coiled-coil,	ankyrin	repeat	and	PH	domains	3 5
9792 SERTAD2 SERTA	domain	containing	2 5
9057 SLC7A6 solute	carrier	family	7	member	6 5
5209 PFKFB3 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase	3 5
84947 SERAC1 serine	active	site	containing	1 5
10927 SPIN1 spindlin	1 5
100463487 MTRNR2L9 MT-RNR2-like	9 5
203522 INTS6L integrator	complex	subunit	6	like 5
94235 GNG8 G	protein	subunit	gamma	8 5
6001 RGS10 regulator	of	G-protein	signaling	10 5
54947 LPCAT2 lysophosphatidylcholine	acyltransferase	2 5
659 BMPR2 bone	morphogenetic	protein	receptor	type	2 5
23479 ISCU iron-sulfur	cluster	assembly	enzyme 5
100287898 TTC34 tetratricopeptide	repeat	domain	34 5
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2908 NR3C1 nuclear	receptor	subfamily	3	group	C	member	1 5
6229 RPS24 ribosomal	protein	S24 5
29121 CLEC2D C-type	lectin	domain	family	2	member	D 5
25893 TRIM58 tripartite	motif	containing	58 5
29095 ORMDL2 ORMDL	sphingolipid	biosynthesis	regulator	2 5
104 ADARB1 adenosine	deaminase,	RNA	specific	B1 5
5272 SERPINB9 serpin	family	B	member	9 5
284611 FAM102B family	with	sequence	similarity	102	member	B 5
27248 ERLEC1 endoplasmic	reticulum	lectin	1 5
10982 MAPRE2 microtubule	associated	protein	RP/EB	family	member	2 5
6794 STK11 serine/threonine	kinase	11 5
3831 KLC1 kinesin	light	chain	1 5
6242 RTKN rhotekin 5
57680 CHD8 chromodomain	helicase	DNA	binding	protein	8 5
85364 ZCCHC3 zinc	finger	CCHC-type	containing	3 5
163126 EID2 EP300	interacting	inhibitor	of	differentiation	2 5
650669 GAS6-AS1 GAS6	antisense	RNA	1 5
55893 ZNF395 zinc	finger	protein	395 5
26228 STAP1 signal	transducing	adaptor	family	member	1 5
51225 ABI3 ABI	family	member	3 5
7187 TRAF3 TNF	receptor	associated	factor	3 5
196 AHR aryl	hydrocarbon	receptor 5
728747 ANKRD20A4 ankyrin	repeat	domain	20	family	member	A4 5
389333 PROB1 proline	rich	basic	protein	1 5
11202 KLK8 kallikrein	related	peptidase	8 5
2530 FUT8 fucosyltransferase	8 5
6224 RPS20 ribosomal	protein	S20 5
55636 CHD7 chromodomain	helicase	DNA	binding	protein	7 5
10188 TNK2 tyrosine	kinase	non	receptor	2 5
170067 SUPT20HL2 SPT20	homolog,	SAGA	complex	component-like	2 5
4363 ABCC1 ATP	binding	cassette	subfamily	C	member	1 5
581 BAX BCL2	associated	X,	apoptosis	regulator 5
7529 YWHAB tyrosine	3-monooxygenase/tryptophan	5-monooxygenase	activation	protein	beta 5
60468 BACH2 BTB	domain	and	CNC	homolog	2 5
57491 AHRR aryl-hydrocarbon	receptor	repressor 5
730098 LOC730098 uncharacterized	LOC730098 5
221937 FOXK1 forkhead	box	K1 5
729020 RPEL1 ribulose-5-phosphate-3-epimerase	like	1 5
4082 MARCKS myristoylated	alanine	rich	protein	kinase	C	substrate 5
5290 PIK3CA phosphatidylinositol-4,5-bisphosphate	3-kinase	catalytic	subunit	alpha 5
63971 KIF13A kinesin	family	member	13A 5
9794 MAML1 mastermind	like	transcriptional	coactivator	1 5
80045 GPR157 G	protein-coupled	receptor	157 5
3097 HIVEP2 human	immunodeficiency	virus	type	I	enhancer	binding	protein	2 5
7044 LEFTY2 left-right	determination	factor	2 5
222658 KCTD20 potassium	channel	tetramerization	domain	containing	20 5
399668 SMIM10L2A small	integral	membrane	protein	10	like	2A 5
125058 TBC1D16 TBC1	domain	family	member	16 5
5753 PTK6 protein	tyrosine	kinase	6 5
65986 ZBTB10 zinc	finger	and	BTB	domain	containing	10 5
727957 MROH1 maestro	heat	like	repeat	family	member	1 5
2779 GNAT1 G	protein	subunit	alpha	transducin	1 5
376497 SLC27A1 solute	carrier	family	27	member	1 5
1427 CRYGS crystallin	gamma	S 5
440955 TMEM89 transmembrane	protein	89 5
9883 POM121 POM121	transmembrane	nucleoporin 5
54863 TOR4A torsin	family	4	member	A 5
8878 SQSTM1 sequestosome	1 5
414318 C9orf106 chromosome	9	open	reading	frame	106 5
7146 TNXA tenascin	XA	(pseudogene) 5
6498 SKIL SKI	like	proto-oncogene 5
3090 HIC1 hypermethylated	in	cancer	1 5
22877 MLXIP MLX	interacting	protein 5
3853 KRT6A keratin	6A 5
84878 ZBTB45 zinc	finger	and	BTB	domain	containing	45 5
		
151 
	
359948 IRF2BP2 interferon	regulatory	factor	2	binding	protein	2 5
23505 TMEM131 transmembrane	protein	131 5
10489 LRRC41 leucine	rich	repeat	containing	41 5
717 C2 complement	C2 5
10014 HDAC5 histone	deacetylase	5 5
3910 LAMA4 laminin	subunit	alpha	4 5
6623 SNCG synuclein	gamma 5
90427 BMF Bcl2	modifying	factor 5
6209 RPS15 ribosomal	protein	S15 5
6205 RPS11 ribosomal	protein	S11 5
6217 RPS16 ribosomal	protein	S16 5
158376 LINC00961 long	intergenic	non-protein	coding	RNA	961 5
79791 FBXO31 F-box	protein	31 5
54795 TRPM4 transient	receptor	potential	cation	channel	subfamily	M	member	4 5
7791 ZYX zyxin 5
123920 CMTM3 CKLF	like	MARVEL	transmembrane	domain	containing	3 5
3718 JAK3 Janus	kinase	3 5
11336 EXOC3 exocyst	complex	component	3 5
23293 SMG6 SMG6,	nonsense	mediated	mRNA	decay	factor 5
7048 TGFBR2 transforming	growth	factor	beta	receptor	2 5
9094 UNC119 unc-119	lipid	binding	chaperone 5
2869 GRK5 G	protein-coupled	receptor	kinase	5 5
8728 ADAM19 ADAM	metallopeptidase	domain	19 5
10800 CYSLTR1 cysteinyl	leukotriene	receptor	1 5
4088 SMAD3 SMAD	family	member	3 5
3927 LASP1 LIM	and	SH3	protein	1 5
178 AGL amylo-alpha-1,	6-glucosidase,	4-alpha-glucanotransferase 5
25766 PRPF40B pre-mRNA	processing	factor	40	homolog	B 5
1455 CSNK1G2 casein	kinase	1	gamma	2 5
5878 RAB5C RAB5C,	member	RAS	oncogene	family 5
2997 GYS1 glycogen	synthase	1 5
80152 CENPT centromere	protein	T 5
940 CD28 CD28	molecule 5
79897 RPP21 ribonuclease	P/MRP	subunit	p21 5
155061 ZNF746 zinc	finger	protein	746 5
6665 SOX15 SRY-box	15 5
79144 PPDPF pancreatic	progenitor	cell	differentiation	and	proliferation	factor 5
169981 SPIN3 spindlin	family	member	3 5
23338 JADE2 jade	family	PHD	finger	2 5
3707 ITPKB inositol-trisphosphate	3-kinase	B 5
9896 FIG4 FIG4	phosphoinositide	5-phosphatase 5
23144 ZC3H3 zinc	finger	CCCH-type	containing	3 5
57479 PRR12 proline	rich	12 5
9143 SYNGR3 synaptogyrin	3 5
80774 LIMD2 LIM	domain	containing	2 5
11337 GABARAP GABA	type	A	receptor-associated	protein 5
54543 TOMM7 translocase	of	outer	mitochondrial	membrane	7 5
10567 RABAC1 Rab	acceptor	1 5
64319 FBRS fibrosin 5
6227 RPS21 ribosomal	protein	S21 5
29123 ANKRD11 ankyrin	repeat	domain	11 5
4041 LRP5 LDL	receptor	related	protein	5 5
64375 IKZF4 IKAROS	family	zinc	finger	4 5
100652768 LOC100652768 uncharacterized	LOC100652768 5
6137 RPL13 ribosomal	protein	L13 5
219968 OR5B21 olfactory	receptor	family	5	subfamily	B	member	21 5
6135 RPL11 ribosomal	protein	L11 5
201163 FLCN folliculin 5
100507347 VIM-AS1 VIM	antisense	RNA	1 5
57154 SMURF1 SMAD	specific	E3	ubiquitin	protein	ligase	1 5
5128 CDK17 cyclin	dependent	kinase	17 5
6208 RPS14 ribosomal	protein	S14 5
10169 SERF2 small	EDRK-rich	factor	2 5
4215 MAP3K3 mitogen-activated	protein	kinase	kinase	kinase	3 5
939 CD27 CD27	molecule 5
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272 AMPD3 adenosine	monophosphate	deaminase	3 5
27287 VENTX VENT	homeobox 5
23094 SIPA1L3 signal	induced	proliferation	associated	1	like	3 5
54463 FAM134B family	with	sequence	similarity	134	member	B 5
57713 SFMBT2 Scm-like	with	four	mbt	domains	2 5
80003 PCNX2 pecanex	homolog	2	(Drosophila) 5
22852 ANKRD26 ankyrin	repeat	domain	26 5
55626 AMBRA1 autophagy	and	beclin	1	regulator	1 5
5339 PLEC plectin 5
55914 ERBIN erbb2	interacting	protein 5
5900 RALGDS ral	guanine	nucleotide	dissociation	stimulator 5
23196 FAM120A family	with	sequence	similarity	120A 5
2634 GBP2 guanylate	binding	protein	2 5
6156 RPL30 ribosomal	protein	L30 5
246175 CNOT6L CCR4-NOT	transcription	complex	subunit	6	like 5
9806 SPOCK2 SPARC/osteonectin,	cwcv	and	kazal	like	domains	proteoglycan	2 5
29997 GLTSCR2 glioma	tumor	suppressor	candidate	region	gene	2 5
5144 PDE4D phosphodiesterase	4D 5
25976 TIPARP TCDD	inducible	poly(ADP-ribose)	polymerase 5
25865 PRKD2 protein	kinase	D2 5
4209 MEF2D myocyte	enhancer	factor	2D 5
23077 MYCBP2 MYC	binding	protein	2,	E3	ubiquitin	protein	ligase 5
57448 BIRC6 baculoviral	IAP	repeat	containing	6 5
645843 TMEM14EP transmembrane	protein	14E,	pseudogene 5
10326 SIRPB1 signal	regulatory	protein	beta	1 5
55668 GPATCH2L G-patch	domain	containing	2	like 5
81855 SFXN3 sideroflexin	3 5
9404 LPXN leupaxin 5
6575 SLC20A2 solute	carrier	family	20	member	2 5
64748 PLPPR2 phospholipid	phosphatase	related	2 5
284346 ZNF575 zinc	finger	protein	575 5
55558 PLXNA3 plexin	A3 5
646962 HRCT1 histidine	rich	carboxyl	terminus	1 5
1564 CYP2D7 cytochrome	P450	family	2	subfamily	D	member	7	(gene/pseudogene) 5
7094 TLN1 talin	1 5
130013 ACMSD aminocarboxymuconate	semialdehyde	decarboxylase 5
57787 MARK4 microtubule	affinity	regulating	kinase	4 5
55690 PACS1 phosphofurin	acidic	cluster	sorting	protein	1 5
81844 TRIM56 tripartite	motif	containing	56 5
196743 PAOX polyamine	oxidase 5
116985 ARAP1 ArfGAP	with	RhoGAP	domain,	ankyrin	repeat	and	PH	domain	1 5
65056 GPBP1 GC-rich	promoter	binding	protein	1 5
84033 OBSCN obscurin,	cytoskeletal	calmodulin	and	titin-interacting	RhoGEF 5
283600 SLC25A47 solute	carrier	family	25	member	47 5
7291 TWIST1 twist	family	bHLH	transcription	factor	1 5
201294 UNC13D unc-13	homolog	D 5
100996693 LOC100996693 CAVP-target	protein-like 5
64781 CERK ceramide	kinase 5
146206 CARMIL2 capping	protein	regulator	and	myosin	1	linker	2 5
653583 PHLDB3 pleckstrin	homology	like	domain	family	B	member	3 5
283385 MORN3 MORN	repeat	containing	3 5
352954 GATS GATS,	stromal	antigen	3	opposite	strand 5
7379 UPK2 uroplakin	2 5
29882 ANAPC2 anaphase	promoting	complex	subunit	2 5
1535 CYBA cytochrome	b-245	alpha	chain 5
5093 PCBP1 poly(rC)	binding	protein	1 5
79958 DENND1C DENN	domain	containing	1C 5
79156 PLEKHF1 pleckstrin	homology	and	FYVE	domain	containing	1 5
60684 TRAPPC11 trafficking	protein	particle	complex	11 5
9821 RB1CC1 RB1	inducible	coiled-coil	1 5
84256 FLYWCH1 FLYWCH-type	zinc	finger	1 5
51669 SARAF store-operated	calcium	entry	associated	regulatory	factor 5
51343 FZR1 fizzy/cell	division	cycle	20	related	1 5
8398 PLA2G6 phospholipase	A2	group	VI 5
54434 SSH1 slingshot	protein	phosphatase	1 5
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2588 GALNS galactosamine	(N-acetyl)-6-sulfatase 5
399669 ZNF321P zinc	finger	protein	321,	pseudogene 5
2621 GAS6 growth	arrest	specific	6 5
57558 USP35 ubiquitin	specific	peptidase	35 5
284439 SLC25A42 solute	carrier	family	25	member	42 5
6181 RPLP2 ribosomal	protein	lateral	stalk	subunit	P2 5
90625 ERVH48-1 endogenous	retrovirus	group	48	member	1 5
4753 NELL2 neural	EGFL	like	2 5
6222 RPS18 ribosomal	protein	S18 5
50840 TAS2R14 taste	2	receptor	member	14 5
11215 AKAP11 A-kinase	anchoring	protein	11 5
81619 TSPAN14 tetraspanin	14 5
9448 MAP4K4 mitogen-activated	protein	kinase	kinase	kinase	kinase	4 5
7750 ZMYM2 zinc	finger	MYM-type	containing	2 5
10806 SDCCAG8 serologically	defined	colon	cancer	antigen	8 5
158078 EEF1A1P5 eukaryotic	translation	elongation	factor	1	alpha	1	pseudogene	5 5
6228 RPS23 ribosomal	protein	S23 5
55423 SIRPG signal	regulatory	protein	gamma 5
919 CD247 CD247	molecule 5
1890 TYMP thymidine	phosphorylase 5
8553 BHLHE40 basic	helix-loop-helix	family	member	e40 5
162972 ZNF550 zinc	finger	protein	550 5
60401 EDA2R ectodysplasin	A2	receptor 5
192668 CYS1 cystin	1 5
57634 EP400 E1A	binding	protein	p400 5
91252 SLC39A13 solute	carrier	family	39	member	13 5
11117 EMILIN1 elastin	microfibril	interfacer	1 5
51315 KRCC1 lysine	rich	coiled-coil	1 5
114132 SIGLEC11 sialic	acid	binding	Ig	like	lectin	11 5
5498 PPOX protoporphyrinogen	oxidase 5
112574 SNX18 sorting	nexin	18 5
58480 RHOU ras	homolog	family	member	U 5
260425 MAGI3 membrane	associated	guanylate	kinase,	WW	and	PDZ	domain	containing	3 5
65998 C11orf95 chromosome	11	open	reading	frame	95 5
23743 BHMT2 betaine--homocysteine	S-methyltransferase	2 5
23492 CBX7 chromobox	7 5
58509 CACTIN cactin,	spliceosome	C	complex	subunit 5
27106 ARRDC2 arrestin	domain	containing	2 5
23053 ZSWIM8 zinc	finger	SWIM-type	containing	8 5
1294 COL7A1 collagen	type	VII	alpha	1	chain 5
79095 C9orf16 chromosome	9	open	reading	frame	16 5
7753 ZNF202 zinc	finger	protein	202 5
116535 MRGPRF MAS	related	GPR	family	member	F 5
5199 CFP complement	factor	properdin 5
8792 TNFRSF11A TNF	receptor	superfamily	member	11a 5
259234 DSCR10 Down	syndrome	critical	region	10	(non-protein	coding) 5
6123 RPL3L ribosomal	protein	L3	like 5
23352 UBR4 ubiquitin	protein	ligase	E3	component	n-recognin	4 5
375033 PEAR1 platelet	endothelial	aggregation	receptor	1 5
10908 PNPLA6 patatin	like	phospholipase	domain	containing	6 5
22863 ATG14 autophagy	related	14 5
4302 MLLT6 MLLT6,	PHD	finger	domain	containing 5
23265 EXOC7 exocyst	complex	component	7 5
1236 CCR7 C-C	motif	chemokine	receptor	7 5
126393 HSPB6 heat	shock	protein	family	B	(small)	member	6 5
9701 PPP6R2 protein	phosphatase	6	regulatory	subunit	2 5
5075 PAX1 paired	box	1 5
126282 TNFAIP8L1 TNF	alpha	induced	protein	8	like	1 5
25950 RWDD3 RWD	domain	containing	3 5
146542 ZNF688 zinc	finger	protein	688 5
56124 PCDHB12 protocadherin	beta	12 5
90987 ZNF251 zinc	finger	protein	251 5
101060376 TBC1D3L TBC1	domain	family	member	3L 5
337867 UBAC2 UBA	domain	containing	2 5
678 ZFP36L2 ZFP36	ring	finger	protein	like	2 5
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6155 RPL27 ribosomal	protein	L27 5
924 CD7 CD7	molecule 5
5869 RAB5B RAB5B,	member	RAS	oncogene	family 5
2687 GGT5 gamma-glutamyltransferase	5 5
3455 IFNAR2 interferon	alpha	and	beta	receptor	subunit	2 5
55114 ARHGAP17 Rho	GTPase	activating	protein	17 5
23300 ATMIN ATM	interactor 5
23157 SEPT6 septin	6 5
84433 CARD11 caspase	recruitment	domain	family	member	11 5
9363 RAB33A RAB33A,	member	RAS	oncogene	family 5
23410 SIRT3 sirtuin	3 5
6141 RPL18 ribosomal	protein	L18 5
4092 SMAD7 SMAD	family	member	7 5
256281 NUDT14 nudix	hydrolase	14 5
222234 FAM185A family	with	sequence	similarity	185	member	A 5
126259 TMIGD2 transmembrane	and	immunoglobulin	domain	containing	2 5
84441 MAML2 mastermind	like	transcriptional	coactivator	2 5
80162 PGGHG protein-glucosylgalactosylhydroxylysine	glucosidase 5
56995 TULP4 tubby	like	protein	4 5
5013 OTX1 orthodenticle	homeobox	1 5
79818 ZNF552 zinc	finger	protein	552 5
4356 MPP3 membrane	palmitoylated	protein	3 5
23770 FKBP8 FK506	binding	protein	8 5
346689 KLRG2 killer	cell	lectin	like	receptor	G2 5
256021 LINC01619 long	intergenic	non-protein	coding	RNA	1619 5
9644 SH3PXD2A SH3	and	PX	domains	2A 5
1384 CRAT carnitine	O-acetyltransferase 5
4925 NUCB2 nucleobindin	2 5
8839 WISP2 WNT1	inducible	signaling	pathway	protein	2 5
27243 CHMP2A charged	multivesicular	body	protein	2A 5
5333 PLCD1 phospholipase	C	delta	1 5
309 ANXA6 annexin	A6 5
3561 IL2RG interleukin	2	receptor	subunit	gamma 5
79705 LRRK1 leucine	rich	repeat	kinase	1 5
100874214 TM4SF19-AS1 TM4SF19	antisense	RNA	1 5
200035 NUDT17 nudix	hydrolase	17 5
3299 HSF4 heat	shock	transcription	factor	4 5
974 CD79B CD79b	molecule 5
9423 NTN1 netrin	1 5
100128675 HPN-AS1 HPN	antisense	RNA	1 5
51005 AMDHD2 amidohydrolase	domain	containing	2 5
64806 IL25 interleukin	25 5
26127 FGFR1OP2 FGFR1	oncogene	partner	2 5
101060684 NBPF26 neuroblastoma	breakpoint	family	member	26 5
55204 GOLPH3L golgi	phosphoprotein	3	like 5
163087 ZNF383 zinc	finger	protein	383 5
83941 TM2D1 TM2	domain	containing	1 5
10780 ZNF234 zinc	finger	protein	234 5
55844 PPP2R2D protein	phosphatase	2	regulatory	subunit	Bdelta 5
36 ACADSB acyl-CoA	dehydrogenase,	short/branched	chain 5
6342 SCP2 sterol	carrier	protein	2 5
219749 ZNF25 zinc	finger	protein	25 5
348094 ANKDD1A ankyrin	repeat	and	death	domain	containing	1A 5
51111 KMT5B lysine	methyltransferase	5B 5
55337 C19orf66 chromosome	19	open	reading	frame	66 5
1731 SEPT1 septin	1 5
11226 GALNT6 polypeptide	N-acetylgalactosaminyltransferase	6 5
55900 ZNF302 zinc	finger	protein	302 5
132160 PPM1M protein	phosphatase,	Mg2+/Mn2+	dependent	1M 5
6775 STAT4 signal	transducer	and	activator	of	transcription	4 5
28951 TRIB2 tribbles	pseudokinase	2 5
1891 ECH1 enoyl-CoA	hydratase	1 5
8195 MKKS McKusick-Kaufman	syndrome 5
388969 C2orf68 chromosome	2	open	reading	frame	68 5
9087 TMSB4Y thymosin	beta	4,	Y-linked 5
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51247 PAIP2 poly(A)	binding	protein	interacting	protein	2 5
11060 WWP2 WW	domain	containing	E3	ubiquitin	protein	ligase	2 5
8434 RECK reversion	inducing	cysteine	rich	protein	with	kazal	motifs 5
5412 UBL3 ubiquitin	like	3 5
55501 CHST12 carbohydrate	sulfotransferase	12 5
83463 MXD3 MAX	dimerization	protein	3 5
55251 PCMTD2 protein-L-isoaspartate	(D-aspartate)	O-methyltransferase	domain	containing	2 5
115817 DHRS1 dehydrogenase/reductase	1 5
10916 MAGED2 MAGE	family	member	D2 5
26152 ZNF337 zinc	finger	protein	337 5
6158 RPL28 ribosomal	protein	L28 5
54532 USP53 ubiquitin	specific	peptidase	53 5
1195 CLK1 CDC	like	kinase	1 5
55219 TMEM57 transmembrane	protein	57 5
2778 GNAS GNAS	complex	locus 5
9746 CLSTN3 calsyntenin	3 5
23523 CABIN1 calcineurin	binding	protein	1 5
100131187 TSTD1 thiosulfate	sulfurtransferase	like	domain	containing	1 5
4007 PRICKLE3 prickle	planar	cell	polarity	protein	3 5
339366 ADAMTSL5 ADAMTS	like	5 5
10045 SH2D3A SH2	domain	containing	3A 5
79132 DHX58 DEXH-box	helicase	58 5
9522 SCAMP1 secretory	carrier	membrane	protein	1 5
11179 ZNF277 zinc	finger	protein	277 5
4926 NUMA1 nuclear	mitotic	apparatus	protein	1 5
390927 ZNF793 zinc	finger	protein	793 5
729238 SFTPA2 surfactant	protein	A2 5
57132 CHMP1B charged	multivesicular	body	protein	1B 5
56925 LXN latexin 5
3590 IL11RA interleukin	11	receptor	subunit	alpha 5
474344 GIMAP6 GTPase,	IMAP	family	member	6 5
1794 DOCK2 dedicator	of	cytokinesis	2 5
255967 PAN3 PAN3	poly(A)	specific	ribonuclease	subunit 5
4627 MYH9 myosin	heavy	chain	9 5
55187 VPS13D vacuolar	protein	sorting	13	homolog	D 5
80325 ABTB1 ankyrin	repeat	and	BTB	domain	containing	1 5
8764 TNFRSF14 TNF	receptor	superfamily	member	14 5
23503 ZFYVE26 zinc	finger	FYVE-type	containing	26 5
9969 MED13 mediator	complex	subunit	13 5
23230 VPS13A vacuolar	protein	sorting	13	homolog	A 5
9354 UBE4A ubiquitination	factor	E4A 5
22992 KDM2A lysine	demethylase	2A 5
113 ADCY7 adenylate	cyclase	7 5
5289 PIK3C3 phosphatidylinositol	3-kinase	catalytic	subunit	type	3 5
7155 TOP2B topoisomerase	(DNA)	II	beta 5
6942 TCF20 transcription	factor	20 5
2316 FLNA filamin	A 5
23550 PSD4 pleckstrin	and	Sec7	domain	containing	4 5
50839 TAS2R10 taste	2	receptor	member	10 5
23215 PRRC2C proline	rich	coiled-coil	2C 5
10838 ZNF275 zinc	finger	protein	275 5
256364 EML3 echinoderm	microtubule	associated	protein	like	3 5
56252 YLPM1 YLP	motif	containing	1 5
25792 CIZ1 CDKN1A	interacting	zinc	finger	protein	1 5
126374 WTIP Wilms	tumor	1	interacting	protein 5
147686 ZNF418 zinc	finger	protein	418 5
23005 MAPKBP1 mitogen-activated	protein	kinase	binding	protein	1 5
129530 LYG1 lysozyme	g1 5
64772 ENGASE endo-beta-N-acetylglucosaminidase 5
5585 PKN1 protein	kinase	N1 5
114904 C1QTNF6 C1q	and	tumor	necrosis	factor	related	protein	6 5
80320 SP6 Sp6	transcription	factor 5
63941 NECAB3 N-terminal	EF-hand	calcium	binding	protein	3 5
8547 FCN3 ficolin	3 5
115196 ZNF554 zinc	finger	protein	554 5
		
156 
	
7786 MAP3K12 mitogen-activated	protein	kinase	kinase	kinase	12 5
673 BRAF B-Raf	proto-oncogene,	serine/threonine	kinase 5
290 ANPEP alanyl	aminopeptidase,	membrane 5
64760 FAM160B2 family	with	sequence	similarity	160	member	B2 5
51043 ZBTB7B zinc	finger	and	BTB	domain	containing	7B 5
100126793 GHRLOS ghrelin	opposite	strand/antisense	RNA 5
23002 DAAM1 dishevelled	associated	activator	of	morphogenesis	1 5
9202 ZMYM4 zinc	finger	MYM-type	containing	4 5
6651 SON SON	DNA	binding	protein 5
55209 SETD5 SET	domain	containing	5 5
23592 LEMD3 LEM	domain	containing	3 5
57683 ZDBF2 zinc	finger	DBF-type	containing	2 5
5062 PAK2 p21	(RAC1)	activated	kinase	2 5
259282 BOD1L1 biorientation	of	chromosomes	in	cell	division	1	like	1 5
10396 ATP8A1 ATPase	phospholipid	transporting	8A1 5
282809 POC1B POC1	centriolar	protein	B 5
63908 NAPB NSF	attachment	protein	beta 5
284459 HKR1 HKR1,	GLI-Kruppel	zinc	finger	family	member 5
7392 USF2 upstream	transcription	factor	2,	c-fos	interacting 5
221037 JMJD1C jumonji	domain	containing	1C 5
3423 IDS iduronate	2-sulfatase 5
26020 LRP10 LDL	receptor	related	protein	10 5
91748 ELMSAN1 ELM2	and	Myb/SANT	domain	containing	1 5
51177 PLEKHO1 pleckstrin	homology	domain	containing	O1 5
4736 RPL10A ribosomal	protein	L10a 5
23262 PPIP5K2 diphosphoinositol	pentakisphosphate	kinase	2 5
22980 TCF25 transcription	factor	25 5
118924 FRA10AC1 fragile	site,	folic	acid	type,	rare,	fra(10)(q23.3)	or	fra(10)(q24.2)	candidate	1 5
23461 ABCA5 ATP	binding	cassette	subfamily	A	member	5 5
57189 KIAA1147 KIAA1147 5
8085 KMT2D lysine	methyltransferase	2D 5
26235 FBXL4 F-box	and	leucine	rich	repeat	protein	4 5
23162 MAPK8IP3 mitogen-activated	protein	kinase	8	interacting	protein	3 5
23067 SETD1B SET	domain	containing	1B 5
200539 ANKRD23 ankyrin	repeat	domain	23 5
23315 SLC9A8 solute	carrier	family	9	member	A8 5
55125 CEP192 centrosomal	protein	192 5
489 ATP2A3 ATPase	sarcoplasmic/endoplasmic	reticulum	Ca2+	transporting	3 5
83931 STK40 serine/threonine	kinase	40 5
730094 C16orf52 chromosome	16	open	reading	frame	52 5
4899 NRF1 nuclear	respiratory	factor	1 5
50832 TAS2R4 taste	2	receptor	member	4 5
26190 FBXW2 F-box	and	WD	repeat	domain	containing	2 5
55827 DCAF6 DDB1	and	CUL4	associated	factor	6 5
27030 MLH3 mutL	homolog	3 5
7620 ZNF69 zinc	finger	protein	69 5
126069 ZNF491 zinc	finger	protein	491 5
221496 LEMD2 LEM	domain	containing	2 5
55454 CSGALNACT2 chondroitin	sulfate	N-acetylgalactosaminyltransferase	2 5
85377 MICALL1 MICAL	like	1 5
80208 SPG11 spastic	paraplegia	11	(autosomal	recessive) 5
57614 KIAA1468 KIAA1468 5
25836 NIPBL NIPBL,	cohesin	loading	factor 5
54799 MBTD1 mbt	domain	containing	1 5
10009 ZBTB33 zinc	finger	and	BTB	domain	containing	33 5
54681 P4HTM prolyl	4-hydroxylase,	transmembrane 5
55139 ANKZF1 ankyrin	repeat	and	zinc	finger	domain	containing	1 5
81932 HDHD3 haloacid	dehalogenase	like	hydrolase	domain	containing	3 5
8924 HERC2 HECT	and	RLD	domain	containing	E3	ubiquitin	protein	ligase	2 5
26260 FBXO25 F-box	protein	25 5
51755 CDK12 cyclin	dependent	kinase	12 5
9205 ZMYM5 zinc	finger	MYM-type	containing	5 5
257218 SHPRH SNF2	histone	linker	PHD	RING	helicase 5
7073 TIAL1 TIA1	cytotoxic	granule	associated	RNA	binding	protein	like	1 5
57148 RALGAPB Ral	GTPase	activating	protein	non-catalytic	beta	subunit 5
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3213 HOXB3 homeobox	B3 5
23637 RABGAP1 RAB	GTPase	activating	protein	1 5
339345 NANOS2 nanos	C2HC-type	zinc	finger	2 5
100507424 LOC100507424 uncharacterized	LOC100507424 5
642819 ZNF487 zinc	finger	protein	487 5
8419 BFSP2 beaded	filament	structural	protein	2 5
1185 CLCN6 chloride	voltage-gated	channel	6 5
84527 ZNF559 zinc	finger	protein	559 5
388564 TMEM238 transmembrane	protein	238 5
51105 PHF20L1 PHD	finger	protein	20-like	1 5
317662 FAM149B1 family	with	sequence	similarity	149	member	B1 5
8481 OFD1 OFD1,	centriole	and	centriolar	satellite	protein 5
89857 KLHL6 kelch	like	family	member	6 5
27125 AFF4 AF4/FMR2	family	member	4 5
7464 CORO2A coronin	2A 5
51304 ZDHHC3 zinc	finger	DHHC-type	containing	3 5
57690 TNRC6C trinucleotide	repeat	containing	6C 5
83692 CD99L2 CD99	molecule	like	2 5
50488 MINK1 misshapen	like	kinase	1 5
55054 ATG16L1 autophagy	related	16	like	1 5
55683 KANSL3 KAT8	regulatory	NSL	complex	subunit	3 5
5991 RFX3 regulatory	factor	X3 5
3570 IL6R interleukin	6	receptor 5
54 ACP5 acid	phosphatase	5,	tartrate	resistant 5
160851 DGKH diacylglycerol	kinase	eta 5
84914 ZNF587 zinc	finger	protein	587 5
22933 SIRT2 sirtuin	2 5
652968 GATSL3 GATS	protein	like	3 5
196403 DTX3 deltex	E3	ubiquitin	ligase	3 5
51191 HERC5 HECT	and	RLD	domain	containing	E3	ubiquitin	protein	ligase	5 5
57498 KIDINS220 kinase	D-interacting	substrate	220kDa 5
1389 CREBL2 cAMP	responsive	element	binding	protein	like	2 5
9980 DOPEY2 dopey	family	member	2 5
8543 LMO4 LIM	domain	only	4 5
91782 CHMP7 charged	multivesicular	body	protein	7 5
5530 PPP3CA protein	phosphatase	3	catalytic	subunit	alpha 5
9847 C2CD5 C2	calcium	dependent	domain	containing	5 5
149041 RC3H1 ring	finger	and	CCCH-type	domains	1 5
5025 P2RX4 purinergic	receptor	P2X	4 5
29068 ZBTB44 zinc	finger	and	BTB	domain	containing	44 5
10585 POMT1 protein	O-mannosyltransferase	1 5
3140 MR1 major	histocompatibility	complex,	class	I-related 5
8556 CDC14A cell	division	cycle	14A 5
54981 NMRK1 nicotinamide	riboside	kinase	1 5
117584 RFFL ring	finger	and	FYVE	like	domain	containing	E3	ubiquitin	protein	ligase 5
841 CASP8 caspase	8 5
1387 CREBBP CREB	binding	protein 5
10347 ABCA7 ATP	binding	cassette	subfamily	A	member	7 5
4820 NKTR natural	killer	cell	triggering	receptor 5
2323 FLT3LG fms	related	tyrosine	kinase	3	ligand 5
274 BIN1 bridging	integrator	1 5
80830 APOL6 apolipoprotein	L6 5
54904 WHSC1L1 Wolf-Hirschhorn	syndrome	candidate	1-like	1 5
6314 ATXN7 ataxin	7 5
8861 LDB1 LIM	domain	binding	1 5
5829 PXN paxillin 5
58485 TRAPPC1 trafficking	protein	particle	complex	1 5
10044 SH2D3C SH2	domain	containing	3C 5
143098 MPP7 membrane	palmitoylated	protein	7 5
11123 RCAN3 RCAN	family	member	3 5
4046 LSP1 lymphocyte-specific	protein	1 5
6404 SELPLG selectin	P	ligand 5
51585 PCF11 PCF11	cleavage	and	polyadenylation	factor	subunit 5
3338 DNAJC4 DnaJ	heat	shock	protein	family	(Hsp40)	member	C4 5
123036 TC2N tandem	C2	domains,	nuclear 5
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53822 FXYD7 FXYD	domain	containing	ion	transport	regulator	7 5
51411 BIN2 bridging	integrator	2 5
79932 KIAA0319L KIAA0319	like 5
25939 SAMHD1 SAM	and	HD	domain	containing	deoxynucleoside	triphosphate	triphosphohydrolase	1 5
11342 RNF13 ring	finger	protein	13 5
53346 TM6SF1 transmembrane	6	superfamily	member	1 5
10559 SLC35A1 solute	carrier	family	35	member	A1 5
900 CCNG1 cyclin	G1 5
84851 TRIM52 tripartite	motif	containing	52 5
84958 SYTL1 synaptotagmin	like	1 5
9840 TESPA1 thymocyte	expressed,	positive	selection	associated	1 5
4050 LTB lymphotoxin	beta 5
150365 MEI1 meiotic	double-stranded	break	formation	protein	1 5
54847 SIDT1 SID1	transmembrane	family	member	1 5
11010 GLIPR1 GLI	pathogenesis	related	1 5
284129 SLC26A11 solute	carrier	family	26	member	11 5
837 CASP4 caspase	4 5
54622 ARL15 ADP	ribosylation	factor	like	GTPase	15 5
5527 PPP2R5C protein	phosphatase	2	regulatory	subunit	B'gamma 5
91523 PCED1B PC-esterase	domain	containing	1B 5
3135 HLA-G major	histocompatibility	complex,	class	I,	G 5
91689 SMDT1 single-pass	membrane	protein	with	aspartate	rich	tail	1 5
23125 CAMTA2 calmodulin	binding	transcription	activator	2 5
5920 RARRES3 retinoic	acid	receptor	responder	3 5
3594 IL12RB1 interleukin	12	receptor	subunit	beta	1 5
360 AQP3 aquaporin	3	(Gill	blood	group) 5
158830 CXorf65 chromosome	X	open	reading	frame	65 5
3955 LFNG LFNG	O-fucosylpeptide	3-beta-N-acetylglucosaminyltransferase 5
57489 ODF2L outer	dense	fiber	of	sperm	tails	2	like 5
7567 ZNF19 zinc	finger	protein	19 5
219402 MTIF3 mitochondrial	translational	initiation	factor	3 5
123688 HYKK hydroxylysine	kinase 5
5588 PRKCQ protein	kinase	C	theta 5
6275 S100A4 S100	calcium	binding	protein	A4 5
118429 ANTXR2 anthrax	toxin	receptor	2 5
177 AGER advanced	glycosylation	end-product	specific	receptor 5
10365 KLF2 Kruppel	like	factor	2 5
51274 KLF3 Kruppel	like	factor	3 5
2537 IFI6 interferon	alpha	inducible	protein	6 5
4063 LY9 lymphocyte	antigen	9 5
201595 STT3B STT3B,	catalytic	subunit	of	the	oligosaccharyltransferase	complex 5
151613 TTC14 tetratricopeptide	repeat	domain	14 5
9725 TMEM63A transmembrane	protein	63A 5
51586 MED15 mediator	complex	subunit	15 5
23515 MORC3 MORC	family	CW-type	zinc	finger	3 5
23046 KIF21B kinesin	family	member	21B 5
2145 EZH1 enhancer	of	zeste	1	polycomb	repressive	complex	2	subunit 5
5175 PECAM1 platelet	and	endothelial	cell	adhesion	molecule	1 5
387357 THEMIS thymocyte	selection	associated 5
29767 TMOD2 tropomodulin	2 5
4599 MX1 MX	dynamin	like	GTPase	1 5
916 CD3E CD3e	molecule 5
972 CD74 CD74	molecule 5
220972 MARCH8 membrane	associated	ring-CH-type	finger	8 5
115209 OMA1 OMA1	zinc	metallopeptidase 5
84456 L3MBTL3 l(3)mbt-like	3	(Drosophila) 5
4179 CD46 CD46	molecule 5
51816 CECR1 cat	eye	syndrome	chromosome	region,	candidate	1 5
51019 CCDC53 coiled-coil	domain	containing	53 5
196513 DCP1B decapping	mRNA	1B 5
23593 HEBP2 heme	binding	protein	2 5
10627 MYL12A myosin	light	chain	12A 5
55217 TMLHE trimethyllysine	hydroxylase,	epsilon 5
55281 TMEM140 transmembrane	protein	140 5
5371 PML promyelocytic	leukemia 5
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55906 ZC4H2 zinc	finger	C4H2-type	containing 5
9113 LATS1 large	tumor	suppressor	kinase	1 5
4494 MT1F metallothionein	1F 5
389289 ANXA2R annexin	A2	receptor 5
22884 WDR37 WD	repeat	domain	37 5
6430 SRSF5 serine	and	arginine	rich	splicing	factor	5 5
317649 EIF4E3 eukaryotic	translation	initiation	factor	4E	family	member	3 5
94241 TP53INP1 tumor	protein	p53	inducible	nuclear	protein	1 5
93550 ZFAND4 zinc	finger	AN1-type	containing	4 5
10397 NDRG1 N-myc	downstream	regulated	1 5
8916 HERC3 HECT	and	RLD	domain	containing	E3	ubiquitin	protein	ligase	3 5
6903 TBCC tubulin	folding	cofactor	C 5
301 ANXA1 annexin	A1 5
79726 WDR59 WD	repeat	domain	59 5
159090 FAM122B family	with	sequence	similarity	122B 5
284004 HEXDC hexosaminidase	D 5
10781 ZNF266 zinc	finger	protein	266 5
151636 DTX3L deltex	E3	ubiquitin	ligase	3L 5
7507 XPA XPA,	DNA	damage	recognition	and	repair	factor 5
23287 AGTPBP1 ATP/GTP	binding	protein	1 5
146198 ZFP90 ZFP90	zinc	finger	protein 5
405 ARNT aryl	hydrocarbon	receptor	nuclear	translocator 5
9867 PJA2 praja	ring	finger	ubiquitin	ligase	2 5
79364 ZXDC ZXD	family	zinc	finger	C 5
158219 TTC39B tetratricopeptide	repeat	domain	39B 5
221178 SPATA13 spermatogenesis	associated	13 5
128346 C1orf162 chromosome	1	open	reading	frame	162 5
9267 CYTH1 cytohesin	1 5
3431 SP110 SP110	nuclear	body	protein 5
157378 TMEM65 transmembrane	protein	65 5
152926 PPM1K protein	phosphatase,	Mg2+/Mn2+	dependent	1K 5
5775 PTPN4 protein	tyrosine	phosphatase,	non-receptor	type	4 5
92797 HELB DNA	helicase	B 5
81704 DOCK8 dedicator	of	cytokinesis	8 5
29909 GPR171 G	protein-coupled	receptor	171 5
147138 TMC8 transmembrane	channel	like	8 5
10466 COG5 component	of	oligomeric	golgi	complex	5 5
6667 SP1 Sp1	transcription	factor 5
8554 PIAS1 protein	inhibitor	of	activated	STAT	1 5
757 TMEM50B transmembrane	protein	50B 5
55825 PECR peroxisomal	trans-2-enoyl-CoA	reductase 5
493 ATP2B4 ATPase	plasma	membrane	Ca2+	transporting	4 5
3655 ITGA6 integrin	subunit	alpha	6 5
5292 PIM1 Pim-1	proto-oncogene,	serine/threonine	kinase 5
9922 IQSEC1 IQ	motif	and	Sec7	domain	1 5
152006 RNF38 ring	finger	protein	38 5
163049 ZNF791 zinc	finger	protein	791 5
4214 MAP3K1 mitogen-activated	protein	kinase	kinase	kinase	1 5
23032 USP33 ubiquitin	specific	peptidase	33 5
23033 DOPEY1 dopey	family	member	1 5
56605 ERO1B endoplasmic	reticulum	oxidoreductase	1	beta 5
27430 MAT2B methionine	adenosyltransferase	2B 5
388558 ZNF808 zinc	finger	protein	808 5
8867 SYNJ1 synaptojanin	1 5
84719 LINC00260 long	intergenic	non-protein	coding	RNA	260 5
51667 NUB1 negative	regulator	of	ubiquitin	like	proteins	1 5
79770 TXNDC15 thioredoxin	domain	containing	15 5
834 CASP1 caspase	1 5
64598 MOSPD3 motile	sperm	domain	containing	3 5
3106 HLA-B major	histocompatibility	complex,	class	I,	B 5
3669 ISG20 interferon	stimulated	exonuclease	gene	20 5
554223 LOC554223 histocompatibility	antigen-related 5
4077 NBR1 NBR1,	autophagy	cargo	receptor 5
10379 IRF9 interferon	regulatory	factor	9 5
64844 MARCH7 membrane	associated	ring-CH-type	finger	7 5
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3841 KPNA5 karyopherin	subunit	alpha	5 5
8644 AKR1C3 aldo-keto	reductase	family	1	member	C3 5
54464 XRN1 5'-3'	exoribonuclease	1 5
80342 TRAF3IP3 TRAF3	interacting	protein	3 5
5335 PLCG1 phospholipase	C	gamma	1 5
55007 FAM118A family	with	sequence	similarity	118	member	A 5
26999 CYFIP2 cytoplasmic	FMR1	interacting	protein	2 5
51478 HSD17B7 hydroxysteroid	17-beta	dehydrogenase	7 5
91351 DDX60L DEAD-box	helicase	60-like 5
9445 ITM2B integral	membrane	protein	2B 5
388552 BLOC1S3 biogenesis	of	lysosomal	organelles	complex	1	subunit	3 5
54809 SAMD9 sterile	alpha	motif	domain	containing	9 5
219285 SAMD9L sterile	alpha	motif	domain	containing	9	like 5
80833 APOL3 apolipoprotein	L3 5
3581 IL9R interleukin	9	receptor 5
1519 CTSO cathepsin	O 5
63935 PCIF1 PDX1	C-terminal	inhibiting	factor	1 5
8615 USO1 USO1	vesicle	transport	factor 5
1655 DDX5 DEAD-box	helicase	5 5
28968 SLC6A16 solute	carrier	family	6	member	16 5
6786 STIM1 stromal	interaction	molecule	1 5
57018 CCNL1 cyclin	L1 5
10455 ECI2 enoyl-CoA	delta	isomerase	2 5
7597 ZBTB25 zinc	finger	and	BTB	domain	containing	25 5
114769 CARD16 caspase	recruitment	domain	family	member	16 5
54891 INO80D INO80	complex	subunit	D 5
8875 VNN2 vanin	2 5
162394 SLFN5 schlafen	family	member	5 5
55196 KIAA1551 KIAA1551 5
397 ARHGDIB Rho	GDP	dissociation	inhibitor	beta 5
91526 ANKRD44 ankyrin	repeat	domain	44 5
5934 RBL2 RB	transcriptional	corepressor	like	2 5
23586 DDX58 DEXD/H-box	helicase	58 5
1388 ATF6B activating	transcription	factor	6	beta 5
10521 DDX17 DEAD-box	helicase	17 5
64771 C6orf106 chromosome	6	open	reading	frame	106 5
89848 FCHSD1 FCH	and	double	SH3	domains	1 5
9881 TRANK1 tetratricopeptide	repeat	and	ankyrin	repeat	containing	1 5
3275 PRMT2 protein	arginine	methyltransferase	2 5
7059 THBS3 thrombospondin	3 5
9976 CLEC2B C-type	lectin	domain	family	2	member	B 5
832 CAPZB capping	actin	protein	of	muscle	Z-line	beta	subunit 5
79903 NAA60 N(alpha)-acetyltransferase	60,	NatF	catalytic	subunit 5
57097 PARP11 poly(ADP-ribose)	polymerase	family	member	11 5
51000 SLC35B3 solute	carrier	family	35	member	B3 5
2633 GBP1 guanylate	binding	protein	1 5
112849 L3HYPDH trans-L-3-hydroxyproline	dehydratase 5
901 CCNG2 cyclin	G2 5
1429 CRYZ crystallin	zeta 5
3105 HLA-A major	histocompatibility	complex,	class	I,	A 5
94240 EPSTI1 epithelial	stromal	interaction	1	(breast) 5
3134 HLA-F major	histocompatibility	complex,	class	I,	F 5
11119 BTN3A1 butyrophilin	subfamily	3	member	A1 5
3139 HLA-L major	histocompatibility	complex,	class	I,	L	(pseudogene) 5
10161 LPAR6 lysophosphatidic	acid	receptor	6 5
10154 PLXNC1 plexin	C1 5
79603 CERS4 ceramide	synthase	4 5
84173 ELMOD3 ELMO	domain	containing	3 5
55837 EAPP E2F	associated	phosphoprotein 5
3107 HLA-C major	histocompatibility	complex,	class	I,	C 5
222223 KIAA1324L KIAA1324	like 5
49855 SCAPER S-phase	cyclin	A	associated	protein	in	the	ER 5
64386 MMP25 matrix	metallopeptidase	25 5
7538 ZFP36 ZFP36	ring	finger	protein 5
55437 STRADB STE20-related	kinase	adaptor	beta 5
		
161 
	
80298 MTERF2 mitochondrial	transcription	termination	factor	2 5
1025 CDK9 cyclin	dependent	kinase	9 5
4943 TBC1D25 TBC1	domain	family	member	25 5
90826 PRMT9 protein	arginine	methyltransferase	9 5
54497 HEATR5B HEAT	repeat	containing	5B 5
22878 TRAPPC8 trafficking	protein	particle	complex	8 5
1513 CTSK cathepsin	K 5
79654 HECTD3 HECT	domain	E3	ubiquitin	protein	ligase	3 5
8450 CUL4B cullin	4B 5
27241 BBS9 Bardet-Biedl	syndrome	9 5
23060 ZNF609 zinc	finger	protein	609 5
8816 DCAF5 DDB1	and	CUL4	associated	factor	5 5
84727 SPSB2 splA/ryanodine	receptor	domain	and	SOCS	box	containing	2 5
51379 CRLF3 cytokine	receptor	like	factor	3 5
3071 NCKAP1L NCK	associated	protein	1	like 5
55288 RHOT1 ras	homolog	family	member	T1 5
10444 ZER1 zyg-11	related	cell	cycle	regulator 5
842 CASP9 caspase	9 5
92 ACVR2A activin	A	receptor	type	2A 5
4690 NCK1 NCK	adaptor	protein	1 5
84307 ZNF397 zinc	finger	protein	397 5
7716 VEZF1 vascular	endothelial	zinc	finger	1 5
64091 POPDC2 popeye	domain	containing	2 5
8934 RAB29 RAB29,	member	RAS	oncogene	family 5
55283 MCOLN3 mucolipin	3 5
23588 KLHDC2 kelch	domain	containing	2 5
4600 MX2 MX	dynamin	like	GTPase	2 5
9860 LRIG2 leucine	rich	repeats	and	immunoglobulin	like	domains	2 5
7852 CXCR4 C-X-C	motif	chemokine	receptor	4 5
64109 CRLF2 cytokine	receptor-like	factor	2 5
9528 TMEM59 transmembrane	protein	59 5
2319 FLOT2 flotillin	2 5
686 BTD biotinidase 5
7046 TGFBR1 transforming	growth	factor	beta	receptor	1 5
3903 LAIR1 leukocyte	associated	immunoglobulin	like	receptor	1 5
22821 RASA3 RAS	p21	protein	activator	3 5
55070 DET1 de-etiolated	homolog	1	(Arabidopsis) 5
57184 FAM219B family	with	sequence	similarity	219	member	B 5
153241 CEP120 centrosomal	protein	120 5
25809 TTLL1 tubulin	tyrosine	ligase	like	1 5
55762 ZNF701 zinc	finger	protein	701 5
22841 RAB11FIP2 RAB11	family	interacting	protein	2 5
119504 ANAPC16 anaphase	promoting	complex	subunit	16 5
286530 P2RY8 purinergic	receptor	P2Y8 5
55080 TAPBPL TAP	binding	protein	like 5
6746 SSR2 signal	sequence	receptor	subunit	2 5
54103 GSAP gamma-secretase	activating	protein 5
79991 OBFC1 oligonucleotide/oligosaccharide	binding	fold	containing	1 5
51170 HSD17B11 hydroxysteroid	17-beta	dehydrogenase	11 5
79758 DHRS12 dehydrogenase/reductase	12 5
283897 C16orf54 chromosome	16	open	reading	frame	54 5
29978 UBQLN2 ubiquilin	2 5
139716 GAB3 GRB2	associated	binding	protein	3 5
6619 SNAPC3 small	nuclear	RNA	activating	complex	polypeptide	3 5
53347 UBASH3A ubiquitin	associated	and	SH3	domain	containing	A 5
57763 ANKRA2 ankyrin	repeat	family	A	member	2 5
6095 RORA RAR	related	orphan	receptor	A 5
6777 STAT5B signal	transducer	and	activator	of	transcription	5B 5
7182 NR2C2 nuclear	receptor	subfamily	2	group	C	member	2 5
85007 PHYKPL 5-phosphohydroxy-L-lysine	phospho-lyase 5
84765 ZNF577 zinc	finger	protein	577 5
10144 FAM13A family	with	sequence	similarity	13	member	A 5
1154 CISH cytokine	inducible	SH2	containing	protein 5
64418 TMEM168 transmembrane	protein	168 5
4689 NCF4 neutrophil	cytosolic	factor	4 5
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1520 CTSS cathepsin	S 5
59307 SIGIRR single	Ig	and	TIR	domain	containing 5
11329 STK38 serine/threonine	kinase	38 5
54440 SASH3 SAM	and	SH3	domain	containing	3 5
545 ATR ATR	serine/threonine	kinase 5
7693 ZNF134 zinc	finger	protein	134 5
10947 AP3M2 adaptor	related	protein	complex	3	mu	2	subunit 5
728743 LOC728743 zinc	finger	protein	pseudogene 5
7311 UBA52 ubiquitin	A-52	residue	ribosomal	protein	fusion	product	1 5
55357 TBC1D2 TBC1	domain	family	member	2 5
6468 FBXW4 F-box	and	WD	repeat	domain	containing	4 5
8698 S1PR4 sphingosine-1-phosphate	receptor	4 5
204851 HIPK1 homeodomain	interacting	protein	kinase	1 5
54778 RNF111 ring	finger	protein	111 5
84532 ACSS1 acyl-CoA	synthetase	short-chain	family	member	1 5
80335 WDR82 WD	repeat	domain	82 5
9905 SGSM2 small	G	protein	signaling	modulator	2 5
4242 MFNG MFNG	O-fucosylpeptide	3-beta-N-acetylglucosaminyltransferase 5
388324 INCA1 inhibitor	of	CDK,	cyclin	A1	interacting	protein	1 5
57567 ZNF319 zinc	finger	protein	319 5
25992 SNED1 sushi,	nidogen	and	EGF	like	domains	1 5
79717 PPCS phosphopantothenoylcysteine	synthetase 5
51091 SEPSECS Sep	(O-phosphoserine)	tRNA:Sec	(selenocysteine)	tRNA	synthase 5
55846 ITFG2 integrin	alpha	FG-GAP	repeat	containing	2 5
64174 DPEP2 dipeptidase	2 5
9834 FAM30A family	with	sequence	similarity	30,	member	A 5
24142 NAT6 N-acetyltransferase	6 5
57181 SLC39A10 solute	carrier	family	39	member	10 5
374986 MIGA1 mitoguardin	1 5
847 CAT catalase 5
9842 PLEKHM1 pleckstrin	homology	and	RUN	domain	containing	M1 5
66035 SLC2A11 solute	carrier	family	2	member	11 5
6872 TAF1 TATA-box	binding	protein	associated	factor	1 5
80230 RUFY1 RUN	and	FYVE	domain	containing	1 5
259290 TAS2R31 taste	2	receptor	member	31 5
51291 GMIP GEM	interacting	protein 5
25900 IFFO1 intermediate	filament	family	orphan	1 5
9736 USP34 ubiquitin	specific	peptidase	34 5
5494 PPM1A protein	phosphatase,	Mg2+/Mn2+	dependent	1A 5
83874 TBC1D10A TBC1	domain	family	member	10A 5
5287 PIK3C2B phosphatidylinositol-4-phosphate	3-kinase	catalytic	subunit	type	2	beta 5
53373 TPCN1 two	pore	segment	channel	1 5
96459 FNIP1 folliculin	interacting	protein	1 5
51592 TRIM33 tripartite	motif	containing	33 5
8720 MBTPS1 membrane	bound	transcription	factor	peptidase,	site	1 5
23167 EFR3A EFR3	homolog	A 5
221491 C6orf1 chromosome	6	open	reading	frame	1 5
887 CCKBR cholecystokinin	B	receptor 5
1509 CTSD cathepsin	D 5
283149 BCL9L B-cell	CLL/lymphoma	9-like 5
6239 RREB1 ras	responsive	element	binding	protein	1 5
6497 SKI SKI	proto-oncogene 5
7745 ZKSCAN8 zinc	finger	with	KRAB	and	SCAN	domains	8 5
23389 MED13L mediator	complex	subunit	13	like 5
8289 ARID1A AT-rich	interaction	domain	1A 5
324 APC APC,	WNT	signaling	pathway	regulator 5
4750 NEK1 NIMA	related	kinase	1 5
89845 ABCC10 ATP	binding	cassette	subfamily	C	member	10 5
5058 PAK1 p21	(RAC1)	activated	kinase	1 5
4680 CEACAM6 carcinoembryonic	antigen	related	cell	adhesion	molecule	6 5
1773 DNASE1 deoxyribonuclease	1 5
64219 PJA1 praja	ring	finger	ubiquitin	ligase	1 5
23339 VPS39 VPS39,	HOPS	complex	subunit 5
57610 RANBP10 RAN	binding	protein	10 5
80124 VCPIP1 valosin	containing	protein	interacting	protein	1 5
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143 PARP4 poly(ADP-ribose)	polymerase	family	member	4 5
9682 KDM4A lysine	demethylase	4A 5
55088 CCDC186 coiled-coil	domain	containing	186 5
23398 PPWD1 peptidylprolyl	isomerase	domain	and	WD	repeat	containing	1 5
59348 ZNF350 zinc	finger	protein	350 5
57674 RNF213 ring	finger	protein	213 5
9583 ENTPD4 ectonucleoside	triphosphate	diphosphohydrolase	4 5
100506736 SLFN12L schlafen	family	member	12	like 5
55667 DENND4C DENN	domain	containing	4C 5
123283 TARSL2 threonyl-tRNA	synthetase	like	2 5
843 CASP10 caspase	10 5
102724748 LOC102724748 uncharacterized	LOC102724748 5
100506639 LOC100506639 uncharacterized	LOC100506639 5
7328 UBE2H ubiquitin	conjugating	enzyme	E2	H 5
9168 TMSB10 thymosin	beta	10 5
84861 KLHL22 kelch	like	family	member	22 5
26157 GIMAP2 GTPase,	IMAP	family	member	2 5
8445 DYRK2 dual	specificity	tyrosine	phosphorylation	regulated	kinase	2 5
80256 FAM214B family	with	sequence	similarity	214	member	B 5
116843 SLC18B1 solute	carrier	family	18	member	B1 5
10077 TSPAN32 tetraspanin	32 5
4189 DNAJB9 DnaJ	heat	shock	protein	family	(Hsp40)	member	B9 5
100505761 RPARP-AS1 RPARP	antisense	RNA	1 5
79573 TTC13 tetratricopeptide	repeat	domain	13 5
9214 FCMR Fc	fragment	of	IgM	receptor 5
84265 POLR3GL RNA	polymerase	III	subunit	G	like 5
6167 RPL37 ribosomal	protein	L37 5
79722 ANKRD55 ankyrin	repeat	domain	55 5
130814 PQLC3 PQ	loop	repeat	containing	3 5
9692 KIAA0391 KIAA0391 5
51449 PCYOX1 prenylcysteine	oxidase	1 5
64919 BCL11B B-cell	CLL/lymphoma	11B 5
84264 HAGHL hydroxyacylglutathione	hydrolase-like 5
221908 PPP1R35 protein	phosphatase	1	regulatory	subunit	35 5
125958 OR7D4 olfactory	receptor	family	7	subfamily	D	member	4 5
6169 RPL38 ribosomal	protein	L38 5
116093 DIRC1 disrupted	in	renal	carcinoma	1 5
57719 ANO8 anoctamin	8 5
283726 SAXO2 stabilizer	of	axonemal	microtubules	2 5
11156 PTP4A3 protein	tyrosine	phosphatase	type	IVA,	member	3 5
58473 PLEKHB1 pleckstrin	homology	domain	containing	B1 5
92714 ARRDC1 arrestin	domain	containing	1 5
55707 NECAP2 NECAP	endocytosis	associated	2 5
79699 ZYG11B zyg-11	family	member	B,	cell	cycle	regulator 5
5465 PPARA peroxisome	proliferator	activated	receptor	alpha 5
54916 TMEM260 transmembrane	protein	260 5
283232 TMEM80 transmembrane	protein	80 5
285268 ZNF621 zinc	finger	protein	621 5
57194 ATP10A ATPase	phospholipid	transporting	10A	(putative) 5
63035 BCORL1 BCL6	corepressor-like	1 5
321 APBA2 amyloid	beta	precursor	protein	binding	family	A	member	2 5
9919 SEC16A SEC16	homolog	A,	endoplasmic	reticulum	export	factor 5
56242 ZNF253 zinc	finger	protein	253 5
10235 RASGRP2 RAS	guanyl	releasing	protein	2 5
9827 RGP1 RGP1	homolog,	RAB6A	GEF	complex	partner	1 5
7673 ZNF222 zinc	finger	protein	222 5
51279 C1RL complement	C1r	subcomponent	like 5
84925 DIRC2 disrupted	in	renal	carcinoma	2 5
10801 SEPT9 septin	9 5
51763 INPP5K inositol	polyphosphate-5-phosphatase	K 5
22864 R3HDM2 R3H	domain	containing	2 5
51063 CALHM2 calcium	homeostasis	modulator	2 5
163882 CNST consortin,	connexin	sorting	protein 5
254531 LPCAT4 lysophosphatidylcholine	acyltransferase	4 5
90273 CEACAM21 carcinoembryonic	antigen	related	cell	adhesion	molecule	21 5
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84142 FAM175A family	with	sequence	similarity	175	member	A 5
23102 TBC1D2B TBC1	domain	family	member	2B 5
50717 DCAF8 DDB1	and	CUL4	associated	factor	8 5
84447 SYVN1 synoviolin	1 5
84897 TBRG1 transforming	growth	factor	beta	regulator	1 5
9451 EIF2AK3 eukaryotic	translation	initiation	factor	2	alpha	kinase	3 5
8621 CDK13 cyclin	dependent	kinase	13 5
155435 RBM33 RNA	binding	motif	protein	33 5
359845 RFLNB refilin	B 5
8535 CBX4 chromobox	4 5
79037 PVRIG poliovirus	receptor	related	immunoglobulin	domain	containing 5
80169 CTC1 CTS	telomere	maintenance	complex	component	1 5
3678 ITGA5 integrin	subunit	alpha	5 5
256987 SERINC5 serine	incorporator	5 5
54462 CCSER2 coiled-coil	serine	rich	protein	2 5
8527 DGKD diacylglycerol	kinase	delta 5
9149 DYRK1B dual	specificity	tyrosine	phosphorylation	regulated	kinase	1B 5
246744 STH saitohin 5
162515 SLC16A11 solute	carrier	family	16	member	11 5
348378 FAM159A family	with	sequence	similarity	159	member	A 5
92840 REEP6 receptor	accessory	protein	6 5
8665 EIF3F eukaryotic	translation	initiation	factor	3	subunit	F 5
393 ARHGAP4 Rho	GTPase	activating	protein	4 5
84836 ABHD14B abhydrolase	domain	containing	14B 5
9788 MTSS1 MTSS1,	I-BAR	domain	containing 5
113878 DTX2 deltex	E3	ubiquitin	ligase	2 5
51092 SIDT2 SID1	transmembrane	family	member	2 5
23295 MGRN1 mahogunin	ring	finger	1 5
401944 LDLRAD2 low	density	lipoprotein	receptor	class	A	domain	containing	2 5
11322 TMC6 transmembrane	channel	like	6 5
168620 BHLHA15 basic	helix-loop-helix	family	member	a15 5
84270 CARD19 caspase	recruitment	domain	family	member	19 5
151176 ERFE erythroferrone 5
84266 ALKBH7 alkB	homolog	7 5
7508 XPC XPC	complex	subunit,	DNA	damage	recognition	and	repair	factor 5
199746 U2AF1L4 U2	small	nuclear	RNA	auxiliary	factor	1	like	4 5
10043 TOM1 target	of	myb1	membrane	trafficking	protein 5
4696 NDUFA3 NADH:ubiquinone	oxidoreductase	subunit	A3 5
9498 SLC4A8 solute	carrier	family	4	member	8 5
3611 ILK integrin	linked	kinase 5
6160 RPL31 ribosomal	protein	L31 5
283450 HECTD4 HECT	domain	E3	ubiquitin	protein	ligase	4 5
105371397 LOC105371397 uncharacterized	LOC105371397 5
197358 NLRC3 NLR	family	CARD	domain	containing	3 5
6122 RPL3 ribosomal	protein	L3 5
30815 ST6GALNAC6 ST6	N-acetylgalactosaminide	alpha-2,6-sialyltransferase	6 5
9022 CLIC3 chloride	intracellular	channel	3 5
56260 C8orf44 chromosome	8	open	reading	frame	44 5
5663 PSEN1 presenilin	1 5
23177 CEP68 centrosomal	protein	68 5
9397 NMT2 N-myristoyltransferase	2 5
10868 USP20 ubiquitin	specific	peptidase	20 5
1107 CHD3 chromodomain	helicase	DNA	binding	protein	3 5
26112 CCDC69 coiled-coil	domain	containing	69 5
115992 RNF166 ring	finger	protein	166 5
51393 TRPV2 transient	receptor	potential	cation	channel	subfamily	V	member	2 5
55229 PANK4 pantothenate	kinase	4 5
113791 PIK3IP1 phosphoinositide-3-kinase	interacting	protein	1 5
92017 SNX29 sorting	nexin	29 5
80095 ZNF606 zinc	finger	protein	606 5
51646 YPEL5 yippee	like	5 5
3476 IGBP1 immunoglobulin	(CD79A)	binding	protein	1 5
22997 IGSF9B immunoglobulin	superfamily	member	9B 5
5790 PTPRCAP protein	tyrosine	phosphatase,	receptor	type	C	associated	protein 5
951 CD37 CD37	molecule 5
		
165 
	
22861 NLRP1 NLR	family	pyrin	domain	containing	1 5
170622 COMMD6 COMM	domain	containing	6 5
2124 EVI2B ecotropic	viral	integration	site	2B 5
10346 TRIM22 tripartite	motif	containing	22 5
151556 GPR155 G	protein-coupled	receptor	155 5
50515 CHST11 carbohydrate	sulfotransferase	11 5
472 ATM ATM	serine/threonine	kinase 5
7626 ZNF75D zinc	finger	protein	75D 5
7294 TXK TXK	tyrosine	kinase 5
10957 PNRC1 proline	rich	nuclear	receptor	coactivator	1 5
339210 C17orf67 chromosome	17	open	reading	frame	67 5
51466 EVL Enah/Vasp-like 5
9750 FAM65B family	with	sequence	similarity	65	member	B 5
5140 PDE3B phosphodiesterase	3B 5
4300 MLLT3 MLLT3,	super	elongation	complex	subunit 5
5252 PHF1 PHD	finger	protein	1 5
5330 PLCB2 phospholipase	C	beta	2 5
4118 MAL mal,	T-cell	differentiation	protein 5
63940 GPSM3 G-protein	signaling	modulator	3 5
645432 ARRDC5 arrestin	domain	containing	5 5
3932 LCK LCK	proto-oncogene,	Src	family	tyrosine	kinase 5
255394 TCP11L2 t-complex	11	like	2 5
80853 KDM7A lysine	demethylase	7A 5
140688 NOL4L nucleolar	protein	4	like 5
55643 BTBD2 BTB	domain	containing	2 5
6277 S100A6 S100	calcium	binding	protein	A6 5
5800 PTPRO protein	tyrosine	phosphatase,	receptor	type	O 5
126375 ZNF792 zinc	finger	protein	792 5
64761 PARP12 poly(ADP-ribose)	polymerase	family	member	12 5
51614 ERGIC3 ERGIC	and	golgi	3 5
90592 ZNF700 zinc	finger	protein	700 5
66008 TRAK2 trafficking	kinesin	protein	2 5
64332 NFKBIZ NFKB	inhibitor	zeta 5
9710 KIAA0355 KIAA0355 5
54665 RSBN1 round	spermatid	basic	protein	1 5
9382 COG1 component	of	oligomeric	golgi	complex	1 5
22839 DLGAP4 DLG	associated	protein	4 5
11035 RIPK3 receptor	interacting	serine/threonine	kinase	3 5
57639 CCDC146 coiled-coil	domain	containing	146 5
23152 CIC capicua	transcriptional	repressor 5
113177 IZUMO4 IZUMO	family	member	4 5
55568 GALNT10 polypeptide	N-acetylgalactosaminyltransferase	10 5
84101 USP44 ubiquitin	specific	peptidase	44 5
85378 TUBGCP6 tubulin	gamma	complex	associated	protein	6 5
10673 TNFSF13B tumor	necrosis	factor	superfamily	member	13b 5
54674 LRRN3 leucine	rich	repeat	neuronal	3 5
6282 S100A11 S100	calcium	binding	protein	A11 5
53827 FXYD5 FXYD	domain	containing	ion	transport	regulator	5 5
79864 C11orf63 chromosome	11	open	reading	frame	63 5
57060 PCBP4 poly(rC)	binding	protein	4 5
3566 IL4R interleukin	4	receptor 5
50650 ARHGEF3 Rho	guanine	nucleotide	exchange	factor	3 5
64393 ZMAT3 zinc	finger	matrin-type	3 5
5147 PDE6D phosphodiesterase	6D 5
491 ATP2B2 ATPase	plasma	membrane	Ca2+	transporting	2 5
129293 TRABD2A TraB	domain	containing	2A 5
284802 FRG1BP FSHD	region	gene	1	family	member	B,	pseudogene 5
3702 ITK IL2	inducible	T-cell	kinase 5
23253 ANKRD12 ankyrin	repeat	domain	12 5
5788 PTPRC protein	tyrosine	phosphatase,	receptor	type	C 5
23471 TRAM1 translocation	associated	membrane	protein	1 5
84910 TMEM87B transmembrane	protein	87B 5
50848 F11R F11	receptor 5
4154 MBNL1 muscleblind	like	splicing	regulator	1 5
9595 CYTIP cytohesin	1	interacting	protein 5
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57591 MKL1 megakaryoblastic	leukemia	(translocation)	1 5
1386 ATF2 activating	transcription	factor	2 5
5324 PLAG1 PLAG1	zinc	finger 5
9781 RNF144A ring	finger	protein	144A 5
284058 KANSL1 KAT8	regulatory	NSL	complex	subunit	1 5
9663 LPIN2 lipin	2 5
23522 KAT6B lysine	acetyltransferase	6B 5
814 CAMK4 calcium/calmodulin	dependent	protein	kinase	IV 5
406 ARNTL aryl	hydrocarbon	receptor	nuclear	translocator	like 5
143686 SESN3 sestrin	3 5
10225 CD96 CD96	molecule 5
9262 STK17B serine/threonine	kinase	17b 5
6206 RPS12 ribosomal	protein	S12 5
3937 LCP2 lymphocyte	cytosolic	protein	2 5
8031 NCOA4 nuclear	receptor	coactivator	4 5
10142 AKAP9 A-kinase	anchoring	protein	9 5
22848 AAK1 AP2	associated	kinase	1 5
129607 CMPK2 cytidine/uridine	monophosphate	kinase	2 5
113612 CYP2U1 cytochrome	P450	family	2	subfamily	U	member	1 5
1508 CTSB cathepsin	B 5
18 ABAT 4-aminobutyrate	aminotransferase 5
391191 OR2AK2 olfactory	receptor	family	2	subfamily	AK	member	2 5
55664 CDC37L1 cell	division	cycle	37	like	1 5
5334 PLCL1 phospholipase	C	like	1 5
6940 ZNF354A zinc	finger	protein	354A 5
116986 AGAP2 ArfGAP	with	GTPase	domain,	ankyrin	repeat	and	PH	domain	2 5
3588 IL10RB interleukin	10	receptor	subunit	beta 5
23064 SETX senataxin 5
2771 GNAI2 G	protein	subunit	alpha	i2 5
26054 SENP6 SUMO1/sentrin	specific	peptidase	6 5
408 ARRB1 arrestin	beta	1 5
9770 RASSF2 Ras	association	domain	family	member	2 5
54832 VPS13C vacuolar	protein	sorting	13	homolog	C 5
149951 COMMD7 COMM	domain	containing	7 5
54469 ZFAND6 zinc	finger	AN1-type	containing	6 5
7188 TRAF5 TNF	receptor	associated	factor	5 5
399 RHOH ras	homolog	family	member	H 5
60313 GPBP1L1 GC-rich	promoter	binding	protein	1	like	1 5
4478 MSN moesin 5
91543 RSAD2 radical	S-adenosyl	methionine	domain	containing	2 5
115362 GBP5 guanylate	binding	protein	5 5
29761 USP25 ubiquitin	specific	peptidase	25 5
399665 FAM102A family	with	sequence	similarity	102	member	A 5
80709 AKNA AT-hook	transcription	factor 5
3603 IL16 interleukin	16 5
64098 PARVG parvin	gamma 5
64839 FBXL17 F-box	and	leucine	rich	repeat	protein	17 5
9263 STK17A serine/threonine	kinase	17a 5
51176 LEF1 lymphoid	enhancer	binding	factor	1 5
9641 IKBKE inhibitor	of	kappa	light	polypeptide	gene	enhancer	in	B-cells,	kinase	epsilon 5
27250 PDCD4 programmed	cell	death	4	(neoplastic	transformation	inhibitor) 5
9402 GRAP2 GRB2-related	adaptor	protein	2 5
197131 UBR1 ubiquitin	protein	ligase	E3	component	n-recognin	1 5
26137 ZBTB20 zinc	finger	and	BTB	domain	containing	20 5
51201 ZDHHC2 zinc	finger	DHHC-type	containing	2 5
23112 TNRC6B trinucleotide	repeat	containing	6B 5
11046 SLC35D2 solute	carrier	family	35	member	D2 5
9665 KIAA0430 KIAA0430 5
151050 KANSL1L KAT8	regulatory	NSL	complex	subunit	1	like 5
7805 LAPTM5 lysosomal	protein	transmembrane	5 5
115294 PCMTD1 protein-L-isoaspartate	(D-aspartate)	O-methyltransferase	domain	containing	1 5
10443 N4BP2L2 NEDD4	binding	protein	2	like	2 5
89846 FGD3 FYVE,	RhoGEF	and	PH	domain	containing	3 5
822 CAPG capping	actin	protein,	gelsolin	like 5
83605 CCM2 CCM2	scaffolding	protein 5
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83719 YPEL3 yippee	like	3 5
157697 ERICH1 glutamate	rich	1 5
79090 TRAPPC6A trafficking	protein	particle	complex	6A 5
60682 SMAP1 small	ArfGAP	1 5
57561 ARRDC3 arrestin	domain	containing	3 5
23348 DOCK9 dedicator	of	cytokinesis	9 5
6904 TBCD tubulin	folding	cofactor	D 5
375056 MIA3 MIA	family	member	3,	ER	export	factor 5
9877 ZC3H11A zinc	finger	CCCH-type	containing	11A 5
10608 MXD4 MAX	dimerization	protein	4 5
112936 VPS26B VPS26,	retromer	complex	component	B 5
92241 RCSD1 RCSD	domain	containing	1 5
6709 SPTAN1 spectrin	alpha,	non-erythrocytic	1 5
643866 CBLN3 cerebellin	3	precursor 5
9857 CEP350 centrosomal	protein	350 5
57134 MAN1C1 mannosidase	alpha	class	1C	member	1 5
81688 C6orf62 chromosome	6	open	reading	frame	62 5
9459 ARHGEF6 Rac/Cdc42	guanine	nucleotide	exchange	factor	6 5
2113 ETS1 ETS	proto-oncogene	1,	transcription	factor 5
23118 TAB2 TGF-beta	activated	kinase	1/MAP3K7	binding	protein	2 5
7267 TTC3 tetratricopeptide	repeat	domain	3 5
54014 BRWD1 bromodomain	and	WD	repeat	domain	containing	1 5
157680 VPS13B vacuolar	protein	sorting	13	homolog	B 5
4863 NPAT nuclear	protein,	coactivator	of	histone	transcription 5
9563 H6PD hexose-6-phosphate	dehydrogenase/glucose	1-dehydrogenase 5
4650 MYO9B myosin	IXB 5
6655 SOS2 SOS	Ras/Rho	guanine	nucleotide	exchange	factor	2 5
7535 ZAP70 zeta	chain	of	T	cell	receptor	associated	protein	kinase	70 5
23240 KIAA0922 KIAA0922 5
57459 GATAD2B GATA	zinc	finger	domain	containing	2B 5
311 ANXA11 annexin	A11 5
54800 KLHL24 kelch	like	family	member	24 5
114823 LENG8 leukocyte	receptor	cluster	member	8 5
10659 CELF2 CUGBP,	Elav-like	family	member	2 5
57551 TAOK1 TAO	kinase	1 5
9815 GIT2 GIT	ArfGAP	2 5
56261 GPCPD1 glycerophosphocholine	phosphodiesterase	1 5
50619 DEF6 DEF6,	guanine	nucleotide	exchange	factor 5
387082 SUMO4 small	ubiquitin-like	modifier	4 5
170954 PPP1R18 protein	phosphatase	1	regulatory	subunit	18 5
23031 MAST3 microtubule	associated	serine/threonine	kinase	3 5
7764 ZNF217 zinc	finger	protein	217 5
9139 CBFA2T2 CBFA2/RUNX1	translocation	partner	2 5
23508 TTC9 tetratricopeptide	repeat	domain	9 5
64131 XYLT1 xylosyltransferase	1 5
57594 HOMEZ homeobox	and	leucine	zipper	encoding 5
55526 DHTKD1 dehydrogenase	E1	and	transketolase	domain	containing	1 5
57506 MAVS mitochondrial	antiviral	signaling	protein 5
55780 ERMARD ER	membrane	associated	RNA	degradation 5
387119 CEP85L centrosomal	protein	85	like 5
57492 ARID1B AT-rich	interaction	domain	1B 5
84726 PRRC2B proline	rich	coiled-coil	2B 5
123720 WHAMM WAS	protein	homolog	associated	with	actin,	golgi	membranes	and	microtubules 5
9138 ARHGEF1 Rho	guanine	nucleotide	exchange	factor	1 5
10401 PIAS3 protein	inhibitor	of	activated	STAT	3 5
57038 RARS2 arginyl-tRNA	synthetase	2,	mitochondrial 5
283219 KCTD21 potassium	channel	tetramerization	domain	containing	21 5
103910 MYL12B myosin	light	chain	12B 5
51084 CRYL1 crystallin	lambda	1 5
79982 DNAJB14 DnaJ	heat	shock	protein	family	(Hsp40)	member	B14 5
90324 CCDC97 coiled-coil	domain	containing	97 5
374868 ATP9B ATPase	phospholipid	transporting	9B	(putative) 5
80146 UXS1 UDP-glucuronate	decarboxylase	1 5
138050 HGSNAT heparan-alpha-glucosaminide	N-acetyltransferase 5
54467 ANKIB1 ankyrin	repeat	and	IBR	domain	containing	1 5
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80232 WDR26 WD	repeat	domain	26 5
1785 DNM2 dynamin	2 5
9266 CYTH2 cytohesin	2 5
9870 AREL1 apoptosis	resistant	E3	ubiquitin	protein	ligase	1 5
93663 ARHGAP18 Rho	GTPase	activating	protein	18 5
80790 CMIP c-Maf	inducing	protein 5
752 FMNL1 formin	like	1 5
10180 RBM6 RNA	binding	motif	protein	6 5
23048 FNBP1 formin	binding	protein	1 5
374879 ZNF699 zinc	finger	protein	699 5
54838 WBP1L WW	domain	binding	protein	1-like 5
167153 PAPD4 poly(A)	RNA	polymerase	D4,	non-canonical 5
132864 CPEB2 cytoplasmic	polyadenylation	element	binding	protein	2 5
10618 TGOLN2 trans-golgi	network	protein	2 5
5978 REST RE1	silencing	transcription	factor 5
54454 ATAD2B ATPase	family,	AAA	domain	containing	2B 5
221322 TBC1D32 TBC1	domain	family	member	32 5
107987150 5
55716 LMBR1L limb	development	membrane	protein	1	like 5
5291 PIK3CB phosphatidylinositol-4,5-bisphosphate	3-kinase	catalytic	subunit	beta 5
55763 EXOC1 exocyst	complex	component	1 5
83989 FAM172A family	with	sequence	similarity	172	member	A 5
23181 DIP2A disco	interacting	protein	2	homolog	A 5
197135 PATL2 PAT1	homolog	2 5
9813 EFCAB14 EF-hand	calcium	binding	domain	14 5
55073 LRRC37A4P leucine	rich	repeat	containing	37	member	A4,	pseudogene 5
83752 LONP2 lon	peptidase	2,	peroxisomal 5
84181 CHD6 chromodomain	helicase	DNA	binding	protein	6 5
29072 SETD2 SET	domain	containing	2 5
8850 KAT2B lysine	acetyltransferase	2B 5
11176 BAZ2A bromodomain	adjacent	to	zinc	finger	domain	2A 5
27436 EML4 echinoderm	microtubule	associated	protein	like	4 5
64224 HERPUD2 HERPUD	family	member	2 5
84678 KDM2B lysine	demethylase	2B 5
91749 MFSD4B major	facilitator	superfamily	domain	containing	4B 5
9439 MED23 mediator	complex	subunit	23 5
55761 TTC17 tetratricopeptide	repeat	domain	17 5
7110 TMF1 TATA	element	modulatory	factor	1 5
3683 ITGAL integrin	subunit	alpha	L 5
80821 DDHD1 DDHD	domain	containing	1 5
51742 ARID4B AT-rich	interaction	domain	4B 5
94103 ORMDL3 ORMDL	sphingolipid	biosynthesis	regulator	3 5
51161 C3orf18 chromosome	3	open	reading	frame	18 5
23228 PLCL2 phospholipase	C	like	2 5
146057 TTBK2 tau	tubulin	kinase	2 5
10260 DENND4A DENN	domain	containing	4A 5
79979 TRMT2B tRNA	methyltransferase	2	homolog	B 5
23347 SMCHD1 structural	maintenance	of	chromosomes	flexible	hinge	domain	containing	1 5
259293 TAS2R30 taste	2	receptor	member	30 5
7072 TIA1 TIA1	cytotoxic	granule	associated	RNA	binding	protein 5
57474 ZNF490 zinc	finger	protein	490 5
79048 SECISBP2 SECIS	binding	protein	2 5
23081 KDM4C lysine	demethylase	4C 5
161176 SYNE3 spectrin	repeat	containing	nuclear	envelope	family	member	3 5
5095 PCCA propionyl-CoA	carboxylase	alpha	subunit 5
79618 HMBOX1 homeobox	containing	1 5
9731 CEP104 centrosomal	protein	104 5
50804 MYEF2 myelin	expression	factor	2 5
64236 PDLIM2 PDZ	and	LIM	domain	2 5
10956 OS9 OS9,	endoplasmic	reticulum	lectin 5
9517 SPTLC2 serine	palmitoyltransferase	long	chain	base	subunit	2 5
5294 PIK3CG phosphatidylinositol-4,5-bisphosphate	3-kinase	catalytic	subunit	gamma 5
55062 WIPI1 WD	repeat	domain,	phosphoinositide	interacting	1 5
64895 PAPOLG poly(A)	polymerase	gamma 5
55106 SLFN12 schlafen	family	member	12 5
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9170 LPAR2 lysophosphatidic	acid	receptor	2 5
85315 PAQR8 progestin	and	adipoQ	receptor	family	member	8 5
222484 LNX2 ligand	of	numb-protein	X	2 5
1739 DLG1 discs	large	MAGUK	scaffold	protein	1 5
6480 ST6GAL1 ST6	beta-galactoside	alpha-2,6-sialyltransferase	1 5
9968 MED12 mediator	complex	subunit	12 5
54625 PARP14 poly(ADP-ribose)	polymerase	family	member	14 5
25851 TECPR1 tectonin	beta-propeller	repeat	containing	1 5
55008 HERC6 HECT	and	RLD	domain	containing	E3	ubiquitin	protein	ligase	family	member	6 5
22828 SCAF8 SR-related	CTD	associated	factor	8 5
5862 RAB2A RAB2A,	member	RAS	oncogene	family 5
9525 VPS4B vacuolar	protein	sorting	4	homolog	B 5
115361 GBP4 guanylate	binding	protein	4 5
57020 C16orf62 chromosome	16	open	reading	frame	62 5
93349 SP140L SP140	nuclear	body	protein	like 5
6464 SHC1 SHC	adaptor	protein	1 5
55601 DDX60 DEXD/H-box	helicase	60 5
22887 FOXJ3 forkhead	box	J3 5
5870 RAB6A RAB6A,	member	RAS	oncogene	family 5
30061 SLC40A1 solute	carrier	family	40	member	1 5
201799 TMEM154 transmembrane	protein	154 5
80063 ATF7IP2 activating	transcription	factor	7	interacting	protein	2 5
149086 LINC01225 long	intergenic	non-protein	coding	RNA	1225 5
4033 LRMP lymphoid	restricted	membrane	protein 5
55770 EXOC2 exocyst	complex	component	2 5
3575 IL7R interleukin	7	receptor 5
7494 XBP1 X-box	binding	protein	1 5
10320 IKZF1 IKAROS	family	zinc	finger	1 5
51149 C5orf45 chromosome	5	open	reading	frame	45 5
7562 ZNF708 zinc	finger	protein	708 5
80012 PHC3 polyhomeotic	homolog	3 5
637 BID BH3	interacting	domain	death	agonist 5
3059 HCLS1 hematopoietic	cell-specific	Lyn	substrate	1 5
80008 TMEM156 transmembrane	protein	156 5
79893 GGNBP2 gametogenetin	binding	protein	2 5
11016 ATF7 activating	transcription	factor	7 5
80167 ABHD18 abhydrolase	domain	containing	18 5
1385 CREB1 cAMP	responsive	element	binding	protein	1 5
64864 RFX7 regulatory	factor	X7 5
114908 TMEM123 transmembrane	protein	123 5
56990 CDC42SE2 CDC42	small	effector	2 5
84923 FAM104A family	with	sequence	similarity	104	member	A 5
10097 ACTR2 ARP2	actin	related	protein	2	homolog 5
223082 ZNRF2 zinc	and	ring	finger	2 5
80705 TSGA10 testis	specific	10 5
79970 ZNF767P zinc	finger	family	member	767,	pseudogene 5
22882 ZHX2 zinc	fingers	and	homeoboxes	2 5
83548 COG3 component	of	oligomeric	golgi	complex	3 5
4891 SLC11A2 solute	carrier	family	11	member	2 5
56650 CLDND1 claudin	domain	containing	1 5
9235 IL32 interleukin	32 5
23533 PIK3R5 phosphoinositide-3-kinase	regulatory	subunit	5 5
8674 VAMP4 vesicle	associated	membrane	protein	4 5
55303 GIMAP4 GTPase,	IMAP	family	member	4 5
3676 ITGA4 integrin	subunit	alpha	4 5
1048 CEACAM5 carcinoembryonic	antigen	related	cell	adhesion	molecule	5 5
6251 RSU1 Ras	suppressor	protein	1 5
596 BCL2 BCL2,	apoptosis	regulator 5
137872 ADHFE1 alcohol	dehydrogenase,	iron	containing	1 5
120 ADD3 adducin	3 5
7454 WAS Wiskott-Aldrich	syndrome 5
283537 SLC46A3 solute	carrier	family	46	member	3 5
79830 ZMYM1 zinc	finger	MYM-type	containing	1 5
81558 FAM117A family	with	sequence	similarity	117	member	A 5
22890 ZBTB1 zinc	finger	and	BTB	domain	containing	1 5
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122773 KLHDC1 kelch	domain	containing	1 5
54893 MTMR10 myotubularin	related	protein	10 5
10068 IL18BP interleukin	18	binding	protein 5
90634 N4BP2L1 NEDD4	binding	protein	2	like	1 5
50618 ITSN2 intersectin	2 5
1060 CENPC centromere	protein	C 5
130872 AHSA2 AHA1,	activator	of	heat	shock	90kDa	protein	ATPase	homolog	2	(yeast) 5
146691 TOM1L2 target	of	myb1	like	2	membrane	trafficking	protein 5
2595 GANC glucosidase	alpha,	neutral	C 5
116068 LYSMD3 LysM	domain	containing	3 5
54557 SGTB small	glutamine	rich	tetratricopeptide	repeat	containing	beta 5
98 ACYP2 acylphosphatase	2 5
2946 GSTM2 glutathione	S-transferase	mu	2 5
9786 KIAA0586 KIAA0586 5
196441 ZFC3H1 zinc	finger	C3H1-type	containing 5
5567 PRKACB protein	kinase	cAMP-activated	catalytic	subunit	beta 5
205717 USF3 upstream	transcription	factor	family	member	3 5
65981 CAPRIN2 caprin	family	member	2 5
25956 SEC31B SEC31	homolog	B,	COPII	coat	complex	component 5
401494 HACD4 3-hydroxyacyl-CoA	dehydratase	4 5
25988 HINFP histone	H4	transcription	factor 5
57035 RSRP1 arginine	and	serine	rich	protein	1 5
133418 EMB embigin 5
6793 STK10 serine/threonine	kinase	10 5
10905 MAN1A2 mannosidase	alpha	class	1A	member	2 5
92822 ZNF276 zinc	finger	protein	276 5
9910 RABGAP1L RAB	GTPase	activating	protein	1	like 5
94039 ZNF101 zinc	finger	protein	101 5
84450 ZNF512 zinc	finger	protein	512 5
2734 GLG1 golgi	glycoprotein	1 5
26091 HERC4 HECT	and	RLD	domain	containing	E3	ubiquitin	protein	ligase	4 5
101928361 LOC101928361 uncharacterized	LOC101928361 5
23043 TNIK TRAF2	and	NCK	interacting	kinase 5
147657 ZNF480 zinc	finger	protein	480 5
64921 CASD1 CAS1	domain	containing	1 5
867 CBL Cbl	proto-oncogene 5
55904 KMT2E lysine	methyltransferase	2E 5
55680 RUFY2 RUN	and	FYVE	domain	containing	2 5
23469 PHF3 PHD	finger	protein	3 5
1803 DPP4 dipeptidyl	peptidase	4 5
128077 LIX1L limb	and	CNS	expressed	1	like 5
5305 PIP4K2A phosphatidylinositol-5-phosphate	4-kinase	type	2	alpha 5
192669 AGO3 argonaute	3,	RISC	catalytic	component 5
80055 PGAP1 post-GPI	attachment	to	proteins	1 5
440193 CCDC88C coiled-coil	domain	containing	88C 5
79956 ERMP1 endoplasmic	reticulum	metallopeptidase	1 5
440345 NPIPB4 nuclear	pore	complex	interacting	protein	family	member	B4 5
23224 SYNE2 spectrin	repeat	containing	nuclear	envelope	protein	2 5
11276 SYNRG synergin	gamma 5
114659 LRRC37B leucine	rich	repeat	containing	37B 5
225 ABCD2 ATP	binding	cassette	subfamily	D	member	2 5
55823 VPS11 VPS11,	CORVET/HOPS	core	subunit 5
55843 ARHGAP15 Rho	GTPase	activating	protein	15 5
342371 ATXN1L ataxin	1	like 5
55754 TMEM30A transmembrane	protein	30A 5
83464 APH1B aph-1	homolog	B,	gamma-secretase	subunit 5
641339 ZNF674 zinc	finger	protein	674 5
23360 FNBP4 formin	binding	protein	4 5
57186 RALGAPA2 Ral	GTPase	activating	protein	catalytic	alpha	subunit	2 5
410 ARSA arylsulfatase	A 5
27244 SESN1 sestrin	1 5
376940 ZC3H6 zinc	finger	CCCH-type	containing	6 5
22869 ZNF510 zinc	finger	protein	510 5
9988 DMTF1 cyclin	D	binding	myb	like	transcription	factor	1 5
81550 TDRD3 tudor	domain	containing	3 5
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6672 SP100 SP100	nuclear	antigen 5
114803 MYSM1 Myb	like,	SWIRM	and	MPN	domains	1 5
7431 VIM vimentin 5
57577 CCDC191 coiled-coil	domain	containing	191 5
7318 UBA7 ubiquitin	like	modifier	activating	enzyme	7 5
254065 BRWD3 bromodomain	and	WD	repeat	domain	containing	3 5
23200 ATP11B ATPase	phospholipid	transporting	11B	(putative) 5
55297 CCDC91 coiled-coil	domain	containing	91 5
64167 ERAP2 endoplasmic	reticulum	aminopeptidase	2 5
9759 HDAC4 histone	deacetylase	4 5
100507419 MMP25-AS1 MMP25	antisense	RNA	1 5
388585 HES5 hes	family	bHLH	transcription	factor	5 5
51621 KLF13 Kruppel	like	factor	13 5
150864 FAM117B family	with	sequence	similarity	117	member	B 5
51316 PLAC8 placenta	specific	8 5
57179 KIAA1191 KIAA1191 5
163050 ZNF564 zinc	finger	protein	564 5
2073 ERCC5 ERCC	excision	repair	5,	endonuclease 5
81669 CCNL2 cyclin	L2 5
5880 RAC2 ras-related	C3	botulinum	toxin	substrate	2	(rho	family,	small	GTP	binding	protein	Rac2) 5
10207 PATJ PATJ,	crumbs	cell	polarity	complex	component 5
1265 CNN2 calponin	2 5
634 CEACAM1 carcinoembryonic	antigen	related	cell	adhesion	molecule	1 5
10123 ARL4C ADP	ribosylation	factor	like	GTPase	4C 5
121506 ERP27 endoplasmic	reticulum	protein	27 5
6451 SH3BGRL SH3	domain	binding	glutamate	rich	protein	like 5
84166 NLRC5 NLR	family	CARD	domain	containing	5 5
30011 SH3KBP1 SH3	domain	containing	kinase	binding	protein	1 5
23499 MACF1 microtubule-actin	crosslinking	factor	1 5
2186 BPTF bromodomain	PHD	finger	transcription	factor 5
1997 ELF1 E74	like	ETS	transcription	factor	1 5
6654 SOS1 SOS	Ras/Rac	guanine	nucleotide	exchange	factor	1 5
107984315 5
1200 TPP1 tripeptidyl	peptidase	1 5
80212 CCDC92 coiled-coil	domain	containing	92 5
1486 CTBS chitobiase 5
27128 CYTH4 cytohesin	4 5
11261 CHP1 calcineurin	like	EF-hand	protein	1 5
54518 APBB1IP amyloid	beta	precursor	protein	binding	family	B	member	1	interacting	protein 5
1606 DGKA diacylglycerol	kinase	alpha 5
153222 CREBRF CREB3	regulatory	factor 5
80024 SLC8B1 solute	carrier	family	8	member	B1 5
2635 GBP3 guanylate	binding	protein	3 5
64784 CRTC3 CREB	regulated	transcription	coactivator	3 5
79813 EHMT1 euchromatic	histone	lysine	methyltransferase	1 5
8906 AP1G2 adaptor	related	protein	complex	1	gamma	2	subunit 5
155006 TMEM213 transmembrane	protein	213 5
442582 STAG3L2 stromal	antigen	3-like	2	(pseudogene) 5
1182 CLCN3 chloride	voltage-gated	channel	3 5
51735 RAPGEF6 Rap	guanine	nucleotide	exchange	factor	6 5
92106 OXNAD1 oxidoreductase	NAD	binding	domain	containing	1 5
100420110 LOC100420110 SCY1	like	pseudokinase	2	pseudogene 5
6164 RPL34 ribosomal	protein	L34 5
4354 MPP1 membrane	palmitoylated	protein	1 5
1487 CTBP1 C-terminal	binding	protein	1 5
58487 CREBZF CREB/ATF	bZIP	transcription	factor 5
4026 LPP LIM	domain	containing	preferred	translocation	partner	in	lipoma 5
26259 FBXW8 F-box	and	WD	repeat	domain	containing	8 5
51773 RSF1 remodeling	and	spacing	factor	1 5
6641 SNTB1 syntrophin	beta	1 5
79161 TMEM243 transmembrane	protein	243 5
5586 PKN2 protein	kinase	N2 5
64766 S100PBP S100P	binding	protein 5
3460 IFNGR2 interferon	gamma	receptor	2	(interferon	gamma	transducer	1) 5
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7273 TTN titin 5
8835 SOCS2 suppressor	of	cytokine	signaling	2 5
11320 MGAT4A
mannosyl	(alpha-1,3-)-glycoprotein	beta-1,4-N-acetylglucosaminyltransferase,	isozyme	
A 5
54861 SNRK SNF	related	kinase 5
4012 LNPEP leucyl	and	cystinyl	aminopeptidase 5
128611 ZNF831 zinc	finger	protein	831 5
7456 WIPF1 WAS/WASL	interacting	protein	family	member	1 5
9830 TRIM14 tripartite	motif	containing	14 5
50852 TRAT1 T	cell	receptor	associated	transmembrane	adaptor	1 5
22990 PCNX1 pecanex	homolog	1	(Drosophila) 5
11083 DIDO1 death	inducer-obliterator	1 5
1106 CHD2 chromodomain	helicase	DNA	binding	protein	2 5
7644 ZNF91 zinc	finger	protein	91 5
1540 CYLD CYLD	lysine	63	deubiquitinase 5
643641 ZNF862 zinc	finger	protein	862 5
10106 CTDSP2 CTD	small	phosphatase	2 5
154881 KCTD7 potassium	channel	tetramerization	domain	containing	7 5
23164 MPRIP myosin	phosphatase	Rho	interacting	protein 5
4299 AFF1 AF4/FMR2	family	member	1 5
93611 FBXO44 F-box	protein	44 5
7402 UTRN utrophin 5
56204 FAM214A family	with	sequence	similarity	214	member	A 5
6844 VAMP2 vesicle	associated	membrane	protein	2 5
9960 USP3 ubiquitin	specific	peptidase	3 5
4297 KMT2A lysine	methyltransferase	2A 5
56829 ZC3HAV1 zinc	finger	CCCH-type	containing,	antiviral	1 5
139818 DOCK11 dedicator	of	cytokinesis	11 5
25777 SUN2 Sad1	and	UNC84	domain	containing	2 5
9744 ACAP1 ArfGAP	with	coiled-coil,	ankyrin	repeat	and	PH	domains	1 5
23054 NCOA6 nuclear	receptor	coactivator	6 5
84162 KIAA1109 KIAA1109 5
23341 DNAJC16 DnaJ	heat	shock	protein	family	(Hsp40)	member	C16 5
23324 MAN2B2 mannosidase	alpha	class	2B	member	2 5
6711 SPTBN1 spectrin	beta,	non-erythrocytic	1 5
165631 PARP15 poly(ADP-ribose)	polymerase	family	member	15 5
5786 PTPRA protein	tyrosine	phosphatase,	receptor	type	A 5
9535 GMFG glia	maturation	factor	gamma 5
256643 CXorf23 chromosome	X	open	reading	frame	23 5
55268 ECHDC2 enoyl-CoA	hydratase	domain	containing	2 5
22838 RNF44 ring	finger	protein	44 5
55870 ASH1L ASH1	like	histone	lysine	methyltransferase 5
64780 MICAL1 microtubule	associated	monooxygenase,	calponin	and	LIM	domain	containing	1 5
84460 ZMAT1 zinc	finger	matrin-type	1 5
200576 PIKFYVE phosphoinositide	kinase,	FYVE-type	zinc	finger	containing 5
58508 KMT2C lysine	methyltransferase	2C 5
8897 MTMR3 myotubularin	related	protein	3 5
2033 EP300 E1A	binding	protein	p300 5
80351 TNKS2 tankyrase	2 5
9648 GCC2 GRIP	and	coiled-coil	domain	containing	2 5
163131 ZNF780B zinc	finger	protein	780B 5
23335 WDR7 WD	repeat	domain	7 5
55599 RNPC3 RNA	binding	region	(RNP1,	RRM)	containing	3 5
3716 JAK1 Janus	kinase	1 5
493753 COA5 cytochrome	c	oxidase	assembly	factor	5 5
55824 PAG1 phosphoprotein	membrane	anchor	with	glycosphingolipid	microdomains	1 5
114801 TMEM200A transmembrane	protein	200A 5
64750 SMURF2 SMAD	specific	E3	ubiquitin	protein	ligase	2 5
57337 SENP7 SUMO1/sentrin	specific	peptidase	7 5
831 CAST calpastatin 5
257106 ARHGAP30 Rho	GTPase	activating	protein	30 5
84945 ABHD13 abhydrolase	domain	containing	13 5
129285 PPP1R21 protein	phosphatase	1	regulatory	subunit	21 5
100507217 LINC01578 long	intergenic	non-protein	coding	RNA	1578 5
285025 CCDC141 coiled-coil	domain	containing	141 5
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387680 FAM21A family	with	sequence	similarity	21	member	A 5
85464 SSH2 slingshot	protein	phosphatase	2 5
59338 PLEKHA1 pleckstrin	homology	domain	containing	A1 5
963 CD53 CD53	molecule 5
57620 STIM2 stromal	interaction	molecule	2 5
10133 OPTN optineurin 5
538 ATP7A ATPase	copper	transporting	alpha 5
23616 SH3BP1 SH3	domain	binding	protein	1 5
23304 UBR2 ubiquitin	protein	ligase	E3	component	n-recognin	2 5
10955 SERINC3 serine	incorporator	3 5
22834 ZNF652 zinc	finger	protein	652 5
3635 INPP5D inositol	polyphosphate-5-phosphatase	D 5
7767 ZNF224 zinc	finger	protein	224 5
92283 ZNF461 zinc	finger	protein	461 5
192670 AGO4 argonaute	4,	RISC	catalytic	component 5
8631 SKAP1 src	kinase	associated	phosphoprotein	1 5
94134 ARHGAP12 Rho	GTPase	activating	protein	12 5
10520 ZNF211 zinc	finger	protein	211 5
64112 MOAP1 modulator	of	apoptosis	1 5
51599 LSR lipolysis	stimulated	lipoprotein	receptor 5
55743 CHFR checkpoint	with	forkhead	and	ring	finger	domains 5
6302 TSPAN31 tetraspanin	31 5
64333 ARHGAP9 Rho	GTPase	activating	protein	9 5
256380 SCML4 sex	comb	on	midleg-like	4	(Drosophila) 5
83604 TMEM47 transmembrane	protein	47 5
10157 AASS aminoadipate-semialdehyde	synthase 5
64926 RASAL3 RAS	protein	activator	like	3 5
9473 THEMIS2 thymocyte	selection	associated	family	member	2 5
10983 CCNI cyclin	I 5
583 BBS2 Bardet-Biedl	syndrome	2 5
25981 DNAH1 dynein	axonemal	heavy	chain	1 5
285346 ZNF852 zinc	finger	protein	852 5
51088 KLHL5 kelch	like	family	member	5 5
57707 TLDC1 TBC/LysM-associated	domain	containing	1 5
1523 CUX1 cut	like	homeobox	1 5
8509 NDST2 N-deacetylase	and	N-sulfotransferase	2 5
57446 NDRG3 NDRG	family	member	3 5
285464 CRIPAK cysteine	rich	PAK1	inhibitor 5
7554 ZNF8 zinc	finger	protein	8 5
765 CA6 carbonic	anhydrase	6 5
79567 FAM65A family	with	sequence	similarity	65	member	A 5
23038 WDTC1 WD	and	tetratricopeptide	repeats	1 5
9683 N4BP1 NEDD4	binding	protein	1 5
5293 PIK3CD phosphatidylinositol-4,5-bisphosphate	3-kinase	catalytic	subunit	delta 5
374403 TBC1D10C TBC1	domain	family	member	10C 5
51339 DACT1 dishevelled	binding	antagonist	of	beta	catenin	1 5
80305 TRABD TraB	domain	containing 5
6932 TCF7 transcription	factor	7	(T-cell	specific,	HMG-box) 5
3983 ABLIM1 actin	binding	LIM	protein	1 5
10013 HDAC6 histone	deacetylase	6 5
102723458 LOC102723458 uncharacterized	LOC102723458 5
9961 MVP major	vault	protein 5
23765 IL17RA interleukin	17	receptor	A 5
93129 ORAI3 ORAI	calcium	release-activated	calcium	modulator	3 5
100505549 LOC100505549 uncharacterized	LOC100505549 5
5927 KDM5A lysine	demethylase	5A 5
7569 ZNF182 zinc	finger	protein	182 5
51147 ING4 inhibitor	of	growth	family	member	4 5
26119 LDLRAP1 low	density	lipoprotein	receptor	adaptor	protein	1 5
6016 RIT1 Ras	like	without	CAAX	1 5
9550 ATP6V1G1 ATPase	H+	transporting	V1	subunit	G1 5
2592 GALT galactose-1-phosphate	uridylyltransferase 5
148932 MOB3C MOB	kinase	activator	3C 5
10943 MSL3 male-specific	lethal	3	homolog	(Drosophila) 5
4752 NEK3 NIMA	related	kinase	3 5
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338657 CCDC84 coiled-coil	domain	containing	84 5
84899 TMTC4 transmembrane	and	tetratricopeptide	repeat	containing	4 5
23355 VPS8 VPS8,	CORVET	complex	subunit 5
23175 LPIN1 lipin	1 5
27334 P2RY10 purinergic	receptor	P2Y10 5
11067 C10orf10 chromosome	10	open	reading	frame	10 5
26959 HBP1 HMG-box	transcription	factor	1 5
168537 GIMAP7 GTPase,	IMAP	family	member	7 5
10550 ARL6IP5 ADP	ribosylation	factor	like	GTPase	6	interacting	protein	5 5
2005 ELK4 ELK4,	ETS	transcription	factor 5
253260 RICTOR RPTOR	independent	companion	of	MTOR	complex	2 5
2533 FYB FYN	binding	protein 5
1806 DPYD dihydropyrimidine	dehydrogenase 5
55249 YY1AP1 YY1	associated	protein	1 5
55197 RPRD1A regulation	of	nuclear	pre-mRNA	domain	containing	1A 5
7586 ZKSCAN1 zinc	finger	with	KRAB	and	SCAN	domains	1 5
23086 EXPH5 exophilin	5 5
10006 ABI1 abl	interactor	1 5
10241 CALCOCO2 calcium	binding	and	coiled-coil	domain	2 5
5926 ARID4A AT-rich	interaction	domain	4A 5
5583 PRKCH protein	kinase	C	eta 5
7769 ZNF226 zinc	finger	protein	226 5
84223 IQCG IQ	motif	containing	G 5
284323 ZNF780A zinc	finger	protein	780A 5
23476 BRD4 bromodomain	containing	4 5
9611 NCOR1 nuclear	receptor	corepressor	1 5
51306 FAM13B family	with	sequence	similarity	13	member	B 5
9802 DAZAP2 DAZ	associated	protein	2 5
5782 PTPN12 protein	tyrosine	phosphatase,	non-receptor	type	12 5
55876 GSDMB gasdermin	B 5
2804 GOLGB1 golgin	B1 5
57658 CALCOCO1 calcium	binding	and	coiled-coil	domain	1 5
23558 WBP2 WW	domain	binding	protein	2 5
147339 C18orf25 chromosome	18	open	reading	frame	25 5
79652 TMEM204 transmembrane	protein	204 5
29108 PYCARD PYD	and	CARD	domain	containing 5
23345 SYNE1 spectrin	repeat	containing	nuclear	envelope	protein	1 5
79026 AHNAK AHNAK	nucleoprotein 5
57153 SLC44A2 solute	carrier	family	44	member	2 5
10505 SEMA4F ssemaphorin	4F 5
6653 SORL1 sortilin	related	receptor	1 5
333929 SNAI3 snail	family	transcriptional	repressor	3 5
1316 KLF6 Kruppel	like	factor	6 5
166 AES amino-terminal	enhancer	of	split 5
1043 CD52 CD52	molecule 5
55728 N4BP2 NEDD4	binding	protein	2 5
10791 VAMP5 vesicle	associated	membrane	protein	5 5
5257 PHKB phosphorylase	kinase	regulatory	subunit	beta 5
23646 PLD3 phospholipase	D	family	member	3 5
492311 IGIP IgA	inducing	protein 5
9885 OSBPL2 oxysterol	binding	protein	like	2 5
10938 EHD1 EH	domain	containing	1 5
1774 DNASE1L1 deoxyribonuclease	1	like	1 5
2647 BLOC1S1 biogenesis	of	lysosomal	organelles	complex	1	subunit	1 5
10870 HCST hematopoietic	cell	signal	transducer 5
203523 ZNF449 zinc	finger	protein	449 5
9924 PAN2 PAN2	poly(A)	specific	ribonuclease	subunit 5
133619 PRRC1 proline	rich	coiled-coil	1 5
51276 ZNF571 zinc	finger	protein	571 5
144699 FBXL14 F-box	and	leucine	rich	repeat	protein	14 5
389072 PLEKHM3 pleckstrin	homology	domain	containing	M3 5
23518 R3HDM1 R3H	domain	containing	1 5
23526 ARHGAP45 Rho	GTPase	activating	protein	45 5
7011 TEP1 telomerase	associated	protein	1 5
54540 FAM193B family	with	sequence	similarity	193	member	B 5
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284996 RNF149 ring	finger	protein	149 5
11104 KATNA1 katanin	catalytic	subunit	A1 5
28971 AAMDC adipogenesis	associated	Mth938	domain	containing 5
26053 AUTS2 autism	susceptibility	candidate	2 5
399687 MYO18A myosin	XVIIIA 5
57659 ZBTB4 zinc	finger	and	BTB	domain	containing	4 5
400986 ANKRD36C ankyrin	repeat	domain	36C 5
79741 CCDC7 coiled-coil	domain	containing	7 5
1629 DBT dihydrolipoamide	branched	chain	transacylase	E2 5
93624 TADA2B transcriptional	adaptor	2B 5
162427 FAM134C family	with	sequence	similarity	134	member	C 5
107984583 5
64788 LMF1 lipase	maturation	factor	1 5
7994 KAT6A lysine	acetyltransferase	6A 5
394 ARHGAP5 Rho	GTPase	activating	protein	5 5
389 RHOC ras	homolog	family	member	C 5
200186 CRTC2 CREB	regulated	transcription	coactivator	2 5
10066 SCAMP2 secretory	carrier	membrane	protein	2 5
9889 ZBED4 zinc	finger	BED-type	containing	4 5
403313 PLPP6 phospholipid	phosphatase	6 5
196528 ARID2 AT-rich	interaction	domain	2 5
51780 KDM3B lysine	demethylase	3B 5
5780 PTPN9 protein	tyrosine	phosphatase,	non-receptor	type	9 5
84498 FAM120B family	with	sequence	similarity	120B 5
23506 GLTSCR1L GLTSCR1	like 5
26207 PITPNC1 phosphatidylinositol	transfer	protein,	cytoplasmic	1 5
158358 KIAA2026 KIAA2026 5
387748 OR56B1 olfactory	receptor	family	56	subfamily	B	member	1 5
11201 POLI DNA	polymerase	iota 5
10211 FLOT1 flotillin	1 5
200765 TIGD1 tigger	transposable	element	derived	1 5
118 ADD1 adducin	1 5
284371 ZNF841 zinc	finger	protein	841 5
5142 PDE4B phosphodiesterase	4B 5
55619 DOCK10 dedicator	of	cytokinesis	10 5
23527 ACAP2 ArfGAP	with	coiled-coil,	ankyrin	repeat	and	PH	domains	2 5
23424 TDRD7 tudor	domain	containing	7 5
373 TRIM23 tripartite	motif	containing	23 5
338440 ANO9 anoctamin	9 5
10000 AKT3 AKT	serine/threonine	kinase	3 5
8569 MKNK1 MAP	kinase	interacting	serine/threonine	kinase	1 5
84159 ARID5B AT-rich	interaction	domain	5B 5
26046 LTN1 listerin	E3	ubiquitin	protein	ligase	1 5
23041 MON2 MON2	homolog,	regulator	of	endosome-to-Golgi	trafficking 5
60412 EXOC4 exocyst	complex	component	4 5
4287 ATXN3 ataxin	3 5
4343 MOV10 Mov10	RISC	complex	RNA	helicase 5
79800 CARF calcium	responsive	transcription	factor 5
2776 GNAQ G	protein	subunit	alpha	q 5
55167 MSL2 male-specific	lethal	2	homolog	(Drosophila) 5
83744 ZNF484 zinc	finger	protein	484 5
64145 RBSN rabenosyn,	RAB	effector 5
55500 ETNK1 ethanolamine	kinase	1 5
317 APAF1 apoptotic	peptidase	activating	factor	1 5
51380 CSAD cysteine	sulfinic	acid	decarboxylase 5
55902 ACSS2 acyl-CoA	synthetase	short-chain	family	member	2 5
8567 MADD MAP	kinase	activating	death	domain 5
7776 ZNF236 zinc	finger	protein	236 5
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